Search for

List of Strains Covered

Suggested search words: constipation diarrhea cough cancer ibs crohn mood stress allergy flu IL-10 obesity

ProbioticSellerStudy (Click to View)
Lactobacillus paracasei (case)i 431 For daily immunity A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation.
Lactobacillus paracasei (case)i 431 For daily immunity Acute and short-term effects of Lactobacillus paracasei subsp. paracasei 431 and inulin intake on appetite control and dietary intake: A two-phases randomized, double blind, placebo-controlled study.
Lactobacillus paracasei (case)i 431 For daily immunity Antibiotic treatment to prevent postextraction complications: a monocentric, randomized clinical trial. Preliminary outcomes.
Lactobacillus paracasei (case)i 431 For daily immunity Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities.
Lactobacillus paracasei (case)i 431 For daily immunity Bacterial extracellular polymeric substances as potential saliva substitute.
Lactobacillus paracasei (case)i 431 For daily immunity Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children.
Lactobacillus paracasei (case)i 431 For daily immunity Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43.
Lactobacillus paracasei (case)i 431 For daily immunity Chemical Constituents, Antioxidant, and a-Glucosidase Inhibitory Activities of Different Fermented Gynostemma Pentaphyllum Leaves and Untargeted Metabolomic Measurement of the Metabolite Variation.
Lactobacillus paracasei (case)i 431 For daily immunity Co-Microencapsulated Black Rice Anthocyanins and Lactic Acid Bacteria: Evidence on Powders Profile and In Vitro Digestion.
Lactobacillus paracasei (case)i 431 For daily immunity Comments on "The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study" by de Roos et al.
Lactobacillus paracasei (case)i 431 For daily immunity Cryoprotective effect of turanose on lyophilized Lactobacillus paracasei subsp. paracasei, L. casei 431.
Lactobacillus paracasei (case)i 431 For daily immunity Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of Feed Additives on Productivity and Campylobacter spp. Loads in Broilers Reared under Free Range Conditions.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of Multi-Strain Probiotic Supplementation on URTI Symptoms and Cytokine Production by Monocytes after a Marathon Race: A Randomized, Double-Blind, Placebo Study.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of probiotic yoghurt on plasma glucose in overweight and obese pregnant women: a randomized controlled clinical trial.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of probiotic yogurt consumption on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A randomized controlled trial.
Lactobacillus paracasei (case)i 431 For daily immunity Effect of Various Bulk Sweeteners on the Survivability of Lactobacillus casei 431 in Milk Chocolate: Rheological and Sensory Properties Analysis.
Lactobacillus paracasei (case)i 431 For daily immunity Effects of cell-free supernatant of Lactobacillus acidophilus LA5 and Lactobacillus casei 431 against planktonic form and biofilm of Staphylococcus aureus.
Lactobacillus paracasei (case)i 431 For daily immunity Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
Lactobacillus paracasei (case)i 431 For daily immunity Effects of Probiotics on Biomarkers of Oxidative Stress and Inflammatory Factors in Petrochemical Workers: A Randomized, Double-blind, Placebo-controlled Trial.
Lactobacillus paracasei (case)i 431 For daily immunity Electrospun probiotics: an alternative for encapsulation.
Lactobacillus paracasei (case)i 431 For daily immunity Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage.
Lactobacillus paracasei (case)i 431 For daily immunity Evaluation of the effects of a probiotic supplementation with respect to placebo on intestinal microflora and secretory IgA production, during antibiotic therapy, in children affected by recurrent airway infections and skin symptoms.
Lactobacillus paracasei (case)i 431 For daily immunity Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Lactobacillus paracasei (case)i 431 For daily immunity Evaluation of the Probiotic Properties of Lacticaseibacillus casei 431(®) Isolated from Food for Special Medical Purposes(§).
Lactobacillus paracasei (case)i 431 For daily immunity Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?
Lactobacillus paracasei (case)i 431 For daily immunity Gut Balance, a synbiotic supplement, increases fecal Lactobacillus paracasei but has little effect on immunity in healthy physically active individuals.
Lactobacillus paracasei (case)i 431 For daily immunity Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
Lactobacillus paracasei (case)i 431 For daily immunity High-intensity ultrasound as pre-treatment in the development of fermented whey and oat beverages: effect on the fermentation, antioxidant activity and consumer acceptance.
Lactobacillus paracasei (case)i 431 For daily immunity Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults.
Lactobacillus paracasei (case)i 431 For daily immunity Immunostimulatory effects of dairy probiotic strains Bifidobacterium animalis ssp. lactis HY8002 and Lactobacillus plantarum HY7717.
Lactobacillus paracasei (case)i 431 For daily immunity Improvement of gastrointestinal discomfort and inflammatory status by a synbiotic in middle-aged adults: a double-blind randomized placebo-controlled trial.
Lactobacillus paracasei (case)i 431 For daily immunity Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet.
Lactobacillus paracasei (case)i 431 For daily immunity Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay.
Lactobacillus paracasei (case)i 431 For daily immunity Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles.
Lactobacillus paracasei (case)i 431 For daily immunity Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials.
Lactobacillus paracasei (case)i 431 For daily immunity Maternal fish oil and/or probiotics intervention: Allergic diseases in children up to two years old.
Lactobacillus paracasei (case)i 431 For daily immunity Metabolic fingerprinting of Lactobacillus paracasei: a multi-criteria evaluation of methods for extraction of intracellular metabolites.
Lactobacillus paracasei (case)i 431 For daily immunity Metagenomics of microbiota following probiotic supplementation in rats subjected to intestinal anastomosis.
Lactobacillus paracasei (case)i 431 For daily immunity Microbiological, biochemical, and functional aspects of sugary kefir fermentation - A review.
Lactobacillus paracasei (case)i 431 For daily immunity Microbiota modulation counteracts Alzheimer`s disease progression influencing neuronal proteolysis and gut hormones plasma levels.
Lactobacillus paracasei (case)i 431 For daily immunity Multi-strain Probiotic Formulation Reverses Maternal Separation and Chronic Unpredictable Mild Stress-Generated Anxiety- and Depression-like Phenotypes by Modulating Gut Microbiome-Brain Activity in Rats.
Lactobacillus paracasei (case)i 431 For daily immunity Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis.
Lactobacillus paracasei (case)i 431 For daily immunity Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.
Lactobacillus paracasei (case)i 431 For daily immunity Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity.
Lactobacillus paracasei (case)i 431 For daily immunity Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era.
Lactobacillus paracasei (case)i 431 For daily immunity Physical, microbiological and rheological properties of probiotic yogurt supplemented with grape extract.
Lactobacillus paracasei (case)i 431 For daily immunity Prenatal exposure to the probiotic Lactococcus lactis decreases anxiety-like behavior and modulates cortical cytoarchitecture in a sex specific manner.
Lactobacillus paracasei (case)i 431 For daily immunity Probiotic Fermented Goat`s and Sheep`s Milk: Effect of Type and Dose of Collagen on Survival of Four Strains of Probiotic Bacteria during Simulated In Vitro Digestion Conditions.
Lactobacillus paracasei (case)i 431 For daily immunity Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial.
Lactobacillus paracasei (case)i 431 For daily immunity Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials.
Lactobacillus paracasei (case)i 431 For daily immunity Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice.
Lactobacillus paracasei (case)i 431 For daily immunity Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate.
Lactobacillus paracasei (case)i 431 For daily immunity Protective Effect of the Intracellular Content from Potential Probiotic Bacteria against Oxidative Damage Induced by Acrylamide in Human Erythrocytes.
Lactobacillus paracasei (case)i 431 For daily immunity Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12(®)Lactobacillus rhamnosus LGG(®) in colorectal cancer patients.
Lactobacillus paracasei (case)i 431 For daily immunity Regulation divergences of Lactobacillus fermentum PCC and Lactobacillus paracasei 431 on penicillin-induced upper respiratory tract microbial dysbiosis in BALB/c mice.
Lactobacillus paracasei (case)i 431 For daily immunity Resistance to acidic environments of caries-associated bacteria: Bifidobacterium dentium and Bifidobacterium longum.
Lactobacillus paracasei (case)i 431 For daily immunity Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt.
Lactobacillus paracasei (case)i 431 For daily immunity Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota.
Lactobacillus paracasei (case)i 431 For daily immunity Selection of Amine-Oxidizing Dairy Lactic Acid Bacteria and Identification of the Enzyme and Gene Involved in the Decrease of Biogenic Amines.
Lactobacillus paracasei (case)i 431 For daily immunity Sheep Milk Symbiotic Ice Cream: Effect of Inulin and Apple Fiber on the Survival of Five Probiotic Bacterial Strains during Simulated In Vitro Digestion Conditions.
Lactobacillus paracasei (case)i 431 For daily immunity Supplementation with fruit and okara soybean by-products and amaranth flour increases the folate production by starter and probiotic cultures.
Lactobacillus paracasei (case)i 431 For daily immunity Sustainable Design of Innovative Kiwi Byproducts-Based Ingredients Containing Probiotics.
Lactobacillus paracasei (case)i 431 For daily immunity Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity.
Lactobacillus paracasei (case)i 431 For daily immunity Table Olive Fermentation Using Starter Cultures with Multifunctional Potential.
Lactobacillus paracasei (case)i 431 For daily immunity The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo.
Lactobacillus paracasei (case)i 431 For daily immunity The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study.
Lactobacillus paracasei (case)i 431 For daily immunity The Efficacy of Combined Arginine and Probiotics as an Add-On to 1,450 ppm Fluoride Toothpaste to Prevent and Control Dental Caries in Children - A Randomized Controlled Trial.
Lactobacillus paracasei (case)i 431 For daily immunity The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial).
Lactobacillus paracasei (case)i 431 For daily immunity The performance of probiotic fermented sheep milk and ice cream sheep milk in inhibiting enamel mineral loss.
Lactobacillus paracasei (case)i 431 For daily immunity The Production of Synbiotic Bread by Microencapsulation.
Lactobacillus paracasei (case)i 431 For daily immunity The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review.
Lactobacillus paracasei (case)i 431 For daily immunity Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
Lactobacillus paracasei (case)i 431 For daily immunity Xanthan gum modified fish gelatin and binary culture modulates the metabolism of probiotics in fermented milk mainly via amino acid metabolism pathways.
Akkermansia muciniphila WB-STR-0001 Pendukum Glucose Control Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.
Aspergillus oryzae NK strong wakamoto w Antioxidant activity of a medicine based on Aspergillus oryzae NK koji measured by a modified t-butyl peroxyl radical scavenging assay.
Aspergillus oryzae NK strong wakamoto w Effects of fermented Sorghum bicolor L. Moench extract on inflammation and thickness in a vascular cell and atherosclerotic mice model.
Aspergillus oryzae NK strong wakamoto w Ergot alkaloid glycosides with immunomodulatory activities.
Aspergillus oryzae NK strong wakamoto w Koji amazake Maintains Water Content in the Left Cheek Skin of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Comparative Trial.
Aspergillus oryzae NK strong wakamoto w Natural killer cell activity, lymphocyte proliferation, and cytokine profile in tumor-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus oryzae.
Aspergillus oryzae NK strong wakamoto w Sorghum Fermented by <b><i>Aspergillus oryzae</i></b> NK Enhances Inhibition of Vascular Inflammation in TNF-a-stimulated Human Aortic Smooth Muscle Cells.
Aspergillus oryzae NK strong wakamoto w Study of the mechanisms of a Japanese traditional fermented medicine in the improvement of constipation.
Aspergillus oryzae NK strong wakamoto w The antiwrinkle and antimelanogenic effects of the nonedible part of <i>Sorghum bicolor</i> (L.) Moench and their augmentation by fermentation.
Bacillus clausii MCC 0538 Biome Ultra A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue.
Bacillus clausii MCC 0538 Biome Ultra Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial.
Bacillus clausii N/R Enterogermina <i>Bacillus clausii</i> as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE).
Bacillus clausii N/R Enterogermina Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study.
Bacillus clausii N/R Enterogermina Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA.
Bacillus clausii N/R Enterogermina Characterization of two Bacillus probiotics.
Bacillus clausii N/R Enterogermina Comparative proteomic analysis of four Bacillus clausii strains: proteomic expression signature distinguishes protein profile of the strains.
Bacillus clausii N/R Enterogermina Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains.
Bacillus clausii N/R Enterogermina Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina<sup>®</sup>, and insights into its probiotic properties.
Bacillus clausii N/R Enterogermina Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study.
Bacillus clausii N/R Enterogermina Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.
Bacillus clausii N/R Enterogermina Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.
Bacillus clausii N/R Enterogermina Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.
Bacillus clausii N/R Enterogermina Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Bacillus clausii N/R Enterogermina Evaluating the Effect of Supplementation with Bacillus clausii on Therapeutic Outcomes in Atopic Eczema-Results of an Observer-Blinded Parallel-Group Randomized Controlled Study.
Bacillus clausii N/R Enterogermina Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.
Bacillus clausii N/R Enterogermina Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Bacillus clausii N/R Enterogermina Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Bacillus clausii N/R Enterogermina Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Bacillus clausii N/R Enterogermina Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Bacillus clausii N/R Enterogermina Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic <i>Bacillus clausii</i> (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts.
Bacillus clausii N/R Enterogermina Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis.
Bacillus clausii N/R Enterogermina Synthesis of silver nanoparticles by <i>Bacillus clausii</i> and computational profiling of nitrate reductase enzyme involved in production.
Bacillus clausii N/R Enterogermina The use of Bacillus subtilis as an antidiarrhoeal microorganism.
Bacillus clausii N/R Enterogermina Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Bacillus clausii N/R Enterogermina Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Bacillus clausii O/C Enterogermina <i>Bacillus clausii</i> as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE).
Bacillus clausii O/C Enterogermina Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study.
Bacillus clausii O/C Enterogermina Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA.
Bacillus clausii O/C Enterogermina Characterization of lipoteichoic acid structures from three probiotic Bacillus strains: involvement of D-alanine in their biological activity.
Bacillus clausii O/C Enterogermina Characterization of two Bacillus probiotics.
Bacillus clausii O/C Enterogermina Comparative proteomic analysis of four Bacillus clausii strains: proteomic expression signature distinguishes protein profile of the strains.
Bacillus clausii O/C Enterogermina Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains.
Bacillus clausii O/C Enterogermina Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina<sup>®</sup>, and insights into its probiotic properties.
Bacillus clausii O/C Enterogermina Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study.
Bacillus clausii O/C Enterogermina Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.
Bacillus clausii O/C Enterogermina Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.
Bacillus clausii O/C Enterogermina Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.
Bacillus clausii O/C Enterogermina Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Bacillus clausii O/C Enterogermina Evaluating the Effect of Supplementation with Bacillus clausii on Therapeutic Outcomes in Atopic Eczema-Results of an Observer-Blinded Parallel-Group Randomized Controlled Study.
Bacillus clausii O/C Enterogermina Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.
Bacillus clausii O/C Enterogermina Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Bacillus clausii O/C Enterogermina Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Bacillus clausii O/C Enterogermina Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Bacillus clausii O/C Enterogermina Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Bacillus clausii O/C Enterogermina Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic <i>Bacillus clausii</i> (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts.
Bacillus clausii O/C Enterogermina Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis.
Bacillus clausii O/C Enterogermina Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Bacillus clausii O/C Enterogermina Synthesis of silver nanoparticles by <i>Bacillus clausii</i> and computational profiling of nitrate reductase enzyme involved in production.
Bacillus clausii O/C Enterogermina The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways.
Bacillus clausii O/C Enterogermina The use of Bacillus subtilis as an antidiarrhoeal microorganism.
Bacillus clausii O/C Enterogermina Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Bacillus clausii O/C Enterogermina Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Bacillus clausii SC-109 MegaSporebiotic Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.
Bacillus clausii SIN Enterogermina <i>Bacillus clausii</i> as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE).
Bacillus clausii SIN Enterogermina A chromosomal chloramphenicol acetyltransferase determinant from a probiotic strain of Bacillus clausii.
Bacillus clausii SIN Enterogermina Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study.
Bacillus clausii SIN Enterogermina Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA.
Bacillus clausii SIN Enterogermina Characterization of two Bacillus probiotics.
Bacillus clausii SIN Enterogermina Chromosomal aadD2 encodes an aminoglycoside nucleotidyltransferase in Bacillus clausii.
Bacillus clausii SIN Enterogermina Comparative proteomic analysis of four Bacillus clausii strains: proteomic expression signature distinguishes protein profile of the strains.
Bacillus clausii SIN Enterogermina Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains.
Bacillus clausii SIN Enterogermina Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina<sup>®</sup>, and insights into its probiotic properties.
Bacillus clausii SIN Enterogermina Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study.
Bacillus clausii SIN Enterogermina Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.
Bacillus clausii SIN Enterogermina Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.
Bacillus clausii SIN Enterogermina Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.
Bacillus clausii SIN Enterogermina Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Bacillus clausii SIN Enterogermina Evaluating the Effect of Supplementation with Bacillus clausii on Therapeutic Outcomes in Atopic Eczema-Results of an Observer-Blinded Parallel-Group Randomized Controlled Study.
Bacillus clausii SIN Enterogermina In vitro assessment of probiotic attributes for strains contained in commercial formulations.
Bacillus clausii SIN Enterogermina Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.
Bacillus clausii SIN Enterogermina Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Bacillus clausii SIN Enterogermina Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Bacillus clausii SIN Enterogermina Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection.
Bacillus clausii SIN Enterogermina Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Bacillus clausii SIN Enterogermina Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic <i>Bacillus clausii</i> (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts.
Bacillus clausii SIN Enterogermina Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis.
Bacillus clausii SIN Enterogermina Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation.
Bacillus clausii SIN Enterogermina Synthesis of silver nanoparticles by <i>Bacillus clausii</i> and computational profiling of nitrate reductase enzyme involved in production.
Bacillus clausii SIN Enterogermina The use of Bacillus subtilis as an antidiarrhoeal microorganism.
Bacillus clausii SIN Enterogermina Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Bacillus clausii SIN Enterogermina Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Bacillus clausii T Enterogermina Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.
Bacillus clausii T Enterogermina Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study.
Bacillus clausii T Enterogermina Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Bacillus clausii T Enterogermina Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.
Bacillus clausii T Enterogermina Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA.
Bacillus clausii T Enterogermina Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial.
Bacillus clausii T Enterogermina Celiac Disease: An Academy of Nutrition and Dietetics Evidence-Based Practice Guideline.
Bacillus clausii T Enterogermina Characterization of two Bacillus probiotics.
Bacillus clausii T Enterogermina Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina<sup>®</sup>, and insights into its probiotic properties.
Bacillus clausii T Enterogermina Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study.
Bacillus clausii T Enterogermina Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.
Bacillus clausii T Enterogermina Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.
Bacillus clausii T Enterogermina Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer`s Disease in App(NL-G-F) Mice.
Bacillus clausii T Enterogermina Efficacy of Bacillus subtilis to replace in-feed antibiotics of broiler chickens under necrotic enteritis-challenged experiments: a systematic review and meta-analysis.
Bacillus clausii T Enterogermina Intelligent Biological Networks: Improving Anti-Microbial Resistance Resilience through Nutritional Interventions to Understand Protozoal Gut Infections.
Bacillus clausii T Enterogermina Isolated Fraction of Gastric-Digested Camel Milk Yogurt with Carao (Cassia grandis) Pulp Fortification Enhances the Anti-Inflammatory Properties of HT-29 Human Intestinal Epithelial Cells.
Bacillus clausii T Enterogermina Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.
Bacillus clausii T Enterogermina Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan.
Bacillus clausii T Enterogermina Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy.
Bacillus clausii T Enterogermina Probiotic supplementation modifies the gut microbiota profile of very low birth weight preterm infants during hospitalization.
Bacillus clausii T Enterogermina Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis.
Bacillus clausii T Enterogermina Sub-1.4 cm(3) capsule for detecting labile inflammatory biomarkers in situ.
Bacillus clausii T Enterogermina Synthesis of silver nanoparticles by <i>Bacillus clausii</i> and computational profiling of nitrate reductase enzyme involved in production.
Bacillus clausii T Enterogermina The use of Bacillus subtilis as an antidiarrhoeal microorganism.
Bacillus clausii T Enterogermina Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, <i>Bacillus coagulans</i> MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Behavior of different Bacillus strains with claimed probiotic properties throughout processed cheese ("requeijão cremoso") manufacturing and storage.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Comparative evaluation for thermostability and gastrointestinal survival of probiotic Bacillus coagulans MTCC 5856.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Evaluation of probiotic Bacillus coagulans MTCC 5856 viability after tea and coffee brewing and its growth in GIT hostile environment.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Galactomannan from <i>Trigonella foenum</i>-<i>graecum</i> L. seed: Prebiotic application and its fermentation by the probiotic <i>Bacillus coagulans</i> strain MTCC 5856.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Quantifying the impact of eight unit operations on the survival of eight Bacillus strains with claimed probiotic properties.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, Rapid assessment of viable but non-culturable Bacillus coagulans MTCC 5856 in commercial formulations using Flow cytometry.
Bacillus coagulans ATCC 5856 Nature's Sunshine Bacillus Coagulans, The resistance of Bacillus, Bifidobacterium, and Lactobacillus strains with claimed probiotic properties in different food matrices exposed to simulated gastrointestinal tract conditions.
Bacillus coagulans DSM 17654 Biome Ultra A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue.
Bacillus coagulans DSM 17654 Biome Ultra Genome based safety assessment for Bacillus coagulans strain LBSC (DSM 17654) for probiotic application.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic <i>Bacillus coagulans</i> GBI-30, 6086 improves amino acid absorption from milk protein.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic A patented strain of Bacillus coagulans increased immune response to viral challenge.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic A prospective, randomized, open-label, placebo-controlled comparative study of <i>Bacillus coagulans</i> GBI-30,6086 with digestive enzymes in improving indigestion in geriatric population.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans GBI-30, 6068 decreases upper respiratory and gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1).
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Behavior of different Bacillus strains with claimed probiotic properties throughout processed cheese ("requeijão cremoso") manufacturing and storage.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Bread as probiotic carriers: Resistance of Bacillus coagulans GBI-30 6086 spores through processing steps.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Combined effect of <i>Bacillus coagulans</i> GBI-30, 6086 and HMB supplementation on muscle integrity and cytokine response during intense military training.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Development of a semi-dynamic in vitro model and its testing using probiotic Bacillus coagulans GBI-30, 6086 in orange juice and yogurt.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Different effects of Bacillus coagulans vegetative cells and spore isolates on constipation-induced gut microbiota dysbiosis in mice.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Draft Genome Sequence of Bacillus coagulans GBI-30, 6086, a Widely Used Spore-Forming Probiotic Strain.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Effects of Bacillus coagulans GBI-30, 6086 as an adjunct starter culture on the production of yogurt.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Effects of functional pasta ingredients on different gut microbiota as revealed by TIM-2 <i>in vitro</i> model of the proximal colon.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Evaluation of acrylamide-removing properties of bacterial consortia under simulated gastrointestinal conditions.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Evaluation of graded levels of Bacillus coagulans GBI-30, 6086 on apparent nutrient digestibility, stool quality, and intestinal health indicators in healthy adult dogs.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic GanedenBC30 cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic In Silico Prediction and In Vitro Assessment of Multifunctional Properties of Postbiotics Obtained From Two Probiotic Bacteria.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Inactivated probiotic <i>Bacillus coagulans</i> GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Orange Juice and Yogurt Carrying Probiotic <i>Bacillus coagulans</i> GBI-30 6086: Impact of Intake on Wistar Male Rats Health Parameters and Gut Bacterial Diversity.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Probiotics for the treatment of Clostridium difficile associated disease.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Quantifying the impact of eight unit operations on the survival of eight Bacillus strains with claimed probiotic properties.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic The Step of Incorporation of <i>Bacillus coagulans</i> GBI-30 6086 Into "requeijão cremoso" Processed Cheese Does Not Affect Metabolic Homeostasis of Rats.
Bacillus coagulans GBI-30 Schiff® Digestive Advantage® Daily Probiotic Use of a continuous culture fermentation system to investigate the effect of GanedenBC30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota.
Bacillus coagulans SC-208 MegaSporebiotic Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.
Bacillus coagulans SC-208 MegaSporebiotic Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk.
Bacillus coagulans SC208 Eded 3 in 1 <i>Bacillus subtilis</i> HU58 and <i>Bacillus coagulans</i> SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in An M-SHIME<sup>®</sup> Model.
Bacillus coagulans SC208 Eded 3 in 1 Effects of synbiotic supplementation on anthropometric indices and body composition in overweight or obese children and adolescents: a randomized, double-blind, placebo-controlled clinical trial.
Bacillus coagulans SC208 Eded 3 in 1 Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.
Bacillus coagulans SC208 Eded 3 in 1 Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk.
Bacillus coagulans SC208 Eded 3 in 1 Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches.
Bacillus coagulans SC208 Eded 3 in 1 Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system.
Bacillus Coagulans SNZ1969 Jetson FIT A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort.
Bacillus Coagulans SNZ1969 Jetson FIT Effect of Bacillus coagulans SNZ 1969 on the Improvement of Bowel Movement in Loperamide-Treated SD Rats.
Bacillus Coagulans SNZ1969 Jetson FIT Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats.
Bacillus Coagulans SNZ1969 Jetson FIT Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: A randomized controlled trial.
Bacillus Coagulans SNZ1969 Jetson FIT The Efficacy and Safety of Combined Senna and Probiotic-Based Bowel Preparation for Colonoscopy in Children.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Anxiolytic- and antidepressant-like effects of Bacillus coagulans Unique IS-2 mediate via reshaping of microbiome gut-brain axis in rats.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Clinical Study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial Vaginosis.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Draft Genome Sequence of the Spore-Forming Probiotic Strain Bacillus coagulans Unique IS-2.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Multi-strain Probiotic Formulation Reverses Maternal Separation and Chronic Unpredictable Mild Stress-Generated Anxiety- and Depression-like Phenotypes by Modulating Gut Microbiome-Brain Activity in Rats.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Preclinical Potential of Probiotic-Loaded Novel Gelatin-Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Self-preserving gelatin emulgel containing whole cell probiotic for topical use: preclinical safety, efficacy, and germination studies.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children.
Bacillus coagulans Unique IS-2 Optibac Probiotics Adult Gummies Probiotics The effect of Bacillus coagulans Unique IS-2 supplementation on plasma amino acid levels and muscle strength in resistance trained males consuming whey protein: a double-blind, placebo-controlled study.
Bacillus indicus HU36 MegaSporebiotic Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.
Bacillus indicus HU36 MegaSporebiotic Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.
Bacillus indicus HU36 MegaSporebiotic Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Bacillus indicus HU36 MegaSporebiotic Carbohydrate-active enzymes from pigmented Bacilli: a genomic approach to assess carbohydrate utilization and degradation.
Bacillus indicus HU36 MegaSporebiotic Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial.
Bacillus indicus HU36 MegaSporebiotic Celiac Disease: An Academy of Nutrition and Dietetics Evidence-Based Practice Guideline.
Bacillus indicus HU36 MegaSporebiotic Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer`s Disease in App(NL-G-F) Mice.
Bacillus indicus HU36 MegaSporebiotic Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.
Bacillus indicus HU36 MegaSporebiotic Inhibition of iron-induced lipid peroxidation by newly identified bacterial carotenoids in model gastric conditions: comparison with common carotenoids.
Bacillus indicus HU36 MegaSporebiotic Intelligent Biological Networks: Improving Anti-Microbial Resistance Resilience through Nutritional Interventions to Understand Protozoal Gut Infections.
Bacillus indicus HU36 MegaSporebiotic Interactions between Carotenoids from Marine Bacteria and Other Micronutrients: Impact on Stability and Antioxidant Activity.
Bacillus indicus HU36 MegaSporebiotic Isolated Fraction of Gastric-Digested Camel Milk Yogurt with Carao (Cassia grandis) Pulp Fortification Enhances the Anti-Inflammatory Properties of HT-29 Human Intestinal Epithelial Cells.
Bacillus indicus HU36 MegaSporebiotic Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers.
Bacillus indicus HU36 MegaSporebiotic Probiotic supplementation modifies the gut microbiota profile of very low birth weight preterm infants during hospitalization.
Bacillus indicus HU36 MegaSporebiotic Stability of bacterial carotenoids in the presence of iron in a model of the gastric compartment - comparison with dietary reference carotenoids.
Bacillus indicus HU36 MegaSporebiotic Sub-1.4 cm(3) capsule for detecting labile inflammatory biomarkers in situ.
Bacillus indicus HU36 MegaSporebiotic Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches.
Bacillus indicus HU36 MegaSporebiotic Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 [Development of isolation and identification of Lactobacillus].
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 [Microbial resistance to formaldehyde. I. Comparative quantitative studies in some selected species of vegetative bacteria, bacterial spores, fungi, bacteriophages and viruses].
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 [The efficiency of probiotics in the prevention of recurrent lower urinary tract infections and bacterial vaginosis].
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A comparison of the 16S ribosomal RNAs from mesophilic and thermophilic bacilli: some modifications in the Sanger method for RNA sequencing.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A new factor from Bacillus mesentericus which promotes the growth of Bifidobacterium.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A Novel Pseudoalteromonas xiamenensis Marine Isolate as a Potential Probiotic: Anti-Inflammatory and Innate Immune Modulatory Effects against Thermal and Pathogenic Stresses.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A Novel Treatment Approach to Treatment-Resistant, Recurrent Clostridium difficile.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A nutritional supplement based on a synbiotic combination of Bacillus subtilis DSM 32315 and L-alanyl-L-glutamine improves glucose metabolism in healthy prediabetic subjects - A real-life post-marketing study.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Ameliorating effect of probiotics in a rat model of chronic kidney disease.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 An agar-based bioassay for accurate screening of the total antioxidant capacity of lactic acid bacteria cell-free supernatants.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 An Inducible Operon Is Involved in Inulin Utilization in Lactobacillus plantarum Strains, as Revealed by Comparative Proteogenomics and Metabolic Profiling.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 An Intestinal Bacillus velezensis Isolate Displays Broad-Spectrum Antibacterial Activity and Prevents Infection of Both Gram-Positive and Gram-Negative Pathogens In Vivo.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Antibiotic production and biocontrol activity by Bacillus subtilis CL27 and Bacillus pumilus CL45.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Anti-caries Streptococcus spp.: A potential preventive tool for special needs patients.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Applicability of the probiotic Lactiplantibacillus plantarum BFL as an adjunct culture in a dry fermented sausage.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Assessing the recovery of steroid levels and gonadal histopathology of tilapia exposed to polystyrene particle pollution by supplementary feed.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bacillus endophyticus sp. nov., isolated from the inner tissues of cotton plants (Gossypium sp.).
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bacillus pumilus KatX2 confers enhanced hydrogen peroxide resistance to a Bacillus subtilis PkatA::katX2 mutant strain.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bacillus pumilus plasmid pPL10: properties and insertion into Bacillus subtilis 168 by transformation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bacillus subtilis TO-A extends the lifespan of Caenorhabditis elegans.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Baru (Dipteryx alata Vog.) agro-industrial by-products promote the growth and metabolism of probiotic strains.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Biodegradation of 2,4-dichlorophenoxyacetic acid by bacteria with highly antibiotic-resistant pattern isolated from wheat field soils in Kurdistan, Iran.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Biofilm-specific cross-species induction of antimicrobial compounds in bacilli.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Bioresponsive systems based on polygalacturonate containing hydrogels.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Biosynthesis of linkage units for teichoic acids in gram-positive bacteria: distribution of related enzymes and their specificities for UDP-sugars and lipid-linked intermediates.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Can acid produced from probiotic bacteria alter the surface roughness, microhardness, and elemental composition of enamel? An in vitro study.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical condition.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA 318 recognizes human A and B blood group antigens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Clostridioides difficile infection in a skilled nursing facility (SNF): cost savings of an automated, standardized probiotic antimicrobial stewardship programme (ASP) policy.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Co-cultivation effects of Lactobacillus helveticus SNA12 and Kluveromyces marxiensis GY1 on the probiotic properties, flavor, and digestion in fermented milk.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Coeliac Disease and Probiotics: Clinicians Need to Provide the Evidence Base for this Unmet Need.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Cold atmospheric air plasma sterilization against spores and other microorganisms of clinical interest.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Construction of a High-Expression System in Bacillus through Transcriptomic Profiling and Promoter Engineering.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Construction of a Temperature-Sensitive Shuttle Vector between Lactic Acid Bacteria and Escherichia coli and Its Application to a Tn10-Based Random Mutagenesis Tool in Lactic Acid Bacteria.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Contamination profiles and characterisation of Bacillus species in wheat bread and raw materials for bread production.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Corrigendum to "Dietary supplementation of Bacillus velezensis improves Vibrio anguillarum clearance in European sea bass by activating essential innate immune mechanisms" [Fish Shellfish Immunol. 124 (2022) 244-253].
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Cyclic-di-AMP signalling in lactic acid bacteria.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Degradation of proteins during the fermentation of African locust bean (Parkia biglobosa) by strains of Bacillus subtilis and Bacillus pumilus for production of Soumbala.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Determination of safety status and probiotic properties of Enterococcus strains isolated from traditional cheeses in Turkey.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Detoxification of aflatoxin M1 in different milk types using probiotics.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Development of a carotenoid enriched probiotic yogurt from fresh biomass of Spirulina and its characterization.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Development of Anti-inflammatory Probiotic Limosilactobacillus reuteri EFEL6901 as Kimchi Starter: in vitro and In vivo Evidence.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Development of strain-specific PCR primers for quantitative detection of Bacillus mesentericus strain TO-A in human feces.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Diet and Immune Function.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Dietary supplementation of Bacillus velezensis improves Vibrio anguillarum clearance in European sea bass by activating essential innate immune mechanisms.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Diversity among Lactobacillus paracasei phages isolated from a probiotic dairy product plant.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Dynamics of Changes in pH and the Contents of Free Sugars, Organic Acids and LAB in Button Mushrooms during Controlled Lactic Fermentation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Editorial: raising the bar on probiotic foods.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of probiotic Lactobacillus paracasei on tumor necrosis factor-alpha level in gingival crevicular fluid of patients undergoing impacted third molar removal.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of probiotics on the intestinal microbiota of patients with giardiasis and ascariasis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of short-term probiotic Enterococcus faecium SF68 dietary supplementation in overweight and obese cats without comorbidities.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effect of supplementation with ruminal probiotics on growth performance, carcass characteristics, plasma metabolites, methane emissions, and the associated rumen microbiome changes in beef cattle.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of chemical treatments on pH and bacterial population in poultry litter: a laboratory experiment.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of Probiotic NVP-1704 on Mental Health and Sleep in Healthy Adults: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of probiotic supplementation on glucose metabolism in pregnant women without diabetes: a systematic review and meta-analysis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: a secondary-data analysis of a randomized double-blind controlled trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of prophylactic probiotics supplementation on infants born very preterm or very low birth weight.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Effects of zinc or synbiotic on the duration of diarrhea in children with acute infectious diarrhea.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Efficiency of a Lactobacillus plantarum-xylanase combination on growth performances, microflora populations, and nutrient digestibilities of broilers infected with Salmonella Typhimurium.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Electrooptical Determination of Polarizability for On-Line Viability and Vitality Quantification of Lactobacillus plantarum Cultures.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Enhancing Fluoride: Clinical Human Studies of Alternatives or Boosters for Caries Management.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Enterobacter asburiae E7, a Novel Potential Probiotic, Enhances Resistance to Aeromonas veronii Infection via Stimulating the Immune Response in Common Carp (Cyprinus carpio).
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Enterococcus faecium and Enterococcus durans isolated from cheese: Survival in the presence of medications under simulated gastrointestinal conditions and adhesion properties.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evaluating the formulae for integrated lethality in ethylene oxide sterilization using six different endospore forming strains of bacteria, and comparisons of integrated lethality for ethylene oxide and steam systems.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evaluation of Microbial-Fructo-Oligosaccharides Metabolism by Human Gut Microbiota Fermentation as Compared to Commercial Inulin-Derived Oligosaccharides.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evaluation of the health properties of lactobacilli isolated from an Iranian traditional dairy product.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evaluation of three Bacillus spp. isolated from the gut of giant freshwater prawn as potential probiotics against pathogens causing Vibriosis and Aeromonosis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Evidence for probiotic potential of a capsular-producing Streptococcus thermophilus CHCC 3534 strain.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Expression of antimicrobial peptides in cecal tonsils of chickens treated with probiotics and infected with Salmonella enterica serovar typhimurium.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Faecalibacterium diversity in dairy cow milk.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Flavonoids from Morus alba L. Leaves: Optimization of Extraction by Response Surface Methodology and Comprehensive Evaluation of Their Antioxidant, Antimicrobial, and Inhibition of a-Amylase Activities through Analytical Hierarchy Process.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Foam-Mat Freeze-Drying of Bifidobacterium longum RO175: Viability and Refrigerated Storage Stability.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Functional Characteristics of Lactic Acid Bacteria In Vitro Isolated from Spontaneously Fermented Sour Porridge with Broomcorn Millet in Northwestern Shanxi Province of China.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Functional genomics of probiotic Lactobacilli.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Functional Properties of Lactobacillus mucosae Strains Isolated from Brazilian Goat Milk.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Gene cloning, transcriptional analysis, purification, and characterization of phenolic acid decarboxylase from Bacillus subtilis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Genetic and nucleotide sequence homologies in bacillus genomes.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Hard surface biocontrol in hospitals using microbial-based cleaning products.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 High Prevalence of Antimicrobial-resistant Gram-negative Colonization in Hospitalized Cambodian Infants.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Homeostatic regulation of neuronal excitability by probiotics in male germ-free mice.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Human microbiome versus food-borne pathogens: friend or foe.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Hydrolysis of rosmarinic acid from rosemary extract with esterases and Lactobacillus johnsonii in vitro and in a gastrointestinal model.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Hymenolepis diminuta Reduce Lactic Acid Bacterial Load and Induce Dysbiosis in the Early Infection of the Probiotic Colonization of Swiss Albino Rat.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Identification of bacteria in pasteurized zucchini purées stored at different temperatures and comparison with those found in other pasteurized vegetable purées.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Immunomodulatory Activity on Human Macrophages by Cell-Free Supernatants to Explore the Probiotic and Postbiotic Potential of Lactiplantibacillus plantarum Strains of Plant Origin.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic Bacillus clausii CSI08.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Improving productive performance and mitigating harmful emissions from laying hen excreta via feeding on graded levels of corn DDGS with or without Bacillus subtilis probiotic.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 In Vitro Assessment of Yeasts Strains with Probiotic Attributes for Aquaculture Use.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 In vitro evaluation of potential prebiotic effects of a freeze-dried juice from Pilosocereus gounellei (A. Weber ex K. Schum. Bly. Ex Rowl) cladodes, an unconventional edible plant from Caatinga biome.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 In vitro evaluation of the safety and probiotic properties of Lactobacilli isolated from chicken and calves.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 In vitro manipulation of the bacterial community to improve the performance of bioflocs in aquaculture systems.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Induced systemic resistance (ISR) in plants: mechanism of action.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Inhibition of Escherichia coli adhesion to human intestinal Caco-2?cells by probiotic candidate Lactobacillus plantarum strain L15.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Inhibition of Streptococcus mutans Biofilm Formation by the Joint Action of Oxyresveratrol and Lactobacillus casei.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Inhibition of the growth of Ascosphaera apis by Bacillus and Paenibacillus strains isolated from honey.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Initiation of Bacillus spore germination by hydrostatic pressure: effect of temperature.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Interactions of Bacillus spp. and plants--with special reference to induced systemic resistance (ISR).
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Intestinal microbiota and colorectal cancer: changes in the intestinal microenvironment and their relation to the disease.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-M? Axis and Modulating Gut Microbiota in Mice.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Isolation and characterization of actinomycetes from healthy goat faeces.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Isolation and characterization of chromosomal promoters of Streptococcus salivarius subsp. thermophilus.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Isolation and identification of local Bacillus isolates for xylanase biosynthesis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Lactobacillus salivarius CML352 Isolated from Chinese Local Breed Chicken Modulates the Gut Microbiota and Improves Intestinal Health and Egg Quality in Late-Phase Laying Hens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Latilactobacillus curvatus FFZZH5L isolated from pickled cowpea enhanced antioxidant activity in Caenorhabditis elegans by upregulating the level of glutathione S-transferase.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Limosilactobacillus fermentum prevent gut-kidney oxidative damage and the rise in blood pressure in male rat offspring exposed to a maternal high-fat diet - CORRIGENDUM.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Limosilactobacillus fermentum prevents gut-kidney oxidative damage and the rise in blood pressure in male rat offspring exposed to a maternal high-fat diet.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Management of dog sperm parameters and gut microbiota composition with Lactobacillus rhamnosus supplementation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Metabolic activity of probiotics-oxalate degradation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Metabolomics and molecular docking analysis of antibiotic exposure in Bifidobacterium adolescentis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Microbiological aspects of ethylene oxide sterilization. II. Microbial resistance to ethylene oxide.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Mixtures of plant growth-promoting rhizobacteria enhance biological control of multiple cucumber pathogens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Modulation of Gut Microbiota by Lactobacillus casei Fermented Raspberry Juice In Vitro and In Vivo.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Molecular cloning of enantioselective ester hydrolase from Bacillus pumilus DBRL-191.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Molecular identification and in vitro evaluation of probiotic functional properties of some Egyptian lactic acid bacteria and yeasts.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Not more, but less studies are warranted-If you take your meta-analysis seriously.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Novel Functional Grape Juices Fortified with Free or Immobilized Lacticaseibacillus rhamnosus OLXAL-1.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Novel Probiotic Mechanisms of the Oral Bacterium Streptococcus sp. A12 as Explored with Functional Genomics.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Nurturing scientific mutualism: a report from the `Young Microbiologists Mini-Symposium on microbe signalling, organisation and pathogenesis`.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Occurrence of Bacillus sporothermodurans and other aerobic spore-forming species in feed concentrate for dairy cattle.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Older adults and healthcare professionals have limited awareness of the link between the Mediterranean diet and the gut microbiome for healthy aging.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Oral probiotics influence oral and respiratory tract infections in pediatric population: a randomized double-blinded placebo-controlled pilot study.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Orally Administered Probiotics in the Prevention of Chemotherapy (± Radiotherapy)-Induced Gastrointestinal Toxicity: A Systematic Review With Meta-Analysis of Randomized Trials.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Phenotypic and genetic diversity of rice seed-associated bacteria and their role in pathogenicity and biological control.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Plant Extracts Rich in Polyphenols as Potent Modulators in the Growth of Probiotic and Pathogenic Intestinal Microorganisms.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Plant Growth-Promoting Rhizobacteria Stimulate Vegetative Growth and Asexual Reproduction of Kalanchoe daigremontiana.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Polyphenols Content and In Vitro a-Glycosidase Activity of Different Italian Monofloral Honeys, and Their Effect on Selected Pathogenic and Probiotic Bacteria.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Portrait of a canine probiotic Bifidobacterium--from gut to gut.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Potential prebiotic properties of cashew apple (Anacardium occidentale L.) agro-industrial byproduct on Lactobacillus species.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Potential Probiotic Properties of Exopolysaccharide-Producing Lacticaseibacillus paracasei EPS DA-BACS and Prebiotic Activity of Its Exopolysaccharide.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Prebiotics and synbiotics - in ovo delivery for improved lifespan condition in chicken.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Preclinical Potential of Probiotic-Loaded Novel Gelatin-Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic Characterization of Lactobacillus brevis MJM60390 and In Vivo Assessment of Its Antihyperuricemic Activity.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic Lactobacillus plantarum Ln4 Showing Antimicrobial and Antibiofilm Effect against Streptococcus mutans KCTC 5124 Causing Dental Caries.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic potential of Weissella paramesenteroides MYPS5.1 isolated from customary dairy products and its therapeutic application.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic supplements might not be universally-effective and safe: A review.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotic Use in Celiac Disease: Results from a National Survey.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics as a Tool for Regulating Molecular Mechanisms in Depression: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics in critically ill patients.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics inhibit the stunted growth defect of perfluorobutanesulfonate via stress and thyroid axes in zebrafish larvae.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics reduce infectious complications after pancreaticoduodenectomy.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Probiotics` effect on visceral and subcutaneous adipose tissue: a systematic review of randomized controlled trials.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Production and Characterization of a Novel Symbiotic Plant-based Beverage Rich in Antioxidant Phenolic: Mung Bean and Rye Sprouts.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Production and in vitro evaluation of prebiotic manno-oligosaccharides prepared with a recombinant Aspergillus niger endo-mannanase, Man26A.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Production of exopolysaccharides by Lactobacillus and Bifidobacterium strains of human origin, and metabolic activity of the producing bacteria in milk.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Prosthetic Aortic Valve Endocarditis in a Patient With Birt-Hogg-Dube Syndrome due to Lactobacillus paracasei.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Protective Effects of Tropical Fruit Processing Coproducts on Probiotic Lactobacillus Strains during Freeze-Drying and Storage.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Proteomic analysis of Lactobacillus pentosus for the identification of potential markers involved in acid resistance and their influence on other probiotic features.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Pseudobutyrivibrio xylanivorans adhesion to epithelial cells.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Purification and characterization of 3,3-dihydroxyazetidine from culture medium of Bacillus mesentericus and B. subtilis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Quantitative Physiology and Proteome Adaptations of Bifidobacterium breve NRBB57 at Near-Zero Growth Rates.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Randomized controlled trial demonstrates response to a probiotic intervention for metabolic syndrome that may correspond to diet.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Refers to: Paul Enck. Not more, but less studies are warranted-If you take your meta-analysis seriously.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Rehydration before Application Improves Functional Properties of Lyophilized Lactiplantibacillus plantarum HAC03.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Resistance of bacterial endospores to outer space for planetary protection purposes--experiment PROTECT of the EXPOSE-E mission.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Role of the Microbiome in Regulating Bone Metabolism and Susceptibility to Osteoporosis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Saccharomyces cerevisiae as a probiotic feed additive to non and pseudo-ruminant feeding: a review.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Safety Assessment of the Potential Probiotic Bacterium Limosilactobacillus fermentum J23 Using the Mexican Fruit Fly (Anastrepha ludens Loew, Diptera: Tephritidae) as a Novel In Vivo Model.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Screening for Candidate Genes Associated with Biocontrol Mechanisms of Bacillus pumilus DX01 Using Tn5 Transposon Mutagenesis and a 2-DE-Based Comparative Proteomic Analysis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Selection of a candidate probiotic strain of Pediococcus pentosaceus from the faecal microbiota of horses by in vitro testing and health claims in a mouse model of Salmonella infection.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Skin Microbiome-The Next Frontier for Probiotic Intervention.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Sleep and probiotics in diabetes management.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Specific in vitro binding of a plasmid to a membrane fraction of Bacillus subtilis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Specific Probiotics for the Treatment of Pediatric Acute Gastroenteritis in India: A Systematic Review and Meta-Analysis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Stable colonization of Akkermansia muciniphila educates host intestinal microecology and immunity to battle against inflammatory intestinal diseases.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Targeting the gut-skin axis-Probiotics as new tools for skin disorder management?
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The acetyl xylan esterase of Bacillus pumilus belongs to a family of esterases with broad substrate specificity.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The effect of synbiotics and probiotics on the growth performance, gastrointestinal function and health status of turkeys.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The effects of inulin, dried Jerusalem artichoke tuber and a multispecies probiotic preparation on microbiota ecology and immune status of the large intestine in young pigs.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The Effects of Probiotic Supplementation on Genetic and Metabolic Profiles in Patients with Gestational Diabetes Mellitus: a Randomized, Double-Blind, Placebo-Controlled Trial.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The effects of probiotic, prebiotic and synbiotic diets containing Bacillus coagulans and inulin on rat intestinal microbiota.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The Efficiency of Probiotics Administrated via Different Routes and Doses in Enhancing Production Performance, Meat Quality, Gut Morphology, and Microbial Profile of Broiler Chickens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The Influence of the Degree of Thermal Inactivation of Probiotic Lactic Acid Bacteria and Their Postbiotics on Aggregation and Adhesion Inhibition of Selected Pathogens.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The role of probiotic bacteria in managing periodontal disease: a systematic review.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 The Use of the Probiotic Lactiplantibacillus plantarum 299v in the Technology of Non-Dairy Ice Cream Based on Avocado.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 To screen or not to screen medical students for carriage of multidrug-resistant pathogens?
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Toxinogenic and spoilage potential of aerobic spore-formers isolated from raw milk.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Travellers` diarrhoea - prevention, trends and role of microbiome.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Update on In Vitro Diagnostic Tools and Treatments for Food Allergies.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Use of colony-based bacterial strain typing for tracking the fate of Lactobacillus strains during human consumption.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization.
Bacillus mesentericus (subtilis) TO-A AOR, Probiotic 3 VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-?-induced Intestinal Epithelial Barrier Defects.
Bacillus subtilis ATCC SD 7280 Biome Ultra A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue.
Bacillus subtilis BG01-4TM VERNX Attempts to limit sporulation in the probiotic strain Bacillus subtilis BG01-4(TM) through mutation accumulation and selection.
Bacillus subtilis DE111 Probiotic w/ DE111 <i>Bacillus subtilis</i> DE111 intake may improve blood lipids and endothelial function in healthy adults.
Bacillus subtilis DE111 Probiotic w/ DE111 Acute physiological effects following Bacillus subtilis DE111 oral ingestion - a randomised, double blinded, placebo-controlled study.
Bacillus subtilis DE111 Probiotic w/ DE111 Altered Respiratory Microbiomes, Plasma Metabolites, and Immune Responses in Influenza A Virus and Methicillin-Resistant Staphylococcus aureus Coinfection.
Bacillus subtilis DE111 Probiotic w/ DE111 Anti-Inflammatory, Antioxidant, Metabolic and Gut Microbiota Modulation Activities of Probiotic in Cardiac Remodeling Condition: Evidence from Systematic Study and Meta-Analysis of Randomized Controlled Trials.
Bacillus subtilis DE111 Probiotic w/ DE111 Daily intake of probiotic strain <i>Bacillus subtilis</i> DE111 supports a healthy microbiome in children attending day-care.
Bacillus subtilis DE111 Probiotic w/ DE111 Effects of Probiotic (<i>Bacillus subtilis</i> DE111) Supplementation on Immune Function, Hormonal Status, and Physical Performance in Division I Baseball Players.
Bacillus subtilis DE111 Probiotic w/ DE111 Effects of Probiotic (Bacillus subtilis) Supplementation During Offseason Resistance Training in Female Division I Athletes.
Bacillus subtilis DE111 Probiotic w/ DE111 Evaluation of Bacillus clausii CSI08, Bacillus megaterium MIT411 and a Bacillus cocktail on gastrointestinal health: a randomised, double-blind, placebo-controlled pilot study.
Bacillus subtilis DE111 Probiotic w/ DE111 Evaluation of Rouxiella badensis Subsp Acadiensis (Canan SV-53) as a Potential Probiotic Bacterium.
Bacillus subtilis DE111 Probiotic w/ DE111 Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic <i>Bacillus subtilis</i> DE111.
Bacillus subtilis DE111 Probiotic w/ DE111 Human small-intestinal gluten-degrading bacteria and its potential implication in celiac disease.
Bacillus subtilis DE111 Probiotic w/ DE111 In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111(®).
Bacillus subtilis DE111 Probiotic w/ DE111 Plasma Amino Acid Response to Whey Protein Ingestion Following 28 Days of Probiotic (<i>Bacillus subtilis</i> DE111) Supplementation in Active Men and Women.
Bacillus subtilis DE111 Probiotic w/ DE111 Presence and Germination of the Probiotic Bacillus subtilis DE111(®) in the Human Small Intestinal Tract: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study.
Bacillus subtilis DE111 Probiotic w/ DE111 Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.
Bacillus subtilis DE111 Probiotic w/ DE111 Rice bran as an encapsulating material to produce a healthy synbiotic product with improved gastrointestinal tolerance.
Bacillus subtilis DE111 Probiotic w/ DE111 The Effect of Probiotic Bacteria on Composition and Metabolite Production of Faecal Microbiota Using In Vitro Batch Cultures.
Bacillus subtilis DE111 Probiotic w/ DE111 The first report of antifungal lipopeptide production by a Bacillus subtilis subsp. inaquosorum strain.
Bacillus subtilis DE111 Probiotic w/ DE111 The Role of Yeast Probiotics in Gastrointestinal Conditions: An Overview.
Bacillus Subtilis HU58 MegaSporebiotic <i>Bacillus subtilis</i> HU58 and <i>Bacillus coagulans</i> SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in An M-SHIME<sup>®</sup> Model.
Bacillus Subtilis HU58 MegaSporebiotic An Oral Formulation of the Probiotic, <i>Bacillus subtilis</i> HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy.
Bacillus Subtilis HU58 MegaSporebiotic Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.
Bacillus Subtilis HU58 MegaSporebiotic Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications.
Bacillus Subtilis HU58 MegaSporebiotic Bio-removal of tetracycline antibiotics under the consortium with probiotics Bacillus clausii T and Bacillus amyloliquefaciens producing biosurfactants.
Bacillus Subtilis HU58 MegaSporebiotic Cardiometabolic benefits of Lacticaseibacillus paracasei 8700:2: A randomized double-blind placebo-controlled trial.
Bacillus Subtilis HU58 MegaSporebiotic Celiac Disease: An Academy of Nutrition and Dietetics Evidence-Based Practice Guideline.
Bacillus Subtilis HU58 MegaSporebiotic Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer`s Disease in App(NL-G-F) Mice.
Bacillus Subtilis HU58 MegaSporebiotic Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.
Bacillus Subtilis HU58 MegaSporebiotic Evaluation of Bacillus subtilis strains as probiotics and their potential as a food ingredient.
Bacillus Subtilis HU58 MegaSporebiotic Intelligent Biological Networks: Improving Anti-Microbial Resistance Resilience through Nutritional Interventions to Understand Protozoal Gut Infections.
Bacillus Subtilis HU58 MegaSporebiotic Isolated Fraction of Gastric-Digested Camel Milk Yogurt with Carao (Cassia grandis) Pulp Fortification Enhances the Anti-Inflammatory Properties of HT-29 Human Intestinal Epithelial Cells.
Bacillus Subtilis HU58 MegaSporebiotic Isolation and characterization of Bacillus subtilis CH16 strain from chicken gastrointestinal tracts for use as a feed supplement to promote weight gain in broilers.
Bacillus Subtilis HU58 MegaSporebiotic Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers.
Bacillus Subtilis HU58 MegaSporebiotic Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk.
Bacillus Subtilis HU58 MegaSporebiotic Probiotic supplementation modifies the gut microbiota profile of very low birth weight preterm infants during hospitalization.
Bacillus Subtilis HU58 MegaSporebiotic Shelf Life and Simulated Gastrointestinal Tract Survival of Selected Commercial Probiotics During a Simulated Round-Trip Journey to Mars.
Bacillus Subtilis HU58 MegaSporebiotic Sub-1.4 cm(3) capsule for detecting labile inflammatory biomarkers in situ.
Bacillus Subtilis HU58 MegaSporebiotic Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches.
Bacillus Subtilis HU58 MegaSporebiotic Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system.
Bacillus Subtilis MB40 Country Farms Super Flora Probiotics A Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating.
Bacillus Subtilis MB40 Country Farms Super Flora Probiotics Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial.
Bacillus Subtilis MB40 Country Farms Super Flora Probiotics Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements.
Bacillus Subtilis MB40 Country Farms Super Flora Probiotics The Probiotic Bacillus subtilis MB40 Improves Immunity in a Porcine Model of Listeriosis.
Bacteroides xylanisolvens DSM 23964 AVI-1 (pending on market) Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFa-specific antibodies in human adults.
Bacteroides xylanisolvens DSM 23964 AVI-1 (pending on market) Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate.
Bacteroides xylanisolvens DSM 23964 AVI-1 (pending on market) Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults.
Bacteroides xylanisolvens DSM 23964 AVI-1 (pending on market) Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964.
Bifidobacterium adolescentis IVS-1 Synbiotic Health ISV-1 Complete genome sequence of the probiotic Bifidobacterium adolescentis strain iVS-1.
Bifidobacterium adolescentis IVS-1 Synbiotic Health ISV-1 In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications.
Bifidobacterium adolescentis IVS-1 Synbiotic Health ISV-1 Phenolic Profile and Bioactivity Changes of Lotus Seedpod and Litchi Pericarp Procyanidins: Effect of Probiotic Bacteria Biotransformation.
Bifidobacterium adolescentis IVS-1 Synbiotic Health ISV-1 Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Bifidobacterium adolescentis PRL2019 Gabapral Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control <i>Bifidobacterium animalis</i> ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control An adaptable and non-invasive method for tracking Bifidobacterium animalis subspecies lactis 420 in the mouse gut.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control An edible coating utilizing Malva sylvestris seed polysaccharide mucilage and postbiotic from Saccharomyces cerevisiae var. boulardii for the preservation of lamb meat.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Bifidobacterium lactis 420 and fish oil enhance intestinal epithelial integrity in Caco-2 cells.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Comparison of the Effects of Feeding Compound Probiotics and Antibiotics on Growth Performance, Gut Microbiota, and Small Intestine Morphology in Yellow-Feather Broilers.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Distinctive features of the oropharyngeal microbiome in Inuit of Nunavik and correlations of mild to moderate bronchial obstruction with dysbiosis.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Dual 6Pß-Galactosidase/6Pß-Glucosidase GH1 Family for Lactose Metabolism in the Probiotic Bacterium Lactiplantibacillus plantarum WCFS1.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Dynamic effects of probiotic formula ecologic®825 on human small intestinal ileostoma microbiota: a network theory approach.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Effect of Adding Cordyceps sinensis Extract and Probiotic to the Diet on Productive Performance of Broiler.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a non-steroidal anti-inflammatory drug: a randomized, placebo-controlled, double-blind clinical trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Engineering Clinically Relevant Probiotics with Switchable "nano-promoter" and "nano-effector" for Precision Tumor Therapy.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Expanding CYLD protein in NF-?ß/TNF-a signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Factors Associated With Fecal Microbiota Transplant Failure in the Treatment of Recurrent Clostridioides difficile Infection: A Single-Center Retrospective Study.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Genes involved in protein metabolism of the probiotic lactic acid bacterium Lactobacillus delbrueckii UFV H2b20.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Improvement of water quality with probiotics inclusion during simulated transport of yellowfin seabream (Acanthopagrus latus) larvae.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Injectable Living Probiotic Dressing Built by Droplet-Based Microfluidics And Photo-Crosslinking to Prevent Pathogenic Infection And Promote Wound Repair.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Intake of Lactiplantibacillus plantarum HEAL9 reduces the inflammatory markers soluble fractalkine and CD163 during acute stress: A randomized, double blind, placebo-controlled study.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Lactobacillus acidophilus 74-2 and butyrate induce cyclooxygenase (COX)-1 expression in gastric cancer cells.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Linking bacterial tetrabromopyrrole biosynthesis to coral metamorphosis.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Multi-strain probiotic ameliorated toxic effects of phthalates and bisphenol A mixture in Wistar rats.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Natural Topical Treatment Contributes to a Reduction of Dry Scalp Symptoms in Children.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Potential pathobionts in vaginal microbiota are affected by fish oil and/or probiotics intervention in overweight and obese pregnant women.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Screening of lactic acid bacteria with anti-adipogenic effect and potential probiotic properties from grains.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Temporal stability and community assembly mechanisms in healthy broiler cecum.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control The role of Elateriospermum tapos yoghurt in mitigating high-fat dietary cause of maternal obesity-an experimental study.
Bifidobacterium animalis ssp. lactis 420 UltraFlora® Control Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil.
Bifidobacterium animalis ssp. lactis CUL-34 (NCIMB 30153) Genestra Brands - HMF Neuro Powder An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention.
Bifidobacterium animalis ssp. lactis CUL-34 (NCIMB 30153) Genestra Brands - HMF Neuro Powder Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> HN019 Effects on Gut Health: A Review.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: A randomized controlled trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Assessment of the bifidogenic and antibacterial activities of xylooligosaccharide.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Biofilm formation on voice prostheses: in vitro influence of probiotics.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Changes in protein synthesis and morphology during acid adaptation of Propionibacterium freudenreichii.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Clinical applications of probiotic agents.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Combined probiotics attenuate chronic unpredictable mild stress-induced depressive-like and anxiety-like behaviors in rats.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Comparison Between Different Delivery Vehicles for the Probiotic Bifidobacterium animalis subsp. lactis HN019 on Experimental Periodontitis in Rats.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Development of a Standard Curve to Account for Viable Loads of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> HN019 Using RNA by Real-Time PCR.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Differential Effects of Transition Metals on Growth and Metal Uptake for Two Distinct Lactobacillus Species.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Differential modification of genetic susceptibility to childhood eczema by two probiotics.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Discussion on probiotic bacteria enhance murine and human intestinal epithelial function.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Droplet Digital PCR Is an Improved Alternative Method for High-Quality Enumeration of Viable Probiotic Strains.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effect of Bifidobacterium lactis HN019 on inflammatory markers and oxidative stress in subjects with and without the metabolic syndrome.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effect of early probiotic supplementation on childhood cognition, behaviour and mood a randomised, placebo-controlled trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effect of probiotics on enterocyte bacterial translocation in vitro.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effectiveness of two probiotics in preventing necrotising enterocolitis in a cohort of very-low-birth-weight premature new-borns.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of Bifidobacterium animalis lactis HN019 (DR10TM), inulin, and micronutrient fortified milk on faecal DR10TM, immune markers, and maternal micronutrients among Indonesian pregnant women.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of Bifidobacterium animalis subsp. lactis HN019 on ligature-induced periodontitis in rats with experimental rheumatoid arthritis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: A randomized clinical trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Evaluation of probiotic treatment in a neonatal animal model.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Fatty acid profile, trans-octadecenoic, a-linolenic and conjugated linoleic acid contents differing in certified organic and conventional probiotic fermented milks.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Fermented or unfermented milk using Bifidobacterium animalis subsp. lactis HN019: Technological approach determines the probiotic modulation of mucosal cellular immunity.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Fibers from fruit by-products enhance probiotic viability and fatty acid profile and increase CLA content in yoghurts.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Functionality of probiotics - potential for product development.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Impact of Bifidobacterium animalis subsp. lactis HN019 probiotic in the prevention of periodontitis associated with immunosuppression.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Impact of coculturing Bifidobacterium animalis subsp. lactis HN019 with yeasts on microbial viability and metabolite formation.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max In vitro effects of Bifidobacterium lactis-based synbiotics on human faecal bacteria.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max In vitro fermentation of prebiotic oligosaccharides by Bifidobacterium lactis HN019 and Lactobacillus spp.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Integrated Role of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Supplementation in Gut Microbiota, Immunity, and Metabolism of Infant Rhesus Monkeys.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Lactobacillus acidophilus ATCC 4356 Exopolysaccharides Suppresses Mediators of Inflammation through the Inhibition of TLR2/STAT-3/P38-MAPK Pathway in DEN-Induced Hepatocarcinogenesis in Rats.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Levilactobacillus brevis from carnivores can ameliorate hypercholesterolemia: In vitro and in vivo mechanistic evidence.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Microbiological and biochemical properties of canestrato pugliese hard cheese supplemented with bifidobacteria.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Probiotic bacteria enhance murine and human intestinal epithelial barrier function.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Probiotic consumption can modify the resilience of periodontal tissues in rats under experimental periodontitis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Probiotics and functional foods in gastrointestinal disorders.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Summary of probiotic activities of Bifidobacterium lactis HN019.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The Effect of Bifidobacterium animalis ssp. lactis HN019 on Cellular Immune Function in Healthy Elderly Subjects: Systematic Review and Meta-Analysis.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The influence of dietary proteins on colon cancer risk.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The suitability of different probiotic strains for the production of fruit-whey beverages.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: An immunoenzymatic and microtomographic study.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline.
Bifidobacterium animalis subsp lactis HN019 Optibac Every Day Max Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement An Infant Milk Formula Supplemented with Heat-Treated Probiotic <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> CECT 8145, Reduces Fat Deposition in <i>C. elegans</i> and Augments Acetate and Lactate in a Fermented Infant Slurry.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: A systematic review and network meta-analysis.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Draft Genome Sequence of Bifidobacterium animalis subsp. lactis Strain CECT 8145, Able To Improve Metabolic Syndrome In Vivo.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial.
Bifidobacterium animalis subsp. lactis CECT 8145 Culturelle Healthy Metabolism + Weight Management Supplement Probiotic Strain Bifidobacterium animalis subsp. lactis CECT 8145 Reduces Fat Content and Modulates Lipid Metabolism and Antioxidant Response in Caenorhabditis elegans.
Bifidobacterium bifidum BB-06 Custom Probiotics Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
Bifidobacterium bifidum BB-06 Custom Probiotics Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis.
Bifidobacterium bifidum CUL-20 (NCIMB 30172) Genestra Brands - HMF Neuro Powder An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention.
Bifidobacterium bifidum CUL-20 (NCIMB 30172) Genestra Brands - HMF Neuro Powder Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Bifidobacterium bifidum CUL-20 (NCIMB 30172) Genestra Brands - HMF Neuro Powder Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health <i>Bifidobacterium bifidum</i> G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Alleviation of low-fiber diet-induced constipation by probiotic <i>Bifidobacterium bifidum</i> G9-1 is based on correction of gut microbiota dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Author Correction: Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Corrigendum: Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Effect of probiotics, <i>Bifidobacterium bifidum</i> G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study).
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Effects of Bifidobacterium bifidum G9-1 on Nasal Symptoms in a Guinea Pig Model of Experimental Allergic Rhinitis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type?2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Longitudinal study of effects of oral dosage of Bifidobacterium bifidum G9-1 on Japanese cedar pollen-induced allergic nasal symptoms in guinea pigs.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health Probiotics (<i>Lactobacillus gasseri</i> KS-13, <i>Bifidobacterium bifidum</i> G9-1, and <i>Bifidobacterium longum</i> MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial.
Bifidobacterium bifidum G9-1 (BBG9-1) Phillips'® Colon Health The protective effect of <i>Bifidobacterium bifidum</i> G9-1 against mucus degradation by <i>Akkermansia muciniphila</i> following small intestine injury caused by a proton pump inhibitor and aspirin.
Bifidobacterium bifidum HA-132 Human Probiotics Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro.
Bifidobacterium bifidum HA-132 Human Probiotics Disentangling factors that shape the gut microbiota in German Shepherd dogs.
Bifidobacterium bifidum HA-132 Human Probiotics Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
Bifidobacterium bifidum HA-132 Human Probiotics Enteral supplementation with probiotics in preterm infants: A retrospective cohort study and 6-year follow-up.
Bifidobacterium bifidum HA-132 Human Probiotics Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.
Bifidobacterium bifidum HA-132 Human Probiotics The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA BopA does not have a major role in the adhesion of Bifidobacterium bifidum to intestinal epithelial cells, extracellular matrix proteins, and mucus.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Effects of Bifidobacterium bifidum in Mice Infected with Citrobacter rodentium.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its cysteine- and histidine-dependent amidohydrolase/peptidase (CHAP) amidase domain.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA TgaA, a VirB1-like component belonging to a putative type IV secretion system of Bifidobacterium bifidum MIMBb75.
Bifidobacterium bifidum MIMBb75 (SYN-HI-001) IRRITABLE COLON PRO KIJIMEA Time- and strain-specific downregulation of intestinal EPAS1 via miR-148a by Bifidobacterium bifidum.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Bifidobacterium bifidum W23 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Bifidobacterium breve HA-129 Human Probiotics Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro.
Bifidobacterium breve HA-129 Human Probiotics Disentangling factors that shape the gut microbiota in German Shepherd dogs.
Bifidobacterium breve HA-129 Human Probiotics Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
Bifidobacterium breve HA-129 Human Probiotics Enteral supplementation with probiotics in preterm infants: A retrospective cohort study and 6-year follow-up.
Bifidobacterium breve HA-129 Human Probiotics Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.
Bifidobacterium breve HA-129 Human Probiotics The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion.
Bifidobacterium breve M-16V Optibac Probiotics Professional [Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis].
Bifidobacterium breve M-16V Optibac Probiotics Professional [Methods of gut microbiota correction for treatment and prevention of food allergy: a review of current research].
Bifidobacterium breve M-16V Optibac Probiotics Professional A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.
Bifidobacterium breve M-16V Optibac Probiotics Professional A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to ß-Lactoglobulin-Derived Peptides.
Bifidobacterium breve M-16V Optibac Probiotics Professional A specific synbiotic-containing amino acid-based formula in dietary management of cow`s milk allergy: a randomized controlled trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional A specific synbiotic-containing amino acid-based formula restores gut microbiota in non-IgE mediated cow`s milk allergic infants: a randomized controlled trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children.
Bifidobacterium breve M-16V Optibac Probiotics Professional A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants.
Bifidobacterium breve M-16V Optibac Probiotics Professional Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy.
Bifidobacterium breve M-16V Optibac Probiotics Professional Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-a induced gene expression.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve during infancy attenuates mobility in low birthweight rats.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve M-16V alters the gut microbiota to alleviate OVA-induced food allergy through IL-33/ST2 signal pathway.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve M-16V as a Probiotic for Preterm Infants: A Strain-Specific Systematic Review.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model.
Bifidobacterium breve M-16V Optibac Probiotics Professional Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma.
Bifidobacterium breve M-16V Optibac Probiotics Professional Colonization of Supplemented Bifidobacterium breve M-16V in Low Birth Weight Infants and Its Effects on Their Gut Microbiota Weeks Post-administration.
Bifidobacterium breve M-16V Optibac Probiotics Professional Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey.
Bifidobacterium breve M-16V Optibac Probiotics Professional Dietary Intervention with ß-Lactoglobulin-Derived Peptides and a Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates the Prevention of Whey-Induced Allergy in Mice by Supporting a Tolerance-Prone Immune Environment.
Bifidobacterium breve M-16V Optibac Probiotics Professional Dietary, nondigestible oligosaccharides and Bifidobacterium breve M-16V suppress allergic inflammation in intestine via targeting dendritic cell maturation.
Bifidobacterium breve M-16V Optibac Probiotics Professional Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment.
Bifidobacterium breve M-16V Optibac Probiotics Professional Difficulties in developmental follow-up of preterm neonates in a randomised-controlled trial of Bifidobacterium breve M16-V - Experience from Western Australia.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of a Bifidobacterium-Containing Acid-Resistant Microcapsule Formulation on Gut Microbiota: A Pilot Study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of Bifidobacterium breve M-16V supplementation on faecal bifidobacteria in growth restricted very preterm infants - analysis from a randomised trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of probiotics on C-reactive protein levels in preterm infants: Secondary analysis of a randomized controlled trial.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants: A Randomized, Double-blind, Multicenter Study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effects of lactoferrin on neonatal pathogens and Bifidobacterium breve in human breast milk.
Bifidobacterium breve M-16V Optibac Probiotics Professional Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.
Bifidobacterium breve M-16V Optibac Probiotics Professional Evaluation of Porcine Intestinal Epitheliocytes as an In vitro Immunoassay System for the Selection of Probiotic Bifidobacteria to Alleviate Inflammatory Bowel Disease.
Bifidobacterium breve M-16V Optibac Probiotics Professional Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
Bifidobacterium breve M-16V Optibac Probiotics Professional Exploring the Science behind Bifidobacterium breve M-16V in Infant Health.
Bifidobacterium breve M-16V Optibac Probiotics Professional Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans.
Bifidobacterium breve M-16V Optibac Probiotics Professional Gut Microbiota Profile in Children with IgE-Mediated Cow`s Milk Allergy and Cow`s Milk Sensitization and Probiotic Intestinal Persistence Evaluation.
Bifidobacterium breve M-16V Optibac Probiotics Professional Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species.
Bifidobacterium breve M-16V Optibac Probiotics Professional Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression.
Bifidobacterium breve M-16V Optibac Probiotics Professional Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides.
Bifidobacterium breve M-16V Optibac Probiotics Professional Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol.
Bifidobacterium breve M-16V Optibac Probiotics Professional Multi-omics reveals that Bifidobacterium breve M-16V may alleviate the immune dysregulation caused by nanopolystyrene.
Bifidobacterium breve M-16V Optibac Probiotics Professional No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis.
Bifidobacterium breve M-16V Optibac Probiotics Professional Novel immunotherapy approaches to food allergy.
Bifidobacterium breve M-16V Optibac Probiotics Professional NutriBrain: protocol for a randomised, double-blind, controlled trial to evaluate the effects of a nutritional product on brain integrity in preterm infants.
Bifidobacterium breve M-16V Optibac Probiotics Professional Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study.
Bifidobacterium breve M-16V Optibac Probiotics Professional Outcomes in preterm small versus appropriate for gestation infants after Bifidobacterium breve M-16 V supplementation.
Bifidobacterium breve M-16V Optibac Probiotics Professional Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice.
Bifidobacterium breve M-16V Optibac Probiotics Professional Preclinical Immunomodulation by the Probiotic Bifidobacterium breve M-16V in Early Life.
Bifidobacterium breve M-16V Optibac Probiotics Professional Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections.
Bifidobacterium breve M-16V Optibac Probiotics Professional Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.
Bifidobacterium breve M-16V Optibac Probiotics Professional Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
Bifidobacterium breve M-16V Optibac Probiotics Professional Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
Bifidobacterium breve M-16V Optibac Probiotics Professional Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model.
Bifidobacterium breve M-16V Optibac Probiotics Professional Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model.
Bifidobacterium breve M-16V Optibac Probiotics Professional Synbiotic containing extensively hydrolyzed formula improves gastrointestinal and atopic symptom severity, growth, caregiver quality of life, and hospital-related healthcare use in infants with cow`s milk allergy.
Bifidobacterium breve M-16V Optibac Probiotics Professional Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis.
Bifidobacterium breve M-16V Optibac Probiotics Professional Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics.
Bifidobacterium breve M-16V Optibac Probiotics Professional Synbiotics-supplemented amino acid-based formula supports adequate growth in cow`s milk allergic infants.
Bifidobacterium breve M-16V Optibac Probiotics Professional The Combination of Bifidobacterium breve and Three Prebiotic Oligosaccharides Modifies Gut Immune and Endocrine Functions in Neonatal Mice.
Bifidobacterium breve M-16V Optibac Probiotics Professional The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.
Bifidobacterium breve M-16V Optibac Probiotics Professional Tolerance development in cow`s milk-allergic infants receiving amino acid-based formula: A randomized controlled trial.
Bifidobacterium breve PRL2020 PharmExtracta / Brevicillin Stick Amoxicillin-Clavulanic Acid Resistance in the Genus Bifidobacterium.
Bifidobacterium breve PRL2020 PharmExtracta / Brevicillin Stick Bifidobacterium breve PRL2020: Antibiotic-Resistant Profile and Genomic Detection of Antibiotic Resistance Determinants.
Bifidobacterium lactis BB-12 Nestlé
Bifidobacterium lactis BB-12 Nestlé "Nourish to Flourish": complementary feeding for a healthy infant gut microbiome-a non-randomised pilot feasibility study.
Bifidobacterium lactis BB-12 Nestlé [Clinical effectiveness of probiotics in complex treatment of infants with cow`s milk allergy].
Bifidobacterium lactis BB-12 Nestlé [Effect of probiotics on the dynamics of gastrointestinal symptoms of food allergy to cow`s milk protein in infants].
Bifidobacterium lactis BB-12 Nestlé [Linex forte in the prevention and treatment of gastrointestinal diseases].
Bifidobacterium lactis BB-12 Nestlé [Role of calcium-alginate gel as protection component of Bifidobacterium lactis BB 12 strain from aggressive agents of gastro-intestical tract].
Bifidobacterium lactis BB-12 Nestlé [The effectiveness of BIFIFORM KIDS in the prevention of the incidence of acute respiratory infections in children].
Bifidobacterium lactis BB-12 Nestlé [The role of a combined probiotic in the treatment of lactase deficiency].
Bifidobacterium lactis BB-12 Nestlé <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12 Improves the State Anxiety and Sports Performance of Young Divers Under Stress Situations: A Single-Arm, Prospective Proof-of-Concept Study.
Bifidobacterium lactis BB-12 Nestlé <i>Bifidobacterium lactis</i> BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization.
Bifidobacterium lactis BB-12 Nestlé <i>In Vitro</i> Effects of Live and Heat-Inactivated <i>Bifidobacterium animalis</i> Subsp. <i>Lactis</i>, BB-12 and <i>Lactobacillus rhamnosus</i> GG on Caco-2 Cells.
Bifidobacterium lactis BB-12 Nestlé A comparative evaluation of probiotic formulations in prevention of dental caries: A clinical study.
Bifidobacterium lactis BB-12 Nestlé A Double-Blind Controlled Study to Evaluate the Effects of Yogurt Enriched with <i>Lactococcus lactis</i> 11/19-B1 and <i>Bifidobacterium lactis</i> on Serum Low-Density Lipoprotein Level and Antigen-Specific Interferon-? Releasing Ability.
Bifidobacterium lactis BB-12 Nestlé A fibre and phenolic-rich flour from Isabel grape by-products with stimulatory effects on distinct probiotics and beneficial impacts on human colonic microbiota in vitro.
Bifidobacterium lactis BB-12 Nestlé A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
Bifidobacterium lactis BB-12 Nestlé A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients.
Bifidobacterium lactis BB-12 Nestlé A prebiotic mixture improved Lactobacillus acidophilus and Bifidobacterium animalis gastrointestinal in vitro resistance in petit-suisse.
Bifidobacterium lactis BB-12 Nestlé A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
Bifidobacterium lactis BB-12 Nestlé Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
Bifidobacterium lactis BB-12 Nestlé Acerola (Malpighia glabra L.) and guava (Psidium guayaba L.) industrial processing by-products stimulate probiotic Lactobacillus and Bifidobacterium growth and induce beneficial changes in colonic microbiota.
Bifidobacterium lactis BB-12 Nestlé Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings.
Bifidobacterium lactis BB-12 Nestlé Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age.
Bifidobacterium lactis BB-12 Nestlé Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation.
Bifidobacterium lactis BB-12 Nestlé Advantageous direct quantification of viable closely related probiotics in petit-suisse cheeses under in vitro gastrointestinal conditions by Propidium Monoazide--qPCR.
Bifidobacterium lactis BB-12 Nestlé Alginate- and gellan-based edible films for probiotic coatings on fresh-cut fruits.
Bifidobacterium lactis BB-12 Nestlé Antiallergic effects of probiotics.
Bifidobacterium lactis BB-12 Nestlé Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.
Bifidobacterium lactis BB-12 Nestlé Antimicrobial activity of bacteriocin-like inhibitory substance produced by Pediococcus pentosaceus: from shake flasks to bioreactor.
Bifidobacterium lactis BB-12 Nestlé Antimicrobial effect of probiotics on bacterial species from dental plaque.
Bifidobacterium lactis BB-12 Nestlé Antimicrobial potential of commercial silver nanoparticles and the characterization of their physical properties toward probiotic bacteria isolated from fermented milk products.
Bifidobacterium lactis BB-12 Nestlé Antioxidant, physicochemical, microbiological, and sensory properties of probiotic yoghurt incorporated with various Annona species pulp.
Bifidobacterium lactis BB-12 Nestlé Antiproliferative and apoptotic effects of probiotic whey dairy beverages in human prostate cell lines.
Bifidobacterium lactis BB-12 Nestlé Application of Cheese Whey Containing Postbiotics of Lactobacillus acidophilus LA5 and Bifidobacterium animalis BB12 as a Preserving Liquid in High-Moisture Mozzarella.
Bifidobacterium lactis BB-12 Nestlé Application of Probiotics in Folate Bio-Fortification of Yoghurt.
Bifidobacterium lactis BB-12 Nestlé Assessing inhibitory activity of probiotic culture supernatants against Pseudomonas aeruginosa: a comparative methodology between agar diffusion, broth culture and microcalorimetry.
Bifidobacterium lactis BB-12 Nestlé Assessment of mucosal inflammation and blood flow in response to four weeks` intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).
Bifidobacterium lactis BB-12 Nestlé Assessment of Physicochemical and Rheological Properties of Xylo-Oligosaccharides and Glucose-Enriched Doughs Fermented with BB-12.
Bifidobacterium lactis BB-12 Nestlé Assessment of Probiotic Viability during Cheddar Cheese Manufacture and Ripening Using Propidium Monoazide-PCR Quantification.
Bifidobacterium lactis BB-12 Nestlé Assessment of stress tolerance acquisition in the heat-tolerant derivative strains of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus rhamnosus GG.
Bifidobacterium lactis BB-12 Nestlé Assessment of the effect of stress-tolerance acquisition on some basic characteristics of specific probiotics.
Bifidobacterium lactis BB-12 Nestlé Bacillus coagulans GBI-30, 6086 (BC30) improves lactose digestion in rats exposed to a high-lactose meal.
Bifidobacterium lactis BB-12 Nestlé Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms.
Bifidobacterium lactis BB-12 Nestlé Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis ssp. lactis BB-12 enumeration by quantitative PCR assay in microcapsules with full-fat goat milk and inulin-type fructans.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: a randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers - Randomized, double blind, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium animalis subsp. lactis XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium lactis Bb-12 and Lactobacillus salivarius UCC500 modify carboxylic acid formation in the hindgut of rats given pectin, inulin, and lactitol.
Bifidobacterium lactis BB-12 Nestlé Bifidobacterium microbiota and parameters of immune function in elderly subjects.
Bifidobacterium lactis BB-12 Nestlé Bioactive compounds and prebiotic activity in Thailand-grown red and white guava fruit (Psidium guajava L.).
Bifidobacterium lactis BB-12 Nestlé Biochemical and kinetic characterisation of a novel xylooligosaccharide-upregulated GH43 ß-d-xylosidase/a-l-arabinofuranosidase (BXA43) from the probiotic Bifidobacterium animalis subsp. lactis BB-12.
Bifidobacterium lactis BB-12 Nestlé Biochemical patterns in ovine cheese: influence of probiotic strains.
Bifidobacterium lactis BB-12 Nestlé Breastfeeding-associated microbiota in human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and Bifidobacterium animalis ssp. lactis Bb-12.
Bifidobacterium lactis BB-12 Nestlé Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé Catabolism of glucose and lactose in Bifidobacterium animalis subsp. lactis, studied by 13C Nuclear Magnetic Resonance.
Bifidobacterium lactis BB-12 Nestlé Cereal bars functionalized through Bifidobacterium animalis subsp. lactis BB-12 and inulin incorporated in edible coatings of whey protein isolate or alginate.
Bifidobacterium lactis BB-12 Nestlé Characteristics of probiotic yoghurts supplemented with Pu-erh tea infusion.
Bifidobacterium lactis BB-12 Nestlé Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.
Bifidobacterium lactis BB-12 Nestlé Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé Combination of the Probiotics <i>Lacticaseibacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial.
Bifidobacterium lactis BB-12 Nestlé Combined effects of inoculation level and sequence on biochemical and microbiological characteristics of probiotic doogh.
Bifidobacterium lactis BB-12 Nestlé Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats.
Bifidobacterium lactis BB-12 Nestlé Combined transcriptome and proteome analysis of Bifidobacterium animalis subsp. lactis BB-12 grown on xylo-oligosaccharides and a model of their utilization.
Bifidobacterium lactis BB-12 Nestlé Comparative analysis of an intestinal strain of Bifidobacterium longum and a strain of Bifidobacterium animalis subspecies lactis in Cheddar cheese.
Bifidobacterium lactis BB-12 Nestlé Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: a systematic review and network meta-analysis.
Bifidobacterium lactis BB-12 Nestlé Comparative effects of probiotic and paraprobiotic addition on microbiological, biochemical and physical properties of yogurt.
Bifidobacterium lactis BB-12 Nestlé Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties.
Bifidobacterium lactis BB-12 Nestlé Comparison of restorative materials and surface alterations after prebiotic and probiotic beverages: A nanoindentation and SEM study.
Bifidobacterium lactis BB-12 Nestlé Complete genome sequence of Bifidobacterium animalis subsp. lactis BB-12, a widely consumed probiotic strain.
Bifidobacterium lactis BB-12 Nestlé Composition and sensory profiling of probiotic Scamorza ewe milk cheese.
Bifidobacterium lactis BB-12 Nestlé Compositional assessment of bacterial communities in probiotic supplements by means of metagenomic techniques.
Bifidobacterium lactis BB-12 Nestlé Consumption effect of a synbiotic beverage made from soy and yacon extracts containing Bifidobacterium animalis ssp. lactis BB-12 on the intestinal polyamine concentrations in elderly individuals.
Bifidobacterium lactis BB-12 Nestlé Consumption of Bifidobacterium animalis subsp. lactis BB-12 impacts upper respiratory tract infection and the function of NK and T cells in healthy adults.
Bifidobacterium lactis BB-12 Nestlé Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults.
Bifidobacterium lactis BB-12 Nestlé Correction: Efficacy of <i>Bifidobacterium animalis</i> subsp. lactis (BB-12), B. <i>infantis</i> and <i>Lactobacillus acidophilus</i> (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study Protocol.
Bifidobacterium lactis BB-12 Nestlé Degradation of 16S rRNA and attributes of viability of viable but nonculturable probiotic bacteria.
Bifidobacterium lactis BB-12 Nestlé Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.
Bifidobacterium lactis BB-12 Nestlé Determination of microbiological and chemical properties of probiotic boza and its consumer acceptability.
Bifidobacterium lactis BB-12 Nestlé Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo[a]pyrene by a modified Ames test.
Bifidobacterium lactis BB-12 Nestlé Development and characterization of an innovative synbiotic fermented beverage based on vegetable soybean.
Bifidobacterium lactis BB-12 Nestlé Development and Comparative Evaluation of a Novel Fermented Juice Mixture with Probiotic Strains of Lactic Acid Bacteria and Bifidobacteria.
Bifidobacterium lactis BB-12 Nestlé Development and in vitro evaluation of an Escherichia coli probiotic able to inhibit the growth of pathogenic Escherichia coli K88.
Bifidobacterium lactis BB-12 Nestlé Development and Validation of a Bioanalytical Method for 3`- and 6`-Sialyllactose in Minipig Liver and Kidney Using Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Analysis of Tissue Distribution.
Bifidobacterium lactis BB-12 Nestlé Development of a rapid SNP-typing assay to differentiate Bifidobacterium animalis ssp. lactis strains used in probiotic-supplemented dairy products.
Bifidobacterium lactis BB-12 Nestlé Dissolution of xylitol from a food supplement administered with a novel slow-release pacifier: preliminary results.
Bifidobacterium lactis BB-12 Nestlé Does Maternal Perinatal Probiotic Supplementation Alter the Intestinal Microbiota of Mother and Child?
Bifidobacterium lactis BB-12 Nestlé Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Bifidobacterium lactis BB-12 Nestlé Drivers of liking for yogurt drinks with prebiotics and probiotics.
Bifidobacterium lactis BB-12 Nestlé Early gut mycobiota and mother-offspring transfer.
Bifidobacterium lactis BB-12 Nestlé Effect of 2 types of resistant starches on the quality of yogurt.
Bifidobacterium lactis BB-12 Nestlé Effect of a multistrain probiotic (Lactoflorene(®) Plus) on inflammatory parameters and microbiota composition in subjects with stress-related symptoms.
Bifidobacterium lactis BB-12 Nestlé Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents.
Bifidobacterium lactis BB-12 Nestlé Effect of a probiotic mixed culture on texture profile and sensory performance of Minas fresh cheese in comparison with the traditional products.
Bifidobacterium lactis BB-12 Nestlé Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria.
Bifidobacterium lactis BB-12 Nestlé Effect of Auricularia auricula aqueous extract on survival of Lactobacillus acidophilus La-5 and Bifidobacterium bifidum Bb-12 and on sensorial and functional properties of synbiotic yogurt.
Bifidobacterium lactis BB-12 Nestlé Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn`s Disease: A Prospective Pilot Study.
Bifidobacterium lactis BB-12 Nestlé Effect of Feeding Soy Milk Fermented by Probiotic Bacteria on Some Blood Criteria and Weight of Experimental Animals.
Bifidobacterium lactis BB-12 Nestlé Effect of full-fat goat`s milk and prebiotics use on Bifidobacterium BB-12 survival and on the physical properties of spray-dried powders under storage conditions.
Bifidobacterium lactis BB-12 Nestlé Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota.
Bifidobacterium lactis BB-12 Nestlé Effect of green tea supplementation on the microbiological, antioxidant, and sensory properties of probiotic milks.
Bifidobacterium lactis BB-12 Nestlé Effect of inulin polymerization degree on various properties of synbiotic fermented milk including Lactobacillus acidophilus La-5 and Bifidobacterium animalis Bb-12.
Bifidobacterium lactis BB-12 Nestlé Effect of kynurenic acid on the viability of probiotics in vitro.
Bifidobacterium lactis BB-12 Nestlé Effect of Lactobacillus rhamnosus and Bifidobacterium lactis on gingival health, dental plaque, and periodontopathogens in adolescents: a randomised placebo-controlled clinical trial.
Bifidobacterium lactis BB-12 Nestlé Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections.
Bifidobacterium lactis BB-12 Nestlé Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome.
Bifidobacterium lactis BB-12 Nestlé Effect of Probiotic Containing Ice-cream on Salivary Mutans Streptococci (SMS) Levels in Children of 6-12 Years of Age: A Randomized Controlled Double Blind Study with Six-months Follow Up.
Bifidobacterium lactis BB-12 Nestlé Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial.
Bifidobacterium lactis BB-12 Nestlé Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical Trial.
Bifidobacterium lactis BB-12 Nestlé Effect of Probiotic Yogurt Supplementation(Bifidobacterium animalis ssp. lactis BB-12) on Gut Microbiota of Female Taekwondo Athletes and Its Relationship with Exercise-Related Psychological Fatigue.
Bifidobacterium lactis BB-12 Nestlé Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: a Randomized Double-Blind Placebo-Controlled Study.
Bifidobacterium lactis BB-12 Nestlé Effect of probiotics on thymus size and markers of infection in late infancy: a randomized controlled trial.
Bifidobacterium lactis BB-12 Nestlé Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
Bifidobacterium lactis BB-12 Nestlé Effect of the addition of the probiotic Bifidobacterium animalis subsp. Lactis (BB-12) in free and microencapsulated form and the prebiotic inulin to synbiotic dry coppa.
Bifidobacterium lactis BB-12 Nestlé Effect of the incorporation of Bifidobacterium BB-12 microencapsulated with sweet whey and inulin on the properties of Greek-style yogurt.
Bifidobacterium lactis BB-12 Nestlé Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Bifidobacterium lactis BB-12 Nestlé Effects of added Lactobacillus acidophilus and Bifidobacterium lactis probiotics on the quality characteristics of goat ricotta and their survival under simulated gastrointestinal conditions.
Bifidobacterium lactis BB-12 Nestlé Effects of Apricot Fibre on the Physicochemical Characteristics, the Sensory Properties and Bacterial Viability of Nonfat Probiotic Yoghurts.
Bifidobacterium lactis BB-12 Nestlé Effects of beta-glucan addition to a probiotic containing yogurt.
Bifidobacterium lactis BB-12 Nestlé Effects of Bifidobacterium animalis subsp. lactis BB-12<sup>®</sup> on the lipid/lipoprotein profile and short chain fatty acids in healthy young adults: a randomized controlled trial.
Bifidobacterium lactis BB-12 Nestlé Effects of food matrix and probiotics on the bioavailability of curcumin in different nanoformulations.
Bifidobacterium lactis BB-12 Nestlé Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life.
Bifidobacterium lactis BB-12 Nestlé Effects of inulin and oligofructose on the rheological characteristics and probiotic culture survival in low-fat probiotic ice cream.
Bifidobacterium lactis BB-12 Nestlé Effects of probiotic and magnesium co-supplementation on mood, cognition, intestinal barrier function and inflammation in individuals with obesity and depressed mood: A randomized, double-blind placebo-controlled clinical trial.
Bifidobacterium lactis BB-12 Nestlé Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial.
Bifidobacterium lactis BB-12 Nestlé Effects of probiotics on the content and bioaccessibility of phenolic compounds in red pitaya pulp.
Bifidobacterium lactis BB-12 Nestlé Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bifidobacterium lactis BB-12 Nestlé Efficacy of Bifidobacterium animalis subsp. lactis, BB-12(®) on infant colic - a randomised, double-blinded, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé Efficacy of Probiotic Therapy on Atopic Dermatitis in Adults Depends on the C-159T Polymorphism of the <i>CD14</i> Receptor Gene - A Pilot Study.
Bifidobacterium lactis BB-12 Nestlé Electrospun probiotics: an alternative for encapsulation.
Bifidobacterium lactis BB-12 Nestlé Encapsulated Bifidobacterium BB-12 addition in a concentrated lactose-free yogurt: Its survival during storage and effects on the product`s properties.
Bifidobacterium lactis BB-12 Nestlé Encapsulation of Bifidobacterium animalis subsp. lactis Through Emulsification Coupled with External Gelation for the Development of Synbiotic Systems.
Bifidobacterium lactis BB-12 Nestlé Enhancement of bifidobacteria survival by Williopsis saturnus var. saturnus in milk.
Bifidobacterium lactis BB-12 Nestlé Enhancement of gene expression by a peptide p(CHWPR) produced by Bifidobacterium lactis BB-12.
Bifidobacterium lactis BB-12 Nestlé Enumeration of the contaminating bacterial microbiota in unfermented pasteurized milks enriched with probiotic bacteria.
Bifidobacterium lactis BB-12 Nestlé Evaluation of culture media for selective enumeration of bifidobacteria and lactic acid bacteria.
Bifidobacterium lactis BB-12 Nestlé Evaluation of probiotic survivability in yogurt exposed to cold chain interruption.
Bifidobacterium lactis BB-12 Nestlé Evaluation of the effect of supplementing fermented milk with quinoa flour on probiotic activity.
Bifidobacterium lactis BB-12 Nestlé Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé Evaluation of the interaction between microencapsulated Bifidobacterium BB-12 added in goat`s milk Frozen Yogurt and Escherichia coli in the large intestine.
Bifidobacterium lactis BB-12 Nestlé Factors influencing the stability of freeze-dried stress-resilient and stress-sensitive strains of bifidobacteria.
Bifidobacterium lactis BB-12 Nestlé Faecal SIgA secretion in infants fed on pre- or probiotic infant formula.
Bifidobacterium lactis BB-12 Nestlé Fermented probiotic beverages based on acid whey.
Bifidobacterium lactis BB-12 Nestlé Functional Characterization of Fermented Beverages Based on Soy Milk and Sea Buckthorn Powder.
Bifidobacterium lactis BB-12 Nestlé Genome-wide identification of small RNAs in Bifidobacterium animalis subsp. lactis KLDS 2.0603 and their regulation role in the adaption to gastrointestinal environment.
Bifidobacterium lactis BB-12 Nestlé Gut Balance, a synbiotic supplement, increases fecal Lactobacillus paracasei but has little effect on immunity in healthy physically active individuals.
Bifidobacterium lactis BB-12 Nestlé Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial.
Bifidobacterium lactis BB-12 Nestlé Health benefits of <i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subspecies <i>lactis</i> BB-12 in children.
Bifidobacterium lactis BB-12 Nestlé Hematobiochemical and Immunological Responses of Rats Treated with Multi-strain Probiotics and Infected with Trypanosoma brucei.
Bifidobacterium lactis BB-12 Nestlé Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers.
Bifidobacterium lactis BB-12 Nestlé Identification, Characterization, and Antioxidant Potential of Bifidobacterium longum subsp. longum Strains Isolated From Feces of Healthy Infants.
Bifidobacterium lactis BB-12 Nestlé Identifying the essential nutritional requirements of the probiotic bacteria Bifidobacterium animalis and Bifidobacterium longum through genome-scale modeling.
Bifidobacterium lactis BB-12 Nestlé Immune status, well-being and gut microbiota in military supplemented with synbiotic ice cream and submitted to field training: a randomised clinical trial.
Bifidobacterium lactis BB-12 Nestlé Immune system stimulation by probiotic microorganisms.
Bifidobacterium lactis BB-12 Nestlé Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults.
Bifidobacterium lactis BB-12 Nestlé Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication.
Bifidobacterium lactis BB-12 Nestlé Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Bifidobacterium lactis BB-12 Nestlé Impact of inulin and okara on Lactobacillus acidophilus La-5 and Bifidobacterium animalis Bb-12 viability in a fermented soy product and probiotic survival under in vitro simulated gastrointestinal conditions.
Bifidobacterium lactis BB-12 Nestlé Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults.
Bifidobacterium lactis BB-12 Nestlé Impact of whey protein coating incorporated with Bifidobacterium and Lactobacillus on sliced ham properties.
Bifidobacterium lactis BB-12 Nestlé In ovo probiotic supplementation promotes muscle growth and development in broiler embryos.
Bifidobacterium lactis BB-12 Nestlé In vitro angiotensin converting enzyme (ACE)-inhibitory and antioxidant activity of probiotic yogurt incorporated with orange fibre during storage.
Bifidobacterium lactis BB-12 Nestlé In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12.
Bifidobacterium lactis BB-12 Nestlé In vitro gastrointestinal resistance of Lactobacillus acidophilus La-5 and Bifidobacterium animalis Bb-12 in soy and/or milk-based synbiotic apple ice creams.
Bifidobacterium lactis BB-12 Nestlé In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.
Bifidobacterium lactis BB-12 Nestlé In vitro removal of polycyclic aromatic hydrocarbons by lactic acid bacteria.
Bifidobacterium lactis BB-12 Nestlé Incorporation of probiotics (Bifidobacterium animalis subsp. Lactis) into 3D printed mashed potatoes: Effects of variables on the viability.
Bifidobacterium lactis BB-12 Nestlé Incorporation of soybean by-product okara and inulin in a probiotic soy yoghurt: texture profile and sensory acceptance.
Bifidobacterium lactis BB-12 Nestlé Influence of Dehydrated Wheat/Rice Cereal Matrices on Probiotic Activity of <i>Bifidobacterium animalis</i> ssp. <i>lactis</i> BB-12®<sup>§</sup>.
Bifidobacterium lactis BB-12 Nestlé Influence of fermentation time, cryoprotectant and neutralization of cell concentrate on freeze-drying survival, storage stability, and acid and bile exposure of Bifidobacterium animalis ssp. lactis cells produced without milk-based ingredients.
Bifidobacterium lactis BB-12 Nestlé Influence of guabiroba pulp (campomanesia xanthocarpa o. berg) added to fermented milk on probiotic survival under in vitro simulated gastrointestinal conditions.
Bifidobacterium lactis BB-12 Nestlé Influence of lamb rennet paste containing probiotic on proteolysis and rheological properties of pecorino cheese.
Bifidobacterium lactis BB-12 Nestlé Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants.
Bifidobacterium lactis BB-12 Nestlé Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
Bifidobacterium lactis BB-12 Nestlé Influence of the addition of Lactobacillus acidophilus La-05, Bifidobacterium animalis subsp. lactis Bb-12 and inulin on the technological, physicochemical, microbiological and sensory features of creamy goat cheese.
Bifidobacterium lactis BB-12 Nestlé Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits.
Bifidobacterium lactis BB-12 Nestlé Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model.
Bifidobacterium lactis BB-12 Nestlé Insights into physiological traits of Bifidobacterium animalis subsp. lactis BB-12 through membrane proteome analysis.
Bifidobacterium lactis BB-12 Nestlé Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production.
Bifidobacterium lactis BB-12 Nestlé Lactic acid fermentation of apricot juice by mono- and mixed cultures of probiotic <i>Lactobacillus</i> and <i>Bifidobacterium</i> strains.
Bifidobacterium lactis BB-12 Nestlé Lactobacillus fermentum ME-3: A Breakthrough in Glutathione Therapy.
Bifidobacterium lactis BB-12 Nestlé Late rather than early responses of human dendritic cells highlight selective induction of cytokines, chemokines and growth factors by probiotic bacteria.
Bifidobacterium lactis BB-12 Nestlé Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials.
Bifidobacterium lactis BB-12 Nestlé Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp. lactis BB-12 on Fecal Microbiota, Gut Transit Time, and Short-Chain Fatty Acids in Healthy Young Adults.
Bifidobacterium lactis BB-12 Nestlé Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line.
Bifidobacterium lactis BB-12 Nestlé Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance.
Bifidobacterium lactis BB-12 Nestlé Microencapsulation of L. acidophilus (La-05) and B. lactis (Bb-12) and evaluation of their survival at the pH values of the stomach and in bile.
Bifidobacterium lactis BB-12 Nestlé Microencapsulation of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis BB-12 in pectin and sodium alginate: A comparative study on viability, stability, and structure.
Bifidobacterium lactis BB-12 Nestlé Milk fat protects Bifidobacterium animalis subsp. lactis Bb-12 from in vitro gastrointestinal stress in potentially synbiotic table spreads.
Bifidobacterium lactis BB-12 Nestlé Modulation of the intestinal microbiota and the metabolites produced by the administration of ice cream and a dietary supplement containing the same probiotics.
Bifidobacterium lactis BB-12 Nestlé Monoassociation of Preterm Germ-Free Piglets with <i>Bifidobacterium animalis</i> Subsp. <i>lactis</i> BB-12 and Its Impact on Infection with <i>Salmonella</i> Typhimurium.
Bifidobacterium lactis BB-12 Nestlé Mucosal blood flow in pouchitis.
Bifidobacterium lactis BB-12 Nestlé Myosin-cross-reactive antigens from four different lactic acid bacteria are fatty acid hydratases.
Bifidobacterium lactis BB-12 Nestlé Ohmic heating as a method of obtaining paraprobiotics: Impacts on cell structure and viability by flow cytometry.
Bifidobacterium lactis BB-12 Nestlé Outcome of four weeks` intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis.
Bifidobacterium lactis BB-12 Nestlé PCR-ELISA II: Analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation.
Bifidobacterium lactis BB-12 Nestlé Performances of new isolates of Bifidobacterium on fermentation of soymilk.
Bifidobacterium lactis BB-12 Nestlé Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial.
Bifidobacterium lactis BB-12 Nestlé Physiological Effects of Whey- and Milk-Based Probiotic Yogurt in Rats.
Bifidobacterium lactis BB-12 Nestlé Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial.
Bifidobacterium lactis BB-12 Nestlé Potential of bacteriocins produced by probiotic bacteria isolated from tiger shrimp and prawns as antibacterial to Vibrio,  Pseudomonas, and Aeromonas species on fish.
Bifidobacterium lactis BB-12 Nestlé Prebiotic activity of monofloral honeys produced by stingless bees in the semi-arid region of Brazilian Northeastern toward Lactobacillus acidophilus LA-05 and Bifidobacterium lactis BB-12.
Bifidobacterium lactis BB-12 Nestlé Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink.
Bifidobacterium lactis BB-12 Nestlé Probiotic BC30 Improves Amino Acid Absorption from Plant Protein Concentrate in Older Women.
Bifidobacterium lactis BB-12 Nestlé Probiotic Beverage From Pineapple Juice Fermented With <i>Lactobacillus</i> and <i>Bifidobacterium</i> Strains.
Bifidobacterium lactis BB-12 Nestlé Probiotic Bifidobacterium lactis, anti-oxidant vitamin E/C and anti-inflammatory dha attenuate lung inflammation due to pm2.5 exposure in mice.
Bifidobacterium lactis BB-12 Nestlé Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Bifidobacterium lactis BB-12 Nestlé Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats.
Bifidobacterium lactis BB-12 Nestlé Probiotic fermented beverages based on acid whey.
Bifidobacterium lactis BB-12 Nestlé Probiotic infant cereal improves children`s gut microbiota: Insights using the Simulator of Human Intestinal Microbial Ecosystem (SHIME®).
Bifidobacterium lactis BB-12 Nestlé Probiotic intervention influences the salivary levels of Matrix Metalloproteinase (MMP)-9 and Tissue Inhibitor of metalloproteinases (TIMP)-1 in healthy adults.
Bifidobacterium lactis BB-12 Nestlé Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity.
Bifidobacterium lactis BB-12 Nestlé Probiotic Sheep Milk Ice Cream with Inulin and Apple Fiber.
Bifidobacterium lactis BB-12 Nestlé Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis.
Bifidobacterium lactis BB-12 Nestlé Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
Bifidobacterium lactis BB-12 Nestlé Probiotic viability and physico-chemical and sensory properties of plain and stirred fruit yogurts made from goat`s milk.
Bifidobacterium lactis BB-12 Nestlé Probiotic Yogurt Culture Bifidobacterium Animalis Subsp. Lactis BB-12 and Lactobacillus Acidophilus LA-5 Modulate the Cytokine Secretion by Peripheral Blood Mononuclear Cells from Patients with Ulcerative Colitis.
Bifidobacterium lactis BB-12 Nestlé Probiotic Yogurt for the Prevention of Antibiotic-associated Diarrhea in Adults: A Randomized Double-blind Placebo-controlled Trial.
Bifidobacterium lactis BB-12 Nestlé Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma.
Bifidobacterium lactis BB-12 Nestlé Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.
Bifidobacterium lactis BB-12 Nestlé Probiotics Evaluation in Oncological Surgery: A Systematic Review of 36 Randomized Controlled Trials Assessing 21 Diverse Formulations.
Bifidobacterium lactis BB-12 Nestlé Probiotics for Preventing Necrotizing Enterocolitis in Preterm Infants: A Network Meta-Analysis.
Bifidobacterium lactis BB-12 Nestlé Probiotics for respiratory tract infections in children attending day care centers-a systematic review.
Bifidobacterium lactis BB-12 Nestlé Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial.
Bifidobacterium lactis BB-12 Nestlé Probiotics in the management of atopic eczema.
Bifidobacterium lactis BB-12 Nestlé Profile of Volatile Compounds in Dessert Yogurts Prepared from Cow and Goat Milk, Using Different Starter Cultures and Probiotics.
Bifidobacterium lactis BB-12 Nestlé Protein profiles from intact cells as a tool in Bifidobacterium characteristics.
Bifidobacterium lactis BB-12 Nestlé Proteolysis in goat "coalho" cheese supplemented with probiotic lactic acid bacteria.
Bifidobacterium lactis BB-12 Nestlé Proteolytic and ACE-inhibitory activities of probiotic yogurt containing non-viable bacteria as affected by different levels of fat, inulin and starter culture.
Bifidobacterium lactis BB-12 Nestlé Protocol for a double-blind placebo-controlled trial to evaluate the efficacy of probiotics in reducing antibiotics for infection in care home residents: the Probiotics to Reduce Infections iN CarE home reSidentS (PRINCESS) trial.
Bifidobacterium lactis BB-12 Nestlé Quantification of live and dead probiotic bacteria in lyophilised product by real-time PCR and by flow cytometry.
Bifidobacterium lactis BB-12 Nestlé Raffinose family of oligosaccharides from lupin seeds as prebiotics: application in dairy products.
Bifidobacterium lactis BB-12 Nestlé Randomised clinical trial of synbiotic therapy in elective surgical patients.
Bifidobacterium lactis BB-12 Nestlé Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
Bifidobacterium lactis BB-12 Nestlé Randomized, double-blind, placebo-controlled study of synbiotic yogurt effect on the health of children.
Bifidobacterium lactis BB-12 Nestlé Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation.
Bifidobacterium lactis BB-12 Nestlé Reduction in the Choking Phenomenon in Elite Diving Athletes Through Changes in Gut Microbiota Induced by Yogurt Containing <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12: A Quasi Experimental Study.
Bifidobacterium lactis BB-12 Nestlé Restitution of gut microbiota in Ugandan children administered with probiotics (<i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12) during treatment for severe acute malnutrition.
Bifidobacterium lactis BB-12 Nestlé Safety and the probiotic potential of Bifidobacterium animalis CP-9.
Bifidobacterium lactis BB-12 Nestlé Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study.
Bifidobacterium lactis BB-12 Nestlé Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
Bifidobacterium lactis BB-12 Nestlé Safety of Bifidobacterium animalis Subsp. Lactis (B. lactis) Strain BB-12-Supplemented Yogurt in Healthy Children.
Bifidobacterium lactis BB-12 Nestlé Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5.
Bifidobacterium lactis BB-12 Nestlé Selection of a Bifidobacterium strain to complement resistant starch in a synbiotic yoghurt.
Bifidobacterium lactis BB-12 Nestlé Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GG.
Bifidobacterium lactis BB-12 Nestlé Sensory and microbiological quality of yogurt drinks with prebiotics and probiotics.
Bifidobacterium lactis BB-12 Nestlé Sheep Milk Symbiotic Ice Cream: Effect of Inulin and Apple Fiber on the Survival of Five Probiotic Bacterial Strains during Simulated In Vitro Digestion Conditions.
Bifidobacterium lactis BB-12 Nestlé Short communication: Effect of the addition of Bifidobacterium monocultures on the physical, chemical, and sensory characteristics of fermented goat milk.
Bifidobacterium lactis BB-12 Nestlé Short communication: Identification and differentiation of bifidobacteria obtained from Ukraine.
Bifidobacterium lactis BB-12 Nestlé Short communication: incorporation of inulin and transglutaminase in fermented goat milk containing probiotic bacteria.
Bifidobacterium lactis BB-12 Nestlé Short communication: survival of the characteristic microbiota in probiotic fermented camel, cow, goat, and sheep milks during refrigerated storage.
Bifidobacterium lactis BB-12 Nestlé Short communication: Viability of culture organisms in honey-enriched acidophilus-bifidus-thermophilus (ABT)-type fermented camel milk.
Bifidobacterium lactis BB-12 Nestlé Short-term effect of ice-cream containing Bifidobacterium lactis Bb-12 on the number of salivary mutans streptococci and lactobacilli.
Bifidobacterium lactis BB-12 Nestlé Silver carp (Hypophthalmichthys molitrix) by-product hydrolysates: A new nitrogen source for Bifidobacterium animalis ssp. lactis BB-12.
Bifidobacterium lactis BB-12 Nestlé Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus.
Bifidobacterium lactis BB-12 Nestlé Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland.
Bifidobacterium lactis BB-12 Nestlé Specific probiotics in enhancing maturation of IgA responses in formula-fed infants.
Bifidobacterium lactis BB-12 Nestlé Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study.
Bifidobacterium lactis BB-12 Nestlé SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women.
Bifidobacterium lactis BB-12 Nestlé Stability of bifidobacteria entrapped in goat`s whey freeze concentrate and inulin as wall materials and powder properties.
Bifidobacterium lactis BB-12 Nestlé Study of Probiotic Effects of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12 and <i>Lactobacillus plantarum</i> 299v Strains on Biochemical and Morphometric Parameters of Rabbits after Obesity Induction.
Bifidobacterium lactis BB-12 Nestlé Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against <i>Escherichia coli</i>.
Bifidobacterium lactis BB-12 Nestlé Study to investigate the potential of probiotics in children attending school.
Bifidobacterium lactis BB-12 Nestlé Supplementation with fruit and okara soybean by-products and amaranth flour increases the folate production by starter and probiotic cultures.
Bifidobacterium lactis BB-12 Nestlé Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity.
Bifidobacterium lactis BB-12 Nestlé Synbiotic supplementation attenuates the promoting effect of indole-3-carbinol on colon tumorigenesis.
Bifidobacterium lactis BB-12 Nestlé Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
Bifidobacterium lactis BB-12 Nestlé Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Bifidobacterium lactis BB-12 Nestlé The ability of probiotic bacteria to bind to human intestinal mucus.
Bifidobacterium lactis BB-12 Nestlé The Ability of Probiotic Lactobacillus Strains in Removal of Benzo[a]pyrene: a Response Surface Methodology Study.
Bifidobacterium lactis BB-12 Nestlé The acquisition of tolerance toward cow`s milk through probiotic supplementation: a randomized, controlled trial.
Bifidobacterium lactis BB-12 Nestlé The Administration Matrix Modifies the Beneficial Properties of a Probiotic Mix of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5.
Bifidobacterium lactis BB-12 Nestlé The Combined Usage of ß-Cyclodextrin and Milk Proteins in Microencapsulation of Bifidobacterium bifidum BB-12.
Bifidobacterium lactis BB-12 Nestlé The effect of early probiotic exposure on the preterm infant gut microbiome development.
Bifidobacterium lactis BB-12 Nestlé The effect of probiotic bacteria (Lactobacillus acidophilus and Bifidobacterium lactis) on the accumulation of lead in rat brains.
Bifidobacterium lactis BB-12 Nestlé The Effect of Probiotic Strains on Myocardial Infarction Size, Biochemical and Immunological Parameters in Rats with Systemic Inflammatory Response Syndrome and Polymorbidity.
Bifidobacterium lactis BB-12 Nestlé The effect of probiotic supplementation on the gut microbiota of preterm infants.
Bifidobacterium lactis BB-12 Nestlé The effect of probiotics on the genotoxicity of furazolidone.
Bifidobacterium lactis BB-12 Nestlé The effect of yogurt co-fortified with probiotic and vitamin D on lipid profile, anthropometric indices and serum 25-hydroxi vitamin D in obese adult: A Double-Blind Randomized- Controlled Trial.
Bifidobacterium lactis BB-12 Nestlé The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial.
Bifidobacterium lactis BB-12 Nestlé The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects.
Bifidobacterium lactis BB-12 Nestlé The impact of inoculation rate and order on physicochemical, microstructural and sensory attributes of probiotic doogh.
Bifidobacterium lactis BB-12 Nestlé The influence of probiotics on gastrointestinal tract infections among children attending childcare: A systematic review and meta-analysis.
Bifidobacterium lactis BB-12 Nestlé The possible causal relationship between fragmentation of genomic DNA and formation of viable, but non-culturable probiotic bacteria upon storage in dry state.
Bifidobacterium lactis BB-12 Nestlé The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants.
Bifidobacterium lactis BB-12 Nestlé The resistance of Bacillus, Bifidobacterium, and Lactobacillus strains with claimed probiotic properties in different food matrices exposed to simulated gastrointestinal tract conditions.
Bifidobacterium lactis BB-12 Nestlé The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®).
Bifidobacterium lactis BB-12 Nestlé The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial.
Bifidobacterium lactis BB-12 Nestlé The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12<sup>®</sup> in infant colic: A randomised, double blind, placebo-controlled trial.
Bifidobacterium lactis BB-12 Nestlé Thymus gland size during recovery from complicated severe acute malnutrition: a prospective study of the role of probiotics.
Bifidobacterium lactis BB-12 Nestlé Topical Lactiplantibacillus plantarum LB244R® ointment alleviates skin aging: An exploratory trial.
Bifidobacterium lactis BB-12 Nestlé Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.
Bifidobacterium lactis BB-12 Nestlé Updated Genome Sequence for the Probiotic Bacterium Bifidobacterium animalis subsp. lactis BB-12.
Bifidobacterium lactis BB-12 Nestlé Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study.
Bifidobacterium lactis BB-12 Nestlé Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3 as prophylaxis to reduce the incidence of acute gastroenteritis and upper respiratory tract infections in children.
Bifidobacterium lactis BB-12 Nestlé Use of probiotics in the NICU: Evaluating the stability of a three-strain probiotic blend in various media for enteral feeding.
Bifidobacterium lactis BB-12 Nestlé Xanthan gum modified fish gelatin and binary culture modulates the metabolism of probiotics in fermented milk mainly via amino acid metabolism pathways.
Bifidobacterium lactis BB-12 Nestlé Xylo-oligosaccharide alleviates Salmonella induced inflammation by stimulating Bifidobacterium animalis and inhibiting Salmonella colonization.
Bifidobacterium lactis Bi-07 UltraFlora® Balance <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
Bifidobacterium lactis Bi-07 UltraFlora® Balance <i>Ex vivo</i> peripheral blood mononuclear cell response to R848 in children after supplementation with the probiotic <i>Lactobacillus acidophilus</i> NCFM/<i>Bifidobacterium lactis</i> Bi-07.
Bifidobacterium lactis Bi-07 UltraFlora® Balance A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial.
Bifidobacterium lactis Bi-07 UltraFlora® Balance A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO).
Bifidobacterium lactis Bi-07 UltraFlora® Balance Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria.
Bifidobacterium lactis Bi-07 UltraFlora® Balance An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Bifidobacterium lactis Bi-07 UltraFlora® Balance An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Complete genome sequences of probiotic strains Bifidobacterium animalis subsp. lactis B420 and Bi-07.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing <i>Saccharomyces</i> to a Mixture of <i>Lactobacillus, Bifidobacterium</i>, and <i>Saccharomyces</i>.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot study.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of homogenization techniques on reducing the size of microcapsules and the survival of probiotic bacteria therein.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of probiotic supplementation on plasma metabolite profile after Roux-Y gastric bypass: a prospective, randomized, double-blind, placebo-controlled clinical trial.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis bi-07) in improving symptoms of constipation.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effect of various encapsulating materials on the stability of probiotic bacteria.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Supplementation on Nutritional and Metabolic Parameters in the Early Postoperative Period after Roux-en-Y Gastric Bypass: a Randomized, Double-Blind, Placebo-Controlled Trial.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Engineered living materials for the conversion of a low-cost food-grade precursor to a high-value flavonoid.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Engineered Probiotic-Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Engineering E. coli strains using antibiotic-resistance-gene-free plasmids.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Enhancing the biotransformation of isoflavones in soymilk supplemented with lactose using probiotic bacteria during extended fermentation.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Fermentation of protopanaxadiol type ginsenosides (PD) with probiotic Bifidobacterium lactis and Lactobacillus rhamnosus.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals.
Bifidobacterium lactis Bi-07 UltraFlora® Balance HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Locked Nucleic Acid Hydrolysis Probes for the Specific Identification of Probiotic Strains Bifidobacterium animalis subsp. lactis DSM 15954 and Bi-07™.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Metabonomic strategy for the detection of metabolic effects of probiotics combined with prebiotic supplementation in weaned rats.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Microbiota-Derived Extracellular Vesicles Promote Immunity and Intestinal Maturation in Suckling Rats.
Bifidobacterium lactis Bi-07 UltraFlora® Balance New compound probiotic beverage protects against antibiotic-associated diarrhea in mice by modulating the microbiota.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Optimization of Viability Treatment Essential for Accurate Droplet Digital PCR Enumeration of Probiotics.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Oral administration of fermented milk supplemented with synbiotics can influence the physiological condition of Wistar rats in a dose-sensitive and sex-specific manner.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotic effects on cold and influenza-like symptom incidence and duration in children.
Bifidobacterium lactis Bi-07 UltraFlora® Balance PROBIOTIC SUPPLEMENTATION ATTENUATES BINGE EATING AND FOOD ADDICTION 1 YEAR AFTER ROUX-EN-Y GASTRIC BYPASS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Probiotics Modulate Intestinal Motility and Inflammation in Zebrafish Models.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Randomized controlled trial of probiotics after colonoscopy.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Safety evaluation of HOWARU<sup>®</sup> Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Simulating colonic survival of probiotics in single-strain products compared to multi-strain products.
Bifidobacterium lactis Bi-07 UltraFlora® Balance The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Bifidobacterium lactis Bi-07 UltraFlora® Balance The effect of probiotics and polysaccharides on the gut microbiota composition and function of weaned rats.
Bifidobacterium lactis Bi-07 UltraFlora® Balance Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO).
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics A ß1-6/ß1-3 galactosidase from Bifidobacterium animalis subsp. lactis Bl-04 gives insight into sub-specificities of ß-galactoside catabolism within Bifidobacterium.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Absolute Enumeration of Probiotic Strains <i>Lactobacillus acidophilus</i> NCFM<sup>®</sup> and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bl-04 <b><sup>®</sup></b> via Chip-Based Digital PCR.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics An ATP Binding Cassette Transporter Mediates the Uptake of a-(1,6)-Linked Dietary Oligosaccharides in Bifidobacterium and Correlates with Competitive Growth on These Substrates.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Complete Genome Sequence of Lactobacillus reuteri PNW1, a Promising Probiotic Candidate.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Complete Genome Sequence of Lactobacillus reuteri SKKU-OGDONS-01, Isolated from a Chicken`s Small Intestine.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing <i>Saccharomyces</i> to a Mixture of <i>Lactobacillus, Bifidobacterium</i>, and <i>Saccharomyces</i>.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Draft Genome Sequence of Enterococcus faecalis Strain CECT7121, a Corn Silage Isolate with Antibacterial Activity against Gram-Positive Pathogens.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Droplet Digital PCR Is an Improved Alternative Method for High-Quality Enumeration of Viable Probiotic Strains.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effect of Bifidobacterium animalis spp. lactis Bl-04 on Rhinovirus-Induced Colds: A Randomized, Placebo-Controlled, Single-Center, Phase II Trial in Healthy Volunteers.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effect of fermented milk on upper respiratory tract infection in adults who lived in the haze area of Northern China: a randomized clinical trial.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effect of various encapsulating materials on the stability of probiotic bacteria.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effects of Bacterial Lysates and Metabolites on Collagen Homeostasis in TNF-a-Challenged Human Dermal Fibroblasts.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Genetic and physiological responses of Bifidobacterium animalis subsp. lactis to hydrogen peroxide stress.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Genome analysis revealed a repertoire of oligosaccharide utilizing CAZymes in Weissella confusa CCK931 and Weissella cibaria YRK005.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Genome sequence of Corynebacterium amycolatum ICIS 99 isolated from human vagina reveals safety and beneficial properties.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Improved single-cell genome amplification by a high-efficiency phi29 DNA polymerase.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Intrinsic and inducible resistance to hydrogen peroxide in Bifidobacterium species.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Limosilactobacillus walteri sp. nov., a novel probiotic antimicrobial lipopeptide-producing bacterium.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Metabiotics Signature through Genome Sequencing and In Vitro Inhibitory Assessment of a Novel Lactococcus lactis Strain UTNCys6-1 Isolated from Amazonian Camu-Camu Fruits.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Molecular evolutionary and 3D protein structural analyses of Lactobacillus fermentum elongation factor Tu, a novel brain health promoting factor.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Potential of Inactivated Bifidobacterium Strain in Attenuating Benzo(A)Pyrene Exposure-Induced Damage in Colon Epithelial Cells In Vitro.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Production of bacteriocin-like inhibitory substance by Bifidobacterium lactis in skim milk supplemented with additives.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Purification, characterization and probiotic proliferation effect of exopolysaccharides produced by Lactiplantibacillus plantarum HDC-01 isolated from sauerkraut.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Safety evaluation of HOWARU<sup>®</sup> Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Simulating colonic survival of probiotics in single-strain products compared to multi-strain products.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Specific probiotics alleviate allergic rhinitis during the birch pollen season.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Strain-specific genotyping of Bifidobacterium animalis subsp. lactis by using single-nucleotide polymorphisms, insertions, and deletions.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Structural basis for arabinoxylo-oligosaccharide capture by the probiotic Bifidobacterium animalis subsp. lactis Bl-04.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Substrate preference of an ABC importer corresponds to selective growth on ß-(1,6)-galactosides in Bifidobacterium animalis subsp. lactis.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics The GH5 1,4-ß-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04.
Bifidobacterium lactis Bl-04 Optibac Probiotics Every Day MAX Probiotics Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline.
Bifidobacterium lactis BL-4 Custom Probiotics Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health In vitro evidence for efficacy in food intolerance for the multispecies probiotic formulation Ecologic® Tolerance (Syngut™).
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Bifidobacterium lactis W51 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Bifidobacterium lactis W52 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Bifidobacterium longum 1714 Zenflore® Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice.
Bifidobacterium longum 1714 Zenflore® Bifidobacteria modulate cognitive processes in an anxious mouse strain.
Bifidobacterium longum 1714 Zenflore® Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers.
Bifidobacterium longum 1714 Zenflore® Bifidobacterium longum 1714 Does Not Modulate Reactivity to Social Stress.
Bifidobacterium longum 1714 Zenflore® Bifidobacterium longum 1714™ Strain Modulates Brain Activity of Healthy Volunteers During Social Stress.
Bifidobacterium longum 1714 Zenflore® Eppur Si Muove: The Cyberball Game Is a Stress Model, and Bifidobacterium longum 1714™ Helps Coping With It.
Bifidobacterium longum 1714 Zenflore® Improvements in sleep indices during exam stress due to consumption of a Bifidobacterium longum.
Bifidobacterium longum 1714 Zenflore® Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.
Bifidobacterium longum 1714 Zenflore® Psychobiotics: Shaping the Mind With Gut Bacteria.
Bifidobacterium longum 35624 Align Acetobacter and lactobacillus alleviate the symptom of insulin resistance by blocking the JNK-JAK/STAT pathway in Drosophila melanogaster.
Bifidobacterium longum 35624 Align An 8-Week Course of Bifidobacterium longum 35624(®) Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome.
Bifidobacterium longum 35624 Align An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism.
Bifidobacterium longum 35624 Align Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex.
Bifidobacterium longum 35624 Align Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms.
Bifidobacterium longum 35624 Align Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial.
Bifidobacterium longum 35624 Align Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response.
Bifidobacterium longum 35624 Align Correction to: Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Bifidobacterium longum 35624 Align Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans.
Bifidobacterium longum 35624 Align Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.
Bifidobacterium longum 35624 Align Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth.
Bifidobacterium longum 35624 Align Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.
Bifidobacterium longum 35624 Align Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
Bifidobacterium longum 35624 Align Effects of Probiotic (<i>Bifidobacterium longum</i> 35624) Supplementation on Exercise Performance, Immune Modulation, and Cognitive Outlook in Division I Female Swimmers.
Bifidobacterium longum 35624 Align Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Bifidobacterium longum 35624 Align Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy.
Bifidobacterium longum 35624 Align Epigenetic Aspects of a New Probiotic Concept-A Pilot Study.
Bifidobacterium longum 35624 Align Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses.
Bifidobacterium longum 35624 Align Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™.
Bifidobacterium longum 35624 Align Going back to prospectively collected results with a probiotic for primary prevention of Clostridium difficile infection at a tertiary-care medical center.
Bifidobacterium longum 35624 Align Identification of two-component regulatory systems in Bifidobacterium infantis by functional complementation and degenerate PCR approaches.
Bifidobacterium longum 35624 Align Is Bifidobacterium a more effective probiotic therapy than Lactobacillus for patients with irritable bowel syndrome?
Bifidobacterium longum 35624 Align Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
Bifidobacterium longum 35624 Align Letter to the Editor.
Bifidobacterium longum 35624 Align Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: an updated systematic review with meta-analysis and trial sequential analysis.
Bifidobacterium longum 35624 Align Limosilactobacillus reuteri DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial.
Bifidobacterium longum 35624 Align Metabolic inputs in the probiotic bacterium Lacticaseibacillus rhamnosus contribute to cell-wall remodeling and increased fitness.
Bifidobacterium longum 35624 Align Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Bifidobacterium longum 35624 Align Probiotic effects of Lactococcus lactis and Leuconostoc mesenteroides on stress and longevity in Caenorhabditis elegans.
Bifidobacterium longum 35624 Align Probiotic interventions promote metabolic health in high fat-fed hamsters in association with gut microbiota and endocannabinoidome alterations.
Bifidobacterium longum 35624 Align Probiotic treatment (Bifidobacterium longum subsp. longum 35624™) affects stress responsivity in male rats after chronic corticosterone exposure.
Bifidobacterium longum 35624 Align Probiotic-derived ecto-5`-nucleotidase produces anti-inflammatory adenosine metabolites in Treg-deficient scurfy mice.
Bifidobacterium longum 35624 Align Probiotic-Derived Ecto-5`-Nucleotidase Produces Anti-Inflammatory Adenosine Metabolites in Treg-Deficient Scurfy Mice.
Bifidobacterium longum 35624 Align Probiotics: an ideal anti-inflammatory treatment for IBS?
Bifidobacterium longum 35624 Align Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
Bifidobacterium longum 35624 Align Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial.
Bifidobacterium longum 35624 Align Seeding the Infant Gut in Early Life-Effects of Maternal and Infant Seeding with Probiotics on Strain Transfer, Microbiota, and Gastrointestinal Symptoms in Healthy Breastfed Infants.
Bifidobacterium longum 35624 Align The effect of probiotic bacteria on transepithelial calcium transport and calcium uptake in human intestinal-like Caco-2 cells.
Bifidobacterium longum 35624 Align The impact of respiratory infections and probiotic use on the nasal microbiota of frail residents in long-term care homes.
Bifidobacterium longum 35624 Align The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects.
Bifidobacterium longum 35624 Align The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses.
Bifidobacterium longum 35624 Align Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Bifidobacterium longum 35624 Align Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes.
Bifidobacterium longum BB536 Probiotic Pro Bb536 <i>In vitro</i> inhibitory activity of <i>Bifidobacterium longum</i> BB536 and <i>Lactobacillus rhamnosus</i> HN001 alone or in combination against bacterial and <i>Candida</i> reference strains and clinical isolates.
Bifidobacterium longum BB536 Probiotic Pro Bb536 A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis.
Bifidobacterium longum BB536 Probiotic Pro Bb536 An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro.
Bifidobacterium longum BB536 Probiotic Pro Bb536 An Infant Milk Formula Supplemented with Heat-Treated Probiotic <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> CECT 8145, Reduces Fat Deposition in <i>C. elegans</i> and Augments Acetate and Lactate in a Fermented Infant Slurry.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: A systematic review and network meta-analysis.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Draft Genome Sequence of Bifidobacterium animalis subsp. lactis Strain CECT 8145, Able To Improve Metabolic Syndrome In Vivo.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of &lt;i&gt;Lactobacillus rhamnosus&lt;/i&gt; HN001 and &lt;i&gt;Bifidobacterium longum&lt;/i&gt; BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of production conditions on the stability of a human bifidobacterial species Bifidobacterium longum in yogurt.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of repeated oral administration of Bifidobacterium longum BB536 on apomorphine-induced rearing behavior in mice.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of <i>Bifidobacterium longum</i> and <i>Lactobacillus rhamnosus</i> on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of Bifidobacterium longum BB536 on lipid profile and histopathological changes in hypercholesterolaemic rats.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Evaluation of Porcine Intestinal Epitheliocytes as an In vitro Immunoassay System for the Selection of Probiotic Bifidobacteria to Alleviate Inflammatory Bowel Disease.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Growth of Bifidobacterium longum BB536 in medida (fermented cereal porridge) and their survival during refrigerated storage.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Gut Microbiota Profile in Children with IgE-Mediated Cow`s Milk Allergy and Cow`s Milk Sensitization and Probiotic Intestinal Persistence Evaluation.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Hypocholesterolaemic effect of yoghurt containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Impact of prebiotics on equol production from soymilk isoflavones by two <i>Bifidobacterium</i> species.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Improved viability of bifidobacteria in fermented milk by cocultivation with Lactococcus lactis subspecies lactis.
Bifidobacterium longum BB536 Probiotic Pro Bb536 In vitro fermentation of oat ß-glucan and hydrolysates by fecal microbiota and selected probiotic strains.
Bifidobacterium longum BB536 Probiotic Pro Bb536 In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.
Bifidobacterium longum BB536 Probiotic Pro Bb536 In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Intake of <i>Bifidobacterium longum</i> and Fructo-oligosaccharides prevents Colorectal Carcinogenesis.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (<i>Bifidobacterium longum</i> BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study).
Bifidobacterium longum BB536 Probiotic Pro Bb536 Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Modulation of T Regulatory and Dendritic Cell Phenotypes Following Ingestion of <i>Bifidobacterium longum</i>, AHCC<sup>®</sup> and Azithromycin in Healthy Individuals.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Oligosaccharides in goats` milk-based infant formula and their prebiotic and anti-infection properties.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Optimization of culture conditions of soymilk for equol production by Bifidobacterium breve 15700 and Bifidobacterium longum BB536.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Th1/Th2 balance in a murine model.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Perioperative supplementation with bifidobacteria improves postoperative nutritional recovery, inflammatory response, and fecal microbiota in patients undergoing colorectal surgery: a prospective, randomized clinical trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Probiotic Strain Bifidobacterium animalis subsp. lactis CECT 8145 Reduces Fat Content and Modulates Lipid Metabolism and Antioxidant Response in Caenorhabditis elegans.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Purification and N-terminal amino acid sequence of fructose-6-phosphate phosphoketolase from Bifidobacterium longum BB536.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Safety evaluation of Bifidobacterium pseudocatenulatum G4 as assessed in BALB/c mice.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
Bifidobacterium longum BB536 Probiotic Pro Bb536 Suppressive effects of Bifidobacterium longum on the production of Th2-attracting chemokines induced with T cell-antigen-presenting cell interactions.
Bifidobacterium longum BB536 Probiotic Pro Bb536 The effect of probiotic fermented milk and inulin on the functions and microecology of the intestine.
Bifidobacterium longum BL-05 Custom Probiotics Development of Whey Protein Concentrate-Pectin-Alginate Based Delivery System to Improve Survival of B. longum BL-05 in Simulated Gastrointestinal Conditions.
Bifidobacterium longum BL-05 Custom Probiotics In vitro growth of four individual human gut bacteria on oligosaccharides produced by chemoenzymatic synthesis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks A Case Report of Bacteremia Due to a Symptomatic and Rare Lactobacillus Rhamnosus Infected Splenic Hematoma and the Ultimate Treatment Model.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks A six-month prospective, randomised, double-blinded, placebo-controlled, crossover, dietary trial design to investigate the potential of psychobiotics on seizure semiology and comorbidities in canine epilepsy: study protocol.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks A systematic review and meta-analysis of randomized controlled trials investigating the effects of probiotics on oxidative stress in healthy adults.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks About Functional Foods: The Probiotics and Prebiotics State of Art.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Antidiabetic Activity of Potential Probiotics Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. Isolated from Fermented Sugarcane Juice: A Comprehensive In Vitro and In Silico Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Apple-derived 3D scaffold for improving gastrointestinal viability and in-situ growth of probiotics.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Association between Pregestational Vaginal Dysbiosis and Incident Hypertensive Disorders of Pregnancy Risk: a Nested Case-Control Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Autonomously Assembled Living Capsules by Microbial Coculture for Enhanced Bacteriotherapy of Inflammatory Bowel Disease.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Characterization of some potentially probiotic Lactobacillus strains isolated from Iranian native chickens.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Dietary host-associated Bacillus subtilis supplementation improves intestinal microbiota, health and disease resistance in Chinese perch (Sinipercachuatsi).
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Early Oral Administration of Ginseng Stem-Leaf Saponins Enhances the Peyer`s Patch-Dependent Maternal IgA Antibody Response to a PEDV Inactivated Vaccine in Mice, with Gut Microbiota Involvement.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Effect of Lactobacillus plantarum P9 on defecation, quality of life and gut microbiome in individuals with chronic diarrhoea: Protocol for a randomized, double-blind, placebo-controlled clinical trial.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Effect of probiotic yogurt on gestational diabetes mellitus: A systematic review and meta-analysis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Engineered living materials for the conversion of a low-cost food-grade precursor to a high-value flavonoid.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Engineered Probiotic-Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Engineering E. coli strains using antibiotic-resistance-gene-free plasmids.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Evaluation of Antibacterial Efficacy of Two Commercially Available Probiotics as Intracanal Medicament against Enterococcus faecalis: An In Vitro Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Immunomodulatory effects of bacteriocinogenic and non-bacteriocinogenic Lactococcus cremoris of aquatic origin on rainbow trout (Oncorhynchus mykiss, Walbaum).
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks In Silico Probiogenomic Characterization of Lactobacillus delbrueckii subsp. lactis A4 Strain Isolated from an Armenian Honeybee Gut.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks In Vitro Preventive Effect and Mechanism of Action of Weissella cibaria CMU against Streptococcus mutans Biofilm Formation and Periodontal Pathogens.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Is Autologous Fecal Microbiota Transfer after Exclusive Enteral Nutrition in Pediatric Crohn`s Disease Patients Rational and Feasible? Data from a Feasibility Test.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Lactobacilli displacement and Candida albicans inhibition on initial adhesion assays: a probiotic analysis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Maternal gut microbiota in the postpartum Period: A Systematic review.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Microbiota-Derived Extracellular Vesicles Promote Immunity and Intestinal Maturation in Suckling Rats.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Non-pharmacological interventions for prophylaxis of vestibular migraine.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Pilot study on non-celiac gluten sensitivity: effects of Bifidobacterium longum ES1 co-administered with a gluten-free diet.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Pioneer colonizers: Bacteria that alter the chicken intestinal morphology and development of the microbiota.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Postbiotics Implication in the Microbiota-Host Intestinal Epithelial Cells Mutualism.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Probiotic disruption of quorum sensing reduces virulence and increases cefoxitin sensitivity in methicillin-resistant Staphylococcus aureus.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Probiotic lactic acid bacteria alleviate pediatric IBD and remodel gut microbiota by modulating macrophage polarization and suppressing epithelial apoptosis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Probiotic Lactobacillus paragasseri K7 Nanofiber Encapsulation Using Nozzle-Free Electrospinning.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Probiotics Mediate Intestinal Microbiome and Microbiota-Derived Metabolites Regulating the Growth and Immunity of Rainbow Trout (Oncorhynchus mykiss).
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Protective Effect of Akkermansia muciniphila on the Preeclampsia-Like Mouse Model.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Role of Honey Bee Gut Microbiota in the Control of American Foulbrood and European Foulbrood Diseases.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Targeted and high-throughput gene knockdown in diverse bacteria using synthetic sRNAs.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks The Consumption of a Synbiotic Does Not Affect the Immune, Inflammatory, and Sympathovagal Parameters in Athletes and Sedentary Individuals: A Triple-Blinded, Randomized, Place-bo-Controlled Pilot Study.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks The Effect of a Planetary Health Diet on the Human Gut Microbiome: A Descriptive Analysis.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks The Gliadin Hydrolysis Capacity of B. longum, L. acidophilus, and L. plantarum and Their Protective Effects on Caco-2 Cells against Gliadin-Induced Inflammatory Responses.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks The leaky gut and the gut microbiome in sepsis - targets in research and treatment.
Bifidobacterium longum ES1 PharmExtracta / Gliadines buccal stickpacks Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study.
Bifidobacterium longum MM-2 Phillips'® Colon Health Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model.
Bifidobacterium longum MM-2 Phillips'® Colon Health Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Bifidobacterium longum MM-2 Phillips'® Colon Health Probiotics (<i>Lactobacillus gasseri</i> KS-13, <i>Bifidobacterium bifidum</i> G9-1, and <i>Bifidobacterium longum</i> MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial.
Bifidobacterium longum R0175 Calm Biotic® <i>Bifidobacterium longum</i> and <i>Lactobacillus helveticus</i> Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.
Bifidobacterium longum R0175 Calm Biotic® Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.
Bifidobacterium longum R0175 Calm Biotic® Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion.
Bifidobacterium longum R0175 Calm Biotic® Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.
Bifidobacterium longum R0175 Calm Biotic® Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers.
Bifidobacterium longum R0175 Calm Biotic® Bifidobacterium longum R0175 attenuates post-myocardial infarction depressive-like behaviour in rats.
Bifidobacterium longum R0175 Calm Biotic® Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure.
Bifidobacterium longum R0175 Calm Biotic® Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and Lactobacillus rhamnosus.
Bifidobacterium longum R0175 Calm Biotic® Chronic administration of a microencapsulated probiotic enhances the bioavailability of orange juice flavanones in humans.
Bifidobacterium longum R0175 Calm Biotic® Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model.
Bifidobacterium longum R0175 Calm Biotic® Effect of fermentation by pure and mixed cultures of Streptococcus thermophilus and Lactobacillus helveticus on isoflavone and B-vitamin content of a fermented soy beverage.
Bifidobacterium longum R0175 Calm Biotic® Effect of probiotic bacteria on porcine rotavirus OSU infection of porcine intestinal epithelial IPEC-J2 cells.
Bifidobacterium longum R0175 Calm Biotic® Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Bifidobacterium longum R0175 Calm Biotic® Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A <i>Post Hoc</i> Analysis of a Randomized Clinical Trial.
Bifidobacterium longum R0175 Calm Biotic® Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer`s disease: A randomized, double-blind, and placebo-controlled study.
Bifidobacterium longum R0175 Calm Biotic® Efficacy of <i>Lactobacillus paracasei</i> HA-196 and <i>Bifidobacterium longum</i> R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study.
Bifidobacterium longum R0175 Calm Biotic® Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon.
Bifidobacterium longum R0175 Calm Biotic® Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME.
Bifidobacterium longum R0175 Calm Biotic® Flow cytometry: a versatile technology for specific quantification and viability assessment of micro-organisms in multistrain probiotic products.
Bifidobacterium longum R0175 Calm Biotic® Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria.
Bifidobacterium longum R0175 Calm Biotic® In Vitro Probiotic Modulation of the Intestinal Microbiota and 2`Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age.
Bifidobacterium longum R0175 Calm Biotic® Ingestion of probiotic (Lactobacillus helveticus and Bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress.
Bifidobacterium longum R0175 Calm Biotic® Isolation and Characteristics of Extracellular Vesicles Produced by Probiotics: Yeast Saccharomyces boulardii CNCM I-745 and Bacterium Streptococcus salivarius K12.
Bifidobacterium longum R0175 Calm Biotic® Membrane fatty acid composition and fluidity are involved in the resistance to freezing of Lactobacillus buchneri R1102 and Bifidobacterium longum R0175.
Bifidobacterium longum R0175 Calm Biotic® Metabolic profiling of bacterial co-cultures reveals intermicrobiome interactions and dominant species.
Bifidobacterium longum R0175 Calm Biotic® Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis.
Bifidobacterium longum R0175 Calm Biotic® Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry.
Bifidobacterium longum R0175 Calm Biotic® Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice.
Bifidobacterium longum R0175 Calm Biotic® Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses to an Arithmetic Stress Task in Healthy Subjects: A Randomised Clinical Trial and Proof-of-Concept Study.
Bifidobacterium longum R0175 Calm Biotic® Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses Toward an Emotional Task in Healthy Subjects: A Randomized Clinical Trial.
Bifidobacterium longum R0175 Calm Biotic® Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 attenuates hippocampal apoptosis induced by lipopolysaccharide in rats.
Bifidobacterium longum R0175 Calm Biotic® Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression.
Bifidobacterium longum R0175 Calm Biotic® Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water.
Bifidobacterium longum R0175 Calm Biotic® Psychobiotic Effects on Anxiety Are Modulated by Lifestyle Behaviors: A Randomized Placebo-Controlled Trial on Healthy Adults.
Bifidobacterium longum R0175 Calm Biotic® Supplementation with Combined <i>Lactobacillus helveticus</i> R0052 and <i>Bifidobacterium longum</i> R0175 Across Development Reveals Sex Differences in Physiological and Behavioural Effects of Western Diet in Long-Evans Rats.
Bifidobacterium longum R0175 Calm Biotic® The effects of antimicrobials and lipopolysaccharide on acute immune responsivity in pubertal male and female CD1 mice.
Bifidobacterium longum R0175 Calm Biotic® The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model.
Bifidobacterium longum R0175 Calm Biotic® The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study.
Bifidobacterium longum R0175 Calm Biotic® The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract.
Bifidobacterium longum R0175 Calm Biotic® The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol.
Bifidobacterium longum R0175 Calm Biotic® Total Transit Time and Probiotic Persistence in Healthy Adults: A Pilot Study.
Bifidobacterium longum R0175 Calm Biotic® Use of Streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomised double-blind study.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Flow cytometry: a versatile technology for specific quantification and viability assessment of micro-organisms in multistrain probiotic products.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Modulatory effect of three probiotic strains on infants` gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study.
Bifidobacterium longum ssp. infantis R0033 Human Probiotics Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics Disentangling factors that shape the gut microbiota in German Shepherd dogs.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics Enteral supplementation with probiotics in preterm infants: A retrospective cohort study and 6-year follow-up.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics ß-Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria.
Bifidobacterium longum ssp. longum HA-135 Human Probiotics The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion.
Bifidobacterium longum subsp. infantis Bi-26 Custom Probiotics <i>Lycium</i><i>barbarum</i> Polysaccharide (LBP): A Novel Prebiotics Candidate for <i>Bifidobacterium</i> and <i>Lactobacillus</i>.
Bifidobacterium longum subsp. infantis Bi-26 Custom Probiotics Evaluation of 2`-Fucosyllactose and Bifidobacterium longum Subspecies infantis on Growth, Organ Weights, and Intestinal Development of Piglets.
Bifidobacterium longum subsp. infantis Bi-26 Custom Probiotics Influence of 2`-Fucosyllactose and Bifidobacterium longum Subspecies infantis Supplementation on Cognitive and Structural Brain Development in Young Pigs.
Bifidobacterium longum subsp. infantis Bi-26 Custom Probiotics Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2`-fucosyllactose.
Bifidobacterium longum subsp. infantis Bi-26 Custom Probiotics Strain-specific strategies of 2`-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697.
Bifidobacterium longum subsp. infantis NLS Life Start 2 Bifidobacterium infantis NLS Super Strain Reduces the Expression of a-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Active Celiac Disease Patients.
Bifidobacterium longum subsp. infantis NLS Life Start 2 Effect of <i>Bifidobacterium infantis</i> NLS super strain in symptomatic coeliac disease patients on long-term gluten-free diet - an exploratory study.
Bifidobacterium longum subsp. infantis NLS Life Start 2 Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Bifidobacteria-mediated immune system imprinting early in life.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Bifidobacterium infantis treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Bifidobacterium longum Subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Bifidobacteriumlongum subsp. infantis EVC001 Administration Is Associated with a Significant Reduction in the Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Colonization Resistance in the Infant Gut: The Role of B. infantis in Reducing pH and Preventing Pathogen Growth.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Effects of probiotic and synbiotic supplementation on ponderal and linear growth in severely malnourished young infants in a randomized clinical trial.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Erratum to: Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Impact of Probiotic B. infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Integrating the Ecosystem Services Framework to Define Dysbiosis of the Breastfed Infant Gut: The Role of B. infantis and Human Milk Oligosaccharides.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.
Bifidobacterium longum Subspecies infantis Strain EVC001 Evivo® Infant Probiotic Powder Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep.
Bifidobacterium longum W108 Ecologic® Relief Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Bifidobacterium longum W11 PharmExtracta / Bowell "The Possible Innovative Use of Bifidobacterium longum W11 in Association With Rifaximin: A New Horizon for Combined Approach?": Erratum.
Bifidobacterium longum W11 PharmExtracta / Bowell Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin.
Bifidobacterium longum W11 PharmExtracta / Bowell Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum.
Bifidobacterium longum W11 PharmExtracta / Bowell Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain.
Bifidobacterium longum W11 PharmExtracta / Bowell Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight).
Bifidobacterium longum W11 PharmExtracta / Bowell Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.
Bifidobacterium longum W11 PharmExtracta / Bowell Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin.
Bifidobacterium longum W11 PharmExtracta / Bowell Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production.
Bifidobacterium longum W11 PharmExtracta / Bowell Role of gut microflora and probiotic effects in the irritable bowel syndrome.
Bifidobacterium longum W11 PharmExtracta / Bowell The Possible Innovative Use of Bifidobacterium longum W11 in Association With Rifaximin: A New Horizon for Combined Approach?
Clostridium Butyricum MIYAIRI Miyarisan [Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7].
Clostridium Butyricum MIYAIRI Miyarisan [Inhibition of enteropathogens by Clostridium butyricum MIYAIRI 588].
Clostridium Butyricum MIYAIRI Miyarisan [Intestinal Care Using L?Glutamine Supplement and Probiotics Can Induce a Strong Anti?Tumor Immune Response through the Induction of Mature Tertiary Lymphoid Structures in Pancreatic Cancer Patients Receiving Preoperative Chemotherapy].
Clostridium Butyricum MIYAIRI Miyarisan <i>Clostridium butyricum</i> MIYAIRI 588 Increases the Lifespan and Multiple-Stress Resistance of <i>Caenorhabditis elegans</i>.
Clostridium Butyricum MIYAIRI Miyarisan <i>Clostridium butyricum</i> MIYAIRI 588-Induced Protectin D1 Has an Anti-inflammatory Effect on Antibiotic-Induced Intestinal Disorder.
Clostridium Butyricum MIYAIRI Miyarisan Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl<sub>4</sub>-induced liver cirrhosis by protecting the intestinal barrier in rats.
Clostridium Butyricum MIYAIRI Miyarisan Association between Nutrition Protocol with Clostridium butyricum MIYAIRI 588 and Reduced Incidence of Clostridioides difficile Infection in Critically Ill Patients: A Single-Center, Before-and-After Study.
Clostridium Butyricum MIYAIRI Miyarisan Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.
Clostridium Butyricum MIYAIRI Miyarisan Association of probiotic use with nivolumab effectiveness against various cancers: A multicenter retrospective cohort study.
Clostridium Butyricum MIYAIRI Miyarisan Cholesterol-lowering effect of Clostridium butyricum in cholesterol-fed rats.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum MIYAIRI 588 alleviates periodontal bone loss in mice with diabetes mellitus.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum Strains Suppress Experimental Acute Pancreatitis by Maintaining Intestinal Homeostasis.
Clostridium Butyricum MIYAIRI Miyarisan Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Clostridium Butyricum MIYAIRI Miyarisan Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients.
Clostridium Butyricum MIYAIRI Miyarisan Contribution of ¹8Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.
Clostridium Butyricum MIYAIRI Miyarisan Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy.
Clostridium Butyricum MIYAIRI Miyarisan Effect of Clostridium butyricum on Gastrointestinal Infections.
Clostridium Butyricum MIYAIRI Miyarisan Effect of Clostridium butyricum on the formation and dissolution of gallstones in experimental cholesterol cholelithiasis.
Clostridium Butyricum MIYAIRI Miyarisan Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial.
Clostridium Butyricum MIYAIRI Miyarisan Effect of probiotics on serum bile acids in patients with ulcerative colitis.
Clostridium Butyricum MIYAIRI Miyarisan Effects of active egg white product/ Clostridium butyricum Miyairi 588 additive on peripheral leukocyte populations in periparturient dairy cows.
Clostridium Butyricum MIYAIRI Miyarisan Effects of high amylose maize starch and Clostridium butyricum on metabolism in colonic microbiota and formation of azoxymethane-induced aberrant crypt foci in the rat colon.
Clostridium Butyricum MIYAIRI Miyarisan Effects of orally administered Clostridium butyricum MIYAIRI 588 on mucosal immunity in mice.
Clostridium Butyricum MIYAIRI Miyarisan Effects of the butyric acid-producing strain Clostridium butyricum MIYAIRI 588 on broiler and piglet zootechnical performance and prevention of necrotic enteritis.
Clostridium Butyricum MIYAIRI Miyarisan Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota.
Clostridium Butyricum MIYAIRI Miyarisan Establishment of an Endogenous <i>Clostridium difficile</i> Rat Infection Model and Evaluation of the Effects of <i>Clostridium butyricum</i> MIYAIRI 588 Probiotic Strain.
Clostridium Butyricum MIYAIRI Miyarisan Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens.
Clostridium Butyricum MIYAIRI Miyarisan Induction of peroxisomes by butyrate-producing probiotics.
Clostridium Butyricum MIYAIRI Miyarisan Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain.
Clostridium Butyricum MIYAIRI Miyarisan Integrated Counts of Carbohydrate-Active Protein Domains as Metabolic Readouts to Distinguish Probiotic Biology and Human Fecal Metagenomes.
Clostridium Butyricum MIYAIRI Miyarisan Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Clostridium Butyricum MIYAIRI Miyarisan Presume Why Probiotics May Not Provide Protection in Inflammatory Bowel Disease through an Azoxymethane and Dextran Sodium Sulfate Murine Model.
Clostridium Butyricum MIYAIRI Miyarisan Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.
Clostridium Butyricum MIYAIRI Miyarisan Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats.
Clostridium Butyricum MIYAIRI Miyarisan Probiotic-related bacteremia after major hepatectomy for biliary cancer: a report of two cases.
Clostridium Butyricum MIYAIRI Miyarisan Rapid species identification and partial strain differentiation of Clostridium butyricum by PCR using 16S-23S rDNA intergenic spacer regions.
Clostridium Butyricum MIYAIRI Miyarisan Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo.
Clostridium Butyricum MIYAIRI Miyarisan Sequence analysis of a bacteriocinogenic plasmid of Clostridium butyricum and expression of the bacteriocin gene in Escherichia coli.
Clostridium Butyricum MIYAIRI Miyarisan Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice.
Clostridium Butyricum MIYAIRI Miyarisan Supplemental Clostridium butyricum MIYAIRI 588 Affects Intestinal Bacterial Composition of Finishing Pigs.
Clostridium Butyricum MIYAIRI Miyarisan The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms.
Clostridium Butyricum MIYAIRI Miyarisan The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis.
Clostridium Butyricum MIYAIRI Miyarisan The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review.
Clostridium Butyricum MIYAIRI Miyarisan The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility.
Clostridium Butyricum MIYAIRI Miyarisan The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Clostridium Butyricum MIYAIRI Miyarisan The Effects of Enteral Nutrition on the Intestinal Environment in Patients in a Persistent Vegetative State.
Clostridium Butyricum MIYAIRI Miyarisan The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
Clostridium Butyricum MIYAIRI Miyarisan The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue.
Clostridium Butyricum MIYAIRI Miyarisan The impact of probiotic Clostridium butyricum MIYAIRI 588 on murine gut metabolic alterations.
Clostridium Butyricum MIYAIRI Miyarisan The Live Bacterial Product CBM588 Improves CPI Response in mRCC.
Clostridium Butyricum MIYAIRI Miyarisan The role of intestinal bacteria in gallstone formation in animal model. A study on biliary lipid composition and bile acid profiles in bile, small intestinal contents and feces of clostridium butyricum Miyairi No. 588 monocontaminated mice.
Clostridium Butyricum MIYAIRI Miyarisan Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Clostridium Butyricum MIYAIRI Miyarisan Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Clostridium butyricum TO-A AOR, Probiotic 3 &lt;i&gt;Clostridium butyricum&lt;/i&gt; CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells.
Clostridium butyricum TO-A AOR, Probiotic 3 [Ecological treatment of bacterial vaginosis and vaginitis with Bio-three].
Clostridium butyricum TO-A AOR, Probiotic 3 [Effects of administration of Clostridium butyricum to patients receiving long-term tube feeding].
Clostridium butyricum TO-A AOR, Probiotic 3 [Inhibition of enteropathogens by Clostridium butyricum MIYAIRI 588].
Clostridium butyricum TO-A AOR, Probiotic 3 [Intestinal Care Using L?Glutamine Supplement and Probiotics Can Induce a Strong Anti?Tumor Immune Response through the Induction of Mature Tertiary Lymphoid Structures in Pancreatic Cancer Patients Receiving Preoperative Chemotherapy].
Clostridium butyricum TO-A AOR, Probiotic 3 [Numerical taxonomy of gram-positive anaerobic bacilli].
Clostridium butyricum TO-A AOR, Probiotic 3 [The new microbiological hazards in food].
Clostridium butyricum TO-A AOR, Probiotic 3 Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.
Clostridium butyricum TO-A AOR, Probiotic 3 Biohydrogen production from microalgal biomass: energy requirement, CO2 emissions and scale-up scenarios.
Clostridium butyricum TO-A AOR, Probiotic 3 Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov.
Clostridium butyricum TO-A AOR, Probiotic 3 Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study.
Clostridium butyricum TO-A AOR, Probiotic 3 Cloning, expression, purification, crystallization and X-ray crystallographic analysis of (S)-3-hydroxybutyryl-CoA dehydrogenase from Clostridium butyricum.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium butyricum Supplement Can Ameliorate the Intestinal Barrier Roles in Broiler Chickens Experimentally Infected With Clostridium perfringens.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells.
Clostridium butyricum TO-A AOR, Probiotic 3 Clostridium butyricum: from beneficial to a new emerging pathogen.
Clostridium butyricum TO-A AOR, Probiotic 3 Colony immunoblot assay of botulinal toxin.
Clostridium butyricum TO-A AOR, Probiotic 3 Community analysis of bacteria colonizing intestinal tissue of neonates with necrotizing enterocolitis.
Clostridium butyricum TO-A AOR, Probiotic 3 Conjugative plasmid transfer from Escherichia coli to Clostridium acetobutylicum.
Clostridium butyricum TO-A AOR, Probiotic 3 Degradation and fermentation of alpha-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats.
Clostridium butyricum TO-A AOR, Probiotic 3 Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms.
Clostridium butyricum TO-A AOR, Probiotic 3 Development and validation of PCR primers to assess the diversity of Clostridium spp. in cheese by temporal temperature gradient gel electrophoresis.
Clostridium butyricum TO-A AOR, Probiotic 3 Dietary administration of probiotics to sows and/or their neonates improves the reproductive performance, incidence of post-weaning diarrhea and histopathological parameters in the intestine of weaned piglets.
Clostridium butyricum TO-A AOR, Probiotic 3 Dietary Supplementation of Chitosan Oligosaccharide-Clostridium butyricum Synbiotic Relieved Early-Weaned Stress by Improving Intestinal Health on Pigeon Squabs (Columba livia).
Clostridium butyricum TO-A AOR, Probiotic 3 Dietary Supplementation with Saccharomyces cerevisiae, Clostridium butyricum and Their Combination Ameliorate Rumen Fermentation and Growth Performance of Heat-Stressed Goats.
Clostridium butyricum TO-A AOR, Probiotic 3 Effect of 1,3-propanediol, organic acids, and ethanol on growth and metabolism of Clostridium butyricum DSP1.
Clostridium butyricum TO-A AOR, Probiotic 3 Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
Clostridium butyricum TO-A AOR, Probiotic 3 Effects of a bacteria-based probiotic on ruminal pH, volatile fatty acids and bacterial flora of Holstein calves.
Clostridium butyricum TO-A AOR, Probiotic 3 Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.
Clostridium butyricum TO-A AOR, Probiotic 3 Effects of Dietary Synbiotic Supplementation as an Alternative to Antibiotic on the Growth Performance, Carcass Characteristics, Meat Quality, Immunity, and Oxidative Status of Cherry Valley Ducks.
Clostridium butyricum TO-A AOR, Probiotic 3 Effects of Live Combined Bacillus subtilis and Enterococcus faecium on Gut Microbiota Composition in C57BL/6 Mice and in Humans.
Clostridium butyricum TO-A AOR, Probiotic 3 Effects of the Clostridium butyricum on growth performance, antioxidant capacity, immunity and disease resistance of Litopenaeus Vannamei fed with cottonseed protein concentrate (CPC) replacement of fishmeal in diet.
Clostridium butyricum TO-A AOR, Probiotic 3 Efficient production of 1,3-propanediol from fermentation of crude glycerol with mixed cultures in a simple medium.
Clostridium butyricum TO-A AOR, Probiotic 3 Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy.
Clostridium butyricum TO-A AOR, Probiotic 3 Enumeration and confirmation of Clostridium tyrobutyricum in silages using neutral red, D-cycloserine, and lactate dehydrogenase activity.
Clostridium butyricum TO-A AOR, Probiotic 3 Evidence for clostridial implication in necrotizing enterocolitis through bacterial fermentation in a gnotobiotic quail model.
Clostridium butyricum TO-A AOR, Probiotic 3 Gene transfer to Clostridium cellulolyticum ATCC 35319.
Clostridium butyricum TO-A AOR, Probiotic 3 Gut microbiota shapes social dominance through modulating HDAC2 in the medial prefrontal cortex.
Clostridium butyricum TO-A AOR, Probiotic 3 Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model.
Clostridium butyricum TO-A AOR, Probiotic 3 Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
Clostridium butyricum TO-A AOR, Probiotic 3 Implantation of bacteria from human pulpal necrosis and translocation from root canals in gnotobiotic mice.
Clostridium butyricum TO-A AOR, Probiotic 3 Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.
Clostridium butyricum TO-A AOR, Probiotic 3 Inclusion of the direct-fed microbial Clostridium butyricum in diets for weanling pigs increases growth performance and tends to increase villus height and crypt depth, but does not change intestinal microbial abundance.
Clostridium butyricum TO-A AOR, Probiotic 3 Influence of glucose on glycerol metabolism by wild-type and mutant strains of Clostridium butyricum E5 grown in chemostat culture.
Clostridium butyricum TO-A AOR, Probiotic 3 Metabolic and energetic aspects of the growth of Clostridium butyricum on glucose in chemostat culture.
Clostridium butyricum TO-A AOR, Probiotic 3 Molecular analysis of the malR gene of Clostridium butyricum NCIMB 7423, a member of the LacI-GalR family of repressor proteins.
Clostridium butyricum TO-A AOR, Probiotic 3 Necrotizing enterocolitis associated with Clostridium butyricum in a Japanese man.
Clostridium butyricum TO-A AOR, Probiotic 3 Oil palm empty fruit bunch as alternative substrate for acetone-butanol-ethanol production by Clostridium butyricum EB6.
Clostridium butyricum TO-A AOR, Probiotic 3 Oral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice.
Clostridium butyricum TO-A AOR, Probiotic 3 Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.
Clostridium butyricum TO-A AOR, Probiotic 3 Priority of the genus name Clostridium Prazmowski 1880 (Approved Lists 1980) vs Sarcina Goodsir 1842 (Approved Lists 1980) and the creation of the illegitimate combinations Clostridium maximum (Lindner 1888) Lawson and Rainey 2016 and Clostridium ventriculi (Goodsir 1842) Lawson and Rainey 2016 that may not be used.
Clostridium butyricum TO-A AOR, Probiotic 3 Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson`s disease via gut microbiota-GLP-1 pathway.
Clostridium butyricum TO-A AOR, Probiotic 3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Clostridium butyricum TO-A AOR, Probiotic 3 Probiotics reduce infectious complications after pancreaticoduodenectomy.
Clostridium butyricum TO-A AOR, Probiotic 3 Probiotics-induced Changes in Intestinal Structure and Gut Microbiota Are Associated with Reduced Rate of Pimpled Eggs in the Late Laying Period of Hens.
Clostridium butyricum TO-A AOR, Probiotic 3 Process optimization of biological hydrogen production from molasses by a newly isolated Clostridium butyricum W5.
Clostridium butyricum TO-A AOR, Probiotic 3 Properties of Allyl Alcohol-Resistant Mutants of Clostridium butyricum Grown on Glycerol.
Clostridium butyricum TO-A AOR, Probiotic 3 Protease or Clostridium butyricum addition to a low-protein diet improves broiler growth performance.
Clostridium butyricum TO-A AOR, Probiotic 3 Psychrotrophic clostridia mediated gas and botulinal toxin production in vacuum-packed chilled meat.
Clostridium butyricum TO-A AOR, Probiotic 3 Public Health Risk Associated with Botulism as Foodborne Zoonoses.
Clostridium butyricum TO-A AOR, Probiotic 3 QM/MM (ONIOM) study of glycerol binding and hydrogen abstraction by the coenzyme B12-independent dehydratase.
Clostridium butyricum TO-A AOR, Probiotic 3 Seasonal shift of the gut microbiome synchronizes host peripheral circadian rhythm for physiological adaptation to a low-fat diet in the giant panda.
Clostridium butyricum TO-A AOR, Probiotic 3 Some properties of the Clostridium butyricum group beta-lactamase.
Clostridium butyricum TO-A AOR, Probiotic 3 Structure and genetic content of the megaplasmids of neurotoxigenic clostridium butyricum type E strains from Italy.
Clostridium butyricum TO-A AOR, Probiotic 3 The Draft Genome Sequence of Clostridium butyricum QXYZ514, a Potent Bacterium for Converting Glycerol into Fuels and Bioproducts in the Waste-Based Biorefinery.
Clostridium butyricum TO-A AOR, Probiotic 3 The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.
Clostridium butyricum TO-A AOR, Probiotic 3 The potential of bacteria isolated from ruminal contents of seaweed-eating North Ronaldsay sheep to hydrolyse seaweed components and produce methane by anaerobic digestion in vitro.
Clostridium butyricum TO-A AOR, Probiotic 3 Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
Clostridium butyricum TO-A AOR, Probiotic 3 Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 12: suitability of taxonomic units notified to EFSA until March 2020.
Clostridium butyricum TO-A AOR, Probiotic 3 Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020.
Clostridium butyricum TO-A AOR, Probiotic 3 Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 15: suitability of taxonomic units notified to EFSA until September 2021.
Clostridium butyricum TO-A AOR, Probiotic 3 Update of the list of QPS-recommended microbiological agents intentionally added to food or feed as notified to EFSA 16: suitability of taxonomic units notified to EFSA until March 2022.
Clostridium butyricum WB-STR-0006 Pendukum Glucose Control Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.
Enterococcus faecalis T-110 AOR, Probiotic 3 [Ecological treatment of bacterial vaginosis and vaginitis with Bio-three].
Enterococcus faecalis T-110 AOR, Probiotic 3 Activity and Anti-Aflatoxigenic Effect of Indigenously Characterized Probiotic Lactobacilli against Aspergillus flavus-A Common Poultry Feed Contaminant.
Enterococcus faecalis T-110 AOR, Probiotic 3 Ameliorating effect of probiotics in a rat model of chronic kidney disease.
Enterococcus faecalis T-110 AOR, Probiotic 3 Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei, L. casei 431 on High-Fat Diet-Induced Obese Rats.
Enterococcus faecalis T-110 AOR, Probiotic 3 Applicability of the probiotic Lactiplantibacillus plantarum BFL as an adjunct culture in a dry fermented sausage.
Enterococcus faecalis T-110 AOR, Probiotic 3 Bacillus subtilis TO-A extends the lifespan of Caenorhabditis elegans.
Enterococcus faecalis T-110 AOR, Probiotic 3 Can acid produced from probiotic bacteria alter the surface roughness, microhardness, and elemental composition of enamel? An in vitro study.
Enterococcus faecalis T-110 AOR, Probiotic 3 Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?
Enterococcus faecalis T-110 AOR, Probiotic 3 Dietary administration of probiotics to sows and/or their neonates improves the reproductive performance, incidence of post-weaning diarrhea and histopathological parameters in the intestine of weaned piglets.
Enterococcus faecalis T-110 AOR, Probiotic 3 Differential activity of lytic a-helical peptides on lactobacilli and lactobacilli-derived liposomes.
Enterococcus faecalis T-110 AOR, Probiotic 3 Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review.
Enterococcus faecalis T-110 AOR, Probiotic 3 Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
Enterococcus faecalis T-110 AOR, Probiotic 3 Effects of heat-killed Enterococcus faecalis T-110 supplementation on gut immunity, gut flora, and intestinal infection in naturally aged hamsters.
Enterococcus faecalis T-110 AOR, Probiotic 3 Effects of prophylactic probiotics supplementation on infants born very preterm or very low birth weight.
Enterococcus faecalis T-110 AOR, Probiotic 3 Enterobacter asburiae E7, a Novel Potential Probiotic, Enhances Resistance to Aeromonas veronii Infection via Stimulating the Immune Response in Common Carp (Cyprinus carpio).
Enterococcus faecalis T-110 AOR, Probiotic 3 First complete genome sequence of a probiotic Enterococcus faecium strain T-110 and its comparative genome analysis with pathogenic and non-pathogenic Enterococcus faecium genomes.
Enterococcus faecalis T-110 AOR, Probiotic 3 Heterologous expression of a broad-spectrum chimeric antimicrobial peptide in Lactococcus lactis: Its safety and molecular modeling evaluation.
Enterococcus faecalis T-110 AOR, Probiotic 3 Heterologous expression of a gene encoding cholesterol oxidase in probiotic strains of Lactobacillus plantarum and Propionibacterium freudenreichii under the control of native promoters.
Enterococcus faecalis T-110 AOR, Probiotic 3 Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.
Enterococcus faecalis T-110 AOR, Probiotic 3 Management of dog sperm parameters and gut microbiota composition with Lactobacillus rhamnosus supplementation.
Enterococcus faecalis T-110 AOR, Probiotic 3 Multi-functional Potential of Five Lactic Acid Bacteria Strains Derived from Giant Panda (Ailuropoda melanoleuca).
Enterococcus faecalis T-110 AOR, Probiotic 3 Novel Functional Grape Juices Fortified with Free or Immobilized Lacticaseibacillus rhamnosus OLXAL-1.
Enterococcus faecalis T-110 AOR, Probiotic 3 Preclinical Potential of Probiotic-Loaded Novel Gelatin-Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies.
Enterococcus faecalis T-110 AOR, Probiotic 3 Probiotics reduce infectious complications after pancreaticoduodenectomy.
Enterococcus faecalis T-110 AOR, Probiotic 3 The complete genome of Propionibacterium freudenreichii CIRM-BIA1, a hardy actinobacterium with food and probiotic applications.
Enterococcus faecium L3 PharmExtracta / INatal Sachets [Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [EFFECT OF PROBIOTIC ENTEROCOCCI AND GLATIRAMER ACETATE ON THE SEVERITY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS ].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [Influence of probiotic enterococci on the growth of Streptococcus agalactiae].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [INFLUENCE OF PROBIOTIC STRAIN E. FAECIUM L3 ON MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY IN THE MODEL OF ANTIBIOTIC-INDUCED INTESTINAL DYSBIOSIS].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [Inhibition of herpes simplex virus type 1 reproduction by probiotic bacteria in vitro].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [PROBIOTICS, NUTRITIONAL STATUS AND RESISTANCE TO RESPIRATORY INFECTIONS IN INFANTS].
Enterococcus faecium L3 PharmExtracta / INatal Sachets [Value of probiotic in reducing frequency of infectious complications in premature infants].
Enterococcus faecium L3 PharmExtracta / INatal Sachets A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Anti-Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Development of experimental pneumococcal vaccine for mucosal immunization.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Draft Genome Sequence of Probiotic Enterococcus faecium Strain L-3.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Evaluation of the Efficacy of Enterococcus faecium L3 as a Feed Probiotic Additive in Chicken.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Influence of different probiotic lactic Acid bacteria on microbiota and metabolism of rats with dysbiosis.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Influence of synthetic peptide inducers on antibacterial activity of enterococci.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Positive clinical outcomes derived from using a proprietary mixture of selected strains during pregnancy.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Treatment with a Probiotic Mixture Containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the Prevention of Allergic Rhinitis Symptoms in Children: A Randomized Controlled Trial.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3 as prophylaxis to reduce the incidence of acute gastroenteritis and upper respiratory tract infections in children.
Enterococcus faecium L3 PharmExtracta / INatal Sachets Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB12 and Enterococcus faecium L3 in atopic children.
Enterococcus faecium SBS 1 Shin Biofermin S Complete genome sequences of two <i>Enterococcus faecium</i> strains and comparative genomic analysis.
Enterococcus faecium SF 68 Bioflorin [Adhesion capacity of Enterococcus faecium (SF 68) and Enterococcus faecalis to various substrates].
Enterococcus faecium SF 68 Bioflorin [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
Enterococcus faecium SF 68 Bioflorin [Mixed culture of Enterococcus faecium SF 68 with pathogenic intestinal bacterial strains].
Enterococcus faecium SF 68 Bioflorin [Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)].
Enterococcus faecium SF 68 Bioflorin [Role of Enterococcus faecium SF 68 in experimental infection in mice].
Enterococcus faecium SF 68 Bioflorin [The role of enterococcus SF 68 in the prevention and treatment of infectious and antibiotic-related gastroenteritis].
Enterococcus faecium SF 68 Bioflorin Are probiotics detectable in human feces after oral uptake by healthy volunteers?
Enterococcus faecium SF 68 Bioflorin Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci.
Enterococcus faecium SF 68 Bioflorin Isolation and biochemical characterisation of enterocins produced by enterococci from different sources.
Enterococcus faecium SF 68 Bioflorin Microbiological properties of Streptococcus faecium SF 68 strain and its relationships with other microorganisms.
Enterococcus faecium SF 68 Bioflorin Microbiological study of Enterococcus faecium SF68: post-antibiotic effect and growth curves.
Enterococcus faecium SF 68 Bioflorin Protection from gastrointestinal diseases with the use of probiotics.
Enterococcus faecium SF 68 Bioflorin The effect of some antibiotics on Enterococcus faecium SF 68 inoculated in germ-free mice.
Enterococcus faecium W54 Ecologic® AAD Author Correction: Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum.
Enterococcus faecium W54 Ecologic® AAD Enlisting Probiotics to Combat Recurrent Urinary Tract Infections in Women-A Military Strategy for Meeting the Challenge.
Enterococcus faecium W54 Ecologic® AAD Hypoxia-tolerant apical-out intestinal organoids to model host-microbiome interactions.
Enterococcus faecium W54 Ecologic® AAD Immunomodulation of the Vaginal Ecosystem by Ligilactobacillus salivarius CECT 30632 Improves Pregnancy Rates among Women with Infertility of Unknown Origin or Habitual Abortions.
Enterococcus faecium W54 Ecologic® AAD Microbiome derived acidity protects against microbial invasion in Drosophila.
Enterococcus faecium W54 Ecologic® AAD Microencapsulation of Probiotics by Oil-in-Water Emulsification Technique Improves Cell Viability under Different Storage Conditions.
Enterococcus faecium W54 Ecologic® AAD Modulating the Microbiome for Crohn`s Disease Treatment.
Enterococcus faecium W54 Ecologic® AAD Multi-omics analysis of the effects of dietary changes and probiotics on diet-induced obesity.
Enterococcus faecium W54 Ecologic® AAD Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Enterococcus faecium W54 Ecologic® AAD Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum.
Enterococcus faecium W54 Ecologic® AAD The Ability of Streptococcus thermophilus BT01 to Modulate Urease Activity in Healthy Subjects` Fecal Samples Depends on the Biomass Production Process.
Enterococcus faecium W54 Ecologic® AAD The Mixture of Saccharomyces cerevisiae and Clostridium butyricum Could Promote Rumen Fermentation and Improve the Growth Performance of Goats in Hot Summer.
Enterococcus faecium W54 Ecologic® AAD Together or Alone: Evaluating the Pathogen Inhibition Potential of Bacterial Cocktails against an Amphibian Pathogen.
Escherichia coli , Laves strain 1931 Colibiogen [Animal experiment studies on the modification of non-pathogen specific immunity by metabolic products of Escherichia coli].
Escherichia coli , Laves strain 1931 Colibiogen [Chemical studies on colibiogen].
Escherichia coli , Laves strain 1931 Colibiogen [Existence of an anabolically acting principle in an extract of E. coli].
Escherichia coli , Laves strain 1931 Colibiogen [Treatment of Crohn`s disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn`s disease].
Escherichia coli , Laves strain 1931 Colibiogen Cytokine production by mononuclear cells following stimulation with a peptide-containing, endotoxin-free Escherichia coli extract.
Escherichia coli , Laves strain 1931 Colibiogen Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.
Escherichia coli , Laves strain 1931 Colibiogen Olaquindox-induced persistent light reaction treated by Escherichia coli filtrate (Colibiogene)
Escherichia coli , Laves strain 1931 Colibiogen Preventive effect of an E. coli-filtrate (Colibiogen) in polymorphous light eruption.
Eubacterium hallii WB-STR-0008 Pendukum Glucose Control Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.
Hafnia alvei HA4597 SymbioLife ® Satylia Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice-a new potential probiotic for appetite and body weight management.
Hafnia alvei HA4597 SymbioLife ® Satylia Hafnia alvei HA4597 Strain Reduces Food Intake and Body Weight Gain and Improves Body Composition, Glucose, and Lipid Metabolism in a Mouse Model of Hyperphagic Obesity.
Hafnia alvei HA4597 SymbioLife ® Satylia The impact of Hafnia alvei HA4597™ on weight loss and glycaemic control after bariatric surgery - study protocol for a triple-blinded, blocked randomized, 12-month, parallel-group, placebo-controlled clinical trial.
Hafnia alvei HA4597 SymbioLife ® Satylia The Probiotic Strain H. alvei HA4597(®) Improves Weight Loss in Overweight Subjects under Moderate Hypocaloric Diet: A Proof-of-Concept, Multicenter Randomized, Double-Blind Placebo-Controlled Study.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Ameliorative effects of Lactobacillus plantarum L-137 on Nile tilapia (Oreochromis niloticus) exposed to deltamethrin toxicity in rearing water.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Daily Intake of Heat-killed Lactobacillus plantarum L-137 Decreases the Probing Depth in Patients Undergoing Supportive Periodontal Therapy.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Daily intake of heat-killed Lactobacillus plantarum L-137 enhances type I interferon production in healthy humans and pigs.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Daily intake of heat-killed Lactobacillus plantarum L-137 improves inflammation and lipid metabolism in overweight healthy adults: a randomized-controlled trial.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Enhanced immunomodulatory activity and stability in simulated digestive juices of Lactobacillus plantarum L-137 by heat treatment.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Heat-killed <i>Lactobacillus plantarum</i> L-137 attenuates obesity and associated metabolic abnormalities in C57BL/6 J mice on a high-fat diet.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Lactobacillus plantarum L-137 and/or ß-glucan impacted the histopathological, antioxidant, immune-related genes and resistance of Nile tilapia (Oreochromis niloticus) against Aeromonas hydrophila.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Lactobacillus plantarum L-137 upregulates hyaluronic acid production in epidermal cells and fibroblasts in mice.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Lipoteichoic acids on Lactobacillus plantarum cell surfaces correlate with induction of interleukin-12p40 production.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Oral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stress.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Safety and efficacy of using heat-killed Lactobacillus plantarum L-137: High-dose and long-term use effects on immune-related safety and intestinal bacterial flora.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Safety studies of LP20 powder produced from heat-killed Lactobacillus plantarum L-137.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Scavenger receptor for lipoteichoic acid is involved in the potent ability of Lactobacillus plantarum strain L-137 to stimulate production of interleukin-12p40.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Synergetic Effects of Lactobacillus plantarum and ß-Glucan on Digestive Enzyme Activity, Intestinal Morphology, Growth, Fatty Acid, and Glucose-Related Gene Expression of Genetically Improved Farmed Tilapia.
Heat Killed Lactobacillus plantarum L-137 Swanson Immunobiotic Immuno-LP20 Therapeutic effect of heat-killed Lactobacillus plantarum L-137 on the gut health and growth of broilers.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive <i>In vitro</i> Study of <i>Lactobacillus paracasei</i> CNCM I-1518 in Healthy and <i>Clostridioides difficile</i> Colonized Elderly Gut Microbiota.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Effects of a Fermented Dairy Drink Containing <i>Lacticaseibacillus paracasei</i> subsp. <i>paracasei</i> CNCM I-1518 (<i>Lactobacillus casei</i> CNCM I-1518) and the Standard Yogurt Cultures on the Incidence, Duration, and Severity of Common Infectious Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Lactobacillus paracasei feeding improves immune control of influenza infection in mice.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Lactobacillus paracasei feeding improves the control of secondary experimental meningococcal infection in flu-infected mice.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review.
Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 DanActive Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics [Investigation on the addition of microbial food cultures in infant and follow-up formula in China from 2017 to 2022].
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics <i>In silico</i> Prediction, <i>in vitro</i> Antibacterial Spectrum, and Physicochemical Properties of a Putative Bacteriocin Produced by <i>Lactobacillus rhamnosus</i> Strain L156.4.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics <i>In vitro</i> inhibitory activity of <i>Bifidobacterium longum</i> BB536 and <i>Lactobacillus rhamnosus</i> HN001 alone or in combination against bacterial and <i>Candida</i> reference strains and clinical isolates.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A Diet Enriched with Lacticaseibacillus rhamnosus HN001 and Milk Fat Globule Membrane Alters the Gut Microbiota and Decreases Amygdala GABA a Receptor Expression in Stress-Sensitive Rats.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A randomised controlled trial of a probiotic and a prebiotic examining metabolic and mental health outcomes in adults with pre-diabetes.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics A randomized trial of probiotic supplementation in nurses to reduce stress and viral illness.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Acid-tolerant Lactiplantibacillus plantarum ZDY2013 shows a colonization niche preference and interacts with enterotoxigenic Bacillus cereus in specific-pathogen-free mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Addition of grape pomace extract to probiotic fermented goat milk: the effect on phenolic content, probiotic viability and sensory acceptability.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: A randomized controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Altered transcription of murine genes induced in the small bowel by administration of probiotic strain Lactobacillus rhamnosus HN001.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Bifidobacterium lactis 420 and fish oil enhance intestinal epithelial integrity in Caco-2 cells.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Cloning and expression of an oligopeptidase, PepO, with novel specificity from Lactobacillus rhamnosus HN001 (DR20).
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Combined probiotics attenuate chronic unpredictable mild stress-induced depressive-like and anxiety-like behaviors in rats.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Comparative evaluation of treatment plan quality for a prototype biology-guided radiotherapy system in the treatment of nasopharyngeal carcinoma.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Comparison of Real-Time PCR and Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Correction: Jang, S.-E.; et al. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice. Nutrients 2017, 9, 531.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Correlation of Lactobacillus rhamnosus Genotypes and Carbohydrate Utilization Signatures Determined by Phenotype Profiling.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Development of a PCR assay for the strain-specific identification of probiotic strain Lactobacillus paracasei IMPC2.1.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Differential modification of genetic susceptibility to childhood eczema by two probiotics.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of &lt;i&gt;Lactobacillus rhamnosus&lt;/i&gt; HN001 and &lt;i&gt;Bifidobacterium longum&lt;/i&gt; BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of a Synbiotic Mix on Lymphoid Organs of Broilers Infected with <i>Salmonella typhimurium</i> and <i>Clostridium perfringens</i>.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of early probiotic supplementation on childhood cognition, behaviour and mood a randomised, placebo-controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of giving probiotic supplement Lactobacillus acidophilus La-14 as an immunomodulator to maintain a respiratory system in Mus musculus.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of Lactobacillus rhamnosus Probiotic in Early Pregnancy on Plasma Conjugated Bile Acids in a Randomised Controlled Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics EFFECT OF PROBIOTIC ORAL ADMINISTRATION ON SKIN WOUND HEALING IN RATS.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics EFFECT OF SUPPLEMENTATION WITH PROBIOTICS ON COLONIC ANASTOMOSES IN RATS: MORPHOLOGICAL AND TENSIOMETRIC STUDY.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of <i>Bifidobacterium longum</i> and <i>Lactobacillus rhamnosus</i> on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of Bifidobacterium longum Subsp. infantis CECT 7210 and Lactobacillus rhamnosus HN001, Combined or Not With Oligofructose-Enriched Inulin, on Weaned Pigs Orally Challenged With Salmonella Typhimurium.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics EFFECTS OF SYNBIOTIC SUPPLEMENTATION ON GUT FUNCTIONING AND SYSTEMIC INFLAMMATION OF COMMUNITY-DWELLING ELDERS - SECONDARY ANALYSES FROM A RANDOMIZED CLINICAL TRIAL.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Effects of the Administration of Bifidobacterium longum subsp. infantis CECT 7210 and Lactobacillus rhamnosus HN001 and Their Synbiotic Combination With Galacto-Oligosaccharides Against Enterotoxigenic Escherichia coli F4 in an Early Weaned Piglet Model.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Enhancing Bioaccessibility of Plant Protein Using Probiotics: An In Vitro Study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Evaluation of probiotic survivability in yogurt exposed to cold chain interruption.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Fermentation of protopanaxadiol type ginsenosides (PD) with probiotic Bifidobacterium lactis and Lactobacillus rhamnosus.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Food 4 Health - He Oranga Kai: Assessing the efficacy, acceptability and economic implications of Lactobacillus rhamnosus HN001 and ß-glucan to improve glycated haemoglobin, metabolic health, and general well-being in adults with pre-diabetes: study protocol for a 2 × 2 factorial design, parallel group, placebo-controlled randomized controlled trial, with embedded qualitative study and economic analysis.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Functionality of probiotics - potential for product development.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Gum Arabic/Chitosan Coacervates for Encapsulation and Protection of Lacticaseibacillus rhamnosus in Storage and Gastrointestinal Environments.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Heat and osmotic stress responses of probiotic Lactobacillus rhamnosus HN001 (DR20) in relation to viability after drying.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics How frequent is routine use of probiotics in UK neonatal units?
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Immune enhancement conferred by oral delivery of Lactobacillus rhamnosus HN001 in different milk-based substrates.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Improving the stability of probiotic bacteria in model fruit juices using vitamins and antioxidants.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Influence of commercial inactivated yeast derivatives on the survival of probiotic bacterium Lactobacillus rhamnosus HN001 in an acidic environment.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Influence of the Probiotic <i>Lactobacillus acidophilus</i> NCFM?and <i>Lactobacillus rhamnosus</i> HN001 on Proteolysis Patterns?of Edam Cheese.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Inhibition of Toxic Shock Syndrome-Associated Staphylococcus aureus by Probiotic Lactobacilli.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Intestinal Dysbiosis Correlates With Sirolimus-induced Metabolic Disorders in Mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Intra-species Genomic and Physiological Variability Impact Stress Resistance in Strains of Probiotic Potential.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study).
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lacticaseibacillus rhamnosus HN001 alters the microbiota composition in the cecum but not the feces in a piglet model.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacilli postbiotics reduce biofilm formation and alter transcription of virulence genes of Aggregatibacter actinomycetemcomitans.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus rhamnosus HN001 Ameliorates BEZ235-Induced Intestinal Dysbiosis and Prolongs Cardiac Transplant Survival.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Maternal fish oil and/or probiotics intervention: Allergic diseases in children up to two years old.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Metabolism of Caprine Milk Carbohydrates by Probiotic Bacteria and Caco-2:HT29?MTX Epithelial Co-Cultures and Their Impact on Intestinal Barrier Integrity.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Metagenomics of microbiota following probiotic supplementation in rats subjected to intestinal anastomosis.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson`s disease in mice by delivering GLP-1 and modulating gut microbiota.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics New compound probiotic beverage protects against antibiotic-associated diarrhea in mice by modulating the microbiota.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Offline Quality Assurance for Intensity Modulated Radiation Therapy Treatment Plans for NRG-HN001 Head and Neck Clinical Trial Using Knowledge-Based Planning.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Optimization and shelf life of a low-lactose yogurt with Lactobacillus rhamnosus HN001.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Polyketides from the Mangrove-Derived Endophytic Fungus Nectria sp. HN001 and Their a-Glucosidase Inhibitory Activity.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Postnatal Administration of Lactobacillus rhamnosus HN001 Ameliorates Perinatal Broad-Spectrum Antibiotic-Induced Reduction in Myelopoiesis and T Cell Activation in Mouse Pups.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Potential of lactic acid bacteria to modulate coffee volatiles and effect of glucose supplementation: fermentation of green coffee beans and impact of coffee roasting.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Potential of three probiotic lactobacilli in transforming star fruit juice into functional beverages.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Potential pathobionts in vaginal microbiota are affected by fish oil and/or probiotics intervention in overweight and obese pregnant women.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Probiotics and immunosenescence: cheese as a carrier.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Probiotics for Reduction of Examination Stress in Students (PRESS) study: A randomized, double-blind, placebo-controlled trial of the probiotic Lacticaseibacillus rhamnosus HN001.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Probiotics Modulate Intestinal Motility and Inflammation in Zebrafish Models.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics PROFAST: A Randomized Trial Assessing the Effects of Intermittent Fasting and Lacticaseibacillus rhamnosus Probiotic among People with Prediabetes.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Saccharomyces cerevisiae EC-1118 enhances the survivability of probiotic Lactobacillus rhamnosus HN001 in an acidic environment.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The effect of probiotics (Lactobacillus rhamnosus HN001, Lactobacillus paracasei LPC-37, and Lactobacillus acidophilus NCFM) on the availability of minerals from Dutch-type cheese.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The identification of a low molecular mass bacteriocin, rhamnosin A, produced by Lactobacillus rhamnosus strain 68.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The impact of fish oil and/or probiotics on serum fatty acids and the interaction with low-grade inflammation in pregnant women with overweight and obesity: secondary analysis of a randomized controlled trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The Possible Role of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 on Locomotor Activity and Oxidative Stress in a Rotenone-Induced Zebrafish Model of Parkinson`s Disease.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics The suitability of different probiotic strains for the production of fruit-whey beverages.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Tolerability of a probiotic in subjects with a history of methicillin-resistant Staphylococcus aureus colonisation.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Unique secreted-surface protein complex of Lactobacillus rhamnosus, identified by phage display.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Viability of the Lactobacillus rhamnosus HN001 probiotic strain in Swiss- and Dutch-type cheese and cheese-like products.
Lacticaseibacillus rhamnosus HN001 Optibac Probiotics Babies & Children Probiotics Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil.
Lactobacillus acidophillus CUL-21 (NCIMB 30156) Genestra Brands - HMF Neuro Powder An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support [Allergen-specific immunotherapy for food allergies in childhood. Current options and future perspectives].
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Akkermansia muciniphila: a novel functional microbe with probiotic properties.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Antagonistic activity of Lactobacillus acidophilus ATCC 4356 on the growth and adhesion/invasion characteristics of human Campylobacter jejuni.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Characterization of the sortase A from Lactobacillus acidophilus ATCC 4356 involved in adherence to intestinal cells.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Construction of a combined physical and genetic map of the chromosome of Lactobacillus acidophilus ATCC 4356 and characterization of the rRNA operons.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Design and Characterization of a Novel Fermented Beverage from Lentil Grains.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Early settlers: which E. coli strains do you not want at birth?
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Effect of Prebiotics-Enhanced Probiotics on the Growth of Streptococcus mutans.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Effect of refrigerated storage on probiotic viability and the production and stability of antimutagenic and antioxidant peptides in yogurt supplemented with pineapple peel.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Effects of penicillin G on morphology and certain physiological parameters of Lactobacillus acidophilus ATCC 4356.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Evaluation of ß-galactosidase from Lactobacillus acidophilus as biocatalyst for galacto-oligosaccharides synthesis: Product structural characterization and enzyme immobilization.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Fermentation of calcium-fortified soymilk with Lactobacillus: effects on calcium solubility, isoflavone conversion, and production of organic acids.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Immunological mechanisms involved in probiotic-mediated protection against Citrobacter rodentium-induced colitis.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Impact of Probiotic SYNBIO(®) Administered by Vaginal Suppositories in Promoting Vaginal Health of Apparently Healthy Women.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Influence of osmotic stress on the profile and gene expression of surface layer proteins in Lactobacillus acidophilus ATCC 4356.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Lacticaseibacillus rhamnosus ATCC 53103 and Limosilactobacillus reuteri ATCC 53608 Synergistically Boost Butyrate Levels upon Tributyrin Administration Ex Vivo.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Lactobacillus acidophilus attenuates Aeromonas hydrophila induced cytotoxicity in catla thymus macrophages by modulating oxidative stress and inflammation.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Late permissive hypercapnia and respiratory stability among very preterm infants: a pilot randomised trial.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Metabolism of biodiesel-derived glycerol in probiotic Lactobacillus strains.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Multifunctional Acidocin 4356 Combats Pseudomonas aeruginosa through Membrane Perturbation and Virulence Attenuation: Experimental Results Confirm Molecular Dynamics Simulation.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Probiotic potential comparison of Lactobacillus strains isolated from Iranian traditional food products and human feces with standard probiotic strains.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Probiotic Properties and Antioxidant Activity In Vitro of Lactic Acid Bacteria.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Protective effect of the probiotic Lactobacillus acidophilus ATCC 4356 in BALB/c mice infected with Toxocara canis.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Recent Advances in Screening of Anti-Campylobacter Activity in Probiotics for Use in Poultry.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Short communication: Modulation of the small intestinal microbial community composition over short-term or long-term administration with Lactobacillus plantarum ZDY2013.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Stability of free and encapsulated Lactobacillus acidophilus ATCC 4356 in yogurt and in an artificial human gastric digestion system.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support Targeted Release of Probiotics from Enteric Microparticulated Formulations.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The inhibitory effect of a Lactobacillus acidophilus derived biosurfactant on biofilm producer Serratia marcescens.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The inhibitory effect of bacteriocin produced by Lactobacillus acidophilusATCC 4356 and Lactobacillus plantarum ATCC 8014 on planktonic cells and biofilms of Serratia marcescens.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The larvicidal effect of the supernatant of Lactobacillus acidophilus ATCC 4356 on Toxocara canis.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The role of probiotic Lactobacillus acidophilus ATCC 4356 bacteriocin on effect of HBsu on planktonic cells and biofilm formation of Bacillus subtilis.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium.
Lactobacillus acidophilus ATCC 4356 resB® Lung Support The Variable Regions of Lactobacillus rhamnosus Genomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires.
Lactobacillus acidophilus CL1285 Bio-K+ A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Lactobacillus acidophilus CL1285 Bio-K+ Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA).
Lactobacillus acidophilus CL1285 Bio-K+ Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?
Lactobacillus acidophilus CL1285 Bio-K+ Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Lactobacillus acidophilus CL1285 Bio-K+ Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Lactobacillus acidophilus CL1285 Bio-K+ Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial.
Lactobacillus acidophilus CL1285 Bio-K+ Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study.
Lactobacillus acidophilus CL1285 Bio-K+ Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
Lactobacillus acidophilus CL1285 Bio-K+ Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Lactobacillus acidophilus CL1285 Bio-K+ In vitro protein digestibility and physico-chemical properties of lactic acid bacteria fermented beverages enriched with plant proteins.
Lactobacillus acidophilus CL1285 Bio-K+ Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis.
Lactobacillus acidophilus CL1285 Bio-K+ Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Lactobacillus acidophilus CL1285 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus acidophilus CL1285 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Lactobacillus acidophilus CL1285 Bio-K+ Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
Lactobacillus acidophilus CL1285 Bio-K+ Probiotics and prevention of Clostridium difficile infection.
Lactobacillus acidophilus CL1285 Bio-K+ Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Lactobacillus acidophilus CL1285 Bio-K+ Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea.
Lactobacillus acidophilus CL1285 Bio-K+ Screening and Characterization of Some Lactobacillaceae for Detection of Cholesterol-Lowering Activities.
Lactobacillus acidophilus CL1285 Bio-K+ Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Lactobacillus acidophilus CL1285 Bio-K+ The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Lactobacillus acidophilus CL1285 Bio-K+ The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
Lactobacillus acidophilus CUL-60 (NCIMB 30157) Genestra Brands - HMF Neuro Powder An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention.
Lactobacillus acidophilus CUL-60 (NCIMB 30157) Genestra Brands - HMF Neuro Powder Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Lactobacillus acidophilus CUL-60 (NCIMB 30157) Genestra Brands - HMF Neuro Powder Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study.
Lactobacillus acidophilus HA-122 Human Probiotics Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.
Lactobacillus acidophilus LA-14 Custom Probiotics [Particular behavior of different Lactobacillus acidophilus strains in petit-suisse cheese].
Lactobacillus acidophilus LA-14 Custom Probiotics Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain.
Lactobacillus acidophilus LA-14 Custom Probiotics Co-encapsulation of probiotic Lactobacillus acidophilus and Reishi medicinal mushroom (Ganoderma lingzhi) extract in moist calcium alginate beads.
Lactobacillus acidophilus LA-14 Custom Probiotics Complete Genome Sequence of Probiotic Strain Lactobacillus acidophilus La-14.
Lactobacillus acidophilus LA-14 Custom Probiotics Correction: Jang, S.-E.; et al. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice. Nutrients 2017, 9, 531.
Lactobacillus acidophilus LA-14 Custom Probiotics Determination of oxalyl-coenzyme A decarboxylase activity in Oxalobacter formigenes and Lactobacillus acidophilus by capillary electrophoresis.
Lactobacillus acidophilus LA-14 Custom Probiotics Differential effects of lactobacilli on activation and maturation of mouse dendritic cells.
Lactobacillus acidophilus LA-14 Custom Probiotics Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage.
Lactobacillus acidophilus LA-14 Custom Probiotics Draft Genome Sequence of the Probiotic Strain Lactobacillus acidophilus ATCC 4356.
Lactobacillus acidophilus LA-14 Custom Probiotics Edible coating with probiotic as a quality factor for minimally processed carrots.
Lactobacillus acidophilus LA-14 Custom Probiotics Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Lactobacillus acidophilus LA-14 Custom Probiotics Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial.
Lactobacillus acidophilus LA-14 Custom Probiotics Functional Characterization of c-di-GMP Signaling-Related Genes in the Probiotic <i>Lactobacillus acidophilus</i>.
Lactobacillus acidophilus LA-14 Custom Probiotics Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
Lactobacillus acidophilus LA-14 Custom Probiotics In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus).
Lactobacillus acidophilus LA-14 Custom Probiotics In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
Lactobacillus acidophilus LA-14 Custom Probiotics Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study.
Lactobacillus acidophilus LA-14 Custom Probiotics Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
Lactobacillus acidophilus LA-14 Custom Probiotics Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis.
Lactobacillus acidophilus LA-14 Custom Probiotics Optimization of Viability Treatment Essential for Accurate Droplet Digital PCR Enumeration of Probiotics.
Lactobacillus acidophilus LA-14 Custom Probiotics Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment.
Lactobacillus acidophilus LA-14 Custom Probiotics Tackling codon usage bias for heterologous expression in Rhodobacter sphaeroides by supplementation of rare tRNAs.
Lactobacillus acidophilus LA-14 Custom Probiotics The effect of using prebiotic and probiotic products on intestinal micro-flora of the honeybee (Apis mellifera carpatica).
Lactobacillus acidophilus LA-14 Custom Probiotics Third-generation L-Lactic acid production by the microwave-assisted hydrolysis of red macroalgae Eucheuma denticulatum extract.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry A partially hydrolyzed formula with synbiotics supports adequate growth and is well tolerated in healthy, Chinese term infants: A double-blind, randomized controlled trial.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Antagonistic activities of some probiotic lactobacilli culture supernatant on Serratia marcescens swarming motility and antibiotic resistance.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Antimicrobial potential of probiotic lactic acid bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Antioxidative ability of lactic acid bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Are probiotics useful in Helicobacter pylori eradication?
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Combinatmarion treatment with Lactobacillus acidophilus LA-1, vitamin B, and curcumin ameliorates the progression of osteoarthritis by inhibiting the pro-inflammatory mediators.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Comparative Effects of L. plantarum CGMCC 1258 and L. reuteri LR1 on Growth Performance, Antioxidant Function, and Intestinal Immunity in Weaned Pigs.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Complete Genome Sequence and Genomic Characterization of <i>Lactobacillus acidophilus</i> LA1 (11869BP).
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Complete genome sequence of Lactobacillus heilongjiangensis DSM 28069(T): Insight into its probiotic potential.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Conservation of the major cold shock protein in lactic acid bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry D-Lactate dehydrogenase gene (ldhD) inactivation and resulting metabolic effects in the Lactobacillus johnsonii strains La1 and N312.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of electro-activated sweet whey on growth of Bifidobacterium, Lactobacillus, and Streptococcus strains under model growth conditions.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of Lactobacillus johnsonii La1 on immune function and serum albumin in aged and malnourished aged mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of pineapple waste powder on probiotic growth, antioxidant and antimutagenic activities of yogurt.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of Probiotic Yogurt and Xylitol-Containing Chewing Gums on Salivary S Mutans Count.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of Short-Term Placebo-Controlled Consumption of Probiotic Yoghurt and Indian Curd on the Streptococcus mutans Level in Children Undergoing Fixed Interceptive Orthodontic Therapy.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Encapsulation of probiotic Lactobacillus acidophilus ATCC 4356 in alginate-galbanum (Ferula Gummosa Boiss) gum microspheres and evaluation of the survival in simulated gastrointestinal conditions in probiotic Tahini halva.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Galectin-9 Induced by Dietary Probiotic Mixture Regulates Immune Balance to Reduce Atopic Dermatitis Symptoms in Mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Hydrolysis of chicoric and caftaric acids with esterases and Lactobacillus johnsonii in Vitro and in a gastrointestinal model.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Improved bioavailability of dietary phenolic acids in whole grain barley and oat groat following fermentation with probiotic Lactobacillus acidophilus , Lactobacillus johnsonii , and Lactobacillus reuteri.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533).
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry In silico prospection of Lactobacillus acidophilus strains with potential probiotic activity.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Industrial Whey Utilization as a Medium Supplement for Biphasic Growth and Bacteriocin Production by Probiotic Lactobacillus casei LA-1.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn`s disease: a randomised, double blind, placebo controlled GETAID trial.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactiplantibacillus biofilm and planktonic cells ameliorate ulcerative colitis in mice via immunoregulatory activity, gut metabolism and microbiota modulation.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus acidophilus Induces a Strain-specific and Toll-Like Receptor 2-Dependent Enhancement of Intestinal Epithelial Tight Junction Barrier and Protection Against Intestinal Inflammation.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus fermentum ATCC 23271 Displays In vitro Inhibitory Activities against Candida spp.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Modeling in vitro cholesterol reduction in relation to growth of probiotic Lactobacillus casei.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn`s disease after lleo-caecal resection.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Multistrain probiotic rescinds quinpirole-induced obsessive-compulsive disorder phenotypes by reshaping of microbiota gut-brain axis in rats.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Plasma cobalamin and folate and their metabolic markers methylmalonic acid and total homocysteine among Egyptian children before and after nutritional supplementation with the probiotic bacteria Lactobacillus acidophilus in yoghurt matrix.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Primary administration of Lactobacillus johnsonii NCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Probiotic fermented beverages based on acid whey.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Probiotics and Helicobacter pylori eradication.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Probiotics for Crohn`s disease: are they all alike?
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Probiotics for Crohn`s disease: what have we learned?
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Probiotics for photoprotection.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Reconstitution conditions for dried probiotic powders represent a critical step in determining cell viability.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Risk factors for hyperglycemia in extremely low birth weight infants during the first 14 days.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Safety assessment of ProBiora3, a probiotic mouthwash: subchronic toxicity study in rats.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry The Effect of the Addition of Chokeberry Fiber on the Quality of Sheep`s Milk Fermented by Lactobacillus rhamnosus and Lactobacillus acidophilus.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry The microbiota shifts the iron sensing of intestinal cells.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry The Responses of Lactobacillus reuteri LR1 or Antibiotic on Intestinal Barrier Function and Microbiota in the Cecum of Pigs.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Transformation kinetics of fermented milk using Lactobacillus casei (Lc1) and Streptococcus thermophilus: comparison of results with other Inocula.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunodeficient mice.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation.
Lactobacillus Acidophilus LA1 Flora Pro Fem with Cranberry What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
Lactobacillus acidophilus NCFM UltraFlora® Balance [Cloning, expression and characterization of a heterodimeric beta-galactosidase from Lactobacillus acidophilus ATCC 4356].
Lactobacillus acidophilus NCFM UltraFlora® Balance [Expression of PTX3 gene in Caco-2 cells treated with Lactobacillus acidophilus NCFM].
Lactobacillus acidophilus NCFM UltraFlora® Balance [Expression profile analysis of intestinal Caco-2 cells treated with Lactobacillus acidophilus NCFM].
Lactobacillus acidophilus NCFM UltraFlora® Balance [Lactobacillus acidophilus NCFM affects host adhesion-related gene expression after adhering to host].
Lactobacillus acidophilus NCFM UltraFlora® Balance [Removal of benzo(a)pyrene by Lactobacillus strains under simulated starch conditions].
Lactobacillus acidophilus NCFM UltraFlora® Balance <i>Ex vivo</i> peripheral blood mononuclear cell response to R848 in children after supplementation with the probiotic <i>Lactobacillus acidophilus</i> NCFM/<i>Bifidobacterium lactis</i> Bi-07.
Lactobacillus acidophilus NCFM UltraFlora® Balance <i>In Vivo</i> Transcriptome of Lactobacillus acidophilus and Colonization Impact on Murine Host Intestinal Gene Expression.
Lactobacillus acidophilus NCFM UltraFlora® Balance <i>Lycium</i><i>barbarum</i> Polysaccharide (LBP): A Novel Prebiotics Candidate for <i>Bifidobacterium</i> and <i>Lactobacillus</i>.
Lactobacillus acidophilus NCFM UltraFlora® Balance 16S ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance 16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance A functional glycogen biosynthesis pathway in Lactobacillus acidophilus: expression and analysis of the glg operon.
Lactobacillus acidophilus NCFM UltraFlora® Balance A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO).
Lactobacillus acidophilus NCFM UltraFlora® Balance A surface-layer protein from Lactobacillus acidophilus NCFM induces autophagic death in HCT116 cells requiring ROS-mediated modulation of mTOR and JNK signaling pathways.
Lactobacillus acidophilus NCFM UltraFlora® Balance Absolute Enumeration of Probiotic Strains <i>Lactobacillus acidophilus</i> NCFM<sup>®</sup> and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bl-04 <b><sup>®</sup></b> via Chip-Based Digital PCR.
Lactobacillus acidophilus NCFM UltraFlora® Balance AcmB Is an S-Layer-Associated ß-N-Acetylglucosaminidase and Functional Autolysin in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Adaptation of Lactobacillus acidophilus to Thermal Stress Yields a Thermotolerant Variant Which Also Exhibits Improved Survival at pH 2.
Lactobacillus acidophilus NCFM UltraFlora® Balance Adjuvant treatment with a symbiotic in patients with inflammatory non-allergic rhinitis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Advancing the use of Lactobacillus acidophilus surface layer protein A for the treatment of intestinal disorders in humans.
Lactobacillus acidophilus NCFM UltraFlora® Balance AI-2 signalling is induced by acidic shock in probiotic strains of Lactobacillus spp.
Lactobacillus acidophilus NCFM UltraFlora® Balance Ameliorative Effect of Surface Proteins of Probiotic Lactobacilli in Colitis Mouse Models.
Lactobacillus acidophilus NCFM UltraFlora® Balance An 1,4-a-Glucosyltransferase Defines a New Maltodextrin Catabolism Scheme in Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Lactobacillus acidophilus NCFM UltraFlora® Balance An Extracellular Cell-Attached Pullulanase Confers Branched a-Glucan Utilization in Human Gut Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance An NAD<sup>+</sup>-Dependent Sirtuin Depropionylase and Deacetylase (Sir2La) from the Probiotic Bacterium Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lactobacillus acidophilus NCFM UltraFlora® Balance Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism.
Lactobacillus acidophilus NCFM UltraFlora® Balance Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli.
Lactobacillus acidophilus NCFM UltraFlora® Balance Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
Lactobacillus acidophilus NCFM UltraFlora® Balance Bacteriocin involved in premature death of Lactobacillus acidophilus NCFM during growth at pH 6.
Lactobacillus acidophilus NCFM UltraFlora® Balance Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Binding and detoxification ability of lactobacillus acidophilus towards di-n-butyl phthalate: Change of MAPK pathway in Caco-2 cell model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responses.
Lactobacillus acidophilus NCFM UltraFlora® Balance Calcium-Induced Alteration of Cellular Morphology Affecting the Resistance of Lactobacillus acidophilus to Freezing.
Lactobacillus acidophilus NCFM UltraFlora® Balance Characterization and Immobilization of a Novel SGNH Family Esterase (<i>La</i>SGNH1) from <i>Lactobacillus acidophilus</i> NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Characterization of a lactose-responsive promoter of ATP-binding cassette (ABC) transporter gene from Lactobacillus acidophilus 05-172.
Lactobacillus acidophilus NCFM UltraFlora® Balance Characterization of a novel bile-inducible operon encoding a two-component regulatory system in Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Characterization of the tre locus and analysis of trehalose cryoprotection in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT.
Lactobacillus acidophilus NCFM UltraFlora® Balance Comparative genomics of lactic acid bacteria reveals a niche-specific gene set.
Lactobacillus acidophilus NCFM UltraFlora® Balance Comparative proteomics of oxidative stress response of Lactobacillus acidophilus NCFM reveals effects on DNA repair and cysteine de novo synthesis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Comparative Transcriptional Analysis of <i>Lactobacillus plantarum</i> and Its <i>ccpA</i>-Knockout Mutant Under Galactooligosaccharides and Glucose Conditions.
Lactobacillus acidophilus NCFM UltraFlora® Balance Complete Genome Sequence of <i>Lactobacillus acidophilus</i> Strain ATCC 53544.
Lactobacillus acidophilus NCFM UltraFlora® Balance Complete Genome Sequence of Probiotic Strain Lactobacillus acidophilus La-14.
Lactobacillus acidophilus NCFM UltraFlora® Balance Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Complete genome sequencing and comparative genomic analysis of Lactobacillus acidophilus C5 as a potential canine probiotics.
Lactobacillus acidophilus NCFM UltraFlora® Balance Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
Lactobacillus acidophilus NCFM UltraFlora® Balance Constitutive expression and cell-surface display of a bacterial ß-mannanase in Lactobacillus plantarum.
Lactobacillus acidophilus NCFM UltraFlora® Balance Construction of vectors for inducible and constitutive gene expression in Lactobacillus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Consumption of probiotics increases the effect of regulatory T cells in transfer colitis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Control of cell morphology of probiotic Lactobacillus acidophilus for enhanced cell stability during industrial processing.
Lactobacillus acidophilus NCFM UltraFlora® Balance Critical analysis of peptidoglycan structure of Lactobacillus acidophilus for phthalate removal.
Lactobacillus acidophilus NCFM UltraFlora® Balance Crystal structure of a-galactosidase from Lactobacillus acidophilus NCFM: insight into tetramer formation and substrate binding.
Lactobacillus acidophilus NCFM UltraFlora® Balance Data regarding the growth of <i>Lactobacillus acidophilus</i> NCFM on different carbohydrates and recombinant production of elongation factor G and pyruvate kinase.
Lactobacillus acidophilus NCFM UltraFlora® Balance Deletion of Lipoteichoic Acid Synthase Impacts Expression of Genes Encoding Cell Surface Proteins in <i>Lactobacillus acidophilus</i>.
Lactobacillus acidophilus NCFM UltraFlora® Balance Deletion of S-Layer Associated Ig-Like Domain Protein Disrupts the <i>Lactobacillus acidophilus</i> Cell Surface.
Lactobacillus acidophilus NCFM UltraFlora® Balance Determining the Role of UTP-Glucose-1-Phosphate Uridylyltransferase (GalU) in Improving the Resistance of Lactobacillus acidophilus NCFM to Freeze-Drying.
Lactobacillus acidophilus NCFM UltraFlora® Balance Development and application of a upp-based counterselective gene replacement system for the study of the S-layer protein SlpX of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Dietary Nutrients, Proteomes, and Adhesion of Probiotic Lactobacilli to Mucin and Host Epithelial Cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Different Effects of Different Lactobacillus acidophilus Strains on DSS-Induced Colitis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Differential proteome and cellular adhesion analyses of the probiotic bacterium Lactobacillus acidophilus NCFM grown on raffinose - an emerging prebiotic.
Lactobacillus acidophilus NCFM UltraFlora® Balance Directed chromosomal integration and expression of the reporter gene gusA3 in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing <i>Saccharomyces</i> to a Mixture of <i>Lactobacillus, Bifidobacterium</i>, and <i>Saccharomyces</i>.
Lactobacillus acidophilus NCFM UltraFlora® Balance Draft Genome Sequence of the Probiotic Strain Lactobacillus acidophilus ATCC 4356.
Lactobacillus acidophilus NCFM UltraFlora® Balance Draft Genome Sequences of Five Strains of Lactobacillus acidophilus, Strain CIP 76.13T, Isolated from Humans, Strains CIRM-BIA 442 and CIRM-BIA 445, Isolated from Dairy Products, and Strains DSM 20242 and DSM 9126 of Unknown Origin.
Lactobacillus acidophilus NCFM UltraFlora® Balance Droplet Digital PCR Is an Improved Alternative Method for High-Quality Enumeration of Viable Probiotic Strains.
Lactobacillus acidophilus NCFM UltraFlora® Balance Dual functions of Lactobacillus acidophilus NCFM as protection against rotavirus diarrhea.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of <i>Lactobacillus acidophilus</i>, <i>Oenococcus oeni</i>, and <i>Lactobacillus brevis</i> on Composition of Bog Bilberry Juice.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot study.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of giving probiotic supplement Lactobacillus acidophilus La-14 as an immunomodulator to maintain a respiratory system in Mus musculus.
Lactobacillus acidophilus NCFM UltraFlora® Balance EFFECT OF PROBIOTIC ORAL ADMINISTRATION ON SKIN WOUND HEALING IN RATS.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of probiotic supplementation on plasma metabolite profile after Roux-Y gastric bypass: a prospective, randomized, double-blind, placebo-controlled clinical trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance EFFECT OF SUPPLEMENTATION WITH PROBIOTICS ON COLONIC ANASTOMOSES IN RATS: MORPHOLOGICAL AND TENSIOMETRIC STUDY.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects and Mechanisms of Resveratrol on the Adhesion of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of galactosyltransferase on EPS biosynthesis and freeze-drying resistance of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Supplementation on Nutritional and Metabolic Parameters in the Early Postoperative Period after Roux-en-Y Gastric Bypass: a Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance EFFECTS OF SYNBIOTIC SUPPLEMENTATION ON GUT FUNCTIONING AND SYSTEMIC INFLAMMATION OF COMMUNITY-DWELLING ELDERS - SECONDARY ANALYSES FROM A RANDOMIZED CLINICAL TRIAL.
Lactobacillus acidophilus NCFM UltraFlora® Balance Effects of yogurt starter cultures on the survival of Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
Lactobacillus acidophilus NCFM UltraFlora® Balance Efficient one-pot enzymatic synthesis of alpha-(1--&gt;4)-glucosidic disaccharides through a coupled reaction catalysed by Lactobacillus acidophilus NCFM maltose phosphorylase.
Lactobacillus acidophilus NCFM UltraFlora® Balance Efficient system for directed integration into the Lactobacillus acidophilus and Lactobacillus gasseri chromosomes via homologous recombination.
Lactobacillus acidophilus NCFM UltraFlora® Balance Electrotransformation of lactobacillus acidophilus group A1.
Lactobacillus acidophilus NCFM UltraFlora® Balance Engineered living materials for the conversion of a low-cost food-grade precursor to a high-value flavonoid.
Lactobacillus acidophilus NCFM UltraFlora® Balance Engineered Probiotic-Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity.
Lactobacillus acidophilus NCFM UltraFlora® Balance Engineering E. coli strains using antibiotic-resistance-gene-free plasmids.
Lactobacillus acidophilus NCFM UltraFlora® Balance Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.
Lactobacillus acidophilus NCFM UltraFlora® Balance Enhancing acid tolerance of the probiotic bacterium Lactobacillus acidophilus NCFM with trehalose.
Lactobacillus acidophilus NCFM UltraFlora® Balance Enhancing Bioaccessibility of Plant Protein Using Probiotics: An In Vitro Study.
Lactobacillus acidophilus NCFM UltraFlora® Balance Enzymology and structure of the GH13_31 glucan 1,6-a-glucosidase that confers isomaltooligosaccharide utilization in the probiotic Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Erratum: Hunaefi, D., et al. The Effect of Lactobacillus plantarum ATCC 8014 and Lactobacillus acidophilus NCFM Fermentation on Antioxidant Properties of Selected in Vitro Sprout Culture of Orthosiphon aristatus (Java Tea) as a Model Study. Antioxidants 2012, 1, 4-32.
Lactobacillus acidophilus NCFM UltraFlora® Balance ESR spin trapping for characterization of radical formation in Lactobacillus acidophilus NCFM and Listeria innocua.
Lactobacillus acidophilus NCFM UltraFlora® Balance Evaluation of Lactobacillus rhamnosus GG and Lactobacillus acidophilus NCFM encapsulated using a novel impinging aerosol method in fruit food products.
Lactobacillus acidophilus NCFM UltraFlora® Balance Evaluation of the Efficacy of Lactobacillus acidophilus in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats.
Lactobacillus acidophilus NCFM UltraFlora® Balance Evidence for the presence of plasmids in four therapeutically important strains of Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study.
Lactobacillus acidophilus NCFM UltraFlora® Balance Exo- and surface proteomes of the probiotic bacterium Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies.
Lactobacillus acidophilus NCFM UltraFlora® Balance Extractable surface proteins of indigenous probiotic strains confer anti-adhesion knack and protect against methicillin-resistant Staphylococcus aureus induced epithelial hyperpermeability in HT-29 cell line.
Lactobacillus acidophilus NCFM UltraFlora® Balance Factors involved in adherence of lactobacilli to human Caco-2 cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment.
Lactobacillus acidophilus NCFM UltraFlora® Balance Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals.
Lactobacillus acidophilus NCFM UltraFlora® Balance First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional Analysis of an S-Layer-Associated Fibronectin-Binding Protein in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional analysis of the gene encoding immunity to lactacin F, lafI, and its use as a Lactobacillus-specific, food-grade genetic marker.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional and phenotypic characterization of a protein from Lactobacillus acidophilus involved in cell morphology, stress tolerance and adherence to intestinal cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Functional roles of aggregation-promoting-like factor in stress tolerance and adherence of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Genes involved in lactose catabolism and organic acid production during growth of Lactobacillus delbrueckii UFV H2b20 in skimmed milk.
Lactobacillus acidophilus NCFM UltraFlora® Balance Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Group-specific comparison of four lactobacilli isolated from human sources using differential blast analysis.
Lactobacillus acidophilus NCFM UltraFlora® Balance Growth, survival, and metabolic activities of probiotic Lactobacillus spp. in fermented coffee brews supplemented with glucose and inactivated yeast derivatives.
Lactobacillus acidophilus NCFM UltraFlora® Balance Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol.
Lactobacillus acidophilus NCFM UltraFlora® Balance High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs.
Lactobacillus acidophilus NCFM UltraFlora® Balance HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis.
Lactobacillus acidophilus NCFM UltraFlora® Balance How frequent is routine use of probiotics in UK neonatal units?
Lactobacillus acidophilus NCFM UltraFlora® Balance Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.
Lactobacillus acidophilus NCFM UltraFlora® Balance Identification and inactivation of genetic loci involved with Lactobacillus acidophilus acid tolerance.
Lactobacillus acidophilus NCFM UltraFlora® Balance Identification and phenotypic characterization of the cell-division protein CdpA.
Lactobacillus acidophilus NCFM UltraFlora® Balance Identification of an operon and inducing peptide involved in the production of lactacin B by Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Identification of extracellular surface-layer associated proteins in Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Identification, characterization, immobilization, and mutational analysis of a novel acetylesterase with industrial potential (LaAcE) from Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Immature wheat grain as a potential prebiotic ingredient in set-type yoghurts: impact on antioxidative, textural properties and survival of different probiotics.
Lactobacillus acidophilus NCFM UltraFlora® Balance Immunoregulatory effects on Caco-2 cells and mice of exopolysaccharides isolated from Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.
Lactobacillus acidophilus NCFM UltraFlora® Balance In vitro gastrointestinal resistance of Lactobacillus acidophilus in some dairy products.
Lactobacillus acidophilus NCFM UltraFlora® Balance In vitro growth of four individual human gut bacteria on oligosaccharides produced by chemoenzymatic synthesis.
Lactobacillus acidophilus NCFM UltraFlora® Balance In Vitro Gut Fermentation of Whey Protein Hydrolysate: An Evaluation of Its Potential Modulation on Infant Gut Microbiome.
Lactobacillus acidophilus NCFM UltraFlora® Balance Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid.
Lactobacillus acidophilus NCFM UltraFlora® Balance Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters.
Lactobacillus acidophilus NCFM UltraFlora® Balance Influence of bile on cellular integrity and beta-galactosidase activity of Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Influence of the Probiotic <i>Lactobacillus acidophilus</i> NCFM?and <i>Lactobacillus rhamnosus</i> HN001 on Proteolysis Patterns?of Edam Cheese.
Lactobacillus acidophilus NCFM UltraFlora® Balance Integrative food grade expression system for lactic acid bacteria.
Lactobacillus acidophilus NCFM UltraFlora® Balance Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention.
Lactobacillus acidophilus NCFM UltraFlora® Balance Investigating the Effect of Growth Phase on the Surface-Layer Associated Proteome of <i>Lactobacillus acidophilus</i> Using Quantitative Proteomics.
Lactobacillus acidophilus NCFM UltraFlora® Balance Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic.
Lactobacillus acidophilus NCFM UltraFlora® Balance Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lactobacillus acidophilus NCFM UltraFlora® Balance Keeping good friends close - The surface and secreted proteomes of a probiotic bacterium provide candidate proteins for intestinal attachment and communication with the host.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study).
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacilli postbiotics reduce biofilm formation and alter transcription of virulence genes of Aggregatibacter actinomycetemcomitans.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus induces a slow but more sustained chemokine and cytokine response in naïve foetal enterocytes compared to commensal Escherichia coli.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus induces cytokine and chemokine production via NF-?B and p38 mitogen-activated protein kinase signaling pathways in intestinal epithelial cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus NCFM affects vitamin E acetate metabolism and intestinal bile acid signature in monocolonized mice.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals.
Lactobacillus acidophilus NCFM UltraFlora® Balance Mannan Enhances IL-12 Production by Increasing Bacterial Uptake and Endosomal Degradation in <i>L. acidophilus</i> and <i>S. aureus</i> Stimulated Dendritic Cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Metabolomic Analysis of Lactobacillus acidophilus, L. gasseri, L. crispatus, and Lacticaseibacillus rhamnosus Strains in the Presence of Pomegranate Extract.
Lactobacillus acidophilus NCFM UltraFlora® Balance Metabonomic strategy for the detection of metabolic effects of probiotics combined with prebiotic supplementation in weaned rats.
Lactobacillus acidophilus NCFM UltraFlora® Balance Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy.
Lactobacillus acidophilus NCFM UltraFlora® Balance Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Microbiota-Derived Extracellular Vesicles Promote Immunity and Intestinal Maturation in Suckling Rats.
Lactobacillus acidophilus NCFM UltraFlora® Balance Microencapsulation of Lactobacillus acidophilus NCFM using polymerized whey proteins as wall material.
Lactobacillus acidophilus NCFM UltraFlora® Balance Molecular cloning, expression and adhesion analysis of silent slpB of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Mucin- and carbohydrate-stimulated adhesion and subproteome changes of the probiotic bacterium Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Multivalent Chromosomal Expression of the Clostridium botulinum Serotype A Neurotoxin Heavy-Chain Antigen and the Bacillus anthracis Protective Antigen in Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Myosin-cross-reactive antigens from four different lactic acid bacteria are fatty acid hydratases.
Lactobacillus acidophilus NCFM UltraFlora® Balance Nanofiber could deliver lactic acid bacteria to the intestine of ruminant in vitro experiment.
Lactobacillus acidophilus NCFM UltraFlora® Balance Nature of bacterial colonization influences transcription of mucin genes in mice during the first week of life.
Lactobacillus acidophilus NCFM UltraFlora® Balance Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson`s disease in mice by delivering GLP-1 and modulating gut microbiota.
Lactobacillus acidophilus NCFM UltraFlora® Balance New compound probiotic beverage protects against antibiotic-associated diarrhea in mice by modulating the microbiota.
Lactobacillus acidophilus NCFM UltraFlora® Balance Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.
Lactobacillus acidophilus NCFM UltraFlora® Balance Novel encapsulation improves recovery of probiotic strains in fecal samples of human volunteers.
Lactobacillus acidophilus NCFM UltraFlora® Balance Oral administration of fermented milk supplemented with synbiotics can influence the physiological condition of Wistar rats in a dose-sensitive and sex-specific manner.
Lactobacillus acidophilus NCFM UltraFlora® Balance Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue.
Lactobacillus acidophilus NCFM UltraFlora® Balance Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection.
Lactobacillus acidophilus NCFM UltraFlora® Balance Plant Polyphenols Stimulate Adhesion to Intestinal Mucosa and Induce Proteome Changes in the Probiotic Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Portable CRISPR-Cas9<sup>N</sup> System for Flexible Genome Engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei.
Lactobacillus acidophilus NCFM UltraFlora® Balance Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Prebiotic Galactooligosaccharide Metabolism by Probiotic Lactobacilli and Bifidobacteria.
Lactobacillus acidophilus NCFM UltraFlora® Balance Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic activity traits in vitro and production of antimicrobial peptides by Lactobacillaceae isolates from pulque using Lactobacillus acidophilus NCFM as control.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic Bacteria Alter Pattern-Recognition Receptor Expression and Cytokine Profile in a Human Macrophage Model Challenged with <i>Candida albicans</i> and Lipopolysaccharide.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic effects on cold and influenza-like symptom incidence and duration in children.
Lactobacillus acidophilus NCFM UltraFlora® Balance PROBIOTIC SUPPLEMENTATION ATTENUATES BINGE EATING AND FOOD ADDICTION 1 YEAR AFTER ROUX-EN-Y GASTRIC BYPASS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotics and immunosenescence: cheese as a carrier.
Lactobacillus acidophilus NCFM UltraFlora® Balance Probiotics Modulate Intestinal Motility and Inflammation in Zebrafish Models.
Lactobacillus acidophilus NCFM UltraFlora® Balance Prophylactic feeding of Lactobacillus acidophilus NCFM to mice attenuates overt colonic hyperplasia.
Lactobacillus acidophilus NCFM UltraFlora® Balance Protective effect of surface layer proteins isolated from four Lactobacillus strains on hydrogen-peroxide-induced HT-29 cells oxidative stress.
Lactobacillus acidophilus NCFM UltraFlora® Balance Proteome reference map of Lactobacillus acidophilus NCFM and quantitative proteomics towards understanding the prebiotic action of lactitol.
Lactobacillus acidophilus NCFM UltraFlora® Balance Randomized controlled trial of probiotics after colonoscopy.
Lactobacillus acidophilus NCFM UltraFlora® Balance Rational engineering of Lactobacillus acidophilus NCFM maltose phosphorylase into either trehalose or kojibiose dual specificity phosphorylase.
Lactobacillus acidophilus NCFM UltraFlora® Balance Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid.
Lactobacillus acidophilus NCFM UltraFlora® Balance Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria.
Lactobacillus acidophilus NCFM UltraFlora® Balance Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Role of autoinducer-2 on the adhesion ability of Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Role of transporter proteins in bile tolerance of Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions.
Lactobacillus acidophilus NCFM UltraFlora® Balance Safety evaluation of HOWARU<sup>®</sup> Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.
Lactobacillus acidophilus NCFM UltraFlora® Balance Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
Lactobacillus acidophilus NCFM UltraFlora® Balance Simulating colonic survival of probiotics in single-strain products compared to multi-strain products.
Lactobacillus acidophilus NCFM UltraFlora® Balance S-layer associated proteins contribute to the adhesive and immunomodulatory properties of Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Sortase-deficient lactobacilli: effect on immunomodulation and gut retention.
Lactobacillus acidophilus NCFM UltraFlora® Balance Specific probiotics alleviate allergic rhinitis during the birch pollen season.
Lactobacillus acidophilus NCFM UltraFlora® Balance Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Study on the Influence of Tea Extract on Probiotics in Skim Milk: From Probiotics Propagation to Metabolite.
Lactobacillus acidophilus NCFM UltraFlora® Balance Surface layer protein from Lactobacillus acidophilus NCFM inhibit intestinal pathogen-induced apoptosis in HT-29 cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Surface-layer protein from Lactobacillus acidophilus NCFM attenuates tumor necrosis factor-a-induced intestinal barrier dysfunction and inflammation.
Lactobacillus acidophilus NCFM UltraFlora® Balance Surface-Layer Protein from Lactobacillus acidophilus NCFM Inhibits Lipopolysaccharide-Induced Inflammation through MAPK and NF-?B Signaling Pathways in RAW264.7 Cells.
Lactobacillus acidophilus NCFM UltraFlora® Balance Survivability of probiotics encapsulated in alginate gel microbeads using a novel impinging aerosols method.
Lactobacillus acidophilus NCFM UltraFlora® Balance Synbiotic effects of lactitol and Lactobacillus acidophilus NCFM™ in a semi-continuous colon fermentation model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance Temporal gene expression and probiotic attributes of Lactobacillus acidophilus during growth in milk.
Lactobacillus acidophilus NCFM UltraFlora® Balance The <i>In Vitro</i> Adsorption Ability of <i>Lactobacillus acidophilus</i> NCFM to Benzo(a)pyrene in PM<sub>2.5</sub>.
Lactobacillus acidophilus NCFM UltraFlora® Balance The beneficial effects of polysaccharide obtained from persimmon (Diospyros kaki L.) on the proliferation of Lactobacillus and gut microbiota.
Lactobacillus acidophilus NCFM UltraFlora® Balance The Differential Proteome of the Probiotic Lactobacillus acidophilus NCFM Grown on the Potential Prebiotic Cellobiose Shows Upregulation of Two ß -Glycoside Hydrolases.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Lactobacillus acidophilus NCFM UltraFlora® Balance The Effect of Lactobacillus plantarum ATCC 8014 and Lactobacillus acidophilus NCFM Fermentation on Antioxidant Properties of Selected in Vitro Sprout Culture of Orthosiphon aristatus (Java Tea) as a Model Study.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of polydextrose and probiotic lactobacilli in a Clostridium difficile-infected human colonic model.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of probiotics (Lactobacillus rhamnosus HN001, Lactobacillus paracasei LPC-37, and Lactobacillus acidophilus NCFM) on the availability of minerals from Dutch-type cheese.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of probiotics and polysaccharides on the gut microbiota composition and function of weaned rats.
Lactobacillus acidophilus NCFM UltraFlora® Balance The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.
Lactobacillus acidophilus NCFM UltraFlora® Balance The hsp 16 gene of the probiotic Lactobacillus acidophilus is differently regulated by salt, high temperature and acidic stresses, as revealed by reverse transcription quantitative PCR (qRT-PCR) analysis.
Lactobacillus acidophilus NCFM UltraFlora® Balance The maltodextrin transport system and metabolism in Lactobacillus acidophilus NCFM and production of novel alpha-glucosides through reverse phosphorolysis by maltose phosphorylase.
Lactobacillus acidophilus NCFM UltraFlora® Balance The quorum sensing luxS gene is induced in Lactobacillus acidophilus NCFM in response to Listeria monocytogenes.
Lactobacillus acidophilus NCFM UltraFlora® Balance The S-layer Associated Serine Protease Homolog PrtX Impacts Cell Surface-Mediated Microbe-Host Interactions of <i>Lactobacillus acidophilus</i> NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance The suitability of different probiotic strains for the production of fruit-whey beverages.
Lactobacillus acidophilus NCFM UltraFlora® Balance Transcriptional analysis of genes associated with stress and adhesion in Lactobacillus acidophilus NCFM during the passage through an in vitro gastrointestinal tract model.
Lactobacillus acidophilus NCFM UltraFlora® Balance Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus.
Lactobacillus acidophilus NCFM UltraFlora® Balance Two-dimensional gel-based alkaline proteome of the probiotic bacterium Lactobacillus acidophilus NCFM.
Lactobacillus acidophilus NCFM UltraFlora® Balance Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunodeficient mice.
Lactobacillus acidophilus NCFM UltraFlora® Balance Variable response to exogenous Lactobacillus acidophilus NCFM consumed in different delivery vehicles.
Lactobacillus acidophilus NCFM UltraFlora® Balance Volatile sulfur compounds produced by probiotic bacteria in the presence of cysteine or methionine.
Lactobacillus acidophilus W22 Ecologic Performance In vitro evidence for efficacy in food intolerance for the multispecies probiotic formulation Ecologic® Tolerance (Syngut™).
Lactobacillus acidophilus W22 Ecologic Performance Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health <i>Lactobacillus acidophilus</i> Attenuates <i>Salmonella</i>-Induced Stress of Epithelial Cells by Modulating Tight-Junction Genes and Cytokine Responses.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Combined dietary supplementation of long chain inulin and Lactobacillus acidophilus W37 supports oral vaccination efficacy against Salmonella Typhimurium in piglets.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Structural Identity of Galactooligosaccharide Molecules Selectively Utilized by Single Cultures of Probiotic Bacterial Strains.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Synbiotic Effects of the Dietary Fiber Long-Chain Inulin and Probiotic Lactobacillus acidophilus W37 Can be Caused by Direct, Synergistic Stimulation of Immune Toll-Like Receptors and Dendritic Cells.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactobacillus acidophilus W37 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus acidophilus W55 Ecologic® Allergycare Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus acidophilus W55 Ecologic® Allergycare Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans.
Lactobacillus acidophilus W55 Ecologic® Allergycare Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health <i>Lactobacillus acidophilus</i> Attenuates <i>Salmonella</i>-Induced Stress of Epithelial Cells by Modulating Tight-Junction Genes and Cytokine Responses.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactobacillus brevis W63 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus casei LBC80R Bio-K+ A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Lactobacillus casei LBC80R Bio-K+ Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA).
Lactobacillus casei LBC80R Bio-K+ Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?
Lactobacillus casei LBC80R Bio-K+ Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Lactobacillus casei LBC80R Bio-K+ Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Lactobacillus casei LBC80R Bio-K+ Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
Lactobacillus casei LBC80R Bio-K+ Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Lactobacillus casei LBC80R Bio-K+ In vitro protein digestibility and physico-chemical properties of lactic acid bacteria fermented beverages enriched with plant proteins.
Lactobacillus casei LBC80R Bio-K+ Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis.
Lactobacillus casei LBC80R Bio-K+ Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Lactobacillus casei LBC80R Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus casei LBC80R Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Lactobacillus casei LBC80R Bio-K+ Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
Lactobacillus casei LBC80R Bio-K+ Probiotics and prevention of Clostridium difficile infection.
Lactobacillus casei LBC80R Bio-K+ Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Lactobacillus casei LBC80R Bio-K+ Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea.
Lactobacillus casei LBC80R Bio-K+ Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Lactobacillus casei LBC80R Bio-K+ The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Lactobacillus casei LBC80R Bio-K+ The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
Lactobacillus casei LC-11 Custom Probiotics Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
Lactobacillus casei LC-11 Custom Probiotics Inhibition of Streptococcus mutans Growth and Biofilm Formation by Probiotics in vitro.
Lactobacillus casei LC-11 Custom Probiotics Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis.
Lactobacillus casei R0215 PharmExtracta / INatal Sachets Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Lactobacillus casei R0215 PharmExtracta / INatal Sachets Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus casei Shirota Yakult [Effect of continuous probiotic fermented milk intake containing Lactobacillus casei strain Shirota on fever in mass infectious gastroenteritis rest home outbreak].
Lactobacillus casei Shirota Yakult [Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone].
Lactobacillus casei Shirota Yakult [Intestinal Care Using L?Glutamine Supplement and Probiotics Can Induce a Strong Anti?Tumor Immune Response through the Induction of Mature Tertiary Lymphoid Structures in Pancreatic Cancer Patients Receiving Preoperative Chemotherapy].
Lactobacillus casei Shirota Yakult [Prevention of irinotecan hydrochloride-induced diarrhea by oral administration of Lactobacillus casei strain Shirota in rats].
Lactobacillus casei Shirota Yakult [Probiotics as therapeutic agents in irritable bowel syndrome].
Lactobacillus casei Shirota Yakult <i>Lactobacillus casei</i> Strain Shirota Alleviates Constipation in Adults by Increasing the Pipecolinic Acid Level in the Gut.
Lactobacillus casei Shirota Yakult <i>Lactobacillus casei</i> Strain Shirota Enhances the In Vitro Antiproliferative Effect of Geniposide in Human Oral Squamous Carcinoma HSC-3 Cells.
Lactobacillus casei Shirota Yakult A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
Lactobacillus casei Shirota Yakult A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic <i>Lactobacillus casei</i> Shirota in Stable Cirrhotic Patients.
Lactobacillus casei Shirota Yakult A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial.
Lactobacillus casei Shirota Yakult A method to maintain introduced DNA sequences stably and safely on the bacterial chromosome: application of prophage integration and subsequent designed excision.
Lactobacillus casei Shirota Yakult A novel dental biosafety device to control the spread of potentially contaminated dispersion particles from dental ultrasonic tips.
Lactobacillus casei Shirota Yakult A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis.
Lactobacillus casei Shirota Yakult A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.
Lactobacillus casei Shirota Yakult A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome.
Lactobacillus casei Shirota Yakult A study into the effect of Lactobacillus casei Shirota in preventing antibiotic associated diarrhoea including Clostridioides difficile infection in patients with spinal cord injuries: a multicentre randomised, double-blind, placebo-controlled trial.
Lactobacillus casei Shirota Yakult Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.
Lactobacillus casei Shirota Yakult Adhesion of inactivated probiotic strains to intestinal mucus.
Lactobacillus casei Shirota Yakult Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments.
Lactobacillus casei Shirota Yakult Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats.
Lactobacillus casei Shirota Yakult Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats.
Lactobacillus casei Shirota Yakult Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.
Lactobacillus casei Shirota Yakult Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.
Lactobacillus casei Shirota Yakult Antitumor activity and action mechanisms of Lactobacillus casei through the regulation of immune responses.
Lactobacillus casei Shirota Yakult Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.
Lactobacillus casei Shirota Yakult Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.
Lactobacillus casei Shirota Yakult Applications of probiotics.
Lactobacillus casei Shirota Yakult Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review.
Lactobacillus casei Shirota Yakult Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms.
Lactobacillus casei Shirota Yakult Assessment of the effect of stress-tolerance acquisition on some basic characteristics of specific probiotics.
Lactobacillus casei Shirota Yakult Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice.
Lactobacillus casei Shirota Yakult Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial.
Lactobacillus casei Shirota Yakult Beneficial effects of long-term consumption of a probiotic combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult may persist after suspension of therapy in lactose-intolerant patients.
Lactobacillus casei Shirota Yakult Binding of extracellular matrix molecules by probiotic bacteria.
Lactobacillus casei Shirota Yakult Bioactivity of Peptides Released During Lactic Fermentation of Amaranth Proteins with Potential Cardiovascular Protective Effect: An <i>In Vitro</i> Study.
Lactobacillus casei Shirota Yakult Biological effects of probiotics: what impact does Lactobacillus casei shirota have on us?
Lactobacillus casei Shirota Yakult Biosafety devices to control the spread of potentially contaminated dispersion particles. New associated strategies for health environments.
Lactobacillus casei Shirota Yakult Characteristics of gut microbiome, organic acid profiles and viral antibody indexes of healthy Japanese with live Lacticaseibacillus detected in stool.
Lactobacillus casei Shirota Yakult Characterization of the properties of human- and dairy-derived probiotics for prevention of infectious diseases in fish.
Lactobacillus casei Shirota Yakult Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins.
Lactobacillus casei Shirota Yakult Clinical Evidence of Effects of Lactobacillus plantarum HY7714 on Skin Aging: A Randomized, Double Blind, Placebo-Controlled Study.
Lactobacillus casei Shirota Yakult Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children.
Lactobacillus casei Shirota Yakult Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea.
Lactobacillus casei Shirota Yakult Comparative effects of six probiotic strains on immune function in vitro.
Lactobacillus casei Shirota Yakult Comparative Study of Probiotic Ice Cream and Probiotic Drink on Salivary Streptococcus mutans Levels in 6-12 Years Age Group Children.
Lactobacillus casei Shirota Yakult Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate.
Lactobacillus casei Shirota Yakult Complete genome sequence of the probiotic Lactobacillus casei strain BL23.
Lactobacillus casei Shirota Yakult Compound(s) secreted by Lactobacillus casei strain Shirota YIT9029 irreversibly and reversibly impair the swimming motility of Helicobacter pylori and Salmonella enterica serovar Typhimurium, respectively.
Lactobacillus casei Shirota Yakult Corrigendum for Takeda K et al. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 2007;137(Suppl):791S-3S.
Lactobacillus casei Shirota Yakult Culture media for differential isolation of Lactobacillus casei Shirota from oral samples.
Lactobacillus casei Shirota Yakult Daily Intake of Fermented Milk Containing <i>Lactobacillus casei</i> Shirota (Lcs) Modulates Systemic and Upper Airways Immune/Inflammatory Responses in Marathon Runners.
Lactobacillus casei Shirota Yakult Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers.
Lactobacillus casei Shirota Yakult Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers.
Lactobacillus casei Shirota Yakult Daily probiotic`s (Lactobacillus casei Shirota) reduction of infection incidence in athletes.
Lactobacillus casei Shirota Yakult Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population.
Lactobacillus casei Shirota Yakult Decreased number of days of fever detection and duration of fever with continuous intake of a fermented milk drink: a randomized, double-blind, placebo-controlled study of elderly nursing home residents.
Lactobacillus casei Shirota Yakult Defatted coconut residue crude polysaccharides as potential prebiotics: study of their effects on proliferation and acidifying activity of probiotics in vitro.
Lactobacillus casei Shirota Yakult Determination of specific activities and kinetic constants of biotinidase and lipoamidase in LEW rat and Lactobacillus casei (Shirota).
Lactobacillus casei Shirota Yakult Different stress tolerance of spray and freeze dried <i>Lactobacillus casei</i> Shirota microcapsules with different encapsulating agents.
Lactobacillus casei Shirota Yakult Differential Effects of <i>Lactobacillus casei</i> Strain Shirota on Patients With Constipation Regarding Stool Consistency in China.
Lactobacillus casei Shirota Yakult Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria.
Lactobacillus casei Shirota Yakult Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.
Lactobacillus casei Shirota Yakult Dynamic analysis of human small intestinal microbiota after an ingestion of fermented milk by small-intestinal fluid perfusion using an endoscopic retrograde bowel insertion technique.
Lactobacillus casei Shirota Yakult Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Early use of probiotics is important therapy in infants with severe congenital anomaly.
Lactobacillus casei Shirota Yakult Effect of <i>Lacticaseibacillus paracasei</i> Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in Gut Microbiota.
Lactobacillus casei Shirota Yakult Effect of <i>Lactobacillus casei</i> strain Shirota-fermented milk on metabolic abnormalities in obese prediabetic Japanese men: a randomised, double-blind, placebo-controlled trial.
Lactobacillus casei Shirota Yakult Effect of administration of Lactobacillus casei shirota on sodium balance in an infant with short bowel syndrome.
Lactobacillus casei Shirota Yakult Effect of an oral administration of Lactobacillus casei strain Shirota on the natural killer activity of blood mononuclear cells in aged mice.
Lactobacillus casei Shirota Yakult Effect of Daily Intake of Lactobacillus casei on Microbial Diversity and Dynamics in a Healthy Pediatric Population.
Lactobacillus casei Shirota Yakult Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities.
Lactobacillus casei Shirota Yakult Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Effect of different encapsulating agent combinations on viability of <i>Lactobacillus casei</i> Shirota during storage, in simulated gastrointestinal conditions and dairy dessert.
Lactobacillus casei Shirota Yakult Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation-related symptoms and haemorrhoids in women during puerperium.
Lactobacillus casei Shirota Yakult Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects.
Lactobacillus casei Shirota Yakult Effect of High Protein Diet and Probiotic <i>Lactobacillus casei</i> Shirota Supplementation in Aflatoxin B<sub>1</sub>-Induced Rats.
Lactobacillus casei Shirota Yakult Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.
Lactobacillus casei Shirota Yakult Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.
Lactobacillus casei Shirota Yakult Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine.
Lactobacillus casei Shirota Yakult Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats.
Lactobacillus casei Shirota Yakult Effect of Lactobacillus casei Shirota strain intraperitoneal administration in CD1 mice on the establishment of Trichinella spiralis adult worms and on IgA anti-T. spiralis production.
Lactobacillus casei Shirota Yakult Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
Lactobacillus casei Shirota Yakult Effect of probiotic bacteria on prevalence of yeasts in oropharyngeal biofilms on silicone rubber voice prostheses in vitro.
Lactobacillus casei Shirota Yakult Effect of probiotic chewing tablets on early childhood caries--a randomized controlled trial.
Lactobacillus casei Shirota Yakult Effect of Probiotic Lactobacilli on the Growth of Streptococcus Mutans and Multispecies Biofilms Isolated from Children with Active Caries.
Lactobacillus casei Shirota Yakult Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study.
Lactobacillus casei Shirota Yakult Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.
Lactobacillus casei Shirota Yakult Effect of probiotics on human blood urea levels in patients with chronic renal failure.
Lactobacillus casei Shirota Yakult Effect of probiotics, Bifidobacterium breve and Lactobacillus casei, on bisphenol A exposure in rats.
Lactobacillus casei Shirota Yakult Effect of superoxide dismutase and manganese on superoxide tolerance in <i>Lactobacillus casei</i> strain Shirota and analysis of multiple manganese transporters.
Lactobacillus casei Shirota Yakult Effect of supplementation of fermented milk drink containing probiotic Lactobacillus casei Shirota on the concentrations of aflatoxin biomarkers among employees of Universiti Putra Malaysia: a randomised, double-blind, cross-over, placebo-controlled study.
Lactobacillus casei Shirota Yakult Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged.
Lactobacillus casei Shirota Yakult Effects of <i>Lactobacillus casei</i> Shirota intake on caries risk in children.
Lactobacillus casei Shirota Yakult Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity.
Lactobacillus casei Shirota Yakult Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects.
Lactobacillus casei Shirota Yakult Effects of a probiotic drink containing <i>Lactobacillus casei</i> strain Shirota on dental plaque microbiota.
Lactobacillus casei Shirota Yakult Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools.
Lactobacillus casei Shirota Yakult Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study.
Lactobacillus casei Shirota Yakult Effects of citrus juice fermented with <i>Lactobacillus plantarum</i> YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study.
Lactobacillus casei Shirota Yakult Effects of Daily Probiotics Supplementation on Anxiety Induced Physiological Parameters among Competitive Football Players.
Lactobacillus casei Shirota Yakult Effects of Fermented Milk Containing <i>Lacticaseibacillus paracasei</i> Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus casei Shirota Yakult Effects of fermented soymilk with Lactobacillus casei Shirota on skin condition and the gut microbiota: a randomised clinical pilot trial.
Lactobacillus casei Shirota Yakult Effects of Lactobacillus casei on Iron Metabolism and Intestinal Microflora in Rats Exposed to Alcohol and Iron.
Lactobacillus casei Shirota Yakult Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial.
Lactobacillus casei Shirota Yakult Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.
Lactobacillus casei Shirota Yakult Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial.
Lactobacillus casei Shirota Yakult Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial.
Lactobacillus casei Shirota Yakult Effects of Probiotics on Anxiety, Stress, Mood and Fitness of Badminton Players.
Lactobacillus casei Shirota Yakult Effects of Short-Term Probiotic Ingestion on Immune Profiles and Microbial Translocation among HIV-1-Infected Vietnamese Children.
Lactobacillus casei Shirota Yakult Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.
Lactobacillus casei Shirota Yakult Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study.
Lactobacillus casei Shirota Yakult Effects of synbiotics on ileal microbiota.
Lactobacillus casei Shirota Yakult Effects of the continuous intake of a milk drink containing Lactobacillus casei strain Shirota on abdominal symptoms, fecal microbiota, and metabolites in gastrectomized subjects.
Lactobacillus casei Shirota Yakult Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents.
Lactobacillus casei Shirota Yakult Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome.
Lactobacillus casei Shirota Yakult Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children.
Lactobacillus casei Shirota Yakult Emerging Roles of Probiotics in Prevention and Treatment of Breast Cancer: A Comprehensive Review of Their Therapeutic Potential.
Lactobacillus casei Shirota Yakult Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats.
Lactobacillus casei Shirota Yakult Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion.
Lactobacillus casei Shirota Yakult Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism.
Lactobacillus casei Shirota Yakult Enrichment and evaluation of galacto-oligosaccharides produced by whole cell treatment of sugar reaction mixture.
Lactobacillus casei Shirota Yakult Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity.
Lactobacillus casei Shirota Yakult Evaluation of acrylamide-removing properties of bacterial consortia under simulated gastrointestinal conditions.
Lactobacillus casei Shirota Yakult Evaluation of acrylamide-removing properties of two Lactobacillus strains under simulated gastrointestinal conditions using a dynamic system.
Lactobacillus casei Shirota Yakult Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression.
Lactobacillus casei Shirota Yakult Evaluation of Microencapsulated Synbiotic Preparations Containing Lactobionic Acid.
Lactobacillus casei Shirota Yakult Evaluation of probiotic milk on salivary mutans streptococci count: an in vivo microbiological study.
Lactobacillus casei Shirota Yakult Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486.
Lactobacillus casei Shirota Yakult Exposing the secrets of two well-known Lactobacillus casei phages, J-1 and PL-1, by genomic and structural analysis.
Lactobacillus casei Shirota Yakult Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress.
Lactobacillus casei Shirota Yakult Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress.
Lactobacillus casei Shirota Yakult Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population.
Lactobacillus casei Shirota Yakult Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities.
Lactobacillus casei Shirota Yakult From by-product to functional food: the survival of L. casei shirota, L. casei immunitas and L. acidophilus johnsonii, during spray drying in orange juice using a maltodextrin/pectin mixture as carrier.
Lactobacillus casei Shirota Yakult Functional analysis of a novel hydrogen peroxide resistance gene in Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult Genetic basis of nutritional requirements in Lactobacillus casei.
Lactobacillus casei Shirota Yakult Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model.
Lactobacillus casei Shirota Yakult Gut Microbiota Profiling of Aflatoxin B1-Induced Rats Treated with <i>Lactobacillus casei</i> Shirota.
Lactobacillus casei Shirota Yakult Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people.
Lactobacillus casei Shirota Yakult Habitual intake of lactic acid bacteria and risk reduction of bladder cancer.
Lactobacillus casei Shirota Yakult Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human ß-defensin-2: dependence on inflammatory cytokines.
Lactobacillus casei Shirota Yakult Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFN?.
Lactobacillus casei Shirota Yakult Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA.
Lactobacillus casei Shirota Yakult Identification of collagen-binding proteins in Lactobacillus spp. with surface-enhanced laser desorption/ionization-time of flight ProteinChip technology.
Lactobacillus casei Shirota Yakult Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery.
Lactobacillus casei Shirota Yakult Immune Response of Healthy Adults to the Ingested Probiotic Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Immune system stimulation by probiotic microorganisms.
Lactobacillus casei Shirota Yakult Immunomodulation by treatment with Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers.
Lactobacillus casei Shirota Yakult Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model.
Lactobacillus casei Shirota Yakult Immunomodulatory function of lactic acid bacteria.
Lactobacillus casei Shirota Yakult Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects.
Lactobacillus casei Shirota Yakult Improving the bowel habits of elderly residents in a nursing home using probiotic fermented milk.
Lactobacillus casei Shirota Yakult In case of obesity, longevity-related mechanisms lead to anti-inflammation.
Lactobacillus casei Shirota Yakult In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult In vitro evaluation of probiotics microorganisms adhesion to an artificial caries model.
Lactobacillus casei Shirota Yakult In Vitro Evaluation of the Probiotic Potential of Halotolerant Lactobacilli Isolated from a Ripened Tropical Mexican Cheese.
Lactobacillus casei Shirota Yakult In vitro study on the cell adhesion ability of immobilized lactobacilli on natural supports.
Lactobacillus casei Shirota Yakult Independent and Interactive Effects of Habitually Ingesting Fermented Milk Products Containing <i>Lactobacillus casei</i> Strain Shirota and of Engaging in Moderate Habitual Daily Physical Activity on the Intestinal Health of Older People.
Lactobacillus casei Shirota Yakult Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion.
Lactobacillus casei Shirota Yakult Influence of a probiotic Lactobacillus casei strain on the colonisation with potential pathogenic streptococci and Staphylococcus aureus in the nasopharyngeal space of healthy men with a low baseline NK cell activity.
Lactobacillus casei Shirota Yakult Inhibition of <i>Streptococcus mutans</i> by a commercial yogurt drink.
Lactobacillus casei Shirota Yakult Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid.
Lactobacillus casei Shirota Yakult Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions.
Lactobacillus casei Shirota Yakult Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidrug-resistant bacteria causing hospital-acquired infections.
Lactobacillus casei Shirota Yakult Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice.
Lactobacillus casei Shirota Yakult Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
Lactobacillus casei Shirota Yakult Injection of Lactobacillus casei strain Shirota affects autonomic nerve activities in a tissue-specific manner, and regulates glucose and lipid metabolism in rats.
Lactobacillus casei Shirota Yakult Insertion of bacteriophage phiFSW into the chromosome of Lactobacillus casei strain Shirota (S-1): characterization of the attachment sites and the integrase gene.
Lactobacillus casei Shirota Yakult Intake of a fermented soymilk beverage containing moderate levels of isoflavone aglycones enhances bioavailability of isoflavones in healthy premenopausal Japanese women: a double-blind, placebo-controlled, single-dose, crossover trial.
Lactobacillus casei Shirota Yakult Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Intestinal Microbiota Profiles of Healthy Pre-School and School-Age Children and Effects of Probiotic Supplementation.
Lactobacillus casei Shirota Yakult Intestinal microflora: probiotics and autoimmunity.
Lactobacillus casei Shirota Yakult Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production.
Lactobacillus casei Shirota Yakult Intragastric injection of Lactobacillus casei strain Shirota suppressed spleen sympathetic activation by central corticotrophin-releasing factor or peripheral 2-deoxy-d-glucose in anesthetized rats.
Lactobacillus casei Shirota Yakult Isolation of Yeasts from Guajillo Pepper (Capsicum annuum L.) Fermentation and Study of Some Probiotic Characteristics.
Lactobacillus casei Shirota Yakult Isolation, Identification and Partial Characterization of a Lactobacillus casei Strain with Bile Salt Hydrolase Activity from Pulque.
Lactobacillus casei Shirota Yakult Key role of teichoic acids on aflatoxin B binding by probiotic bacteria.
Lactobacillus casei Shirota Yakult Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds.
Lactobacillus casei Shirota Yakult Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection.
Lactobacillus casei Shirota Yakult Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes.
Lactobacillus casei Shirota Yakult Lactic Acid Fermentation, Urea and Lime Addition: Promising Faecal Sludge Sanitizing Methods for Emergency Sanitation.
Lactobacillus casei Shirota Yakult Lacticaseibacillus casei Strain Shirota Modulates Macrophage-Intestinal Epithelial Cell Co-Culture Barrier Integrity, Bacterial Sensing and Inflammatory Cytokines.
Lactobacillus casei Shirota Yakult Lactobacillus casei acquires the binding activity to fibronectin by the expression of the fibronectin binding domain of Streptococcus pyogenes on the cell surface.
Lactobacillus casei Shirota Yakult Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice.
Lactobacillus casei Shirota Yakult Lactobacillus casei Shirota does not decrease the food allergic response to peanut extract in Brown Norway rats.
Lactobacillus casei Shirota Yakult Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer.
Lactobacillus casei Shirota Yakult Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.
Lactobacillus casei Shirota Yakult Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.
Lactobacillus casei Shirota Yakult Lactobacillus casei Strain Shirota Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Increasing Taurine-Conjugated Bile Acids and Inhibiting NF-?B Signaling via Stabilization of I?Ba.
Lactobacillus casei Shirota Yakult Lactobacillus casei Strain Shirota Enhances the Ability of Geniposide to Activate SIRT1 and Decrease Inflammation and Oxidative Stress in Septic Mice.
Lactobacillus casei Shirota Yakult Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model.
Lactobacillus casei Shirota Yakult Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model.
Lactobacillus casei Shirota Yakult Lactobacillus casei strain Shirota-fermented milk stimulates indigenous Lactobacilli in the pig intestine.
Lactobacillus casei Shirota Yakult Lactobacillus plantarum LB95 impairs the virulence potential of Gram-positive and Gram-negative food-borne pathogens in HT-29 and Vero cell cultures.
Lactobacillus casei Shirota Yakult Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors.
Lactobacillus casei Shirota Yakult Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin).
Lactobacillus casei Shirota Yakult Lactobacillus Spp.-Enhanced Memory is Strain-Dependent and Associated, in Part, with Amyloidogenic and anti-Oxidant/Oxidative Stress Interplay in Amyloid Beta Precursor Protein Transgenic Mice.
Lactobacillus casei Shirota Yakult Lectin microarray reveals binding profiles of Lactobacillus casei strains in a comprehensive analysis of bacterial cell wall polysaccharides.
Lactobacillus casei Shirota Yakult Lower plasma triglyceride level in Syrian hamsters fed on skim milk fermented with Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult Management of Mild-to-Moderate Ulcerative Colitis.
Lactobacillus casei Shirota Yakult Metabolism of Caprine Milk Carbohydrates by Probiotic Bacteria and Caco-2:HT29?MTX Epithelial Co-Cultures and Their Impact on Intestinal Barrier Integrity.
Lactobacillus casei Shirota Yakult Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line.
Lactobacillus casei Shirota Yakult Metabolomic approach assisted high resolution LC-ESI-MS based identification of a xenobiotic derivative of fenhexamid produced by Lactobacillus casei.
Lactobacillus casei Shirota Yakult Metagenomic and proteomic approaches in elucidating aflatoxin B(1) detoxification mechanisms of probiotic Lactobacillus casei Shirota towards intestine.
Lactobacillus casei Shirota Yakult Microbial products from probiotic bacteria inhibit Salmonella enteritidis 857-induced IL-8 synthesis in Caco-2 cells.
Lactobacillus casei Shirota Yakult Miniaturized pH Holographic Sensors for the Monitoring of Lactobacillus casei Shirota Growth in a Microfluidic Chip.
Lactobacillus casei Shirota Yakult Modulating immune responses with probiotic bacteria.
Lactobacillus casei Shirota Yakult M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus.
Lactobacillus casei Shirota Yakult Nutritionally enhanced fermented sausages as a vehicle for potential probiotic lactobacilli delivery.
Lactobacillus casei Shirota Yakult Oral administration of Lactobacillus casei Shirota can ameliorate the adverse effect of an acute aflatoxin exposure in Sprague Dawley rats.
Lactobacillus casei Shirota Yakult Oral administration of Lactobacillus casei Shirota improves recovery of hand functions after distal radius fracture among elder patients: a placebo-controlled, double-blind, and randomized trial.
Lactobacillus casei Shirota Yakult Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis.
Lactobacillus casei Shirota Yakult Oral Administration of Probiotic Lactobacillus Casei Shirota Decreases Pneumonia and Increases Pulmonary Functions after Single Rib Fracture: A Randomized Double-Blind, Placebo-Controlled Clinical Trial.
Lactobacillus casei Shirota Yakult Oral administration of probiotic Lactobacillus casei Shirota relieves pain after single rib fracture: a randomized double-blind, placebo-controlled clinical trial.
Lactobacillus casei Shirota Yakult Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial.
Lactobacillus casei Shirota Yakult Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis.
Lactobacillus casei Shirota Yakult Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.
Lactobacillus casei Shirota Yakult p-Cresol inhibits IL-12 production by murine macrophages stimulated with bacterial immunostimulant.
Lactobacillus casei Shirota Yakult Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut.
Lactobacillus casei Shirota Yakult pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.
Lactobacillus casei Shirota Yakult Preliminary observations on influence of dairy products on biofilm removal from silicone rubber voice prostheses in vitro.
Lactobacillus casei Shirota Yakult Probiotic <i>Lactobacillus casei Shirota</i> improves efficacy of amoxicillin-sulbactam against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical study.
Lactobacillus casei Shirota Yakult Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.
Lactobacillus casei Shirota Yakult Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study.
Lactobacillus casei Shirota Yakult Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice.
Lactobacillus casei Shirota Yakult Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus casei Shirota supplementation does not modulate immunity in healthy men with reduced natural killer cell activity.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus fermentum UCO-979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition.
Lactobacillus casei Shirota Yakult Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.
Lactobacillus casei Shirota Yakult Probiotic modulation of dendritic cell function is influenced by ageing.
Lactobacillus casei Shirota Yakult Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strains.
Lactobacillus casei Shirota Yakult Probiotic Properties and Immunomodulatory Activity of <i>Lactobacillus</i> Strains Isolated from Dairy Products.
Lactobacillus casei Shirota Yakult Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study.
Lactobacillus casei Shirota Yakult Probiotic supplementation attenuates age-related sarcopenia via the gut-muscle axis in SAMP8 mice.
Lactobacillus casei Shirota Yakult Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects.
Lactobacillus casei Shirota Yakult Probiotic treatment for the prevention of antibiotic-associated diarrhoea in geriatric patients: a multicentre randomised controlled pilot study.
Lactobacillus casei Shirota Yakult Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models.
Lactobacillus casei Shirota Yakult Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials.
Lactobacillus casei Shirota Yakult Probiotics and the urologist.
Lactobacillus casei Shirota Yakult Probiotics as efficient immunopotentiators: translational role in cancer prevention.
Lactobacillus casei Shirota Yakult Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer.
Lactobacillus casei Shirota Yakult Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
Lactobacillus casei Shirota Yakult Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review.
Lactobacillus casei Shirota Yakult Probiotics into outer space: feasibility assessments of encapsulated freeze-dried probiotics during 1 month`s storage on the International Space Station.
Lactobacillus casei Shirota Yakult Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.
Lactobacillus casei Shirota Yakult Production and shelf-life studies of low cost beverage with soymilk, buffalo cheese whey and cow milk fermented by mixed cultures of Lactobacillus casei ssp. shirota and Bifidobacterium adolescentis.
Lactobacillus casei Shirota Yakult Properties of Lactobacillus casei Shirota strain as probiotics.
Lactobacillus casei Shirota Yakult Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice.
Lactobacillus casei Shirota Yakult Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.
Lactobacillus casei Shirota Yakult Protective Effect of the Intracellular Content from Potential Probiotic Bacteria against Oxidative Damage Induced by Acrylamide in Human Erythrocytes.
Lactobacillus casei Shirota Yakult Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria.
Lactobacillus casei Shirota Yakult Randomized controlled study of probiotics containing Lactobacillus casei (Shirota strain) for prevention of ventilator-associated pneumonia.
Lactobacillus casei Shirota Yakult Re: Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain shirota on the murine orthotopic bladder tumor MBT-2.
Lactobacillus casei Shirota Yakult Recovery of <i>Lactobacillus casei</i> strain Shirota (LcS) from faeces of healthy Singapore adults after intake of fermented milk.
Lactobacillus casei Shirota Yakult Recovery of Lactobacillus casei strain Shirota (LcS) from faeces with 14 days of fermented milk supplementation in healthy Australian adults.
Lactobacillus casei Shirota Yakult Recovery of Lactobacillus casei strain Shirota (LcS) from the intestine of healthy Vietnamese adults after intake of fermented milk.
Lactobacillus casei Shirota Yakult Redox Role of <i>Lactobacillus casei</i> Shirota Against the Cellular Damage Induced by 2,2`-Azobis (2-Amidinopropane) Dihydrochloride-Induced Oxidative and Inflammatory Stress in Enterocytes-Like Epithelial Cells.
Lactobacillus casei Shirota Yakult Reduction in biogenic amines in douchi fermented by probiotic bacteria.
Lactobacillus casei Shirota Yakult Reduction of aflatoxin level in aflatoxin-induced rats by the activity of probiotic Lactobacillus casei strain Shirota.
Lactobacillus casei Shirota Yakult Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Regulation of EPS production in Lactobacillus casei LC2W through metabolic engineering.
Lactobacillus casei Shirota Yakult Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse.
Lactobacillus casei Shirota Yakult Release studies of Lactobacillus casei strain Shirota from chitosan-coated alginate-starch microcapsules in ex vivo porcine gastrointestinal contents.
Lactobacillus casei Shirota Yakult Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum.
Lactobacillus casei Shirota Yakult Roles of thioredoxin and thioredoxin reductase in the resistance to oxidative stress in Lactobacillus casei.
Lactobacillus casei Shirota Yakult Scavenging peptides, antioxidant activity, and hypoglycemic activity of a germinated amaranth (Amaranthus hypochondriacus L.) beverage fermented by Lactiplantibacillus plantarum.
Lactobacillus casei Shirota Yakult Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests.
Lactobacillus casei Shirota Yakult Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.
Lactobacillus casei Shirota Yakult Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, ß-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study.
Lactobacillus casei Shirota Yakult Short communication: Probiotic induction of interleukin-10 and interleukin-12 production by macrophages is modulated by co-stimulation with microbial components.
Lactobacillus casei Shirota Yakult Single bioreactor gastrointestinal tract simulator for study of survival of probiotic bacteria.
Lactobacillus casei Shirota Yakult Single-species versus dual-species probiotic supplementation as an emerging therapeutic strategy for obesity.
Lactobacillus casei Shirota Yakult Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri.
Lactobacillus casei Shirota Yakult Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress.
Lactobacillus casei Shirota Yakult Strain gauge force transducer and its application in a pig model to evaluate the effect of probiotic on colonic motility.
Lactobacillus casei Shirota Yakult Strain-specific immunomodulatory effects of Lactobacillus plantarum strains on birch-pollen-allergic subjects out of season.
Lactobacillus casei Shirota Yakult Structural determination of the cell wall polysaccharide LCPS-1 in Lacticaseibacillus paracasei strain Shirota YIT 9029.
Lactobacillus casei Shirota Yakult Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides.
Lactobacillus casei Shirota Yakult Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice.
Lactobacillus casei Shirota Yakult Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies.
Lactobacillus casei Shirota Yakult Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults.
Lactobacillus casei Shirota Yakult Survival of probiotic lactobacilli in the upper gastrointestinal tract using an in vitro gastric model of digestion.
Lactobacillus casei Shirota Yakult Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial.
Lactobacillus casei Shirota Yakult Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties.
Lactobacillus casei Shirota Yakult Synthesis and immunestimulating activity of lactobacilli-originated polysaccharide-polymeric microparticle conjugates.
Lactobacillus casei Shirota Yakult Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus casei Shirota Yakult Technological Characterisation of Probiotic Lactic Acid Bacteria as Starter Cultures for Dry Fermented Sausages.
Lactobacillus casei Shirota Yakult The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats.
Lactobacillus casei Shirota Yakult The antioxidant and prebiotic properties of lactobionic acid.
Lactobacillus casei Shirota Yakult The Binding Efficiency and Interaction of <i>Lactobacillus casei</i> Shirota Toward Aflatoxin B1.
Lactobacillus casei Shirota Yakult The differences in the number of fibroblasts and blood vessels after the topical and systemic administration of Lactobacillus casei Shirota probiotics for the treatment of traumatic ulcers in Wistar rats (Rattus norvegicus).
Lactobacillus casei Shirota Yakult The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people.
Lactobacillus casei Shirota Yakult The effect of a commercial probiotic drink on oral microbiota in healthy complete denture wearers.
Lactobacillus casei Shirota Yakult The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat.
Lactobacillus casei Shirota Yakult The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans.
Lactobacillus casei Shirota Yakult The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans.
Lactobacillus casei Shirota Yakult The Effect of Lactobacillus casei Consumption in Improvement of Obsessive-Compulsive Disorder: an Animal Study.
Lactobacillus casei Shirota Yakult The effect of Lactobacillus casei strain Shirota on the cecal fermentation pattern depends on the individual cecal microflora in pigs.
Lactobacillus casei Shirota Yakult The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice.
Lactobacillus casei Shirota Yakult The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus.
Lactobacillus casei Shirota Yakult The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial.
Lactobacillus casei Shirota Yakult The effect of probiotic treatment on elderly patients with distal radius fracture: a prospective double-blind, placebo-controlled randomised clinical trial.
Lactobacillus casei Shirota Yakult The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
Lactobacillus casei Shirota Yakult The Effectiveness of Lactobacillus Beverages in Controlling Infections among the Residents of an Aged Care Facility: A Randomized Placebo-Controlled Double-Blind Trial.
Lactobacillus casei Shirota Yakult The effects of heat-killed wild-type Lactobacillus casei Shirota on allergic immune responses in an allergy mouse model.
Lactobacillus casei Shirota Yakult The effects of the Lactobacillus casei strain on obesity in children: a pilot study.
Lactobacillus casei Shirota Yakult The immunomodulatory effects of long-term supplementation with Lactobacillus casei Shirota depend on ovalbumin presentation in BALB/c mice.
Lactobacillus casei Shirota Yakult The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers.
Lactobacillus casei Shirota Yakult The influence of polyunsaturated fatty acids on probiotic growth and adhesion.
Lactobacillus casei Shirota Yakult The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study.
Lactobacillus casei Shirota Yakult The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium.
Lactobacillus casei Shirota Yakult The probiotic <i>Lactobacillus casei</i> Shirota attenuates symptoms of vestibular migraine: a randomised placebo-controlled double-blind clinical trial.
Lactobacillus casei Shirota Yakult The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice.
Lactobacillus casei Shirota Yakult The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration.
Lactobacillus casei Shirota Yakult Transit of radical scavenging activity of milk products prepared by Maillard reaction and Lactobacillus casei strain Shirota fermentation through the hamster intestine.
Lactobacillus casei Shirota Yakult Transition of the probiotic bacteria, Lactobacillus casei strain Shirota, in the gastrointestinal tract of a pig.
Lactobacillus casei Shirota Yakult Trends in dairy and non-dairy probiotic products - a review.
Lactobacillus casei Shirota Yakult Use of probiotics for the treatment of constipation in Parkinson`s disease patients.
Lactobacillus casei Shirota Yakult Valorisation of food waste via fungal hydrolysis and lactic acid fermentation with Lactobacillus casei Shirota.
Lactobacillus casei Shirota Yakult Very Long-Term Treatment with a <i>Lactobacillus</i> Probiotic Preparation, <i>Lactobacillus casei</i> Strain Shirota, Suppresses Weight Loss in the Elderly.
Lactobacillus casei Shirota Yakult Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health <i>Lactobacillus acidophilus</i> Attenuates <i>Salmonella</i>-Induced Stress of Epithelial Cells by Modulating Tight-Junction Genes and Cytokine Responses.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Comparative genome analysis of Lactobacillus casei strains isolated from Actimel and Yakult products reveals marked similarities and points to a common origin.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by <i>Lactobacillus casei</i> Effectively Induces Antigen-Specific Immune Responses via Oral Vaccination.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Draft genome sequence of Lactobacillus casei W56.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactobacillus casei W56 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus casei W79 Ecologic® Relief Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus crispatus LbV 88 (DSM 22566) AZO Complete Feminine Balance Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Lactobacillus crispatus LbV 88 (DSM 22566) AZO Complete Feminine Balance Impact of oral administration of four <i>Lactobacillus</i> strains on Nugent score - systematic review and meta-analysis.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 [Antioxidant properties of lactic acid bacteria--probiotic and yogurt strains].
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 [Probiotic properties of industrial strains of lactobacilli and bifidobacteria].
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 A new probiotic cheese with antioxidative and antimicrobial activity.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 A probiotic, Lactobacillus fermentum ME-3, has antioxidative capacity in soft cheese spreads with different fats.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Antioxidative probiotic fermented goats` milk decreases oxidative stress-mediated atherogenicity in human subjects.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Complete glutathione system in probiotic Lactobacillus fermentum ME-3.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Effect of stress pretreatment on survival of probiotic bacteria in gastrointestinal tract simulator.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Effects of probiotic and prebiotic on gastrointestinal motility in newborns.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Identification of a new adhesin-like protein from Lactobacillus mucosae ME-340 with specific affinity to the human blood group A and B antigens.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 In vitro effects of selected synbiotics on the human faecal microbiota composition.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Interaction of dietary Bacillus subtilis and fructooligosaccharide on the growth performance, non-specific immunity of sea cucumber, Apostichopus japonicus.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Microfabrication of patterns of adherent marine bacterium Phaeobacter inhibens using soft lithography and scanning probe lithography.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Post-surgical recurrence of ileal Crohn`s disease.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Postsurgical recurrence of ileal Crohn`s disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 The Effect of Lactobacillus fermentum ME-3 Treatment on Glycation and Diabetes Complications.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 The probiotic paradox: live and dead cells are biological response modifiers.
Lactobacillus fermentum ME-3 Reg'Activ Essential ME-3 The use of probiotic L. fermentum ME-3 containing Reg`Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study.
Lactobacillus gasseri KS-13 Phillips'® Colon Health Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Lactobacillus gasseri KS-13 Phillips'® Colon Health Probiotics (<i>Lactobacillus gasseri</i> KS-13, <i>Bifidobacterium bifidum</i> G9-1, and <i>Bifidobacterium longum</i> MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial.
Lactobacillus gasseri LbV 150N (DSM 22583) AZO Complete Feminine Balance Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Lactobacillus gasseri LbV 150N (DSM 22583) AZO Complete Feminine Balance Impact of oral administration of four <i>Lactobacillus</i> strains on Nugent score - systematic review and meta-analysis.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Cell surface-associated aggregation-promoting factor from Lactobacillus gasseri SBT2055 facilitates host colonization and competitive exclusion of Campylobacter jejuni.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Characterization of the amylovorin locus of Lactobacillus amylovorus DCE 471, producer of a bacteriocin active against Pseudomonas aeruginosa, in combination with colistin and pyocins.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule In vitro investigation of molecules involved in Lactobacillus gasseri SBT2055 adhesion to host intestinal tract components.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Lactobacillus gasseri SBT2055 induces TGF-ß expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Lactobacillus gasseri SBT2055 reduces infection by and colonization of Campylobacter jejuni.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Primary amino acid and DNA sequences of gassericin T, a lactacin F-family bacteriocin produced by Lactobacillus gasseri SBT2055.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Protective effects and functional mechanisms of Lactobacillus gasseri SBT2055 against oxidative stress.
Lactobacillus gasseri SBT2055 gasseri SP strain capsule Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 [Current issues regarding organic food].
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 [New in light of immune modulation by probiotics bacteria and increase IL10 producing regulatory T cells].
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 A standard quantitative method to measure acid tolerance of probiotic cells.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Administration of Bacillus subtilis strains in the rearing water enhances the water quality, growth performance, immune response, and resistance against Vibrio harveyi infection in juvenile white shrimp, Litopenaeus vannamei.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Basic Reproduction Number and Transmission Dynamics of Common Serogroups of Enterohemorrhagic Escherichia coli.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Bile salt biotransformations by human intestinal bacteria.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Bioprospecting of Ribosomally Synthesized and Post-translationally Modified Peptides Through Genome Characterization of a Novel Probiotic Lactiplantibacillus plantarum UTNGt21A Strain: A Promising Natural Antimicrobials Factory.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 C18:1 Improves the Freeze-Drying Resistance of Lactobacillus plantarum by Maintaining the Cell Membrane.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Clinical and Microbiological Investigation of the Effects of Probiotics Combined with Scaling and Root Planing in the Management of Chronic Periodontitis: A Randomized, Controlled Study.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Comparative genomics analysis of Pediococcus acidilactici species.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Daily rhythms of cloacal temperature in broiler chickens of different age groups administered with zinc gluconate and probiotic during the hot-dry season.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Determination of safety status and probiotic properties of Enterococcus strains isolated from traditional cheeses in Turkey.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Development of a real-time RT-PCR method for enumeration of viable Bifidobacterium longum cells in different morphologies.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Differential Stability of Aurein 1.2 Pores in Model Membranes of Two Probiotic Strains.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 DNA-based gels for oral delivery of probiotic bacteria.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of dietary supplementation of Bacillus subtilis DSM29784 on hen performance, egg quality indices, and apparent retention of dietary components in laying hens from 19 to 48 weeks of age.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of High-intensity Training and Probiotics on Gut Microbiota Diversity in Competitive Swimmers: Randomized Controlled Trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of probiotic Pediococcus acidilactici on antioxidant defences and oxidative stress of Litopenaeus stylirostris under Vibrio nigripulchritudo challenge.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effects of Lactobacillus rhamnosus on zebrafish oocyte maturation: an FTIR imaging and biochemical analysis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effects of probiotic bacteria on the bioaccessibility of aflatoxin B(1) and ochratoxin A using an in vitro digestion model under fed conditions.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effects of probiotic supplementation on glucose metabolism in pregnant women without diabetes: a systematic review and meta-analysis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Effects of Probiotic Supplementation on Selected Parameters of Blood Prooxidant-Antioxidant Balance in Elite Athletes: A Double-Blind Randomized Placebo-Controlled Study.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Efficiency of early, single-dose probiotic administration methods on performance, small intestinal morphology, blood biochemistry, and immune response of Japanese quail.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Enhanced gastrointestinal survivability of recombinant Lactococcus lactis using a double coated mucoadhesive film approach.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Evaluation of nutraceutical application of xylooligosaccharide enzymatically produced from cauliflower stalk for its value addition through a sustainable approach.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Exercise combined with a probiotics treatment alters the microbiome, but moderately affects signalling pathways in the liver of male APP/PS1 transgenic mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Fermented Maesil (Prunus mume) with probiotics inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Functional Characteristics of Lactic Acid Bacteria In Vitro Isolated from Spontaneously Fermented Sour Porridge with Broomcorn Millet in Northwestern Shanxi Province of China.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Genetically modified Lactococcus lactis producing a green fluorescent protein-bovine lactoferrin fusion protein suppresses proinflammatory cytokine expression in lipopolysaccharide-stimulated RAW 264.7 cells.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Gut Microbiota, Probiotics and Psychological States and Behaviors after Bariatric Surgery-A Systematic Review of Their Interrelation.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Impact of a synbiotic food on the gut microbial ecology and metabolic profiles.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Impact of inulin and a multispecies probiotic formulation on performance, microbial ecology and concomitant fermentation patterns in newly weaned piglets.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Improvement of the Sensory Characteristics of Goat Milk Yogurt.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Improving the outcome of fractional CO2 laser resurfacing using a probiotic skin cream: Preliminary clinical evaluation.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 In Situ ß-Glucan Fortification of Cereal-Based Matrices by Pediococcus parvulus 2.6: Technological Aspects and Prebiotic Potential.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 In vitro evaluation of potential prebiotic effects of a freeze-dried juice from Pilosocereus gounellei (A. Weber ex K. Schum. Bly. Ex Rowl) cladodes, an unconventional edible plant from Caatinga biome.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 In vitro evaluation of the safety and probiotic properties of Lactobacilli isolated from chicken and calves.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 In vitro cytokine profile revealed differences from dorsal and ventral skin susceptibility to pathogen-probiotic interaction in gilthead seabream.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Influence of probiotic Lactobacillus acidophilus and L. helveticus on proteolysis, organic acid profiles, and ACE-inhibitory activity of cheddar cheeses ripened at 4, 8, and 12 degrees C.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Intake of probiotic food and risk of spontaneous preterm delivery.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Investigating the Proteomic Profile of HT-29 Colon Cancer Cells After Lactobacillus kefiri SGL 13 Exposure Using the SWATH Method.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactic acid bacteria, Enterococcus faecalis Y17 and Pediococcus pentosaceus G11, improved growth performance, and immunity of mud crab (Scylla paramamosain).
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactobacillus helveticus Lafti L10 Supplementation Modulates Mucosal and Humoral Immunity in Elite Athletes: A Randomized, Double-Blind, Placebo-Controlled Trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactobacillus helveticus Lafti L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized, double-blind, placebo-controlled trial.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactobacillus rhamnosus FJSYC4-1 and Lactobacillus reuteri FGSZY33L6 alleviate metabolic syndrome via gut microbiota regulation.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactobacillus salivarius NK02: a Potent Probiotic for Clinical Application in Mouthwash.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Lactose intolerance and health.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Long-Lasting Decrease of the Acquisition of Enterococcus faecium and Gram-Negative Bacteria Producing Extended Spectrum Beta-Lactamase (ESBL) by Transient Application of Probiotics.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Long-term administration of a commercial supplement enriched with bioactive compounds does not affect feed intake, health status, and growth performances in beef cattle.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Metabolites produced by probiotic Lactobacilli rapidly increase glucose uptake by Caco-2 cells.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Microbiota restoration: natural and supplemented recovery of human microbial communities.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Modulating the Microbiome and Immune Responses Using Whole Plant Fibre in Synbiotic Combination with Fibre-Digesting Probiotic Attenuates Chronic Colonic Inflammation in Spontaneous Colitic Mice Model of IBD.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Molecular identification and in vitro evaluation of probiotic functional properties of some Egyptian lactic acid bacteria and yeasts.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Multi-domain probiotic consortium as an alternative to chemical remediation of oil spills at coral reefs and adjacent sites.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Multifarious Plant Probiotic Features of Bacillus sp. W11 Isolated from Vermicast and Its Promises for Biocontrol Activity Against Phytopathogens.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 National Safety Survey of Animal-use Commercial Probiotics and Their Spillover Effects From Farm to Humans: An Emerging Threat to Public Health.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Neonatal Necrotizing Enterocolitis -Inflammation and Intestinal Immaturity.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 New aspects and new concepts of maintaining "microbiological" health.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Not infection with parasitic worms, but rather colonization with therapeutic helminths.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Novel bifidobacteria strains isolated from nonconventional sources. Technological, antimicrobial and biological characterization for their use as probiotics.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Oral administration of the probiotic bacterium Lactobacillus acidophilus strain L-55 modulates the immunological parameters of the laying hen inoculated with a Newcastle disease virus-based live attenuated vaccine.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Pharmacotherapy for inducing and maintaining remission in pouchitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Polysaccharides from soybean residue fermented by Neurospora crassa alleviate DSS-induced gut barrier damage and microbiota disturbance in mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Potential Immunomodulatory Effects from Consumption of Nutrients in Whole Foods and Supplements on the Frequency and Course of Infection: Preliminary Results.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Potential of functional strains, isolated from traditional Maasai milk, as starters for the production of fermented milks.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Potential of three probiotic lactobacilli in transforming star fruit juice into functional beverages.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Potential prebiotic properties of cashew apple (Anacardium occidentale L.) agro-industrial byproduct on Lactobacillus species.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Potentially probiotic Lactobacillus strains with anti-proliferative activity induce cytokine/chemokine production and neutrophil recruitment in mice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotic characterization of Bacillus subtilis P223 isolated from kimchi.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotic cheddar cheese: influence of ripening temperatures on proteolysis and sensory characteristics of cheddar cheeses.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotic Features of Lactic Acid Bacteria Isolated from a Diverse Pool of Traditional Greek Dairy Products Regarding Specific Strain-Host Interactions.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotic Yoghurts with Sea Buckthorn, Elderberry, and Sloe Fruit Purees.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotics Enhance Bone Growth and Rescue BMP Inhibition: New Transgenic Zebrafish Lines to Study Bone Health.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotics for pregnant women and preterm neonates.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotics for preventing acute otitis media in children.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Probiotics in critically ill children.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Proceedings of the 3rd IPLeiria`s International Health Congress : Leiria, Portugal. 6-7 May 2016.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Production of beta-glucosidase and hydrolysis of isoflavone phytoestrogens by Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei in soymilk.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Protective Effects of Tropical Fruit Processing Coproducts on Probiotic Lactobacillus Strains during Freeze-Drying and Storage.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Proteomic analysis of Lactobacillus pentosus for the identification of potential markers involved in acid resistance and their influence on other probiotic features.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Real-Time PCR Assays for the Specific Identification of Probiotic Strains Lactobacillus gasseri BNR17 and Lactobacillus reuteri LRC (NCIMB 30242).
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Recent advances in marine algae oligosaccharides: structure, analysis, and potential prebiotic activities.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Response of nursery pigs to a synbiotic preparation of starch and an anti-Escherichia coli K88 probiotic.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Response of performance characteristics and fecal consistency to long-lasting dietary supplementation with the probiotic strain Bacillus cereus var. toyoi to sows and piglets.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Selected prebiotics support the growth of probiotic mono-cultures in vitro.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Selection and identification of non-pathogenic bacteria isolated from fermented pickles with antagonistic properties against two shrimp pathogens.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Sequence analysis of two cryptic plasmids from Bifidobacterium longum DJO10A and construction of a shuttle cloning vector.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Synergistic Effect of Omega-3 and Probiotic Supplementation on Preventing Ligature-Induced Periodontitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The Antihypertensive Effects and Potential Molecular Mechanism of Microalgal Angiotensin I-Converting Enzyme Inhibitor-Like Peptides: A Mini Review.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The colonic microflora and probiotic therapy in health and disease.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The effect of probiotic supplementation on performance, inflammatory markers and gastro-intestinal symptoms in elite road cyclists.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The Effects of G2013 (a-L-guluronic Acid) in a Pentylenetetrazole-induced Kindling Animal Model of Epilepsy.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 The serum metabolite response to diet intervention with probiotic acidified milk in irritable bowel syndrome patients is indistinguishable from that of non-probiotic acidified milk by 1H NMR-based metabonomic analysis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Therapeutical use of probiotic formulations in clinical practice.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Three Candidate Probiotic Strains Impact Gut Microbiota and Induce Anergy in Mice with Cow`s Milk Allergy.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Treatment with the probiotic VSL#3 as an adjunctive therapy in relapsing mild-to-moderate ulcerative colitis significantly reduces ulcerative colitis disease activity.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Unexpected consequences of administering bacteriocinogenic probiotic strains for Salmonella populations, revealed by an in vitro colonic model of the child gut.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Using bifidobacterium and propionibacterium strains in probiotic consortia to normalize the gastrointestinal tract.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 VSL#3 and remission in active ulcerative colitis: larger studies required.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 VSL#3 for ulcerative colitis: growing evidence?
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Widely distributed lysogeny in probiotic lactobacilli represents a potentially high risk for the fermentative dairy industry.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Woodfordia fruticosa extract supplementation stimulates the growth of Lacticaseibacillus casei and Lacticaseibacillus rhamnosus with adapted intracellular and extracellular metabolite pool.
LACTOBACILLUS HELVETICUS L10 LACTOBACILLUS HELVETICUS LAFTI® L10 Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures.
Lactobacillus helveticus R0052 Calm Biotic® <i>Bifidobacterium longum</i> and <i>Lactobacillus helveticus</i> Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.
Lactobacillus helveticus R0052 Calm Biotic® A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011.
Lactobacillus helveticus R0052 Calm Biotic® A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Lactobacillus helveticus R0052 Calm Biotic® A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial.
Lactobacillus helveticus R0052 Calm Biotic® A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.
Lactobacillus helveticus R0052 Calm Biotic® A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli.
Lactobacillus helveticus R0052 Calm Biotic® Acid production in dental plaque after exposure to probiotic bacteria.
Lactobacillus helveticus R0052 Calm Biotic® Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.
Lactobacillus helveticus R0052 Calm Biotic® Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion.
Lactobacillus helveticus R0052 Calm Biotic® Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.
Lactobacillus helveticus R0052 Calm Biotic® Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers.
Lactobacillus helveticus R0052 Calm Biotic® Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
Lactobacillus helveticus R0052 Calm Biotic® Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study.
Lactobacillus helveticus R0052 Calm Biotic® Bifidobacterium longum R0175 attenuates post-myocardial infarction depressive-like behaviour in rats.
Lactobacillus helveticus R0052 Calm Biotic® Calcium phosphate supplementation increases faecal Lactobacillus spp. in a randomised trial of young adults.
Lactobacillus helveticus R0052 Calm Biotic® Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model.
Lactobacillus helveticus R0052 Calm Biotic® Complete genome sequence of Lactobacillus helveticus R0052, a commercial probiotic strain.
Lactobacillus helveticus R0052 Calm Biotic® Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour.
Lactobacillus helveticus R0052 Calm Biotic® Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci and lactobacilli.
Lactobacillus helveticus R0052 Calm Biotic® Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Lactobacillus helveticus R0052 Calm Biotic® Effect of fermentation by pure and mixed cultures of Streptococcus thermophilus and Lactobacillus helveticus on isoflavone and B-vitamin content of a fermented soy beverage.
Lactobacillus helveticus R0052 Calm Biotic® Effect of Lactobacillus reuteri on Cell Viability and PGE<sub>2</sub> Production in Human Gingival Fibroblasts.
Lactobacillus helveticus R0052 Calm Biotic® Effect of Probiotic Bacteria on Oral Candida in Frail Elderly.
Lactobacillus helveticus R0052 Calm Biotic® Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Effect of tablets containing probiotic bacteria (Lactobacillus reuteri) on early caries lesions in adolescents: a pilot study.
Lactobacillus helveticus R0052 Calm Biotic® Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Effects of <i>Lactobacillus reuteri</i>-containing lozenges on healing after surgical removal of mandibular third molars: a randomised controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A <i>Post Hoc</i> Analysis of a Randomized Clinical Trial.
Lactobacillus helveticus R0052 Calm Biotic® Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study.
Lactobacillus helveticus R0052 Calm Biotic® Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon.
Lactobacillus helveticus R0052 Calm Biotic® Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME.
Lactobacillus helveticus R0052 Calm Biotic® Flow cytometry: a versatile technology for specific quantification and viability assessment of micro-organisms in multistrain probiotic products.
Lactobacillus helveticus R0052 Calm Biotic® Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination.
Lactobacillus helveticus R0052 Calm Biotic® Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Lactobacillus helveticus R0052 Calm Biotic® Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.
Lactobacillus helveticus R0052 Calm Biotic® Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults.
Lactobacillus helveticus R0052 Calm Biotic® Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Lactobacillus helveticus R0052 Calm Biotic® Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Lactobacillus helveticus R0052 Calm Biotic® IDENTIFICATION OF BACTERIOCIN GENES IN PROBIOTIC STRAINS OF LACTIC ACID BACTERIA LACTOBACLLUS ACIDOPHILUS D-75 AND LACTOBACILLUS ACIDOPHILUS D-76.
Lactobacillus helveticus R0052 Calm Biotic® Immune signalling responses in intestinal epithelial cells exposed to pathogenic Escherichia coli and lactic acid-producing probiotics.
Lactobacillus helveticus R0052 Calm Biotic® Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection.
Lactobacillus helveticus R0052 Calm Biotic® Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria.
Lactobacillus helveticus R0052 Calm Biotic® In Vitro Probiotic Modulation of the Intestinal Microbiota and 2`Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age.
Lactobacillus helveticus R0052 Calm Biotic® Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects.
Lactobacillus helveticus R0052 Calm Biotic® Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial.
Lactobacillus helveticus R0052 Calm Biotic® Ingestion of probiotic (Lactobacillus helveticus and Bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress.
Lactobacillus helveticus R0052 Calm Biotic® Isolation and Characteristics of Extracellular Vesicles Produced by Probiotics: Yeast Saccharomyces boulardii CNCM I-745 and Bacterium Streptococcus salivarius K12.
Lactobacillus helveticus R0052 Calm Biotic® Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.
Lactobacillus helveticus R0052 Calm Biotic® Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Lactobacillus helveticus R0052 Calm Biotic® Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Lactobacillus helveticus R0052 Calm Biotic® Lactobacillus suntoryeus Cachat and Priest 2005 is a later synonym of Lactobacillus helveticus (Orla-Jensen 1919) Bergey et al. 1925 (Approved Lists 1980).
Lactobacillus helveticus R0052 Calm Biotic® LC-MS/MS analysis of surface layer proteins as a useful method for the identification of lactobacilli from the Lactobacillus acidophilus group.
Lactobacillus helveticus R0052 Calm Biotic® Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Metabolic profiling of bacterial co-cultures reveals intermicrobiome interactions and dominant species.
Lactobacillus helveticus R0052 Calm Biotic® Modulatory effect of three probiotic strains on infants` gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study.
Lactobacillus helveticus R0052 Calm Biotic® Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.
Lactobacillus helveticus R0052 Calm Biotic® Multistrain probiotic modulation of intestinal epithelial cells` immune response to a double-stranded RNA ligand, poly(i·c).
Lactobacillus helveticus R0052 Calm Biotic® Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Lactobacillus helveticus R0052 Calm Biotic® Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis.
Lactobacillus helveticus R0052 Calm Biotic® Oral probiotics in the management of gingivitis in diabetic patients: a double blinded randomized controlled study.
Lactobacillus helveticus R0052 Calm Biotic® Orodispersible lozenges containing a combination of <i>Lactobacillus reuteri</i> DSM 17938 and <i>Lactobacillus reuteri</i> ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
Lactobacillus helveticus R0052 Calm Biotic® Pea-protein alginate encapsulation adversely affects development of clinical signs of Citrobacter rodentium-induced colitis in mice treated with probiotics.
Lactobacillus helveticus R0052 Calm Biotic® Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry.
Lactobacillus helveticus R0052 Calm Biotic® Prevention of Recurrent Childhood Caries with Probiotic Supplements: A Randomized Controlled Trial with a 12-Month Follow-Up.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic <i>Lactobacillus reuteri</i> has antifungal effects on oral <i>Candida</i> species <i>in vitro</i>.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic mixture of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 attenuates hippocampal apoptosis induced by lipopolysaccharide in rats.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic supplements (Lactobacillus reuteri DSM 17938 and ATCC PTA 5289) do not affect regrowth of mutans streptococci after full-mouth disinfection with chlorhexidine: a randomized controlled multicenter trial.
Lactobacillus helveticus R0052 Calm Biotic® Probiotic treatment restores normal developmental trajectories of fear memory retention in maternally separated infant rats.
Lactobacillus helveticus R0052 Calm Biotic® Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression.
Lactobacillus helveticus R0052 Calm Biotic® Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
Lactobacillus helveticus R0052 Calm Biotic® Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.
Lactobacillus helveticus R0052 Calm Biotic® Probiotics: To Use or Not to Use? That Is the Question.
Lactobacillus helveticus R0052 Calm Biotic® Psychobiotic Effects on Anxiety Are Modulated by Lifestyle Behaviors: A Randomized Placebo-Controlled Trial on Healthy Adults.
Lactobacillus helveticus R0052 Calm Biotic® Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients.
Lactobacillus helveticus R0052 Calm Biotic® Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT.
Lactobacillus helveticus R0052 Calm Biotic® Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus helveticus R0052 Calm Biotic® Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.
Lactobacillus helveticus R0052 Calm Biotic® Sequence analysis of plasmid pIR52-1 from Lactobacillus helveticus R0052 and investigation of its origin of replication.
Lactobacillus helveticus R0052 Calm Biotic® Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid.
Lactobacillus helveticus R0052 Calm Biotic® Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.
Lactobacillus helveticus R0052 Calm Biotic® Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model.
Lactobacillus helveticus R0052 Calm Biotic® Supplementation with Combined <i>Lactobacillus helveticus</i> R0052 and <i>Bifidobacterium longum</i> R0175 Across Development Reveals Sex Differences in Physiological and Behavioural Effects of Western Diet in Long-Evans Rats.
Lactobacillus helveticus R0052 Calm Biotic® Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells.
Lactobacillus helveticus R0052 Calm Biotic® Survival of probiotics in pea protein-alginate microcapsules with or without chitosan coating during storage and in a simulated gastrointestinal environment.
Lactobacillus helveticus R0052 Calm Biotic® The effects of antimicrobials and lipopolysaccharide on acute immune responsivity in pubertal male and female CD1 mice.
Lactobacillus helveticus R0052 Calm Biotic® The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model.
Lactobacillus helveticus R0052 Calm Biotic® The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study.
Lactobacillus helveticus R0052 Calm Biotic® The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract.
Lactobacillus helveticus R0052 Calm Biotic® The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection.
Lactobacillus helveticus R0052 Calm Biotic® The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol.
Lactobacillus helveticus R0052 Calm Biotic® The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Lactobacillus helveticus R0052 Calm Biotic® The use of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 on oral health indexes in a school population: A pilot randomized clinical trial.
Lactobacillus helveticus R0052 Calm Biotic® Total Transit Time and Probiotic Persistence in Healthy Adults: A Pilot Study.
Lactobacillus helveticus R0052 Calm Biotic® Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Lactobacillus helveticus R0052 Calm Biotic® Use of Streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomised double-blind study.
Lactobacillus jensenii LbV 116 (DSM 22567) AZO Complete Feminine Balance Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Lactobacillus jensenii LbV 116 (DSM 22567) AZO Complete Feminine Balance Impact of oral administration of four <i>Lactobacillus</i> strains on Nugent score - systematic review and meta-analysis.
Lactobacillus Kefiri LKF01 (DSM 32079) LKEF Kefibios Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals.
Lactobacillus Kefiri LKF01 (DSM 32079) LKEF Kefibios Lactobacillus Kefiri LKF01 (Kefibios<sup>®</sup>) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: A Prospective Study.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Antimicrobial and immunoregulatory effects of Lactobacillus delbrueckii 45E against genitourinary pathogens.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Assessing the Probiotic Effects of Pediococcus pentosaceus CACC616 in Weaned Piglets.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Characterization of adhesion, anti-adhesion, co-aggregation, and hydrophobicity of Helicobacter pylori and probiotic strains.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Correction to: Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Determining the In Vivo Efficacy of Plant-Based and Probiotic-Based Antibiotic Alternatives against Mixed Infection with Salmonella enterica and Escherichia coli in Domestic Chickens.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Effects of <i>Lactobacillus plantarum</i> and <i>Lactobacillus paracasei</i> on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children With Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Extracellular Proteins Isolated from L. acidophilus as an Osteomicrobiological Therapeutic Agent to Reduce Pathogenic Biofilm Formation, Regulate Chronic Inflammation, and Augment Bone Formation In Vitro.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Feeding Strategies with Multi-Strain Probiotics Affect Growth, Health Condition, and Disease Resistance in Asian Seabass (Lates calcarifer).
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Fewer Community-Acquired Colds with Daily Consumption of Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2. A Randomized, Placebo-Controlled Clinical Trial.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Gut Microbe-Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Gut Microbiome Analysis and Screening of Lactic Acid Bacteria with Probiotic Potential in Anhui Swine.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Human supplementation with Pediococcus acidilactici GR-1 decreases heavy metals levels through modifying the gut microbiota and metabolome.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support In vitro effects of selected synbiotics on the human faecal microbiota composition.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support In vivo investigation of Lcr35(®) anti-candidiasis properties in Caenorhabditis elegans reveals the involvement of highly conserved immune pathways.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Influence of Hydrogen Peroxide, Lactic Acid, and Surfactants from Vaginal Lactobacilli on the Antibiotic Sensitivity of Opportunistic Bacteria.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support INFLUENCE OF PROBIOTICS ON THE MESOTHELIN LEVEL IN WOMEN WITH ENDOMETRIOSIS ASSOCIATED WITH INFERTILITY IN COMPLEX PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Lactate- and acetate-based cross-feeding interactions between selected strains of lactobacilli, bifidobacteria and colon bacteria in the presence of inulin-type fructans.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Lactobacillus paracasei subsp. paracasei 8700:2 degrades inulin-type fructans exhibiting different degrees of polymerization.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Microbial production of high value molecules using rayon waste material as carbon-source.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Probiotics for preventing acute upper respiratory tract infections.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Probiotics Inhibit Cartilage Damage and Progression of Osteoarthritis in Mice.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Probiotics protect mice from ovariectomy-induced cortical bone loss.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Probiotics, prebiotics, and synbiotics in chronic constipation: Outstanding aspects to be considered for the current evidence.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Protective Properties of S-layer Protein 2 from Lactobacillus crispatus 2029 against Candida albicans Infections.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Real-time polymerase chain reaction methods for strain specific identification and enumeration of strain Lacticaseibacillus paracasei 8700:2.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support The probiotic approach: an alternative treatment option in urology.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Ultrasound-assisted fermentation of Porphyra yezoensis sauce at different growth stages using Lactiplantibacillus plantarum: Metabolic response and biological activity.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Unveiling the Gut Microbiome: How Junk Food Impacts the Gut.
Lactobacillus paracasei 8700:2 UltraFlora® Cold Support Use of Lactobacillus to prevent infection by pathogenic bacteria.
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis].
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics Brewer`s Spent Grain Enhanced the Recovery of Potential Probiotic Strains in Fermented Milk After Exposure to In Vitro-Simulated Gastrointestinal Conditions.
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics Effect of potato fiber on survival of Lactobacillus species at simulated gastric conditions and composition of the gut microbiota in vitro.
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics Lactobacillus paracasei subsp. paracasei F19 in Bell`s stage 2 of necrotizing enterocolitis.
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics Metabolic Phenotype and Microbiome of Infants Fed Formula Containing Lactobacillus paracasei Strain F-19.
Lactobacillus paracasei F-19 Optibac Probiotics For Women Probiotics The effect of pectins on survival of probiotic Lactobacillus spp. in gastrointestinal juices is related to their structure and physical properties.
Lactobacillus paracasei Lpc-37 Custom Probiotics A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO).
Lactobacillus paracasei Lpc-37 Custom Probiotics Adjuvant use of multispecies probiotic in the treatment of peri-implant mucositis: A randomized controlled trial.
Lactobacillus paracasei Lpc-37 Custom Probiotics An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1.
Lactobacillus paracasei Lpc-37 Custom Probiotics An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lactobacillus paracasei Lpc-37 Custom Probiotics Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Lactobacillus paracasei Lpc-37 Custom Probiotics Characterization of pMC11, a plasmid with dual origins of replication isolated from Lactobacillus casei MCJ and construction of shuttle vectors with each replicon.
Lactobacillus paracasei Lpc-37 Custom Probiotics Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
Lactobacillus paracasei Lpc-37 Custom Probiotics Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing <i>Saccharomyces</i> to a Mixture of <i>Lactobacillus, Bifidobacterium</i>, and <i>Saccharomyces</i>.
Lactobacillus paracasei Lpc-37 Custom Probiotics Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage.
Lactobacillus paracasei Lpc-37 Custom Probiotics Dried tomato-flavored probiotic cream cheese with Lactobacillus paracasei.
Lactobacillus paracasei Lpc-37 Custom Probiotics Effect of giving probiotic supplement Lactobacillus acidophilus La-14 as an immunomodulator to maintain a respiratory system in Mus musculus.
Lactobacillus paracasei Lpc-37 Custom Probiotics EFFECT OF PROBIOTIC ORAL ADMINISTRATION ON SKIN WOUND HEALING IN RATS.
Lactobacillus paracasei Lpc-37 Custom Probiotics Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children.
Lactobacillus paracasei Lpc-37 Custom Probiotics EFFECT OF SUPPLEMENTATION WITH PROBIOTICS ON COLONIC ANASTOMOSES IN RATS: MORPHOLOGICAL AND TENSIOMETRIC STUDY.
Lactobacillus paracasei Lpc-37 Custom Probiotics Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
Lactobacillus paracasei Lpc-37 Custom Probiotics Engineered living materials for the conversion of a low-cost food-grade precursor to a high-value flavonoid.
Lactobacillus paracasei Lpc-37 Custom Probiotics Engineered Probiotic-Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity.
Lactobacillus paracasei Lpc-37 Custom Probiotics Engineering E. coli strains using antibiotic-resistance-gene-free plasmids.
Lactobacillus paracasei Lpc-37 Custom Probiotics Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.
Lactobacillus paracasei Lpc-37 Custom Probiotics Enhancing Bioaccessibility of Plant Protein Using Probiotics: An In Vitro Study.
Lactobacillus paracasei Lpc-37 Custom Probiotics Evaluation of probiotic survivability in yogurt exposed to cold chain interruption.
Lactobacillus paracasei Lpc-37 Custom Probiotics Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study.
Lactobacillus paracasei Lpc-37 Custom Probiotics Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment.
Lactobacillus paracasei Lpc-37 Custom Probiotics Growth, survival, and metabolic activities of probiotic Lactobacillus spp. in fermented coffee brews supplemented with glucose and inactivated yeast derivatives.
Lactobacillus paracasei Lpc-37 Custom Probiotics HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis.
Lactobacillus paracasei Lpc-37 Custom Probiotics How frequent is routine use of probiotics in UK neonatal units?
Lactobacillus paracasei Lpc-37 Custom Probiotics Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.
Lactobacillus paracasei Lpc-37 Custom Probiotics Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study).
Lactobacillus paracasei Lpc-37 Custom Probiotics Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.
Lactobacillus paracasei Lpc-37 Custom Probiotics Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy.
Lactobacillus paracasei Lpc-37 Custom Probiotics Microbiota-Derived Extracellular Vesicles Promote Immunity and Intestinal Maturation in Suckling Rats.
Lactobacillus paracasei Lpc-37 Custom Probiotics Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson`s disease in mice by delivering GLP-1 and modulating gut microbiota.
Lactobacillus paracasei Lpc-37 Custom Probiotics Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection.
Lactobacillus paracasei Lpc-37 Custom Probiotics Portable CRISPR-Cas9<sup>N</sup> System for Flexible Genome Engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei.
Lactobacillus paracasei Lpc-37 Custom Probiotics Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.
Lactobacillus paracasei Lpc-37 Custom Probiotics Preparation and prebiotic potential of pectin oligosaccharides obtained from citrus peel pectin.
Lactobacillus paracasei Lpc-37 Custom Probiotics Restorative effects of probiotics on memory impairment in sleep-deprived mice.
Lactobacillus paracasei Lpc-37 Custom Probiotics Safety evaluation of HOWARU<sup>®</sup> Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.
Lactobacillus paracasei Lpc-37 Custom Probiotics Simulating colonic survival of probiotics in single-strain products compared to multi-strain products.
Lactobacillus paracasei Lpc-37 Custom Probiotics Strain specific stress-modulating effects of candidate probiotics: A systematic screening in a mouse model of chronic restraint stress.
Lactobacillus paracasei Lpc-37 Custom Probiotics Targeted and Nontargeted Metabolomics of Amino Acids and Bioactive Metabolites in Probiotic-Fermented Unhopped Beers Using Liquid Chromatography High-Resolution Mass Spectrometry.
Lactobacillus paracasei Lpc-37 Custom Probiotics Technological Characterisation of Probiotic Lactic Acid Bacteria as Starter Cultures for Dry Fermented Sausages.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of polydextrose and probiotic lactobacilli in a Clostridium difficile-infected human colonic model.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of probiotics (Lactobacillus rhamnosus HN001, Lactobacillus paracasei LPC-37, and Lactobacillus acidophilus NCFM) on the availability of minerals from Dutch-type cheese.
Lactobacillus paracasei Lpc-37 Custom Probiotics The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Lactobacillus paracasei Lpc-37 Custom Probiotics The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention.
Lactobacillus paracasei Lpc-37 Custom Probiotics The suitability of different probiotic strains for the production of fruit-whey beverages.
Lactobacillus paracasei W20 Ecologic® AAD Cross-Feeding among Probiotic Bacterial Strains on Prebiotic Inulin Involves the Extracellular <i>exo</i>-Inulinase of Lactobacillus paracasei Strain W20.
Lactobacillus paracasei W20 Ecologic® AAD Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus paracasei W20 Ecologic® AAD Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support "Masato de Yuca" and "Chicha de Siete Semillas" Two Traditional Vegetable Fermented Beverages from Peru as Source for the Isolation of Potential Probiotic Bacteria.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support [Effect of probiotic administration on colic anastomosis healing].
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support [Irritable bowel syndrome--irritable bowel or irritable mind?].
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support <i>Lactobacillus plantarum 299v</i> Reduces the Incidence of <i>Clostridium difficile</i> Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A bilberry drink with fermented oatmeal decreases postprandial insulin demand in young healthy adults.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A lactic acid-fermented oat gruel increases non-haem iron absorption from a phytate-rich meal in healthy women of childbearing age.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A prospective randomised trial of probiotics in critically ill patients.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A Systematic Review and Meta-Analysis on the Effects of Probiotic Species on Iron Absorption and Iron Status.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support A tangible prospect for the treatment of gingivitis using a potentially probiotic strain Lactobacillus plantarum MK06 isolated from traditional dairy products: a triple blind randomized clinical trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Acid production in dental plaque after exposure to probiotic bacteria.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Adhesive capability of Lactobacillus plantarum 299v is important for preventing bacterial translocation in endotoxemic rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Administration of Lactobacillus plantarum 299v reduces side-effects of external radiation on colon anastomotic healing in an experimental model.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Age-related effects of the probiotic bacterium Lactobacillus plantarum 299v on gastrointestinal function in suckling rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Alleviation of aflatoxin-related oxidative damage to liver and improvement of growth performance in broiler chickens consumed Lactobacillus plantarum 299v for entire growth period.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support An agar-based bioassay for accurate screening of the total antioxidant capacity of lactic acid bacteria cell-free supernatants.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support An investigation into the effect of a probiotic on gut immune function in surgical patients.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Analysis of Biofilm Formation on the Surface of Organic Mung Bean Seeds, Sprouts and in the Germination Environment.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Anchorless surface associated glycolytic enzymes from Lactobacillus plantarum 299v bind to epithelial cells and extracellular matrix proteins.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Assessment of the bacterial diversity of agave sap concentrate, resistance to in vitro gastrointestinal conditions and short-chain fatty acids production.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta-analysis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Bifidobacteria Encapsulation and Viability of Probiotic Culture during Oral Delivery in a Milk Drink Matrix.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Biodiversity of mannose-specific adhesion in Lactobacillus plantarum revisited: strain-specific domain composition of the mannose-adhesin.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Catabolism of hydroxycinnamic acids in contact with probiotic Lactobacillus.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Clostridium Difficile Infection in the Nephrology Ward.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Collaborative cytometric inter-laboratory ring test for probiotics quantification.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Convergence in probiotic Lactobacillus gut-adaptive responses in humans and mice.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Correction: OjiNjideka Hemphill et al. Feasibility Study of Lactobacillus Plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals. Nutrients 2023, 15, 875.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Cytokine expression in response to bacterial antigens in preterm and term infant cord blood monocytes.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Development of Probiotic Formulation for the Treatment of Iron Deficiency Anemia.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Dynamics of Changes in pH and the Contents of Free Sugars, Organic Acids and LAB in Button Mushrooms during Controlled Lactic Fermentation.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT).
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of lactobacilli on paracellular permeability in the gut.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of probiotic bacteria on porcine rotavirus OSU infection of porcine intestinal epithelial IPEC-J2 cells.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effect of probiotics on the intestinal microbiota of patients with giardiasis and ascariasis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Effects of Lactobacillus plantarum on the intestinal morphology, intestinal barrier function and microbiota composition of suckling piglets.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Enhancement in Iron Absorption on Intake of Chemometrically Optimized Ratio of Probiotic Strain Lactobacillus plantarum 299v with Iron Supplement Pearl Millet.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Evaluation of the Antimicrobial Activity of Phytochemicals from Tea and Agarwood Leaf Extracts against Isolated Bacteria from Poultry and Curd.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Evaluation of the potential use of probiotic strain Lactobacillus plantarum 299v in lactic fermentation of button mushroom fruiting bodies.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Feasibility Study of Lactobacillus Plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Fermentation of pseudocereals quinoa, canihua, and amaranth to improve mineral accessibility through degradation of phytate.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Freeze-dried Lactobacillus plantarum 299v increases iron absorption in young females-Double isotope sequential single-blind studies in menstruating women.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Gamma aminobutyric acid production by commercially available probiotic strains.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Growth of Lactic Acid Bacteria on Gold-Influence of Surface Roughness and Chemical Composition.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Growth, survival, and metabolic activities of probiotic Lactobacillus spp. in fermented coffee brews supplemented with glucose and inactivated yeast derivatives.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Gut microbiota mediated benefits of barley kernel products on metabolism, gut hormones, and inflammatory markers as affected by co-ingestion of commercially available probiotics: a randomized controlled study in healthy subjects.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Hepatoprotective effects of Lactobacillus plantarum 299v supplemented via drinking water against aflatoxin-induced liver damage.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support In Vitro Evaluation of the Probiotic Potential of Halotolerant Lactobacilli Isolated from a Ripened Tropical Mexican Cheese.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support In-feed nutritional additive probiotic Saccharomyces boulardii RC009 can substitute for prophylactic antibiotics and improve the production and health of weaning pigs.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Influence of a drink containing different antioxidants and Lactobacillus plantarum 299v on plasma total antioxidant capacity, selenium status and faecal microbial flora.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Influence of sub-lethal stresses on the survival of lactic acid bacteria after spray-drying in orange juice.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Intake of Lactiplantibacillus plantarum HEAL9 Improves Cognition in Moderately Stressed Subjects: A Randomized Controlled Study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Intestinal microbiota determine severity of myocardial infarction in rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Iron Supplements Containing <i>Lactobacillus plantarum</i> 299v Increase Ferric Iron and Up-regulate the Ferric Reductase DCYTB in Human Caco-2/HT29 MTX Co-Cultures.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactiplantibacillus plantarum 299v (LP299V(®)): three decades of research.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactiplantibacillus plantarum 299v as starter culture suppresses Enterobacteriaceae more efficiently than spontaneous fermentation of carrots.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactiplantibacillus plantarum 299v supplementation modulates ß-cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus Plantarum 299v Changes miRNA Expression in the Intestines of Piglets and Leads to Downregulation of LITAF by Regulating ssc-miR-450a.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299V improves the microbiological quality of legume sprouts and effectively survives in these carriers during cold storage and in vitro digestion.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v Prevents Caspase-Dependent Apoptosis In Vitro.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v probiotic supplementation in men with stable coronary artery disease suppresses systemic inflammation.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum 299v surface-bound GAPDH: a new insight into enzyme cell walls location.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Mannose-specific interaction of Lactobacillus plantarum with porcine jejunal epithelium.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Maternal consumption of Lactobacillus plantarum 299v affects gastrointestinal growth and function in the suckling rat.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Metabolism of Caprine Milk Carbohydrates by Probiotic Bacteria and Caco-2:HT29?MTX Epithelial Co-Cultures and Their Impact on Intestinal Barrier Integrity.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Microarray analysis reveals the potential molecular mechanism of Lp299v in stable coronary atherosclerotic disease.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Microbial products from probiotic bacteria inhibit Salmonella enteritidis 857-induced IL-8 synthesis in Caco-2 cells.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Microencapsulation of Lactobacillus plantarum spp in an alginate matrix coated with whey proteins.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Modulation of the Gut Microbiome and Obesity Biomarkers by Lactobacillus Plantarum KC28 in a Diet-Induced Obesity Murine Model.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Molecular Switch Controlling Expression of the Mannose-Specific Adhesin, Msa, in <i>Lactobacillus plantarum</i>.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Natural gum modified emulsion gel as single carrier for the oral delivery of probiotic-drug combination.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Nutritional quality of fresh and stored legumes sprouts - Effect of Lactobacillus plantarum 299v enrichment.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Nutritionally enhanced fermented sausages as a vehicle for potential probiotic lactobacilli delivery.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Oral Administration of <i>Lactobacillus plantarum</i> 299v Reduces Cortisol Levels in Human Saliva during Examination Induced Stress: A Randomized, Double-Blind Controlled Trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Oral administration of Lactobacillus plantarum 299v modulates gene expression in the ileum of pigs: prediction of crosstalk between intestinal immune cells and sub-mucosal adipocytes.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Plant Extracts Rich in Polyphenols as Potent Modulators in the Growth of Probiotic and Pathogenic Intestinal Microorganisms.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Population genomics of Lacticaseibacillus paracasei: pan-genome, integrated prophage, antibiotic resistance, and carbohydrate utilization.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Postbiotic Fractions of Probiotics Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG Show Immune-Modulating Effects.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Potentially Bioaccessible Phenolic and Antioxidant Potential of Fresh and Stored Lentil Sprouts-Effect of <i>Lactobacillus plantarum</i> 299v Enrichment.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Potentially Bioaccessible Phenolics from Mung Bean and Adzuki Bean Sprouts Enriched with Probiotic-Antioxidant Properties and Effect on the Motility and Survival of AGS Human Gastric Carcinoma Cells.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic Beverage From Pineapple Juice Fermented With <i>Lactobacillus</i> and <i>Bifidobacterium</i> Strains.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic lactobacilli attenuate oxysterols-induced alteration of intestinal epithelial cell monolayer permeability: Focus on tight junction modulation.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic Lactobacillus plantarum 299v does not counteract unfavorable phytohemagglutinin-induced changes in the rat intestinal microbiota.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic Properties of Leuconostoc mesenteroides Isolated from Aguamiel of Agave salmiana.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic screening and safety evaluation of Lactobacillus strains from plants, artisanal goat cheese, human stools, and breast milk.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic strain Lactobacillus plantarum 299v increases iron absorption from 2 an iron-supplemented fruit drink: a double-isotope cross-over single-blind 3 study in women of reproductive age--ERRATUM.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic strain Lactobacillus plantarum 299v increases iron absorption from an iron-supplemented fruit drink: a double-isotope cross-over single-blind study in women of reproductive age.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic use in the critically ill.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotic-Induced Priming of Innate Immunity to Protect Against Rotaviral Infection.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotics and immune response.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotics for infantile colic: Is there evidence beyond doubt? A meta-analysis and systematic review.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Production of probiotic bovine salami using Lactobacillus plantarum 299v as adjunct.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Proteomic analysis of cell surface-associated proteins from probiotic Lactobacillus plantarum.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Rehydration before Application Improves Functional Properties of Lyophilized Lactiplantibacillus plantarum HAC03.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Screening of Lactic Acid Bacteria for Anti-Fusarium Activity and Optimization of Incubation Conditions.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Sensory characterization of functional guava symbiotic petit cheese product.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Specific Probiotics for the Treatment of Pediatric Acute Gastroenteritis in India: A Systematic Review and Meta-Analysis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Streptococcus strain D19(T) as a probiotic candidate to modulate oral health.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Structural and biosynthetic diversity of plantaricins from Lactiplantibacillus.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Study of Probiotic Effects of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12 and <i>Lactobacillus plantarum</i> 299v Strains on Biochemical and Morphometric Parameters of Rabbits after Obesity Induction.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT).
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Sugar fermentation in probiotic bacteria--an in vitro study.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Sugar-Free Milk Chocolate as a Carrier of Omega-3 Polyunsaturated Fatty Acids and Probiotics: A Potential Functional Food for the Diabetic Population.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Susceptibility to antibiotics in isolates of Lactobacillus plantarum RAPD-type Lp299v, harvested from antibiotic treated, critically ill patients after administration of probiotics.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The Effect of <i>Lactobacillus plantarum</i> 299v on Iron Status and Physical Performance in Female Iron-Deficient Athletes: A Randomized Controlled Trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The impact of fermentation and in vitro digestion on formation angiotensin converting enzyme (ACE) inhibitory peptides from pea proteins.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The Influence of the Degree of Thermal Inactivation of Probiotic Lactic Acid Bacteria and Their Postbiotics on Aggregation and Adhesion Inhibition of Selected Pathogens.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The microbiota is essential for the generation of black tea theaflavins-derived metabolites.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The role of <i>Lactobacillus plantarum</i> 299v in supporting treatment of selected diseases.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The Sensory Quality and Volatile Profile of Dark Chocolate Enriched with Encapsulated Probiotic <i>Lactobacillus plantarum</i> Bacteria.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support The Use of the Probiotic Lactiplantibacillus plantarum 299v in the Technology of Non-Dairy Ice Cream Based on Avocado.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support TNF-alpha sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Topical Probiotic Formulation Promotes Rapid Healing in Dog Keratinocyte Cells: A Promising Approach for Wound Management.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Undaria pinnatifida fucoidan contributes to anti-inflammation activity of Bacteroides in fiber-deficient mice via modulation of gut microbiota and protection of intestinal barrier integrity.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Unravelling the functionality of anionic and non-ionic plant seed gums on milk protein cryogels conveying Lacticaseibacillus rhamnosus GG.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Use of colony-based bacterial strain typing for tracking the fate of Lactobacillus strains during human consumption.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Use of whey permeate containing in situ synthesised galacto-oligosaccharides for the growth and preservation of Lactobacillus plantarum.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Variation of mucin adhesion, cell surface characteristics, and molecular mechanisms among Lactobacillus plantarum isolated from different habitats.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Viable, lyophilized lactobacilli do not increase iron absorption from a lactic acid-fermented meal in healthy young women, and no iron absorption occurs in the distal intestine.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Volatile sulfur compounds produced by probiotic bacteria in the presence of cysteine or methionine.
Lactobacillus plantarum 299v Jarrow Formulas Ideal Bowel Support Wheat Germ Fermentation with Saccharomyces cerevisiae and Lactobacillus plantarum: Process Optimization for Enhanced Composition and Antioxidant Properties In Vitro.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Allantoin, a Potential Metabolite That Promotes AMPK Phosphorylation and Suppresses Cholesterol Biosynthesis Via the Mevalonate Pathway and Bloch Pathway.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Effects of a Lactobacilli Probiotic on Reducing Duration of URTI and Fever, and Use of URTI-Associated Medicine: A Re-Analysis of a Randomized, Placebo-Controlled Study.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Effects of Potential Probiotic Strains on the Fecal Microbiota and Metabolites of D-Galactose-Induced Aging Rats Fed with High-Fat Diet.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacilli modulated AMPK activity and prevented telomere shortening in ageing rats.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus plantarum DR7 improved brain health in aging rats via the serotonin, inflammatory and apoptosis pathways.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus plantarum DR7 Modulated Bowel Movement and Gut Microbiota Associated with Dopamine and Serotonin Pathways in Stressed Adults.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus plantarum DR7 Reduces Cholesterol via Phosphorylation of AMPK That Down-regulated the mRNA Expression of HMG-CoA Reductase.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus probiotics improved the gut microbiota profile of a Drosophila melanogaster Alzheimer`s disease model and alleviated neurodegeneration in the eye.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK.
Lactobacillus plantarum DR7 SymbioLact ® Pro Sleep Modulating the Bidirectional Communication of the Gut-Brain Axis in Times of Stress with Lactobacillus plantarum DR7.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Assessing the Probiotic Effects of Pediococcus pentosaceus CACC616 in Weaned Piglets.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Correction to: Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Determining the In Vivo Efficacy of Plant-Based and Probiotic-Based Antibiotic Alternatives against Mixed Infection with Salmonella enterica and Escherichia coli in Domestic Chickens.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Effects of <i>Lactobacillus plantarum</i> and <i>Lactobacillus paracasei</i> on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Extracellular Proteins Isolated from L. acidophilus as an Osteomicrobiological Therapeutic Agent to Reduce Pathogenic Biofilm Formation, Regulate Chronic Inflammation, and Augment Bone Formation In Vitro.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Feeding Strategies with Multi-Strain Probiotics Affect Growth, Health Condition, and Disease Resistance in Asian Seabass (Lates calcarifer).
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Gut Microbiome Analysis and Screening of Lactic Acid Bacteria with Probiotic Potential in Anhui Swine.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support INFLUENCE OF PROBIOTICS ON THE MESOTHELIN LEVEL IN WOMEN WITH ENDOMETRIOSIS ASSOCIATED WITH INFERTILITY IN COMPLEX PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support New Lactiplantibacillus plantarum and Lacticaseibacillus rhamnosus strains: well tolerated and improve infant microbiota.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Probiotic reduced the impact of phthalates and bisphenol A mixture on type 2 diabetes mellitus development: Merging bioinformatics with in vivo analysis.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Probiotics for preventing acute upper respiratory tract infections.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Protective Properties of S-layer Protein 2 from Lactobacillus crispatus 2029 against Candida albicans Infections.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Role of Probiotics in Preventing Carbapenem-Resistant Enterobacteriaceae Colonization in the Intensive Care Unit: Risk Factors and Microbiome Analysis Study.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Ultrasound-assisted fermentation of Porphyra yezoensis sauce at different growth stages using Lactiplantibacillus plantarum: Metabolic response and biological activity.
Lactobacillus plantarum HEAL9 UltraFlora® Cold Support Unveiling the Gut Microbiome: How Junk Food Impacts the Gut.
Lactobacillus plantarum Lp-115 Custom Probiotics An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lactobacillus plantarum Lp-115 Custom Probiotics Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
Lactobacillus plantarum Lp-115 Custom Probiotics Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Lactobacillus plantarum Lp-115 Custom Probiotics Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage.
Lactobacillus plantarum Lp-115 Custom Probiotics Effect of giving probiotic supplement Lactobacillus acidophilus La-14 as an immunomodulator to maintain a respiratory system in Mus musculus.
Lactobacillus plantarum Lp-115 Custom Probiotics Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
Lactobacillus plantarum Lp-115 Custom Probiotics Enhancement of bile resistance by maltodextrin supplementation in Lactobacillus plantarum Lp-115.
Lactobacillus plantarum Lp-115 Custom Probiotics Enhancing Bioaccessibility of Plant Protein Using Probiotics: An In Vitro Study.
Lactobacillus plantarum Lp-115 Custom Probiotics How frequent is routine use of probiotics in UK neonatal units?
Lactobacillus plantarum Lp-115 Custom Probiotics Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.
Lactobacillus plantarum Lp-115 Custom Probiotics Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study).
Lactobacillus plantarum Lp-115 Custom Probiotics Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.
Lactobacillus plantarum Lp-115 Custom Probiotics Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson`s disease in mice by delivering GLP-1 and modulating gut microbiota.
Lactobacillus plantarum Lp-115 Custom Probiotics Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.
Lactobacillus plantarum Lp-115 Custom Probiotics Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Lactobacillus plantarum Lp-115 Custom Probiotics Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
lactobacillus plantarum LP45 Natealth [The Immunomodulatory and Anti-allergy Effects of Lactobacilli].
lactobacillus plantarum LP45 Natealth A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation.
lactobacillus plantarum LP45 Natealth Author Correction: Effects of Lactobacillus salivarius isolated from feces of fast-growing pigs on intestinal microbiota and morphology of suckling piglets.
lactobacillus plantarum LP45 Natealth Effect of a Bifidobacterium-Containing Acid-Resistant Microcapsule Formulation on Gut Microbiota: A Pilot Study.
lactobacillus plantarum LP45 Natealth Effects of Ilisha elongata protein, soy protein and whey protein on growth characteristics and adhesion of probiotics.
lactobacillus plantarum LP45 Natealth Effects of Ilisha elongata proteins on proliferation and adhesion of Lactobacillus plantarum.
lactobacillus plantarum LP45 Natealth Effects of Lactobacillus salivarius isolated from feces of fast-growing pigs on intestinal microbiota and morphology of suckling piglets.
lactobacillus plantarum LP45 Natealth Fluctuation of fecal microbiota in individuals with Japanese cedar pollinosis during the pollen season and influence of probiotic intake.
lactobacillus plantarum LP45 Natealth Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by Bifidobacterium longum BB536 supplementation: A RCT.
lactobacillus plantarum LP45 Natealth Lactobacillus plantarum LP45 inhibits the RANKL/OPG signaling pathway and prevents glucocorticoid-induced osteoporosis.
lactobacillus plantarum LP45 Natealth Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity.
lactobacillus plantarum LP45 Natealth Long-term combined administration of Bifidobacterium bifidum TMC3115 and Lactobacillus plantarum 45 alleviates spatial memory impairment and gut dysbiosis in APP/PS1 mice.
lactobacillus plantarum LP45 Natealth Polyelectrolytes-stabilized liposomes for efficient encapsulation of Lactobacillus rhamnosus and improvement of its survivability under adverse conditions.
lactobacillus plantarum LP45 Natealth Preparation of Edible Films with Lactobacillus plantarum and Lactobionic Acid Produced by Sweet Whey Fermentation.
lactobacillus plantarum LP45 Natealth Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.
lactobacillus plantarum LP45 Natealth Production of wheat bread without preservatives using sourdough starters.
lactobacillus plantarum LP45 Natealth Recovery of recombinant Mycobacterium tuberculosis antigens fused with cell wall-anchoring motif (LysM) from inclusion bodies using non-denaturing reagent (N-laurylsarcosine).
lactobacillus plantarum LP45 Natealth Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial.
lactobacillus plantarum ps128 Neurobiotique PS128 <i>Lactobacillus plantarum</i> PS128 and Other Probiotics in Children and Adolescents with Autism Spectrum Disorder: A Real-World Experience.
lactobacillus plantarum ps128 Neurobiotique PS128 <i>Lactobacillus plantarum</i> PS128 Improves Physiological Adaptation and Performance in Triathletes through Gut Microbiota Modulation.
lactobacillus plantarum ps128 Neurobiotique PS128 Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice.
lactobacillus plantarum ps128 Neurobiotique PS128 Clinical Application Value of Lactobacillus Plantarum PS128 in Patients with Anxiety Disorders.
lactobacillus plantarum ps128 Neurobiotique PS128 Correction: Lactobacillus plantarum PS128 prevents cognitive dysfunction in alzheimer`s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis.
lactobacillus plantarum ps128 Neurobiotique PS128 Effect of Daily Oral <i>Lactobacillus plantarum</i> PS128 on Exercise Capacity Recovery after a Half-Marathon.
lactobacillus plantarum ps128 Neurobiotique PS128 Effect of Lactobacillus plantarum PS128 on neuromuscular efficiency after a half-marathon.
lactobacillus plantarum ps128 Neurobiotique PS128 Effect of systemic administration of Bifidobacterium animalis subsp. lactis HN019 on apical periodontitis.
lactobacillus plantarum ps128 Neurobiotique PS128 Effects of <i>Lactobacillus plantarum</i> PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial.
lactobacillus plantarum ps128 Neurobiotique PS128 Effects of <i>Lactobacillus plantarum</i> PS128 on Depressive Symptoms and Sleep Quality in Self-Reported Insomniacs: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial.
lactobacillus plantarum ps128 Neurobiotique PS128 Effects of probiotic supplementation on performance of resistance and aerobic exercises: a systematic review.
lactobacillus plantarum ps128 Neurobiotique PS128 Genome architecture of Lactobacillus plantarum PS128, a probiotic strain with potential immunomodulatory activity.
lactobacillus plantarum ps128 Neurobiotique PS128 Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson`s disease.
lactobacillus plantarum ps128 Neurobiotique PS128 Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.
lactobacillus plantarum ps128 Neurobiotique PS128 Lactobacillus plantarum PS128 ameliorates 2,5-Dimethoxy-4-iodoamphetamine-induced tic-like behaviors via its influences on the microbiota-gut-brain-axis.
lactobacillus plantarum ps128 Neurobiotique PS128 Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer`s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis.
lactobacillus plantarum ps128 Neurobiotique PS128 Lactobacillus plantarum PS128 Promotes Intestinal Motility, Mucin Production, and Serotonin Signaling in Mice.
lactobacillus plantarum ps128 Neurobiotique PS128 Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial.
lactobacillus plantarum ps128 Neurobiotique PS128 Psychobiotic Supplementation of PS128<sup>TM</sup> Improves Stress, Anxiety, and Insomnia in Highly Stressed Information Technology Specialists: A Pilot Study.
lactobacillus plantarum ps128 Neurobiotique PS128 Psychophysiological Effects of <i>Lactobacillus plantarum</i> PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial.
lactobacillus plantarum ps128 Neurobiotique PS128 Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice.
lactobacillus plantarum ps128 Neurobiotique PS128 Randomized Controlled Trial of Probiotic PS128 in Children with Tourette Syndrome.
lactobacillus plantarum ps128 Neurobiotique PS128 The Add-On Effect of <i>Lactobacillus plantarum</i> PS128 in Patients With Parkinson`s Disease: A Pilot Study.
lactobacillus plantarum ps128 Neurobiotique PS128 The Beneficial Effects of Lactobacillus plantarum PS128 on High-Intensity, Exercise-Induced Oxidative Stress, Inflammation, and Performance in Triathletes.
lactobacillus plantarum ps128 Neurobiotique PS128 The Effect of Tannin-Rich Witch Hazel on Growth of Probiotic <i>Lactobacillus plantarum</i>.
lactobacillus plantarum ps128 Neurobiotique PS128 The probiotic Lacticaseibacillus rhamnosus HN001 influences the architecture and gene expression of small intestine tissue in a piglet model.
lactobacillus plantarum ps128 Neurobiotique PS128 Toxicity Studies of Lactobacillus plantarum PS128<sup>TM</sup> Isolated from Spontaneously Fermented Mustard Greens.
Lactobacillus plantarum W1 Winclove Senior Assessment of the bacterial viability of chlorine- and quaternary ammonium compounds-treated Lactobacillus cells via a multi-method approach.
Lactobacillus plantarum W1 Winclove Senior Decoding the Capability of <i>Lactobacillus plantarum</i> W1 Isolated from Soybean Whey in Producing an Exopolysaccharide.
Lactobacillus plantarum W1 Winclove Senior Screening of Antifungal Lactic Acid Bacteria as Bioprotective Cultures in Yogurt and a Whey Beverage.
Lactobacillus plantarum W21 Ecologic Travel In vitro evidence for efficacy in food intolerance for the multispecies probiotic formulation Ecologic® Tolerance (Syngut™).
Lactobacillus plantarum W21 Ecologic Travel Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Lactobacillus plantarum W21 Ecologic Travel Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion.
Lactobacillus plantarum W62 Ecologic® AAD Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus plantarum W62 Ecologic® AAD In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases.
Lactobacillus plantarum W62 Ecologic® AAD Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus plantarum W62 Ecologic® AAD Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans.
Lactobacillus plantarum W62 Ecologic® AAD Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Acid production in dental plaque after exposure to probiotic bacteria.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans streptococci and lactobacilli.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of Lactobacillus reuteri on Cell Viability and PGE<sub>2</sub> Production in Human Gingival Fibroblasts.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of Probiotic Bacteria on Oral Candida in Frail Elderly.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effect of tablets containing probiotic bacteria (Lactobacillus reuteri) on early caries lesions in adolescents: a pilot study.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Effects of <i>Lactobacillus reuteri</i>-containing lozenges on healing after surgical removal of mandibular third molars: a randomised controlled trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Oral probiotics in the management of gingivitis in diabetic patients: a double blinded randomized controlled study.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Orodispersible lozenges containing a combination of <i>Lactobacillus reuteri</i> DSM 17938 and <i>Lactobacillus reuteri</i> ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Prevention of Recurrent Childhood Caries with Probiotic Supplements: A Randomized Controlled Trial with a 12-Month Follow-Up.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Probiotic <i>Lactobacillus reuteri</i> has antifungal effects on oral <i>Candida</i> species <i>in vitro</i>.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Probiotic supplements (Lactobacillus reuteri DSM 17938 and ATCC PTA 5289) do not affect regrowth of mutans streptococci after full-mouth disinfection with chlorhexidine: a randomized controlled multicenter trial.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Lactobacillus reuteri ATCC PTA 5289 BioGaia® ProDentis The use of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 on oral health indexes in a school population: A pilot randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® "The role of L. reuteri DSM17938 in nutritional recovery and treatment of constipation in children and adolescents with anorexia nervosa - a randomized, double blind, placebo controlled study".
Lactobacillus reuteri DSM 17938 BioGaia® &lt;i&gt;Lactobacillus reuteri&lt;/i&gt; DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites.
Lactobacillus reuteri DSM 17938 BioGaia® [Probiotics for the treatment of infant colic: a clinical case].
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> Colonisation of Extremely Preterm Infants in a Randomised Placebo-Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial.
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis.
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> DSM 17938 Improves Feeding Intolerance in Preterm Infants.
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic.
Lactobacillus reuteri DSM 17938 BioGaia® <i>Lactobacillus reuteri</i> Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota.
Lactobacillus reuteri DSM 17938 BioGaia® 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Lactobacillus reuteri DSM 17938 BioGaia® A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.
Lactobacillus reuteri DSM 17938 BioGaia® A phase one safety study of Lactobacillus reuteri conducted in the Peruvian Amazon: Observations from the field.
Lactobacillus reuteri DSM 17938 BioGaia® A Phylogenetic View on the Role of Glycerol for Growth Enhancement and Reuterin Formation in Limosilactobacillus reuteri.
Lactobacillus reuteri DSM 17938 BioGaia® A systematic review of prevention and treatment of infantile colic.
Lactobacillus reuteri DSM 17938 BioGaia® Acid production in dental plaque after exposure to probiotic bacteria.
Lactobacillus reuteri DSM 17938 BioGaia® Adenosine A<sub>2A</sub> Receptor Deletion Blocks the Beneficial Effects of <i>Lactobacillus reuteri</i> in Regulatory T-Deficient Scurfy Mice.
Lactobacillus reuteri DSM 17938 BioGaia® Airways allergic inflammation and L. reuterii treatment in asthmatic children.
Lactobacillus reuteri DSM 17938 BioGaia® An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.
Lactobacillus reuteri DSM 17938 BioGaia® Application of ultrasound and microencapsulation on Limosilactobacillus reuteri DSM 17938 as a metabolic attenuation strategy for tomato juice probiotication.
Lactobacillus reuteri DSM 17938 BioGaia® Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
Lactobacillus reuteri DSM 17938 BioGaia® Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease?
Lactobacillus reuteri DSM 17938 BioGaia® Catabolism of hydroxycinnamic acids in contact with probiotic Lactobacillus.
Lactobacillus reuteri DSM 17938 BioGaia® Characterization of biosurfactants produced by Lactobacillus spp. and their activity against oral streptococci biofilm.
Lactobacillus reuteri DSM 17938 BioGaia® Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice.
Lactobacillus reuteri DSM 17938 BioGaia® Coconut milk beverage fermented by <i>Lactobacillus reuteri</i>: optimization process and stability during refrigerated storage.
Lactobacillus reuteri DSM 17938 BioGaia® Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by <i>Lactobacillus reuteri</i> DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Crude Pectic Oligosaccharide Recovery from Thai Chok Anan Mango Peel Using Pectinolytic Enzyme Hydrolysis.
Lactobacillus reuteri DSM 17938 BioGaia® Crying Time and ROR?/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Culture conditions affect Lactobacillus reuteri DSM 17938 ability to perform glycerol bioconversion into 3-hydroxypropionic acid.
Lactobacillus reuteri DSM 17938 BioGaia® Cytokine Secretion, Viability, and Real-Time Proliferation of Apical-Papilla Stem Cells Upon Exposure to Oral Bacteria.
Lactobacillus reuteri DSM 17938 BioGaia® Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of <i>Lactobacillus reuteri</i> DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Detection and Quantification of eDNA-Associated Bacterial Membrane Vesicles by Flow Cytometry.
Lactobacillus reuteri DSM 17938 BioGaia® Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Diversity of Lactobacillus reuteri Strains in Converting Glycerol into 3-Hydroxypropionic Acid.
Lactobacillus reuteri DSM 17938 BioGaia® Draft genome sequence of Lactiplantibacillus plantarum subsp. plantarum strain HF43, a human gut-associated potential probiotic.
Lactobacillus reuteri DSM 17938 BioGaia® Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Formula Containing Lactobacillus reuteri DSM 17938 on Fecal Microbiota of Infants Born by Cesarean-Section.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of L. reuteri on bowel movements in children aged 6 months to 4 years: A double-blind randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Lactobacillaceae Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Lactobacillus reuteri on Cell Viability and PGE<sub>2</sub> Production in Human Gingival Fibroblasts.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Microencapsulation on Survival at Simulated Gastrointestinal Conditions and Heat Treatment of a Non Probiotic Strain, Lactiplantibacillus plantarum 48M, and the Probiotic Strain Limosilactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of Probiotic Bacteria on Oral Candida in Frail Elderly.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight &lt; 1000 grams: a sequential analysis.
Lactobacillus reuteri DSM 17938 BioGaia® Effect of tablets containing probiotic bacteria (Lactobacillus reuteri) on early caries lesions in adolescents: a pilot study.
Lactobacillus reuteri DSM 17938 BioGaia® Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial.
Lactobacillus reuteri DSM 17938 BioGaia® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus reuteri DSM 17938 BioGaia® Effects of <i>Lactobacillus reuteri</i>-containing lozenges on healing after surgical removal of mandibular third molars: a randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Effects of dietary Lactobacillus rhamnosus GG supplementation on the production performance, egg quality, eggshell ultrastructure, and lipid metabolism of late-phase laying hens.
Lactobacillus reuteri DSM 17938 BioGaia® Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study.
Lactobacillus reuteri DSM 17938 BioGaia® Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of a partially hydrolysed formula, with reduced lactose content and with Lactobacillus reuteri DSM 17938 in infant colic: A double blind, randomised clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of a standardized extract of Matricariae chamomilla L., Melissa officinalis L. and tyndallized Lactobacillus acidophilus (HA122) in infantile colic: An open randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of an Oral Rehydration Solution Enriched with <i>Lactobacillus reuteri DSM 17938</i> and Zinc in the Management of Acute Diarrhoea in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis: Erratum.
Lactobacillus reuteri DSM 17938 BioGaia® Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Enteroadsorbent Polymethylsiloxane Polyhydrate vs. Probiotic <i>Lactobacillus reuteri</i> DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Environmental conditions during glycerol bioconversion affect 3-hydroxypropionic acid bioproduction by Limosilactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Evaluation of an Immunomodulatory Probiotic Intervention for Veterans With Co-occurring Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study.
Lactobacillus reuteri DSM 17938 BioGaia® Evaluation of growth, metabolism and production of potentially bioactive components during fermentation of barley with Lactobacillus reuteri.
Lactobacillus reuteri DSM 17938 BioGaia® Evidence of Lactobacillus reuteri to reduce colic in breastfed babies: Systematic review and meta-analysis.
Lactobacillus reuteri DSM 17938 BioGaia® Exopolysaccharides of Lactobacillus reuteri: Their influence on adherence of E. coli to epithelial cells and inflammatory response.
Lactobacillus reuteri DSM 17938 BioGaia® Extracellular Membrane Vesicles from Lactobacilli Dampen IFN-? Responses in a Monocyte-Dependent Manner.
Lactobacillus reuteri DSM 17938 BioGaia® Extracellular membrane vesicles from Limosilactobacillus reuteri strengthen the intestinal epithelial integrity, modulate cytokine responses and antagonize activation of TRPV1.
Lactobacillus reuteri DSM 17938 BioGaia® Faecalibacterium: a bacterial genus with promising human health applications.
Lactobacillus reuteri DSM 17938 BioGaia® Flow cytometric analysis reveals culture condition dependent variations in phenotypic heterogeneity of Limosilactobacillus reuteri.
Lactobacillus reuteri DSM 17938 BioGaia® Gut microbiota mediated benefits of barley kernel products on metabolism, gut hormones, and inflammatory markers as affected by co-ingestion of commercially available probiotics: a randomized controlled study in healthy subjects.
Lactobacillus reuteri DSM 17938 BioGaia® Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice.
Lactobacillus reuteri DSM 17938 BioGaia® HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains.
Lactobacillus reuteri DSM 17938 BioGaia® Human Breast Milk Promotes the Immunomodulatory Function of Probiotic <i>Lactobacillus reuteri</i> DSM 17938 in the Neonatal Rat Intestine.
Lactobacillus reuteri DSM 17938 BioGaia® Human Breast Milk Promotes the Secretion of Potentially Beneficial Metabolites by Probiotic <i>Lactobacillus reuteri</i> DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Human Skin Bacterial Community Response to Probiotic (<i>Lactobacillus reuteri</i> DSM 17938) Introduction.
Lactobacillus reuteri DSM 17938 BioGaia® Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Lactobacillus reuteri DSM 17938 BioGaia® Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
Lactobacillus reuteri DSM 17938 BioGaia® Impact of probiotic Limosilactobacillus reuteri DSM 17938 on amino acid metabolism in the healthy newborn mouse.
Lactobacillus reuteri DSM 17938 BioGaia® Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® In infants with `colic`/persistent crying, administration of daily Lactobacillus reuteri DSM 17938 was associated with reduced crying time at 1, 2 and 3 weeks.
Lactobacillus reuteri DSM 17938 BioGaia® In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Lactobacillus reuteri DSM 17938 BioGaia® In vitro assessment of probiotic attributes for strains contained in commercial formulations.
Lactobacillus reuteri DSM 17938 BioGaia® In vitro selection and transferability of antibiotic resistance in the probiotic strain Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series.
Lactobacillus reuteri DSM 17938 BioGaia® Indications and Recommendations by Societies and Institutions for the Use of Probiotics and Prebiotics in Paediatric Functional Intestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Infantile Colic: Recognition and Treatment.
Lactobacillus reuteri DSM 17938 BioGaia® Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters.
Lactobacillus reuteri DSM 17938 BioGaia® Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
Lactobacillus reuteri DSM 17938 BioGaia® Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lack of Benefit of Lactobacillus reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation.
Lactobacillus reuteri DSM 17938 BioGaia® Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri Biofilms Inhibit Pathogens and Regulate Microbiota in In Vitro Fecal Fermentation.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 appears to be effective in reducing crying time for colic.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 for managing infant colic: protocol for an individual participant data meta-analysis.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 plus vitamin D<sub>3</sub> as ancillary treatment in allergic children with asthma.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 Protects against Gastric Damage Induced by Ethanol Administration in Mice: Role of TRPV1/Substance P Axis.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri effects on maternal separation stress in newborn mice.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri in children with functional abdominal pain (FAP).
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri in the treatment of Helicobacter pylori infection.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri strains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenic Escherichia coli.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-?B signaling in the intestine.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Lactobacillus reuteri DSM 17938 BioGaia® Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic.
Lactobacillus reuteri DSM 17938 BioGaia® Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency.
Lactobacillus reuteri DSM 17938 BioGaia® Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study.
Lactobacillus reuteri DSM 17938 BioGaia® Limosilactobacillus reuteri DSM-17938 for preventing cough in adults with mild allergic asthma: A double-blind randomized placebo-controlled cross-over study.
Lactobacillus reuteri DSM 17938 BioGaia® Living, quiescent Lactobacillus plantarum Lp90 probiotic, delivered topically to full thickness tissues in vitro via a just-add-water cream delivery system, stimulates the expression of elastin protein.
Lactobacillus reuteri DSM 17938 BioGaia® Management of the Most Common Functional Gastrointestinal Disorders in Infancy: The Middle East Expert Consensus.
Lactobacillus reuteri DSM 17938 BioGaia® Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children.
Lactobacillus reuteri DSM 17938 BioGaia® Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice.
Lactobacillus reuteri DSM 17938 BioGaia® Mind the gut: probiotics in paediatric neurogastroenterology.
Lactobacillus reuteri DSM 17938 BioGaia® Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis.
Lactobacillus reuteri DSM 17938 BioGaia® Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or Lactobacillus reuteri DSM 17938: a multicentre, randomised, controlled, factorial trial in Botswana.
Lactobacillus reuteri DSM 17938 BioGaia® Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Lactobacillus reuteri DSM 17938 BioGaia® Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Lactobacillus reuteri DSM 17938 BioGaia® Oral probiotics in the management of gingivitis in diabetic patients: a double blinded randomized controlled study.
Lactobacillus reuteri DSM 17938 BioGaia® Orodispersible lozenges containing a combination of <i>Lactobacillus reuteri</i> DSM 17938 and <i>Lactobacillus reuteri</i> ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
Lactobacillus reuteri DSM 17938 BioGaia® Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention.
Lactobacillus reuteri DSM 17938 BioGaia® Postbiotic Modulation of Retinoic Acid Imprinted Mucosal-like Dendritic Cells by Probiotic Lactobacillus reuteri 17938 In Vitro.
Lactobacillus reuteri DSM 17938 BioGaia® Pre-, pro-, syn-, and Postbiotics in Infant Formulas: What Are the Immune Benefits for Infants?
Lactobacillus reuteri DSM 17938 BioGaia® Prevention of Recurrent Childhood Caries with Probiotic Supplements: A Randomized Controlled Trial with a 12-Month Follow-Up.
Lactobacillus reuteri DSM 17938 BioGaia® Preventive contamination with <i>Lactobacillus reuteri</i> of the implant-abutment connection: an <i>in vivo</i> study.
Lactobacillus reuteri DSM 17938 BioGaia® Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic <i>Lactobacillus reuteri</i> has antifungal effects on oral <i>Candida</i> species <i>in vitro</i>.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic interventions in infantile colic.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic prophylaxis to prevent ventilator-associated pneumonia in children on mechanical ventilation: A randomized double-blind clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic Supplementation in Preterm: Feeding Intolerance and Hospital Cost.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic supplements (Lactobacillus reuteri DSM 17938 and ATCC PTA 5289) do not affect regrowth of mutans streptococci after full-mouth disinfection with chlorhexidine: a randomized controlled multicenter trial.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotic-educated Tregs are more potent than naïve Tregs for immune tolerance in stressed new-born mice.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics enhance resistance to Streptococcus iniae in Nile tilapia (Oreochromis niloticus) reared in biofloc systems.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for colic? A PURL update.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for management of infantile colic: a systematic review of randomized controlled trials.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for paediatric functional abdominal pain disorders: A rapid review.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics for the Management of Infantile Colic: A Systematic Review.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics in Functional Gastrointestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics Increase Intramuscular Fat and Improve the Composition of Fatty Acids in Sunit Sheep through the Adenosine 5`-Monophosphate-Activated Protein Kinase (AMPK) Signaling Pathway.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1-6 years.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics on Pediatric Functional Gastrointestinal Disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics to improve outcomes of colic in the community: protocol for the Baby Biotics randomised controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders.
Lactobacillus reuteri DSM 17938 BioGaia® Probiotics: To Use or Not to Use? That Is the Question.
Lactobacillus reuteri DSM 17938 BioGaia® Prophylactic probiotics to prevent death and nosocomial infection in preterm infants.
Lactobacillus reuteri DSM 17938 BioGaia® Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.
Lactobacillus reuteri DSM 17938 BioGaia® Protective Effects of Lactobacillus reuteri on Intestinal Barrier Function in a Mouse Model of Neonatal Necrotizing Enterocolitis.
Lactobacillus reuteri DSM 17938 BioGaia® Putative probiotics decrease cell viability and enhance chemotherapy effectiveness in human cancer cells: role of butyrate and secreted proteins.
Lactobacillus reuteri DSM 17938 BioGaia® Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Lactobacillus reuteri DSM 17938 BioGaia® Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.
Lactobacillus reuteri DSM 17938 BioGaia® Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients.
Lactobacillus reuteri DSM 17938 BioGaia® Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori.
Lactobacillus reuteri DSM 17938 BioGaia® Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Regular consumption of Lactobacillus reuteri-containing lozenges reduces pregnancy gingivitis: an RCT.
Lactobacillus reuteri DSM 17938 BioGaia® Regulatory T cells and Toll-like receptor 2 and 4 mRNA expression in infants with colic treated with <i>Lactobacillus reuteri</i> DSM17938.
Lactobacillus reuteri DSM 17938 BioGaia® Relationships between the use of Embden Meyerhof pathway (EMP) or Phosphoketolase pathway (PKP) and lactate production capabilities of diverse Lactobacillus reuteri strains.
Lactobacillus reuteri DSM 17938 BioGaia® Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® Reuterin-producing Limosilactobacillus reuteri: Optimization of in situ reuterin production in alginate-based filmogenic solutions.
Lactobacillus reuteri DSM 17938 BioGaia® Role of Lactobacillus reuteri&nbsp;DSM 17938 on Crying Time Reduction in Infantile Colic and Its Impact on Maternal Depression: A Real-Life Clinic-Based Study.
Lactobacillus reuteri DSM 17938 BioGaia® Role of Probiotics in <i>Helicobacter pylori</i> Eradication: Lessons from a Study of <i>Lactobacillus reuteri</i> Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor.
Lactobacillus reuteri DSM 17938 BioGaia® Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® Safety and efficacy of a probiotic-containing infant formula supplemented with 2`-fucosyllactose: a double-blind randomized controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial.
Lactobacillus reuteri DSM 17938 BioGaia® Safety of Lactobacillus Reuteri DSM 17938 in Healthy Children 2-5 Years of Age.
Lactobacillus reuteri DSM 17938 BioGaia® Selective Antagonism of Lactiplantibacillus plantarum and Pediococcus acidilactici against Vibrio and Aeromonas in the Bacterial Community of Artemia nauplii.
Lactobacillus reuteri DSM 17938 BioGaia® Should we treat every infant with a probiotic?
Lactobacillus reuteri DSM 17938 BioGaia® Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains.
Lactobacillus reuteri DSM 17938 BioGaia® Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against <i>Escherichia coli</i>.
Lactobacillus reuteri DSM 17938 BioGaia® Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Lactobacillus reuteri DSM 17938 BioGaia® Systematic Review with Meta-Analysis: <i>Lactobacillus reuteri</i> DSM 17938 for Treating Acute Gastroenteritis in Children. An Update.
Lactobacillus reuteri DSM 17938 BioGaia® Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children.
Lactobacillus reuteri DSM 17938 BioGaia® Tenth year reenrollment randomized trial investigating the effects of childhood probiotics and calcium supplementation on height and weight at adolescence.
Lactobacillus reuteri DSM 17938 BioGaia® The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.
Lactobacillus reuteri DSM 17938 BioGaia® The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants.
Lactobacillus reuteri DSM 17938 BioGaia® The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri DSM 17938 BioGaia® The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.
Lactobacillus reuteri DSM 17938 BioGaia® The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials.
Lactobacillus reuteri DSM 17938 BioGaia® The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence.
Lactobacillus reuteri DSM 17938 BioGaia® The good bugs: the use of probiotics in pediatrics.
Lactobacillus reuteri DSM 17938 BioGaia® The role of Lactobacillus reuteri DSM 17938 for the absorption of iron preparations in children with iron deficiency anemia.
Lactobacillus reuteri DSM 17938 BioGaia® The role of potential probiotic strains Lactobacillus reuteri in various intestinal diseases: New roles for an old player.
Lactobacillus reuteri DSM 17938 BioGaia® The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938.
Lactobacillus reuteri DSM 17938 BioGaia® The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Lactobacillus reuteri DSM 17938 BioGaia® The use of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 on oral health indexes in a school population: A pilot randomized clinical trial.
Lactobacillus reuteri DSM 17938 BioGaia® The use of probiotics and prebiotics can enable the ingestion of dairy products by lactose intolerant individuals.
Lactobacillus reuteri DSM 17938 BioGaia® The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.
Lactobacillus reuteri DSM 17938 BioGaia® To add or not to add probiotics to infant formulae? An updated systematic review.
Lactobacillus reuteri DSM 17938 BioGaia® Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans.
Lactobacillus reuteri DSM 17938 BioGaia® Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
Lactobacillus reuteri DSM 17938 BioGaia® Urinary metabolome of infants with colic treated with Lactobacillus reuteri DSM 17938: a pilot randomized trial.
Lactobacillus reuteri DSM 17938 BioGaia® Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review.
Lactobacillus reuteri DSM 17938 BioGaia® Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics.
Lactobacillus reuteri DSM 17938 BioGaia® Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Lactobacillus reuteri DSM 17938 BioGaia® Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic [A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)].
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic [Effect of oral <i>Lactobacillus</i> <i>rhamnosus</i> GR-1 and <i>Lactobacillus</i> <i>reuteri</i> RC-14 on vaginal Group B <i>Streptococcus</i> colonization and vaginal microbiome in late pregnancy].
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic [Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses].
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic A Randomized Controlled Open Label Crossover Trial to Study Vaginal Colonization of Orally Administered Lactobacillus Reuteri RC-14 and Rhamnosus GR-1 in Pregnant Women at High Risk for Preterm Labor.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Adhesion forces and coaggregation between vaginal staphylococci and lactobacilli.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Administration of Bifidobacterium animalis subsp. lactis Strain BB-12 (®) in Healthy Children: Characterization, Functional Composition, and Metabolism of the Gut Microbiome.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Administration of Bifidobacterium animalis subsp. lactis strain BB-12(®) in healthy children: characterization, functional composition, and metabolism of the gut microbiome.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Changes in vaginal microbiota following antimicrobial and probiotic therapy.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Chemical composition and prebiotic activity of baru (Dipteryx alata Vog.) pulp on probiotic strains and human colonic microbiota.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of 25 weeks probiotic supplementation on immune function of HIV patients.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of Oral Probiotic <i>Lactobacillus rhamnosus</i> GR-1 and <i>Lactobacillus</i> <i>reuteri</i> RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of potato fiber on survival of Lactobacillus species at simulated gastric conditions and composition of the gut microbiota in vitro.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effectiveness of oral intake of <i>Lactobacillus rhamnosus GR-1</i> and <i>Lactobacillus reuteri RC-14</i> on Group B <i>Streptococcus</i> colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Evaluation of reuterin production in urogenital probiotic Lactobacillus reuteri RC-14.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Non-Antibiotic Prophylaxis for Urinary Tract Infections.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Novel Insights into the Molecular Mechanisms Underlying Robustness and Stability in Probiotic Bifidobacteria.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Passion fruit by-product and fructooligosaccharides stimulate the growth and folate production by starter and probiotic cultures in fermented soymilk.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Pilot assessment of probiotics for pregnant women in Rwanda.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Prebiotic, Probiotic, and Synbiotic Consumption Alter Behavioral Variables and Intestinal Permeability and Microbiota in BTBR Mice.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic fermented whey-milk beverages: Effect of different probiotic strains on the physicochemical characteristics, biological activity, and bioactive peptides.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel-Group, Randomized, Controlled Study.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacilli for urogenital health in women.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 is a unique prophylactic agent that suppresses infection-induced myometrial cell responses.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 supplementation attenuates Pb-induced learning and memory deficits by reshaping the gut microbiota.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic use in the critically ill.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotic Whey-Based Beverages from Cow, Sheep and Goat Milk: Antioxidant Activity, Culture Viability, Amino Acid Contents.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotics to prevent urinary tract infections: the rationale and evidence.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Probiotics. Some evidence of their effectiveness.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Rapid identification of probiotic lactobacillus biosurfactant proteins by ProteinChip tandem mass spectrometry tryptic peptide sequencing.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Release of HMGB1 and Toll-like Receptors 2, 4, and 9 Signaling Are Modulated by Bifidobacterium animalis subsp. lactis BB-12 and Salmonella Typhimurium in a Gnotobiotic Piglet Model of Preterm Infants.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Supplementation with fruit and okara soybean by-products and amaranth flour increases the folate production by starter and probiotic cultures.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic The effect of pectins on survival of probiotic Lactobacillus spp. in gastrointestinal juices is related to their structure and physical properties.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic The influence of probiotics on the cervical malignancy diagnostics quality.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Viability and In Vitro Gastrointestinal Transit Tolerance of Multispecies Probiotic Combinations Incorporated into Orange Juice and Drinking Water.
Lactobacillus reuteri RC-14 RepHresh™ Pro-B™ Probiotic Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients.
Lactobacillus rhamnosus CLR2 Bio-K+ A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Lactobacillus rhamnosus CLR2 Bio-K+ Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Lactobacillus rhamnosus CLR2 Bio-K+ Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Lactobacillus rhamnosus CLR2 Bio-K+ In vitro protein digestibility and physico-chemical properties of lactic acid bacteria fermented beverages enriched with plant proteins.
Lactobacillus rhamnosus CLR2 Bio-K+ Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis.
Lactobacillus rhamnosus CLR2 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Lactobacillus rhamnosus CLR2 Bio-K+ Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Lactobacillus rhamnosus CLR2 Bio-K+ Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
Lactobacillus rhamnosus CLR2 Bio-K+ Probiotics and prevention of Clostridium difficile infection.
Lactobacillus rhamnosus CLR2 Bio-K+ Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus CLR2 Bio-K+ The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Lactobacillus rhamnosus CLR2 Bio-K+ The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
Lactobacillus rhamnosus GG Culturelle®
Lactobacillus rhamnosus GG Culturelle® [Administration of probiotic lactobacilli to children with gastrointestinal problems: there is still little evidence].
Lactobacillus rhamnosus GG Culturelle® [Alleviation and recovery effects of Lactobacillus on the antibiotic-induced intestinal dysbiosis in early life stages of mice].
Lactobacillus rhamnosus GG Culturelle® [Anti-inflammatory mechanism of Lactobacillus rhamnosus GG in lipopolysaccharide- stimulated HT-29 cell].
Lactobacillus rhamnosus GG Culturelle® [Assessment of antagonistic activity in vitro Lactobacillus spp. strains againts Clostridum difficile strains isolated from gastrointestinal tract of patients hospitalized in three hospitals in region Mazovia].
Lactobacillus rhamnosus GG Culturelle® [Cholic acid metabolism in human fecal cultures during diet supplementation with Lacto-bacillus rhamnosus GG].
Lactobacillus rhamnosus GG Culturelle® [Construction of Lactobacillus rhamnosus GG particles surface display system].
Lactobacillus rhamnosus GG Culturelle® [Effect of Lactobacillus rhamnosus GG on immune response: experiment with autoimmune mice induced by Campylobacter jejuni].
Lactobacillus rhamnosus GG Culturelle® [Effect on Muc2 gene knockdown in Ht29 cells by CRISPR/Cas9 on probiotics-mediated inhibition of E.coli K1 adhesion and invasion].
Lactobacillus rhamnosus GG Culturelle® [Effectiveness and safety of probiotics in children on the basis of clinical trials].
Lactobacillus rhamnosus GG Culturelle® [Effectiveness of cultured milk foods, enriched by bifidus bacteria and Lactobacillus rhamnosis GG (ATCC 53103, LGG) in patients with slackening of motility function of intestines].
Lactobacillus rhamnosus GG Culturelle® [Influence of selected Lactobacillus sp. on Clostridium difficile strains with different toxigenicity profile].
Lactobacillus rhamnosus GG Culturelle® [Isolation and identification of cholesterol-degrading intestinal bacteria by culturomics and evaluation of their functions].
Lactobacillus rhamnosus GG Culturelle® [Lactobacillus rhamnosus GG conditioned medium prevents E. coli meningitis by inhibiting nuclear factor-?B pathway].
Lactobacillus rhamnosus GG Culturelle® [Lactobacillus rhamnosus GG improves symptoms and its mechnism in mice with ovalbumin-induced food allergy].
Lactobacillus rhamnosus GG Culturelle® [Lactobacillus rhamnosus GG inhibits Cronobacter-induced meningitis in neonatal rats].
Lactobacillus rhamnosus GG Culturelle® [Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment].
Lactobacillus rhamnosus GG Culturelle® [Methods of gut microbiota correction for treatment and prevention of food allergy: a review of current research].
Lactobacillus rhamnosus GG Culturelle® [Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products].
Lactobacillus rhamnosus GG Culturelle® [Probiotics for the treating acute diarrhea and preventing antibiotic-associated diarrhea in children].
Lactobacillus rhamnosus GG Culturelle® [Prophylactic effect of Lactobacillus GG in animal colitis and its effect on cytokine secretion and mucin gene expressions].
Lactobacillus rhamnosus GG Culturelle® [Protective effect and mechanism of <i>Lactobacillus rhamnosus</i> on immune checkpoint inhibitors related colitis in mice].
Lactobacillus rhamnosus GG Culturelle® [Susceptibility of Lactobacillus rhamnosus strains isolated from probiotic products to antimicrobial agents].
Lactobacillus rhamnosus GG Culturelle® [Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea].
Lactobacillus rhamnosus GG Culturelle® [The effectiveness of BIFIFORM KIDS in the prevention of the incidence of acute respiratory infections in children].
Lactobacillus rhamnosus GG Culturelle® [The Immunomodulatory and Anti-allergy Effects of Lactobacilli].
Lactobacillus rhamnosus GG Culturelle® [The postbiotic HM0539 from <i>Lactobacillus rhamnosus</i> GG prevents intestinal infection by enterohemorrhagic <i>E. coli</i> O157: H7 in mice].
Lactobacillus rhamnosus GG Culturelle® [The regulatory role of gut microbiota in inflammation in depression and anxiety].
Lactobacillus rhamnosus GG Culturelle® [Therapeutic possibilities of probiotics in antibiotic-related diarrhea].
Lactobacillus rhamnosus GG Culturelle® <i>In silico</i> Prediction, <i>in vitro</i> Antibacterial Spectrum, and Physicochemical Properties of a Putative Bacteriocin Produced by <i>Lactobacillus rhamnosus</i> Strain L156.4.
Lactobacillus rhamnosus GG Culturelle® <i>In situ</i> spectroscopic analysis of <i>Lactobacillus rhamnosus</i> GG flow on an abiotic surface reveals a role for nutrients in biofilm development.
Lactobacillus rhamnosus GG Culturelle® <i>In Vitro</i> Effects of Live and Heat-Inactivated <i>Bifidobacterium animalis</i> Subsp. <i>Lactis</i>, BB-12 and <i>Lactobacillus rhamnosus</i> GG on Caco-2 Cells.
Lactobacillus rhamnosus GG Culturelle® <i>In vitro</i> Probiotic Potential and Anti-cancer Activity of Newly Isolated Folate-Producing <i>Streptococcus thermophilus</i> Strains.
Lactobacillus rhamnosus GG Culturelle® <i>In vitro</i> Selection of Probiotics for Microbiota Modulation in Normal-Weight and Severely Obese Individuals: Focus on Gas Production and Interaction With Intestinal Epithelial Cells.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus animalis</i> pZL8a: a potential probiotic isolated from pig feces for further research.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus paracasei</i> K5 displays adhesion, anti-proliferative activity and apoptotic effects in human colon cancer cells.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus plantarum</i> ZS2058 and <i>Lactobacillus rhamnosus</i> GG Use Different Mechanisms to Prevent <i>Salmonella</i> Infection <i>in vivo</i>.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus reuteri</i> ZJ617 maintains intestinal integrity via regulating tight junction, autophagy and apoptosis in mice challenged with lipopolysaccharide.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus GG</i> (ATCC 53103) for the Management of Infantile Colic: A Randomized Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG Affects Microbiota and Suppresses Autophagy in the Intestines of Pigs Challenged with <i>Salmonella</i> Infantis.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus Rhamnosus</i> GG Affects the BDNF System in Brain Samples of Wistar Rats with Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG and <i>Saccharomyces cerevisiae boulardii</i> exert synergistic antipathogenic activity <i>in vitro</i> against enterotoxigenic <i>Escherichia coli</i>.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG and Biochemical Agents Enrich the Shelf Life of Fresh-Cut Bell Pepper (<i>Capsicum annuum</i> L. var. grossum (L.) Sendt).
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice <i>via</i> gut-microbiota-dependent anti-inflammation.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG attenuates the pathology of <i>Chlamydial muridarium</i> in the upper genital tract in mice.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG can protect malnourished children.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG conditioned media modulates acute reactive oxygen species and nitric oxide in J774 murine macrophages.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG in the Primary Prevention of Eczema in Children: A Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG Reduces <i>ß-conglycinin-</i>Allergy-Induced Apoptotic Cells by Regulating <i>Bacteroides</i> and Bile Secretion Pathway in Intestinal Contents of BALB/c Mice.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG reverses mortality of neonatal mice against <i>Salmonella</i> challenge.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG soluble mediators ameliorate early life stress-induced visceral hypersensitivity and changes in spinal cord gene expression.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG Usage in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children with Gastroesophageal Reflux Disease Treated with Proton Pump Inhibitors: A Randomized Double-Blinded Placebo-Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG: An Overview to Explore the Rationale of Its Use in Cancer.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG: An Updated Strategy to Use Microbial Products to Promote Health.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> GG-Derived Soluble Mediators Modulate Adaptive Immune Cells.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus rhamnosus</i> Probiotic Food as a Tool for Empowerment Across the Value Chain in Africa.
Lactobacillus rhamnosus GG Culturelle® <i>Lactobacillus</i> raises <i>in vitro</i> anticancer effect of geniposide in HSC-3 human oral squamous cell carcinoma cells.
Lactobacillus rhamnosus GG Culturelle® <i>Porphyromonas gingivalis</i> and <i>Lactobacillus rhamnosus</i> GG regulate the Th17/Treg balance in colitis via TLR4 and TLR2.
Lactobacillus rhamnosus GG Culturelle® <i>Pro</i>biotics: Prevention of <i>S</i>evere <i>P</i>neumonia and <i>E</i>ndotracheal <i>C</i>olonization <i>T</i>rial-PROSPECT: protocol for a feasibility randomized pilot trial.
Lactobacillus rhamnosus GG Culturelle® <i>Weissella cibaria</i> Attenuated LPS-Induced Dysfunction of Intestinal Epithelial Barrier in a Caco-2 Cell Monolayer Model.
Lactobacillus rhamnosus GG Culturelle® A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
Lactobacillus rhamnosus GG Culturelle® A combination of probiotics and whey proteins enhances anti-obesity effects of calcium and dairy products during nutritional energy restriction in aP2-agouti transgenic mice.
Lactobacillus rhamnosus GG Culturelle® A combined approach to study the protein glycosylation potential of Lactobacillus rhamnosus GG (LGG).
Lactobacillus rhamnosus GG Culturelle® A comparative pan-genome perspective of niche-adaptable cell-surface protein phenotypes in Lactobacillus rhamnosus.
Lactobacillus rhamnosus GG Culturelle® A comparative study of procedures for binding of aflatoxin M1 to Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player.
Lactobacillus rhamnosus GG Culturelle® A Fast, Efficient and Easy to Implement Method to Purify Bacterial Pili From Lacticaseibacillus rhamnosus GG Based on Multimodal Chromatography.
Lactobacillus rhamnosus GG Culturelle® A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.
Lactobacillus rhamnosus GG Culturelle® A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in Apc&lt;sup&gt;Min/+&lt;/sup&gt; mice.
Lactobacillus rhamnosus GG Culturelle® A microfluidics-based in vitro model of the gastrointestinal human-microbe interface.
Lactobacillus rhamnosus GG Culturelle® A network-based approach to identify substrate classes of bacterial glycosyltransferases.
Lactobacillus rhamnosus GG Culturelle® A new score to predict allergic march in patients with IgE-mediated cow milk allergy.
Lactobacillus rhamnosus GG Culturelle® A new use of <i>Lactobacillus rhamnosus</i> GG administration in the NICU: colonized vancomycin-resistant enterococcus eradication in the gastrointestinal system.
Lactobacillus rhamnosus GG Culturelle® A novel consortium of Lactobacillus rhamnosus and Streptococcus thermophilus for increased access to functional fermented foods.
Lactobacillus rhamnosus GG Culturelle® A Novel Postbiotic From <i>Lactobacillus rhamnosus</i> GG With a Beneficial Effect on Intestinal Barrier Function.
Lactobacillus rhamnosus GG Culturelle® A Pilot Randomized Control Trial With the Probiotic Strain <i>Lactobacillus rhamnosus</i> GG (LGG) in ADHD: Children and Adolescents Report Better Health-Related Quality of Life.
Lactobacillus rhamnosus GG Culturelle® A Platform for Co-Culture of Primary Human Colonic Epithelium With Anaerobic Probiotic Bacteria.
Lactobacillus rhamnosus GG Culturelle® A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial.
Lactobacillus rhamnosus GG Culturelle® A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands.
Lactobacillus rhamnosus GG Culturelle® A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Lactobacillus rhamnosus GG Culturelle® A probiotic mixture including galactooligosaccharides decreases fecal ß-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention.
Lactobacillus rhamnosus GG Culturelle® A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats.
Lactobacillus rhamnosus GG Culturelle® A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption.
Lactobacillus rhamnosus GG Culturelle® A randomised controlled demonstration trial of multifaceted nutritional intervention and or probiotics: the healthy mums and babies (HUMBA) trial.
Lactobacillus rhamnosus GG Culturelle® A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults.
Lactobacillus rhamnosus GG Culturelle® A randomized controlled trial of <i>Lactobacillus rhamnosus</i> GG on antimicrobial-resistant organism colonization.
Lactobacillus rhamnosus GG Culturelle® A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain.
Lactobacillus rhamnosus GG Culturelle® A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea.
Lactobacillus rhamnosus GG Culturelle® A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children.
Lactobacillus rhamnosus GG Culturelle® A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn`s disease.
Lactobacillus rhamnosus GG Culturelle® A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1.
Lactobacillus rhamnosus GG Culturelle® A review of dose-responses of probiotics in human studies.
Lactobacillus rhamnosus GG Culturelle® A role for gut microbiota in early-life stress-induced widespread muscle pain in the adult rat.
Lactobacillus rhamnosus GG Culturelle® A single intravesical instillation of <i>Lactobacillus rhamnosus</i> GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial.
Lactobacillus rhamnosus GG Culturelle® A survey of probiotic use practices among patients at a tertiary medical centre.
Lactobacillus rhamnosus GG Culturelle® A tangible prospect for the treatment of gingivitis using a potentially probiotic strain Lactobacillus plantarum MK06 isolated from traditional dairy products: a triple blind randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® A Validated Real-Time PCR Method for the Specific Identification of Probiotic Strain Lactobacillus rhamnosus GG (ATCC 53103).
Lactobacillus rhamnosus GG Culturelle® Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1.
Lactobacillus rhamnosus GG Culturelle® Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum.
Lactobacillus rhamnosus GG Culturelle® Ability of prebiotic polysaccharides to activate a HIF1a-antimicrobial peptide axis determines liver injury risk in zebrafish.
Lactobacillus rhamnosus GG Culturelle® Absence of adverse events in healthy individuals using probiotics--analysis of six randomised studies by one study group.
Lactobacillus rhamnosus GG Culturelle® Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler`s diarrhea: a randomized, double-blind, controlled study.
Lactobacillus rhamnosus GG Culturelle® ACE-Inhibitory Activity of Whey Proteins Fractions Derived of Fermentation by Lacticaseibacillus rhamnosus GG and Streptococcus thermophilus SY-102.
Lactobacillus rhamnosus GG Culturelle® Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein.
Lactobacillus rhamnosus GG Culturelle® Adaptation factors of the probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.
Lactobacillus rhamnosus GG Culturelle® Adhesion and anti-inflammatory potential of Lactobacillus rhamnosus GG in a sea buckthorn based beverage matrix.
Lactobacillus rhamnosus GG Culturelle® Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Adhesion of bacteria to resected human colonic tissue: quantitative analysis of bacterial adhesion and viability.
Lactobacillus rhamnosus GG Culturelle® Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures.
Lactobacillus rhamnosus GG Culturelle® Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments.
Lactobacillus rhamnosus GG Culturelle® Adhesion of vancomycin-resistant enterococcus to human intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Adhesion Potential of Intestinal Microbes Predicted by Physico-Chemical Characterization Methods.
Lactobacillus rhamnosus GG Culturelle® Adhesion properties of Lactobacillus rhamnosus mucus-binding factor to mucin and extracellular matrix proteins.
Lactobacillus rhamnosus GG Culturelle® Adhesion, anti-adhesion and aggregation properties relating to surface charges of selected Lactobacillus strains: study in Caco-2 and H357 cells.
Lactobacillus rhamnosus GG Culturelle® Adhesive ability means inhibition activities for lactobacillus against pathogens and S-layer protein plays an important role in adhesion.
Lactobacillus rhamnosus GG Culturelle® Adhesive and chemokine stimulatory properties of potentially probiotic Lactobacillus strains.
Lactobacillus rhamnosus GG Culturelle® Adhesive Interactions Between Lactic Acid Bacteria and ß-Lactoglobulin: Specificity and Impact on Bacterial Location in Whey Protein Isolate.
Lactobacillus rhamnosus GG Culturelle® Adhesive interactions between milk fat globule membrane and Lactobacillus rhamnosus GG inhibit bacterial attachment to Caco-2 TC7 intestinal cell.
Lactobacillus rhamnosus GG Culturelle® Adhesive properties, extracellular protein production, and metabolism in the Lactobacillus rhamnosus GG strain when grown in the presence of mucin.
Lactobacillus rhamnosus GG Culturelle® Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Administration of Extensive Hydrolysates From Caseins and <i>Lactobacillus rhamnosus</i> GG Probiotic Does Not Prevent Cow`s Milk Proteins Allergy in a Mouse Model.
Lactobacillus rhamnosus GG Culturelle® Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl<sub>4</sub>-induced liver cirrhosis by protecting the intestinal barrier in rats.
Lactobacillus rhamnosus GG Culturelle® Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization.
Lactobacillus rhamnosus GG Culturelle® Administration of probiotics Lactobacillus rhamnosus GG and Lactobacillus gasseri K7 during pregnancy and lactation changes mouse mesenteric lymph nodes and mammary gland microbiota.
Lactobacillus rhamnosus GG Culturelle® Advanced "Green" Prebiotic Composite of Bacterial Cellulose/Pullulan Based on Synthetic Biology-Powered Microbial Coculture Strategy.
Lactobacillus rhamnosus GG Culturelle® AI-2 signalling is induced by acidic shock in probiotic strains of Lactobacillus spp.
Lactobacillus rhamnosus GG Culturelle® AI-2/LuxS Quorum Sensing System Promotes Biofilm Formation of Lactobacillus rhamnosus GG and Enhances the Resistance to Enterotoxigenic Escherichia coli in Germ-Free Zebrafish.
Lactobacillus rhamnosus GG Culturelle® Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats.
Lactobacillus rhamnosus GG Culturelle® Alginate-based double-network hydrogel improves the viability of encapsulated probiotics during simulated sequential gastrointestinal digestion: Effect of biopolymer type and concentrations.
Lactobacillus rhamnosus GG Culturelle® Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Allergy in marathon runners and effect of Lactobacillus GG supplementation on allergic inflammatory markers.
Lactobacillus rhamnosus GG Culturelle® Altering and assessing persistence of genetically modified E. coli MG1655 in the large bowel.
Lactobacillus rhamnosus GG Culturelle® Amelioration of ovalbumin induced allergic symptoms in Balb/c mice by potentially probiotic strains of lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Ameliorative effect of Lactobacillus rhamnosus GG on acetaminophen-induced hepatotoxicity via PKC/Nrf2/PGC-1a pathway.
Lactobacillus rhamnosus GG Culturelle® Ameliorative effects of high intensity interval training and Lactobacillus rhamnosus GG Protect against tetracycline-induced fatty liver in rats: a gene expression profiling comparative study.
Lactobacillus rhamnosus GG Culturelle® An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children.
Lactobacillus rhamnosus GG Culturelle® An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.
Lactobacillus rhamnosus GG Culturelle® An in vitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations.
Lactobacillus rhamnosus GG Culturelle® An L-Fucose Operon in the Probiotic Lactobacillus rhamnosus GG Is Involved in Adaptation to Gastrointestinal Conditions.
Lactobacillus rhamnosus GG Culturelle® An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® An ultrasensitive bacterial imprinted electrochemical sensor for the determination of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Analysis of Lactobacillus rhamnosus GG in Mulberry Galacto-Oligosaccharide Medium by Comparative Transcriptomics and Metabolomics.
Lactobacillus rhamnosus GG Culturelle® Analysis of promoter sequences from Lactobacillus and Lactococcus and their activity in several Lactobacillus species.
Lactobacillus rhamnosus GG Culturelle® Analysis of the peptidoglycan hydrolase complement of Lactobacillus casei and characterization of the major ?-D-glutamyl-L-lysyl-endopeptidase.
Lactobacillus rhamnosus GG Culturelle® Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Lactobacillus rhamnosus GG Culturelle® Antagonistic and antioxidant effect of probiotic <i>Weissella cibaria</i> JW15.
Lactobacillus rhamnosus GG Culturelle® Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells.
Lactobacillus rhamnosus GG Culturelle® Anti-allergic effects of Lactobacillus crispatus KT-11 strain on ovalbumin-sensitized BALB/c mice.
Lactobacillus rhamnosus GG Culturelle® Antiallergic effects of probiotics.
Lactobacillus rhamnosus GG Culturelle® Antibacterial activity of supernatants of Lactoccocus lactis, Lactobacillus rhamnosus, Pediococcus pentosaceus and curcumin against Aeromonas hydrophila. In vitro study.
Lactobacillus rhamnosus GG Culturelle® Antibacterial and Antibiofilm Activity of Lactic Acid Bacteria Isolated from Traditional Artisanal Milk Cheese from Northeast China Against Enteropathogenic Bacteria.
Lactobacillus rhamnosus GG Culturelle® Antibacterial peptides derived from caprine whey proteins, by digestion with human gastrointestinal juice.
Lactobacillus rhamnosus GG Culturelle® Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis.
Lactobacillus rhamnosus GG Culturelle® Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Lactobacillus rhamnosus GG Culturelle® Antibiotics can cause weight loss by impairing gut microbiota in mice and the potent benefits of lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity.
Lactobacillus rhamnosus GG Culturelle® Anti-cancer Properties of Potential Probiotics and Their Cell-free Supernatants for the Prevention of Colorectal Cancer: an In Vitro Study.
Lactobacillus rhamnosus GG Culturelle® Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats.
Lactobacillus rhamnosus GG Culturelle® Anti-caries Streptococcus spp.: A potential preventive tool for special needs patients.
Lactobacillus rhamnosus GG Culturelle® Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice.
Lactobacillus rhamnosus GG Culturelle® Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion.
Lactobacillus rhamnosus GG Culturelle® Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.
Lactobacillus rhamnosus GG Culturelle® Anti-Infective Effect of Adhesive Probiotic Lactobacillus in Fish is Correlated With Their Spatial Distribution in the Intestinal Tissue.
Lactobacillus rhamnosus GG Culturelle® Anti-Inflammatory and Gut Microbiota Modulatory Effect of <i>Lactobacillus rhamnosus</i> Strain LDTM 7511 in a Dextran Sulfate Sodium-Induced Colitis Murine Model.
Lactobacillus rhamnosus GG Culturelle® Anti-inflammatory capacity of Lactobacillus rhamnosus GG in monophasic variant Salmonella infected piglets is correlated with impeding NLRP6-mediated host inflammatory responses.
Lactobacillus rhamnosus GG Culturelle® Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans.
Lactobacillus rhamnosus GG Culturelle® Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food.
Lactobacillus rhamnosus GG Culturelle® Antimicrobial activity of human ß-defensins against lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Antimicrobial activity of lysostaphin and a Listeria monocytogenes bacteriophage endolysin produced and secreted by lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Antimicrobial and antiadhesive effects of Lactobacillus isolates of healthy human gut origin on Enterotoxigenic Escherichia coli (ETEC) and Enteroaggregative Escherichia coli (EAEC).
Lactobacillus rhamnosus GG Culturelle® Antioxidant and Angiotensin-Converting Enzyme (ACE) Inhibitory Activities of Yogurt Supplemented with Lactiplantibacillus plantarum NK181 and Lactobacillus delbrueckii KU200171 and Sensory Evaluation.
Lactobacillus rhamnosus GG Culturelle® Antioxidant and immune-enhancing effects of probiotic <i>Lactobacillus plantarum</i> 200655 isolated from kimchi.
Lactobacillus rhamnosus GG Culturelle® Antioxidant and immunostimulatory effect of potential probiotic Lactobacillus paraplantarum SC61 isolated from Korean traditional fermented food, jangajji.
Lactobacillus rhamnosus GG Culturelle® Antioxidative and Probiotic Activities of Lactic Acid Bacteria Isolated from Traditional Artisanal Milk Cheese from Northeast China.
Lactobacillus rhamnosus GG Culturelle® Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.
Lactobacillus rhamnosus GG Culturelle® Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® ANTIPSEUDOMONAL ACTIVITY OF METABOLIC COMPLEXES OF L. RHAMNOSUS GG AND S. BOULARDII AGAINST THE POLYRESISTENT PATHOGEN IN IN VITRO AND IN VIVO TESTS.
Lactobacillus rhamnosus GG Culturelle® Anti-rotavirus Properties and Mechanisms of Selected Gram-Positive and Gram-Negative Probiotics on Polarized Human Colonic (HT-29) Cells.
Lactobacillus rhamnosus GG Culturelle® Apigenin Impacts the Growth of the Gut Microbiota and Alters the Gene Expression of Enterococcus.
Lactobacillus rhamnosus GG Culturelle® Application of Two-Dimensional Fluorescence Spectroscopy for the On-Line Monitoring of Teff-Based Substrate Fermentation Inoculated with Certain Probiotic Bacteria.
Lactobacillus rhamnosus GG Culturelle® Application of whey protein micro-bead coatings for enhanced strength and probiotic protection during fruit juice storage and gastric incubation.
Lactobacillus rhamnosus GG Culturelle® Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Arabinoxylans, inulin and <i>Lactobacillus reuteri</i> 1063 repress the adherent-invasive <i>Escherichia coli</i> from mucus in a mucosa-comprising gut model.
Lactobacillus rhamnosus GG Culturelle® Are probiotics and prebiotics effective in the prevention of travellers` diarrhea: A systematic review and meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Assessing the efficacy of probiotics in augmenting bovine reproductive health: an integrated in vitro, in silico, and in vivo study.
Lactobacillus rhamnosus GG Culturelle® Assessing the Safety and Probiotic Characteristics of Lacticaseibacillus rhamnosus X253 via Complete Genome and Phenotype Analysis.
Lactobacillus rhamnosus GG Culturelle® Assessing the viability of three Lactobacillus bacterial species protected in the cryoprotectants containing whey and maltodextrin during freeze-drying process.
Lactobacillus rhamnosus GG Culturelle® Assessment of adhesion properties of novel probiotic strains to human intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Assessment of cell surface properties and adhesion potential of selected probiotic strains.
Lactobacillus rhamnosus GG Culturelle® Assessment of probiotic adhesion and inhibitory effect on Escherichia coli and Salmonella adhesion.
Lactobacillus rhamnosus GG Culturelle® Assessment of stress tolerance acquisition in the heat-tolerant derivative strains of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Assessment of the effect of stress-tolerance acquisition on some basic characteristics of specific probiotics.
Lactobacillus rhamnosus GG Culturelle® Association between Age, Weight, and Dose and Clinical Response to Probiotics in Children with Acute Gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Association Between Diarrhea Duration and Severity and Probiotic Efficacy in Children With Acute Gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Association of levels of antibodies from patients with inflammatory bowel disease with extracellular proteins of food and probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data.
Lactobacillus rhamnosus GG Culturelle® Bacillus licheniformis Isolated from Traditional Korean Food Resources Enhances the Longevity of Caenorhabditis elegans through Serotonin Signaling.
Lactobacillus rhamnosus GG Culturelle® Bacillus subtilis RBT-7/32 and Bacillus licheniformis RBT-11/17 as New Promising Strains for Use in Probiotic Feed Additives.
Lactobacillus rhamnosus GG Culturelle® Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case report.
Lactobacillus rhamnosus GG Culturelle® Bacterial community dynamics in lait caillé, a traditional product of spontaneous fermentation from Senegal.
Lactobacillus rhamnosus GG Culturelle® Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?
Lactobacillus rhamnosus GG Culturelle® Bacteriocin-producing strains of Lactobacillus plantarum inhibit adhesion of Staphylococcus aureus to extracellular matrix: quantitative insight and implications in antibacterial therapy.
Lactobacillus rhamnosus GG Culturelle® Baru (Dipteryx alata Vog.) agro-industrial by-products promote the growth and metabolism of probiotic strains.
Lactobacillus rhamnosus GG Culturelle® Beneficial effect of probiotics on <i>Pseudomonas aeruginosa</i>-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.
Lactobacillus rhamnosus GG Culturelle® Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats.
Lactobacillus rhamnosus GG Culturelle® Bent conformation of a backbone pilin N-terminal domain supports a three-stage pilus assembly mechanism.
Lactobacillus rhamnosus GG Culturelle® Bifidobacterium and the intestinal mucus layer.
Lactobacillus rhamnosus GG Culturelle® Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.
Lactobacillus rhamnosus GG Culturelle® Bifidobacterium longum 070103 Fermented Milk Improve Glucose and Lipid Metabolism Disorders by Regulating Gut Microbiota in Mice.
Lactobacillus rhamnosus GG Culturelle® Bile salt and acid tolerance of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano cheese.
Lactobacillus rhamnosus GG Culturelle® Bile stimulates cell surface hydrophobicity, Congo red binding and biofilm formation of Lactobacillus strains.
Lactobacillus rhamnosus GG Culturelle® Binding of aflatoxin B1 alters the adhesion properties of Lactobacillus rhamnosus strain GG in a Caco-2 model.
Lactobacillus rhamnosus GG Culturelle® Binding of aflatoxin B1 to cell wall components of Lactobacillus rhamnosus strain GG.
Lactobacillus rhamnosus GG Culturelle® Binding of extracellular matrix molecules by probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Binding rather than metabolism may explain the interaction of two food-Grade Lactobacillus strains with zearalenone and its derivative (`)alpha-earalenol.
Lactobacillus rhamnosus GG Culturelle® Bioavailability assessment of zinc enriched lactobacillus biomass in a human colon carcinoma cell line (Caco-2).
Lactobacillus rhamnosus GG Culturelle® Biochemical characterization of the major N-acetylmuramidase from Lactobacillus buchneri.
Lactobacillus rhamnosus GG Culturelle® Biodiversity of meatborne <i>Listeria</i> spp. in Himachal Pradesh and their interaction with indigenous probiotics.
Lactobacillus rhamnosus GG Culturelle® Biopolymer-Based Minimal Formulations Boost Viability and Metabolic Functionality of Probiotics Lactobacillus rhamnosus GG through Gastrointestinal Passage.
Lactobacillus rhamnosus GG Culturelle® Biovalorization of Market Surplus Bread for Development of Probiotic-Fermented Potential Functional Beverages.
Lactobacillus rhamnosus GG Culturelle® Bladder instillation for urinary tract infection prevention in neurogenic bladder patients practicing clean intermittent catheterization: A systematic review.
Lactobacillus rhamnosus GG Culturelle® Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
Lactobacillus rhamnosus GG Culturelle® Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® Boza, a natural source of probiotic lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature.
Lactobacillus rhamnosus GG Culturelle® Breastfeeding-associated microbiota in human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and Bifidobacterium animalis ssp. lactis Bb-12.
Lactobacillus rhamnosus GG Culturelle® Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.
Lactobacillus rhamnosus GG Culturelle® Bugs for atopy: the Lactobacillus rhamnosus GG strategy for food allergy prevention and treatment in children.
Lactobacillus rhamnosus GG Culturelle® Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2.
Lactobacillus rhamnosus GG Culturelle® Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products?
Lactobacillus rhamnosus GG Culturelle® Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study.
Lactobacillus rhamnosus GG Culturelle® Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the epithelial cell line HT29-MTX.
Lactobacillus rhamnosus GG Culturelle® Carbohydrate-binding specificities of potential probiotic Lactobacillus strains in porcine jejunal (IPEC-J2) cells and porcine mucin.
Lactobacillus rhamnosus GG Culturelle® Cariogenic effects of probiotic Lactobacillus rhamnosus GG in a dental biofilm model.
Lactobacillus rhamnosus GG Culturelle® Catabolism of hydroxycinnamic acids in contact with probiotic Lactobacillus.
Lactobacillus rhamnosus GG Culturelle® Catabolism of L-ascorbate by Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro.
Lactobacillus rhamnosus GG Culturelle® Characteration of a novel arylesterase from probiotics Lacticaseibacillus rhamnosus GG with the preference for medium- and long-chain p-Nitrophenyl esters.
Lactobacillus rhamnosus GG Culturelle® Characterisation of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics.
Lactobacillus rhamnosus GG Culturelle® Characterization of a Panela cheese with added probiotics and fava bean starch.
Lactobacillus rhamnosus GG Culturelle® Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases.
Lactobacillus rhamnosus GG Culturelle® Characterization of Biosynthesized Silver Nanoparticles Using Lactobacillus rhamnosus GG and its In Vitro Assessment Against Colorectal Cancer Cells.
Lactobacillus rhamnosus GG Culturelle® Characterization of cottage cheese using Weissella cibaria D30: Physicochemical, antioxidant, and antilisterial properties.
Lactobacillus rhamnosus GG Culturelle® Characterization of Highly Mucus-Adherent Non-GMO Derivatives of Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Characterization of MabA, a modulator of Lactobacillus rhamnosus GG adhesion and biofilm formation.
Lactobacillus rhamnosus GG Culturelle® Characterization of mutual relations between Geotrichum candidum and Lactobacillus rhamnosus GG in milk: a quantitative approach.
Lactobacillus rhamnosus GG Culturelle® Characterization of potentially probiotic lactic acid bacteria and bifidobacteria isolated from human colostrum.
Lactobacillus rhamnosus GG Culturelle® Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray.
Lactobacillus rhamnosus GG Culturelle® Characterization of Short Chain Fatty Acids Produced by Selected Potential Probiotic Lactobacillus Strains.
Lactobacillus rhamnosus GG Culturelle® Characterization of the integration site of Yersinia high-pathogenicity island in Escherichia coli.
Lactobacillus rhamnosus GG Culturelle® Characterization of the SpaCBA pilus fibers in the probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Chemical Functionalization of the Zinc Selenide Surface and Its Impact on <i>Lactobacillus rhamnosus</i> GG Biofilms.
Lactobacillus rhamnosus GG Culturelle® Chemical moieties and interactions involved in the binding of zearalenone to the surface of Lactobacillus rhamnosus strains GG.
Lactobacillus rhamnosus GG Culturelle® Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins.
Lactobacillus rhamnosus GG Culturelle® Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats.
Lactobacillus rhamnosus GG Culturelle® Chemoprevention of DMH-Induced Early Colon Carcinogenesis in Male BALB/c Mice by Administration of <i>Lactobacillus Paracasei</i> DTA81.
Lactobacillus rhamnosus GG Culturelle® Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse.
Lactobacillus rhamnosus GG Culturelle® Chlamydia pneumoniae enhances the Th2 profile of stimulated peripheral blood mononuclear cells from asthmatic patients.
Lactobacillus rhamnosus GG Culturelle® Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation.
Lactobacillus rhamnosus GG Culturelle® Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.
Lactobacillus rhamnosus GG Culturelle® Clinical indications for probiotics: an overview.
Lactobacillus rhamnosus GG Culturelle® Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Lactobacillus rhamnosus GG Culturelle® Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Lactobacillus rhamnosus GG Culturelle® Cloning, expression, purification, and activity assay of proteins related to D-lactic acid formation in Lactobacillus rhamnosus.
Lactobacillus rhamnosus GG Culturelle® Clostridioides difficile infection in a skilled nursing facility (SNF): cost savings of an automated, standardized probiotic antimicrobial stewardship programme (ASP) policy.
Lactobacillus rhamnosus GG Culturelle® Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice.
Lactobacillus rhamnosus GG Culturelle® Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study.
Lactobacillus rhamnosus GG Culturelle® Coating Lacticaseibacillus rhamnosus GG in Alginate Systems: an Emerging Strategy Towards Improved Viability in Orange Juice.
Lactobacillus rhamnosus GG Culturelle® Collaborative cytometric inter-laboratory ring test for probiotics quantification.
Lactobacillus rhamnosus GG Culturelle® Colonization and immunoregulation of Lactobacillus plantarum BF_15, a novel probiotic strain from the feces of breast-fed infants.
Lactobacillus rhamnosus GG Culturelle® Colonization of Lactobacillus rhamnosus GG in the oral cavity.
Lactobacillus rhamnosus GG Culturelle® Colonization of preterm gnotobiotic piglets with probiotic Lactobacillus rhamnosus GG and its interference with Salmonella Typhimurium.
Lactobacillus rhamnosus GG Culturelle® Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.
Lactobacillus rhamnosus GG Culturelle® Combination of the Probiotics <i>Lacticaseibacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Combined effect of arginine and fluoride on the growth of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Combined effects of probiotic fermentation and high-pressure extraction on the antioxidant, antimicrobial, and antimutagenic activities of deodeok (Codonopsis lanceolata).
Lactobacillus rhamnosus GG Culturelle® Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution.
Lactobacillus rhamnosus GG Culturelle® Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses.
Lactobacillus rhamnosus GG Culturelle® Commercial probiotic formulas Bactocell and Levucell promote spring brood production in Apis mellifera L. (Hymenoptera: Apidae) colonies.
Lactobacillus rhamnosus GG Culturelle® Comparative Analysis of Antigiardial Potential of Heat Inactivated and Probiotic Protein of Probiotic Lactobacillus rhamnosus GG in Murine Giardiasis.
Lactobacillus rhamnosus GG Culturelle® Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: A systematic review and network meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: a systematic review and network meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Comparative effects of six probiotic strains on immune function in vitro.
Lactobacillus rhamnosus GG Culturelle® Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Comparative genome analysis of Lactobacillus rhamnosus clinical isolates from initial stages of dental pulp infection: identification of a new exopolysaccharide cluster.
Lactobacillus rhamnosus GG Culturelle® Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein.
Lactobacillus rhamnosus GG Culturelle® Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG.
Lactobacillus rhamnosus GG Culturelle® Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics.
Lactobacillus rhamnosus GG Culturelle® Comparative Genomic and Phenotypic Analysis of the Vaginal Probiotic <i>Lactobacillus rhamnosus</i> GR-1.
Lactobacillus rhamnosus GG Culturelle® Comparative genomics and functional analysis of a highly adhesive dairy Lactobacillus paracasei subsp. paracasei IBB3423 strain.
Lactobacillus rhamnosus GG Culturelle® Comparative proteome cataloging of Lactobacillus rhamnosus strains GG and Lc705.
Lactobacillus rhamnosus GG Culturelle® Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances.
Lactobacillus rhamnosus GG Culturelle® Comparison and selection of probiotic Lactobacillus from human intestinal tract and traditional fermented food in vitro via PCA, unsupervised clustering algorithm, and heat-map analysis.
Lactobacillus rhamnosus GG Culturelle® Comparison between Lactobacillus rhamnosus GG and LuxS-deficient strain in regulating gut barrier function and inflammation in early-weaned piglets.
Lactobacillus rhamnosus GG Culturelle® Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium.
Lactobacillus rhamnosus GG Culturelle® Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.
Lactobacillus rhamnosus GG Culturelle® Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
Lactobacillus rhamnosus GG Culturelle® Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate.
Lactobacillus rhamnosus GG Culturelle® Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis.
Lactobacillus rhamnosus GG Culturelle® Compositional and physicochemical factors governing the viability of <i>Lactobacillus rhamnosus</i> GG embedded in starch-protein based edible films.
Lactobacillus rhamnosus GG Culturelle® Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects.
Lactobacillus rhamnosus GG Culturelle® Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients.
Lactobacillus rhamnosus GG Culturelle® Context-dependent differences in the functional responses of Lactobacillaceae strains to fermentable sugars.
Lactobacillus rhamnosus GG Culturelle® Core-shell alginate@silica microparticles encapsulating probiotics.
Lactobacillus rhamnosus GG Culturelle® Correction to: Coating Lacticaseibacillus rhamnosus GG in Alginate Systems: an Emerging Strategy Towards Improved Viability in Orange Juice.
Lactobacillus rhamnosus GG Culturelle® Correction to: Viability of Free and Encapsulated Lactobacillus rhamnosus GG and Their Effect On Physical, Chemical and Sensory Properties of Kunnu During Ambient Storage.
Lactobacillus rhamnosus GG Culturelle® Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.
Lactobacillus rhamnosus GG Culturelle® Correlation of Lactobacillus rhamnosus Genotypes and Carbohydrate Utilization Signatures Determined by Phenotype Profiling.
Lactobacillus rhamnosus GG Culturelle® Corrigendum to `Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice` Mol Metabol 29 (November 2019) 145-157.
Lactobacillus rhamnosus GG Culturelle® Cost-effectiveness of using an extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG in managing infants with cow`s milk allergy in the US.
Lactobacillus rhamnosus GG Culturelle® Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow`s milk allergy in the US.
Lactobacillus rhamnosus GG Culturelle® Cost-effectiveness of using an extensively hydrolyzed casein formula supplemented with <i>Lactobacillus rhamnosus</i> GG in managing IgE-mediated cow`s milk protein allergy in the UK.
Lactobacillus rhamnosus GG Culturelle® Cow`s milk allergy is associated with changes in urinary organic acid concentrations.
Lactobacillus rhamnosus GG Culturelle® Crude Turmeric Extract Improves the Suppressive Effects of <i>Lactobacillus rhamnosus</i> GG on Allergic Inflammation in a Murine Model of House Dust Mite-Induced Asthma.
Lactobacillus rhamnosus GG Culturelle® Crystal structure of basal pilin SpaE reveals the molecular basis of its incorporation in the lactobacillar SpaFED pilus.
Lactobacillus rhamnosus GG Culturelle® Crystal structure of lactobacillar SpaC reveals an atypical five-domain pilus tip adhesin: Exposing its substrate-binding and assembly in SpaCBA pili.
Lactobacillus rhamnosus GG Culturelle® Crystal structure of the atypically adhesive SpaB basal pilus subunit: Mechanistic insights about its incorporation in lactobacillar SpaCBA pili.
Lactobacillus rhamnosus GG Culturelle® Crystallization and X-ray Crystallographic Analysis of the Adhesive SpaC Pilin Subunit in the SpaCBA Pilus of Gut-adapted Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Crystallization and X-ray diffraction analysis of SpaE, a basal pilus protein from the gut-adapted Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats.
Lactobacillus rhamnosus GG Culturelle® Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure.
Lactobacillus rhamnosus GG Culturelle® Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1.
Lactobacillus rhamnosus GG Culturelle® Daily Intake of a Functional Synbiotic Yogurt Increases Calcium Absorption in Young Adult Women.
Lactobacillus rhamnosus GG Culturelle® Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections.
Lactobacillus rhamnosus GG Culturelle® Deciphering the nanometer-scale organization and assembly of Lactobacillus rhamnosus GG pili using atomic force microscopy.
Lactobacillus rhamnosus GG Culturelle® Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature.
Lactobacillus rhamnosus GG Culturelle® Decrease of Postchemotherapy Complications With the Use of Probiotics in Children With Acute Lymphoblastic Leukemia.
Lactobacillus rhamnosus GG Culturelle® Decreased training volume and increased carbohydrate intake increases oxidized LDL levels.
Lactobacillus rhamnosus GG Culturelle® Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation.
Lactobacillus rhamnosus GG Culturelle® Deoxynivalenol exposure induces liver damage in mice: Inflammation and immune responses, oxidative stress, and protective effects of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy.
Lactobacillus rhamnosus GG Culturelle® Detecting host responses to microbial stimulation using primary epithelial organoids.
Lactobacillus rhamnosus GG Culturelle® Detection, localization, and conformational analysis of single polysaccharide molecules on live bacteria.
Lactobacillus rhamnosus GG Culturelle® Determining antioxidant activities of lactobacilli cell-free supernatants by cellular antioxidant assay: a comparison with traditional methods.
Lactobacillus rhamnosus GG Culturelle® Detoxification of aflatoxin M1 in different milk types using probiotics.
Lactobacillus rhamnosus GG Culturelle® Development and evaluation of probiotic delivery systems using the rennet-induced gelation of milk proteins.
Lactobacillus rhamnosus GG Culturelle® Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections.
Lactobacillus rhamnosus GG Culturelle® Development of a mixed jussara and mango juice with added <i>Lactobacillus rhamnosus</i> GG submitted to sub-lethal acid and baric stresses.
Lactobacillus rhamnosus GG Culturelle® Development of carboxymethyl cellulose-chitosan hybrid micro- and macroparticles for encapsulation of probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Development of cost-effective media to increase the economic potential for larger-scale bioproduction of natural food additives by Lactobacillus rhamnosus , Debaryomyces hansenii , and Aspergillus niger.
Lactobacillus rhamnosus GG Culturelle® Development of enteric polymer-based microspheres by spray-drying for colonic delivery of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Development of Freeze-Thaw Tolerant <i>Lactobacillus rhamnosus</i> GG by Adaptive Laboratory Evolution.
Lactobacillus rhamnosus GG Culturelle® Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?
Lactobacillus rhamnosus GG Culturelle® Development of pelleted feed containing probiotic Lactobacillus rhamnosus GG and Jerusalem artichoke for Nile Tilapia and its biocompatibility studies.
Lactobacillus rhamnosus GG Culturelle® Development of uncoated near-spherical gold nanoparticles for the label-free quantification of Lactobacillus rhamnosus GG by surface-enhanced Raman spectroscopy.
Lactobacillus rhamnosus GG Culturelle® Development, characterisation and sensory qualities of probiotic beverage from provitamin A cassava (Manihot esculenta crantz) starch hydrolysate with free and encapsulated Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Dietary addition of Lactobacillus rhamnosus GG impairs the health of Escherichia coli F4-challenged piglets.
Lactobacillus rhamnosus GG Culturelle® Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus.
Lactobacillus rhamnosus GG Culturelle® Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity.
Lactobacillus rhamnosus GG Culturelle® Dietary sugar utilisation by putative oral probiotics.
Lactobacillus rhamnosus GG Culturelle® Dietary supplementation with lactic acid bacteria attenuates the development of atopic-dermatitis-like skin lesions in NC/Nga mice in a strain-dependent manner.
Lactobacillus rhamnosus GG Culturelle® Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients.
Lactobacillus rhamnosus GG Culturelle® Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow`s Milk Allergy.
Lactobacillus rhamnosus GG Culturelle® Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow`s milk allergy.
Lactobacillus rhamnosus GG Culturelle® Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization.
Lactobacillus rhamnosus GG Culturelle® Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.
Lactobacillus rhamnosus GG Culturelle® Direct lactic acid production from household food waste by lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa.
Lactobacillus rhamnosus GG Culturelle® Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Distribution of Genes Related to Probiotic Effects Across Lacticaseibacillus rhamnosus Revealed by Population Structure.
Lactobacillus rhamnosus GG Culturelle® Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.
Lactobacillus rhamnosus GG Culturelle® Do probiotics prevent colonization with multi-resistant Enterobacteriaceae during travel? A randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Does Maternal Perinatal Probiotic Supplementation Alter the Intestinal Microbiota of Mother and Child?
Lactobacillus rhamnosus GG Culturelle® Dopamine Level Affects Social Interaction and Color Preference Possibly Through Intestinal Microbiota in Zebrafish.
Lactobacillus rhamnosus GG Culturelle® Doses Lactobacillus reuteri depend on adhesive ability to modulate the intestinal immune response and metabolism in mice challenged with lipopolysaccharide.
Lactobacillus rhamnosus GG Culturelle® Double Bacteria Synergistic Catalytic Reduction System for Heavy Metal Detoxification Treatment.
Lactobacillus rhamnosus GG Culturelle® Down-regulation of TSGA10, AURKC, OIP5 and AKAP4 genes by Lactobacillus rhamnosus GG and Lactobacillus crispatus SJ-3C-US supernatants in HeLa cell line.
Lactobacillus rhamnosus GG Culturelle® Draft genome sequence of Lactiplantibacillus plantarum subsp. plantarum strain HF43, a human gut-associated potential probiotic.
Lactobacillus rhamnosus GG Culturelle® Draft Genome Sequence of Lactobacillus rhamnosus 2166.
Lactobacillus rhamnosus GG Culturelle® Dry sausage fermented by Lactobacillus rhamnosus strains.
Lactobacillus rhamnosus GG Culturelle® Dual Effects of Cell Free Supernatants from Lactobacillus acidophilus and Lactobacillus rhamnosus GG in Regulation of MMP-9 by Up-Regulating TIMP-1 and Down-Regulating CD147 in PMADifferentiated THP-1 Cells.
Lactobacillus rhamnosus GG Culturelle® Dual-label flow cytometry-based host cell adhesion assay to ascertain the prospect of probiotic Lactobacillus plantarum in niche-specific antibacterial therapy.
Lactobacillus rhamnosus GG Culturelle® Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.
Lactobacillus rhamnosus GG Culturelle® Early gut mycobiota and mother-offspring transfer.
Lactobacillus rhamnosus GG Culturelle® Early life Lactobacillus rhamnosus GG colonisation inhibits intestinal tumour formation.
Lactobacillus rhamnosus GG Culturelle® Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Early probiotics to prevent childhood metabolic syndrome: A systematic review.
Lactobacillus rhamnosus GG Culturelle® Early-life gut bacteria associate with IL-4-, IL-10- and IFN-? production at two years of age.
Lactobacillus rhamnosus GG Culturelle® Eating Patterns and Dietary Interventions in ADHD: A Narrative Review.
Lactobacillus rhamnosus GG Culturelle® Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.
Lactobacillus rhamnosus GG Culturelle® Editorial: Lactobacillus GG for diarrhoea in children-reports of its demise have been premature!
Lactobacillus rhamnosus GG Culturelle® Effect of <i>Lactobacillus rhamnosus</i> GG on Energy Metabolism, Leptin Resistance, and Gut Microbiota in Mice with Diet-Induced Obesity.
Lactobacillus rhamnosus GG Culturelle® Effect of <i>Lactobacillus rhamnosus</i> GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome.
Lactobacillus rhamnosus GG Culturelle® Effect of 3 lactobacilli on immunoregulation and intestinal microbiota in a ß-lactoglobulin-induced allergic mouse model.
Lactobacillus rhamnosus GG Culturelle® Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.
Lactobacillus rhamnosus GG Culturelle® Effect of a novel synbiotic on Streptococcus mutans.
Lactobacillus rhamnosus GG Culturelle® Effect of a Synbiotic Mix on Lymphoid Organs of Broilers Infected with <i>Salmonella typhimurium</i> and <i>Clostridium perfringens</i>.
Lactobacillus rhamnosus GG Culturelle® Effect of acid stress on protein expression and phosphorylation in Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells.
Lactobacillus rhamnosus GG Culturelle® Effect of antenatal dietary interventions in maternal obesity on pregnancy weight-gain and birthweight: Healthy Mums and Babies (HUMBA) randomized trial.
Lactobacillus rhamnosus GG Culturelle® Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure.
Lactobacillus rhamnosus GG Culturelle® Effect of chlorhexidine pretreatment on the stability of salivary lactobacilli probiotic in six- to twelve-year-old children: a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effect of combination treatment with Lactobacillus rhamnosus and corticosteroid in reducing airway inflammation in a mouse asthma model.
Lactobacillus rhamnosus GG Culturelle® Effect of culture medium and cryoprotectants on the growth and survival of probiotic lactobacilli during freeze drying.
Lactobacillus rhamnosus GG Culturelle® Effect of drying methods on Lactobacillus Rhamnosus GG microcapsules prepared using the complex coacervation method.
Lactobacillus rhamnosus GG Culturelle® Effect of Drying Methods on Protein and DNA Conformation Changes in Lactobacillus rhamnosus GG Cells by Fourier Transform Infrared Spectroscopy.
Lactobacillus rhamnosus GG Culturelle® Effect of Early Infant Lactobacillus rhamnosus GG Supplementation in Preventing Viral Respiratory Illness.
Lactobacillus rhamnosus GG Culturelle® Effect of extracellular vesicles of Lactobacillus rhamnosus GG on the expression of CEA gene and protein released by colorectal cancer cells.
Lactobacillus rhamnosus GG Culturelle® Effect of food models and low-temperature storage on the adhesion of Lactobacillus rhamnosus GG to Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Effect of growth time on the surface and adhesion properties of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Effect of kynurenic acid on the viability of probiotics in vitro.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactic Acid Bacteria Addition on the Microbiological Safety of Pasta-Filata Types of Cheeses.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillaceae Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus GG and conditioned media on IL-1beta-induced IL-8 production in Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus and Bifidobacterium lactis on gingival health, dental plaque, and periodontopathogens in adolescents: a randomised placebo-controlled clinical trial.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG fermentation on the structural and functional properties of dietary fiber in bamboo shoot and its application in bread.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients-Reply.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus on growth of Listeria monocytogenes and Staphylococcus aureus in a probiotic Minas Frescal cheese.
Lactobacillus rhamnosus GG Culturelle® Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro.
Lactobacillus rhamnosus GG Culturelle® Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial.
Lactobacillus rhamnosus GG Culturelle® Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children.
Lactobacillus rhamnosus GG Culturelle® Effect of maifan stone on the growth of probiotics and regulation of gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates.
Lactobacillus rhamnosus GG Culturelle® Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids.
Lactobacillus rhamnosus GG Culturelle® Effect of phenolic compounds on the growth of selected probiotic and pathogenic bacteria.
Lactobacillus rhamnosus GG Culturelle® Effect of potential probiotic Leuconostoc mesenteroides FB111 in prevention of cholesterol absorption by modulating NPC1L1/PPARa/SREBP-2 pathways in epithelial Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotic supplementation on cognitive function in children and adolescents: a systematic review of randomised trials.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical Trial.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses.
Lactobacillus rhamnosus GG Culturelle® Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
Lactobacillus rhamnosus GG Culturelle® Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effect of set-type yoghurt supplemented with the novel probiotic Lantiplantibacillus plantarum 200655 on physicochemical properties and the modulation of oxidative stress-induced damage.
Lactobacillus rhamnosus GG Culturelle® Effect of Simulated Gastrointestinal Tract Conditions on Survivability of Probiotic Bacteria Present in Commercial Preparations.
Lactobacillus rhamnosus GG Culturelle® Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production.
Lactobacillus rhamnosus GG Culturelle® Effect of storage temperature on the chemical, microbiological, and sensory characteristics of pasta filata soft cheese containing probiotic lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Effect of stress pretreatment on survival of probiotic bacteria in gastrointestinal tract simulator.
Lactobacillus rhamnosus GG Culturelle® Effect of sublethal preculturing on the survival of probiotics and metabolite formation in set-yoghurt.
Lactobacillus rhamnosus GG Culturelle® Effect of Supplementing a Bacillus Multi-Strain Probiotic to a Post-Weaning Diet on Nutrient Utilisation and Nitrogen Retention of Piglets.
Lactobacillus rhamnosus GG Culturelle® Effect of the Lactobacillus rhamnosus strain GG and tagatose as a synbiotic combination in a dextran sulfate sodium-induced colitis murine model.
Lactobacillus rhamnosus GG Culturelle® Effect of Various Preterm Infant Milk Formulas on NEC-Like Gut Injury in Mice.
Lactobacillus rhamnosus GG Culturelle® Effect of Vibrio cholerae on chemokine gene expression in HT29 cells and its modulation by Lactobacillus GG.
Lactobacillus rhamnosus GG Culturelle® Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats.
Lactobacillus rhamnosus GG Culturelle® Effect on Viability of Microencapsulated <i>Lactobacillus rhamnosus</i> with the Whey Protein-pullulan Gels in Simulated Gastrointestinal Conditions and Properties of Gels.
Lactobacillus rhamnosus GG Culturelle® Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies.
Lactobacillus rhamnosus GG Culturelle® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus rhamnosus GG Culturelle® Effectiveness of using an extensively hydrolyzed casein formula supplemented with <i>Lactobacillus rhamnosus</i> GG compared with an extensively hydrolysed whey formula in managing cow`s milk protein allergic infants.
Lactobacillus rhamnosus GG Culturelle® Effects of <i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium lactis</i> Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: protocol of a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Lactobacillus rhamnosus GG Culturelle® Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota.
Lactobacillus rhamnosus GG Culturelle® Effects of bile salt deconjugation by probiotic strains on the survival of antibiotic-resistant foodborne pathogens under simulated gastric conditions.
Lactobacillus rhamnosus GG Culturelle® Effects of dietary Lactobacillus rhamnosus GG supplementation on the production performance, egg quality, eggshell ultrastructure, and lipid metabolism of late-phase laying hens.
Lactobacillus rhamnosus GG Culturelle® Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effects of enteropathogenic bacteria &amp; lactobacilli on chemokine secretion &amp; Toll like receptor gene expression in two human colonic epithelial cell lines.
Lactobacillus rhamnosus GG Culturelle® Effects of fermentation with Lactobacillus rhamnosus GG on product quality and fatty acids of goat milk yogurt.
Lactobacillus rhamnosus GG Culturelle® Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model.
Lactobacillus rhamnosus GG Culturelle® Effects of Intravesical Lactobacillus Rhamnosus GG on Urinary Symptom Burden in People with Neurogenic Lower Urinary Tract Dysfunction.
Lactobacillus rhamnosus GG Culturelle® Effects of Lacticaseibacillus rhamnosus GG supplementation, via food and non-food matrices, on children`s health promotion: A scoping review.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the single-cell fecal parasitome in children with celiac disease autoimmunity: a randomized, double-blind placebo-controlled clinical trial.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus johnsonii and Lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG and Escherichia coli Nissle 1917 Cell-Free Supernatants on Modulation of Mucin and Cytokine Secretion on Human Intestinal Epithelial HT29-MTX Cells.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG as a probiotic on neonatal hyperbilirubinemia.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on early postoperative outcome after pylorus-preserving pancreatoduodenectomy: a randomized trial.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on hepatic and serum lipid profiles in zebrafish exposed to ethanol.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on saliva-derived microcosms.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG on the maturation and differentiation of dendritic cells in rotavirus-infected mice.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus GG supplementation on cow`s milk allergy in a mouse model.
Lactobacillus rhamnosus GG Culturelle® Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease.
Lactobacillus rhamnosus GG Culturelle® Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.
Lactobacillus rhamnosus GG Culturelle® Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Lactobacillus rhamnosus GG Culturelle® Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation.
Lactobacillus rhamnosus GG Culturelle® Effects of potential synbiotic interaction between Lactobacillus rhamnosus GG and salicylic acid on human colon and prostate cancer cells.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotic supplementation on serum trimethylamine-N-oxide level and gut microbiota composition in young males: a double-blinded randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study.
Lactobacillus rhamnosus GG Culturelle® Effects of probiotics in the treatment of food hypersensitivity in children: a systematic review.
Lactobacillus rhamnosus GG Culturelle® Effects of Probiotics on Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Lactobacillus rhamnosus GG Culturelle® Effects of regular and decaffeinated roasted coffee (Coffea arabica and Coffea canephora) extracts and bioactive compounds on in vitro probiotic bacterial growth.
Lactobacillus rhamnosus GG Culturelle® Effects of Soluble Corn Fiber Alone or in Synbiotic Combination with <i>Lactobacillus rhamnosus</i> GG and the Pilus-Deficient Derivative GG-PB12 on Fecal Microbiota, Metabolism, and Markers of Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Elderly (Saimes Study).
Lactobacillus rhamnosus GG Culturelle® Effects of Spore-Displayed p75 Protein from Lacticaseibacillus rhamnosus GG on the Transcriptional Response of HT-29 Cells.
Lactobacillus rhamnosus GG Culturelle® Effects of synbiotic fermentation products on primary chemoprevention in human colon cells.
Lactobacillus rhamnosus GG Culturelle® Effects of the probiotic, Lactobacillus rhamnosus GG, on ulcer pathogenesis, HSP70 stress protein and nitric oxide levels in stress induced ulcer.
Lactobacillus rhamnosus GG Culturelle® Effects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats.
Lactobacillus rhamnosus GG Culturelle® Efficacy and Safety of Probiotics in Geriatric Patients with Constipation: Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus GG Culturelle® Efficacy of <i>Lactobacillus rhamnosus</i> GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk.
Lactobacillus rhamnosus GG Culturelle® Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials.
Lactobacillus rhamnosus GG Culturelle® Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.
Lactobacillus rhamnosus GG Culturelle® Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity.
Lactobacillus rhamnosus GG Culturelle® Efficacy of synbiotic Jerusalem artichoke and Lactobacillus rhamnosus GG-supplemented diets on growth performance, serum biochemical parameters, intestinal morphology, immune parameters and protection against Aeromonas veronii in juvenile red tilapia (Oreochromis spp.).
Lactobacillus rhamnosus GG Culturelle® Efficacy of whey protein gel networks as potential viability-enhancing scaffolds for cell immobilization of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Efficiency of transcription from promoter sequence variants in Lactobacillus is both strain and context dependent.
Lactobacillus rhamnosus GG Culturelle® Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
Lactobacillus rhamnosus GG Culturelle® Elastic recovery of filler-binders to safeguard viability of Lactobacillus rhamnosus GG during direct compression.
Lactobacillus rhamnosus GG Culturelle® Elucidation of the fucose metabolism of probiotic Lactobacillus rhamnosus GG by metabolomic and flux balance analyses.
Lactobacillus rhamnosus GG Culturelle® Encapsulation of Lactobacillus rhamnosus GG in edible electrospun mats from calcium and sodium caseinates with pullulan blends.
Lactobacillus rhamnosus GG Culturelle® Encapsulation of Lactobacillus rhamnosus GG Using Milk Protein-Based Delivery Systems: Effects of Reaction Temperature and Holding Time on Their Physicochemical and Functional Properties.
Lactobacillus rhamnosus GG Culturelle® Endogenous biotin-binding proteins: an overlooked factor causing false positives in streptavidin-based protein detection.
Lactobacillus rhamnosus GG Culturelle® Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model.
Lactobacillus rhamnosus GG Culturelle® Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin.
Lactobacillus rhamnosus GG Culturelle® Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease.
Lactobacillus rhamnosus GG Culturelle® Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.
Lactobacillus rhamnosus GG Culturelle® Enteric commensal bacteria induce extracellular signal-regulated kinase pathway signaling via formyl peptide receptor-dependent redox modulation of dual specific phosphatase 3.
Lactobacillus rhamnosus GG Culturelle® Enumeration of Probiotic Strain Lacticaseibacillus rhamnosus GG (ATCC 53103) Using Viability Real-time PCR.
Lactobacillus rhamnosus GG Culturelle® Epigenetic features of FoxP3 in children with cow`s milk allergy.
Lactobacillus rhamnosus GG Culturelle® Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses.
Lactobacillus rhamnosus GG Culturelle® Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model.
Lactobacillus rhamnosus GG Culturelle® Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.
Lactobacillus rhamnosus GG Culturelle® Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.
Lactobacillus rhamnosus GG Culturelle® Evaluating the Effect of Lactobacillus casei FEGY 9973 and Curcumin on Experimental Giardiasis.
Lactobacillus rhamnosus GG Culturelle® Evaluation of anti-biofilm activity of Lactobacillus rhamnosus GG and Nisin on the expression of aap, ica-A and ica-D as biofilm-associated genes of Staphylococcus epidermidis.
Lactobacillus rhamnosus GG Culturelle® Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions.
Lactobacillus rhamnosus GG Culturelle® Evaluation of beneficial attributes for phytate-degrading Pediococcus pentosaceus CFR R123.
Lactobacillus rhamnosus GG Culturelle® Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Commercial Anti-Listerial Products for Improvement of Food Safety in Ready-to-Eat Meat and Dairy Products.
Lactobacillus rhamnosus GG Culturelle® Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years.
Lactobacillus rhamnosus GG Culturelle® Evaluation of indigenous lactic acid bacteria of raw mare milk from pastoral areas in Xinjiang, China, for potential use in probiotic fermented dairy products.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Lactobacillus rhamnosus GG and Lactobacillus acidophilus NCFM encapsulated using a novel impinging aerosol method in fruit food products.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Lactobacillus rhamnosus GG using an Escherichia coli K88 model of piglet diarrhoea: Effects on diarrhoea incidence, faecal microflora and immune responses.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs.
Lactobacillus rhamnosus GG Culturelle® Evaluation of postharvest calcium treatment and biopreservation with Lactobacillus rhamnosus GG on the quality of fresh-cut `Conference` pears.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Potential Probiotic Properties of Lactobacillus and Bacillus Strains Derived from Various Sources for Their Potential Use in Swine Feeding.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Prebiotic Activity of Stellariae Radix Polysaccharides and Its Effects on Gut Microbiota.
Lactobacillus rhamnosus GG Culturelle® Evaluation of probiotic potential and anti-hyperglycemic properties of a novel <i>Lactobacillus</i> strain isolated from water kefir grains.
Lactobacillus rhamnosus GG Culturelle® Evaluation of probiotic potential of autochthonous lactobacilli strains isolated from Zabuli yellow kashk, an Iranian dairy product.
Lactobacillus rhamnosus GG Culturelle® Evaluation of Probiotic-Beverage Matrix Interaction for Efficient Control of Enterobacter aerogenes and Staphylococcus aureus.
Lactobacillus rhamnosus GG Culturelle® Evaluation of some in vitro probiotic properties of <i>Lactobacillus fermentum</i> Strains.
Lactobacillus rhamnosus GG Culturelle® Evaluation of strain-specific primers for identification of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Evaluation of the Antimicrobial Activity of Phytochemicals from Tea and Agarwood Leaf Extracts against Isolated Bacteria from Poultry and Curd.
Lactobacillus rhamnosus GG Culturelle® Evaluation of the functional potential of Weissella and Lactobacillus isolates obtained from Nigerian traditional fermented foods and cow`s intestine.
Lactobacillus rhamnosus GG Culturelle® Evaluation of the probiotic potential of Bacillus polyfermenticus CJ6 isolated from Meju, a Korean soybean fermentation starter.
Lactobacillus rhamnosus GG Culturelle® Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486.
Lactobacillus rhamnosus GG Culturelle® Evidence on the role of protein biosynthesis in the induction of heat tolerance of Lactobacillus rhamnosus GG by pressure pre-treatment.
Lactobacillus rhamnosus GG Culturelle® Examining the cognitive benefits of probiotic supplementation in physically active older adults: A randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis.
Lactobacillus rhamnosus GG Culturelle® Exfoliated bentonite/alginate nanocomposite hydrogel enhances intestinal delivery of probiotics by resistance to gastric pH and on-demand disintegration.
Lactobacillus rhamnosus GG Culturelle® Exogenous Polyamines Influence In Vitro Microbial Adhesion to Human Mucus According to the Age of Mucus Donor.
Lactobacillus rhamnosus GG Culturelle® Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine.
Lactobacillus rhamnosus GG Culturelle® Exopolysaccharides produced by Lactobacillus and Bifidobacterium strains abrogate in vitro the cytotoxic effect of bacterial toxins on eukaryotic cells.
Lactobacillus rhamnosus GG Culturelle® Exopolysaccharides produced by Lactobacillus rhamnosus GG alleviate hydrogen peroxide-induced intestinal oxidative damage and apoptosis through the Keap1/Nrf2 and Bax/Bcl-2 pathways in vitro.
Lactobacillus rhamnosus GG Culturelle® Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Exosome-Like Nanoparticles From Lactobacillus rhamnosusGG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice.
Lactobacillus rhamnosus GG Culturelle® Exosomes isolated from sera of mice fed Lactobacillus strains affect inflammatory cytokine production in macrophages in vitro.
Lactobacillus rhamnosus GG Culturelle® Exploring the integrity of cellular membrane and resistance to digestive juices of dehydrated lactic acid bacteria as influenced by drying kinetics.
Lactobacillus rhamnosus GG Culturelle® Exploring the interactions between Lactobacillus rhamnosus GG and whey protein isolate for preservation of the viability of bacteria through spray drying.
Lactobacillus rhamnosus GG Culturelle® Exploring the prebiotic effect of cyclodextrins on probiotic bacteria entrapped in carboxymetyl cellulose-chitosan particles.
Lactobacillus rhamnosus GG Culturelle® Exploring the protective effects of calcium-containing carrier against drying-induced cellular injuries of probiotics using single droplet drying technique.
Lactobacillus rhamnosus GG Culturelle® Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect.
Lactobacillus rhamnosus GG Culturelle® Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guérin or Lactobacillus rhamnosus strain GG in the healthy murine bladder.
Lactobacillus rhamnosus GG Culturelle® Expression of heterologous heparan sulphate binding protein of Helicobacter pylori on the surface of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial.
Lactobacillus rhamnosus GG Culturelle® Extensively hydrolyzed casein formula alone or with L. rhamnosus GG reduces ß-lactoglobulin sensitization in mice.
Lactobacillus rhamnosus GG Culturelle® Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow`s milk allergy: 3-year randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Extracellular and intracellular DNA for bacterial profiling of long-ripened cheeses.
Lactobacillus rhamnosus GG Culturelle® Extracellular fructooligosaccharide degradation in Anaerostipes hadrus for co-metabolism with non-fructooligosaccharide utilizers.
Lactobacillus rhamnosus GG Culturelle® Extracellular Membrane Vesicles from Lactobacilli Dampen IFN-? Responses in a Monocyte-Dependent Manner.
Lactobacillus rhamnosus GG Culturelle® Fabrication of Delivery Gels with Micellar Casein Concentrates (MCC) Using Microfiltration Embedding <i>Lactobacillus Rhamnosus</i> GG (LGG): Effect of Temperature on Structure, Rheological Behavior, and Texture.
Lactobacillus rhamnosus GG Culturelle® Factors Affecting Spontaneous Endocytosis and Survival of Probiotic Lactobacilli in Human Intestinal Epithelial Cells.
Lactobacillus rhamnosus GG Culturelle® Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG.
Lactobacillus rhamnosus GG Culturelle® Factors Associated With Nonadherence in an Emergency Department-based Multicenter Randomized Clinical Trial of a Probiotic in Children With Acute Gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Factors Associated with the Development of Immune Tolerance in Children with Cow`s Milk Allergy.
Lactobacillus rhamnosus GG Culturelle® Faecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in Adults.
Lactobacillus rhamnosus GG Culturelle® Faecalibacterium: a bacterial genus with promising human health applications.
Lactobacillus rhamnosus GG Culturelle® Feasibility of Metatranscriptome Analysis from Infant Gut Microbiota: Adaptation to Solid Foods Results in Increased Activity of Firmicutes at Six Months.
Lactobacillus rhamnosus GG Culturelle® Feasibility Study of Lactobacillus Plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals.
Lactobacillus rhamnosus GG Culturelle® Featured Prebiotic Agent: The Roles and Mechanisms of Direct and Indirect Prebiotic Activities of Lactoferrin and Its Application in Disease Control.
Lactobacillus rhamnosus GG Culturelle® Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.
Lactobacillus rhamnosus GG Culturelle® Fecal Changes Following Introduction of Milk in Infants With Outgrowing Non-IgE Cow`s Milk Protein Allergy Are Influenced by Previous Consumption of the Probiotic LGG.
Lactobacillus rhamnosus GG Culturelle® Fecal virome transfer improves proliferation of commensal gut Akkermansia muciniphila and unexpectedly enhances the fertility rate in laboratory mice.
Lactobacillus rhamnosus GG Culturelle® Fermentation of non-digestible raffinose family oligosaccharides and galactomannans by probiotics.
Lactobacillus rhamnosus GG Culturelle® Fermentative lactic acid production from seaweed hydrolysate using Lactobacillus sp. And Weissella sp.
Lactobacillus rhamnosus GG Culturelle® Fermented carrot juice attenuates type 2 diabetes by mediating gut microbiota in rats.
Lactobacillus rhamnosus GG Culturelle® Fermented milk containing Lactobacillus GG alleviated DSS-induced colitis in mice and activated epidermal growth factor receptor and Akt signaling in intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Fermented milk with Lactobacillus curvatus SMFM2016-NK alleviates periodontal and gut inflammation, and alters oral and gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Fermented soy beverages as vehicle of probiotic lactobacilli strains and source of bioactive isoflavones: A potential double functional effect.
Lactobacillus rhamnosus GG Culturelle® Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
Lactobacillus rhamnosus GG Culturelle® First Evidence of Acyl-Hydrolase/Lipase Activity From Human Probiotic Bacteria: <i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium longum</i> NCC 2705.
Lactobacillus rhamnosus GG Culturelle® Flavour profiles of dry sausages fermented by selected novel meat starter cultures.
Lactobacillus rhamnosus GG Culturelle® Flow cytometric testing of green fluorescent protein-tagged Lactobacillus rhamnosus GG for response to defensins.
Lactobacillus rhamnosus GG Culturelle® Flow Cytometry: Evolution of Microbiological Methods for Probiotics Enumeration.
Lactobacillus rhamnosus GG Culturelle® Fluidized-Bed Granulation of Probiotics-Encapsulated Spray-Dried Skim Milk Powder: Effects of a Fluidizing Aid, Moisture-Activation and Dehydration.
Lactobacillus rhamnosus GG Culturelle® Food matrices and cell conditions influence survival of Lactobacillus rhamnosus GG under heat stresses and during storage.
Lactobacillus rhamnosus GG Culturelle® Formula selection for management of children with cow`s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study.
Lactobacillus rhamnosus GG Culturelle® Frequency of Antibiotic-Associated Diarrhea and Related Complications in Pediatric Patients Who Underwent Hypospadias Repair: a Comparative Study Using Probiotics vs Placebo.
Lactobacillus rhamnosus GG Culturelle® From probiotics to therapeutics: another step forward?
Lactobacillus rhamnosus GG Culturelle® Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Functional analysis of luxS in the probiotic strain Lactobacillus rhamnosus GG reveals a central metabolic role important for growth and biofilm formation.
Lactobacillus rhamnosus GG Culturelle® Functional analysis of the fructooligosaccharide utilization operon in Lactobacillus paracasei 1195.
Lactobacillus rhamnosus GG Culturelle® Functional analysis of the Lactobacillus casei BL23 sortases.
Lactobacillus rhamnosus GG Culturelle® Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23.
Lactobacillus rhamnosus GG Culturelle® Functional characterization of a mucus-specific LPXTG surface adhesin from probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Functional dynamics of the gut microbiome in elderly people during probiotic consumption.
Lactobacillus rhamnosus GG Culturelle® Functional identification of conserved residues involved in Lactobacillus rhamnosus strain GG sortase specificity and pilus biogenesis.
Lactobacillus rhamnosus GG Culturelle® Functional properties of Lactobacillus strains isolated from kimchi.
Lactobacillus rhamnosus GG Culturelle® Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens.
Lactobacillus rhamnosus GG Culturelle® Gastroenteric pathology and probiotics: from myth to scientific evidence. Current aspects.
Lactobacillus rhamnosus GG Culturelle® G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages.
Lactobacillus rhamnosus GG Culturelle® Generation of Lactose- and Protease-Positive Probiotic <i>Lacticaseibacillus rhamnosus</i> GG by Conjugation with <i>Lactococcus lactis</i> NCDO 712.
Lactobacillus rhamnosus GG Culturelle® Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Genome instability in Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Genomic adaptation of the Lactobacillus casei group.
Lactobacillus rhamnosus GG Culturelle® Genomic and Functional Characterization of the Unusual pLOCK 0919 Plasmid Harboring the spaCBA Pili Cluster in Lactobacillus casei LOCK 0919.
Lactobacillus rhamnosus GG Culturelle® Genomic characterization of non-mucus-adherent derivatives of Lactobacillus rhamnosus GG reveals genes affecting pilus biogenesis.
Lactobacillus rhamnosus GG Culturelle® Genomic Stability and Phenotypic Characteristics of Industrially Produced Lacticaseibacillus rhamnosus GG in a Yogurt Matrix.
Lactobacillus rhamnosus GG Culturelle® Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.
Lactobacillus rhamnosus GG Culturelle® Global analysis of clinical trials with probiotics.
Lactobacillus rhamnosus GG Culturelle® Glucan type exopolysaccharide (EPS) shows prebiotic effect and reduces syneresis in chocolate pudding.
Lactobacillus rhamnosus GG Culturelle® Glutamine synthetase and glucose-6-phosphate isomerase are adhesive moonlighting proteins of Lactobacillus crispatus released by epithelial cathelicidin LL-37.
Lactobacillus rhamnosus GG Culturelle® Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Growth and metabolism of selected strains of probiotic bacteria in milk.
Lactobacillus rhamnosus GG Culturelle® Growth and metabolism of selected strains of probiotic bacteria, in maize porridge with added malted barley.
Lactobacillus rhamnosus GG Culturelle® Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial.
Lactobacillus rhamnosus GG Culturelle® Growth and tolerance of healthy, term infants fed lower protein extensively hydrolyzed or amino acid-based formula: double-blind, randomized, controlled trial.
Lactobacillus rhamnosus GG Culturelle® Growth conditions and survival kinetics during storage of Lactobacillus rhamnosus GG for the design of a sustainable probiotic whey-based beverage containing Costa Rican guava fruit pulp.
Lactobacillus rhamnosus GG Culturelle® Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial.
Lactobacillus rhamnosus GG Culturelle® Growth Mode and Carbon Source Impact the Surfaceome Dynamics of <i>Lactobacillus rhamnosus</i> GG.
Lactobacillus rhamnosus GG Culturelle® Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials.
Lactobacillus rhamnosus GG Culturelle® Growth of Lactic Acid Bacteria on Gold-Influence of Surface Roughness and Chemical Composition.
Lactobacillus rhamnosus GG Culturelle® Growth of probiotic bacteria and bifidobacteria in a soy yogurt formulation.
Lactobacillus rhamnosus GG Culturelle® Growth of probiotic lactobacilli in the presence of oleic acid enhances subsequent survival in gastric juice.
Lactobacillus rhamnosus GG Culturelle® Growth phase-associated changes in the proteome and transcriptome of Lactobacillus rhamnosus GG in industrial-type whey medium.
Lactobacillus rhamnosus GG Culturelle® Growth, health, rumen fermentation, and bacterial community of Holstein calves fed Lactobacillus rhamnosus GG during the preweaning stage1.
Lactobacillus rhamnosus GG Culturelle® Growth, survival, and metabolic activities of probiotic Lactobacillus spp. in fermented coffee brews supplemented with glucose and inactivated yeast derivatives.
Lactobacillus rhamnosus GG Culturelle® Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Lactobacillus rhamnosus GG Culturelle® Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis.
Lactobacillus rhamnosus GG Culturelle® Gut Microbiota and Cancer: From Pathogenesis to Therapy.
Lactobacillus rhamnosus GG Culturelle® Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow`s milk allergy.
Lactobacillus rhamnosus GG Culturelle® Gut Microbiota Mediates Lactobacillus rhamnosus GG Alleviation of Deoxynivalenol-Induced Anorexia.
Lactobacillus rhamnosus GG Culturelle® Gut Microbiota Regulates Epigenetic Remodelling in the Amygdala: A Role in Repeated Mild Traumatic Brain Injury (rMTBI)-Induced Anxiety.
Lactobacillus rhamnosus GG Culturelle® Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury.
Lactobacillus rhamnosus GG Culturelle® Health benefits of <i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subspecies <i>lactis</i> BB-12 in children.
Lactobacillus rhamnosus GG Culturelle® Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis.
Lactobacillus rhamnosus GG Culturelle® Heat stability of Lactobacillus rhamnosus GG and its cellular membrane during droplet drying and heat treatment.
Lactobacillus rhamnosus GG Culturelle® Heat-Killed <i>Lactobacillus plantarum</i> KCTC 13314BP Enhances Phagocytic Activity and Immunomodulatory Effects Via Activation of MAPK and STAT3 Pathways.
Lactobacillus rhamnosus GG Culturelle® Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primary trophoblast cells.
Lactobacillus rhamnosus GG Culturelle® Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice.
Lactobacillus rhamnosus GG Culturelle® Hepatoprotective Effect of Probiotic <i>Lactobacillus rhamnosus</i> GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish.
Lactobacillus rhamnosus GG Culturelle® Hepato-protective role of chemo-preventive probiotics during DMH-induced CRC in rats.
Lactobacillus rhamnosus GG Culturelle® Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation.
Lactobacillus rhamnosus GG Culturelle® High Fat Diet Dysbiotic Mechanism of Decreased Gingival Blood Flow.
Lactobacillus rhamnosus GG Culturelle® High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE<sup>-/-</sup> mice.
Lactobacillus rhamnosus GG Culturelle® High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs.
Lactobacillus rhamnosus GG Culturelle® High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunity.
Lactobacillus rhamnosus GG Culturelle® High-efficient L-lactic acid production from inedible starchy biomass by one-step open fermentation using thermotolerant Lactobacillus rhamnosus DUT1908.
Lactobacillus rhamnosus GG Culturelle® High-Shear Granulation of Hygroscopic Probiotic-Encapsulated Skim Milk Powder: Effects of Moisture-Activation and Resistant Maltodextrin.
Lactobacillus rhamnosus GG Culturelle® Histopathological study and intestinal mucous cell responses against <i>Aeromonas hydrophila</i> in Nile tilapia administered with <i>Lactobacillus rhamnosus</i> GG.
Lactobacillus rhamnosus GG Culturelle® Human bocavirus in the nasopharynx of otitis-prone children.
Lactobacillus rhamnosus GG Culturelle® Human Breast Milk: A Source of Potential Probiotic Candidates.
Lactobacillus rhamnosus GG Culturelle® Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.
Lactobacillus rhamnosus GG Culturelle® Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics.
Lactobacillus rhamnosus GG Culturelle® Human rhinovirus in experimental infection after peroral Lactobacillus rhamnosus GG consumption, a pilot study.
Lactobacillus rhamnosus GG Culturelle® Hybrid coating of alginate microbeads based on protein-biopolymer multilayers for encapsulation of probiotics.
Lactobacillus rhamnosus GG Culturelle® Hypoallergenic formula with Lactobacillus rhamnosus GG for babies with colic: A pilot study of recruitment, retention, and fecal biomarkers.
Lactobacillus rhamnosus GG Culturelle® Identification and characterization of the novel LysM domain-containing surface protein Sep from Lactobacillus fermentum BR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus.
Lactobacillus rhamnosus GG Culturelle® Identification of a Gene Cluster for the Biosynthesis of a Long, Galactose-Rich Exopolysaccharide in Lactobacillus rhamnosus GG and Functional Analysis of the Priming Glycosyltransferase.
Lactobacillus rhamnosus GG Culturelle® Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner.
Lactobacillus rhamnosus GG Culturelle® Identification of novel proteins secreted by Lactobacillus rhamnosus GG grown in de Mann-Rogosa-Sharpe broth.
Lactobacillus rhamnosus GG Culturelle® Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin.
Lactobacillus rhamnosus GG Culturelle® Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Immune signalling responses in intestinal epithelial cells exposed to pathogenic Escherichia coli and lactic acid-producing probiotics.
Lactobacillus rhamnosus GG Culturelle® Immune synergistic oligodeoxynucleotide from Lactobacillus rhamnosus GG enhances the immune response upon co-stimulation by bacterial and fungal cell wall components.
Lactobacillus rhamnosus GG Culturelle® Immune system stimulation by probiotic microorganisms.
Lactobacillus rhamnosus GG Culturelle® Immune-enhancing effects of <i>Lactobacillus plantarum</i> 200655 isolated from Korean kimchi in a cyclophosphamide-induced immunocompromised mouse model.
Lactobacillus rhamnosus GG Culturelle® Immune-stimulating effects of lactic acid bacteria in vivo and in vitro.
Lactobacillus rhamnosus GG Culturelle® Immunomodulation and signaling mechanism of Lactobacillus rhamnosus GG and its components on porcine intestinal epithelial cells stimulated by lipopolysaccharide.
Lactobacillus rhamnosus GG Culturelle® Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors.
Lactobacillus rhamnosus GG Culturelle® Immunomodulation of monocytes by probiotic and selected lactic Acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers.
Lactobacillus rhamnosus GG Culturelle® Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Immunomodulatory Potential of Weissella cibaria in Aged C57BL/6J Mice.
Lactobacillus rhamnosus GG Culturelle® Immunomodulatory properties of Enterococcus faecium JWS 833 isolated from duck intestinal tract and suppression of Listeria monocytogenes infection.
Lactobacillus rhamnosus GG Culturelle® Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice.
Lactobacillus rhamnosus GG Culturelle® Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
Lactobacillus rhamnosus GG Culturelle® Impact of a novel synbiotic supplementation during gestation and lactation on immune responses in the Swiss albino mice offspring.
Lactobacillus rhamnosus GG Culturelle® Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Impact of Lacticaseibacillus rhamnosus GG on the Emulsion Stability of Raw Milk.
Lactobacillus rhamnosus GG Culturelle® Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.
Lactobacillus rhamnosus GG Culturelle® Impact of luxS and suppressor mutations on the gastrointestinal transit of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study.
Lactobacillus rhamnosus GG Culturelle® Impact of maternal probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration: a prospective, randomized, placebo-controlled study.
Lactobacillus rhamnosus GG Culturelle® Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study.
Lactobacillus rhamnosus GG Culturelle® Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults.
Lactobacillus rhamnosus GG Culturelle® Impact of Potential Probiotic Lactobacillus Strains on Host Growth and Development in a Drosophila melanogaster Model.
Lactobacillus rhamnosus GG Culturelle® Impact of probiotics on development and behaviour in Drosophila melanogaster - a potential in vivo model to assess probiotics.
Lactobacillus rhamnosus GG Culturelle® Impact of spray-drying on the pili of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition.
Lactobacillus rhamnosus GG Culturelle® Impacts of pH-mediated EPS structure on probiotic bacterial pili-whey proteins interactions.
Lactobacillus rhamnosus GG Culturelle® Importance of pressure plasticity during compression of probiotic tablet formulations.
Lactobacillus rhamnosus GG Culturelle® Improved gut microbiome recovery following drug therapy is linked to abundance and replication of probiotic strains.
Lactobacillus rhamnosus GG Culturelle® Improved in vitro assay for determining the mucin adherence of bacteria sensitive to Triton X-100 treatment.
Lactobacillus rhamnosus GG Culturelle® In situ alginate crosslinking during spray-drying of lactobacilli probiotics promotes gastrointestinal-targeted delivery.
Lactobacillus rhamnosus GG Culturelle® In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
Lactobacillus rhamnosus GG Culturelle® In vitro adhesion and anti-inflammatory properties of Limosilactobacillus fermentum FS-10 isolated from infant fecal sample.
Lactobacillus rhamnosus GG Culturelle® In vitro and in vivo biotransformation of glucosinolates from mashua (Tropaeolum tuberosum) by lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® In Vitro and In Vivo Evaluation of Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis Bb12 Against Avian Pathogenic Escherichia coli and Identification of Novel Probiotic-Derived Bioactive Peptides.
Lactobacillus rhamnosus GG Culturelle® In vitro and in vivo resistance of Lactobacillus rhamnosus GG carried by a mixed pineapple (Ananas comosus L. Merril) and jussara (Euterpe edulis Martius) juice to the gastrointestinal tract.
Lactobacillus rhamnosus GG Culturelle® In vitro anti-inflammatory and antibiofilm activities of bacterial lysates from lactobacilli against oral pathogenic bacteria.
Lactobacillus rhamnosus GG Culturelle® In vitro bioactivities of coffee brews fermented with the probiotics Lacticaseibacillus rhamnosus GG and Saccharomyces boulardii CNCM-I745.
Lactobacillus rhamnosus GG Culturelle® In Vitro Characterization of <i>Lactobacillus plantarum</i> Strains with Inhibitory Activity on Enteropathogens for Use as Potential Animal Probiotics.
Lactobacillus rhamnosus GG Culturelle® In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially Campylobacter jejuni.
Lactobacillus rhamnosus GG Culturelle® In vitro characterization of lactic acid bacterial strains isolated from fermented foods with anti-inflammatory and dipeptidyl peptidase-IV inhibition potential.
Lactobacillus rhamnosus GG Culturelle® In vitro characterization of the digestive stress response and immunomodulatory properties of microorganisms isolated from smear-ripened cheese.
Lactobacillus rhamnosus GG Culturelle® In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples.
Lactobacillus rhamnosus GG Culturelle® In Vitro Evaluation of Probiotic Potential of Lactic Acid Bacteria Isolated from Yunnan De`ang Pickled Tea.
Lactobacillus rhamnosus GG Culturelle® In vitro evaluation of the mucin-adhesion ability and probiotic potential of Lactobacillus mucosae LM1.
Lactobacillus rhamnosus GG Culturelle® In vitro evaluation of yoghurt starter lactobacilli and Lactobacillus rhamnosus GG adhesion to saliva-coated surfaces.
Lactobacillus rhamnosus GG Culturelle® In vitro fermentation of oat ß-glucan and hydrolysates by fecal microbiota and selected probiotic strains.
Lactobacillus rhamnosus GG Culturelle® In vitro interactions between probiotic bacteria and milk proteins probed by atomic force microscopy.
Lactobacillus rhamnosus GG Culturelle® In vitro model to study the modulation of the mucin-adhered bacterial community.
Lactobacillus rhamnosus GG Culturelle® In vitro probiotic characterization of Lactobacillus strains from fermented radish and their anti-adherence activity against enteric pathogens.
Lactobacillus rhamnosus GG Culturelle® In Vitro Screening of Indigenous Lactobacillus Isolates for Selecting Organisms with Better Health-Promoting Attributes.
Lactobacillus rhamnosus GG Culturelle® In vitro selection of antibiotic resistance in the probiotic strain Lactobacillus rhamnosus GG ATCC 53103.
Lactobacillus rhamnosus GG Culturelle® In vitro studies of the digestion of caprine whey proteins by human gastric and duodenal juice and the effects on selected microorganisms.
Lactobacillus rhamnosus GG Culturelle® In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets.
Lactobacillus rhamnosus GG Culturelle® In vivo murine breast cancer targeting by magnetic iron nanoparticles involving L. GG cytoplasmic fraction.
Lactobacillus rhamnosus GG Culturelle® In vivo probiotic and antimicrobial photodynamic therapy as alternative therapies against cryptococcosis are ineffective.
Lactobacillus rhamnosus GG Culturelle® In vivo study of the immunomodulatory capacity and the impact of probiotic strains on physicochemical and sensory characteristics: Case of pasta filata soft cheeses.
Lactobacillus rhamnosus GG Culturelle® Inactivation of Lactobacillus rhamnosus GG by fixation modifies its probiotic properties.
Lactobacillus rhamnosus GG Culturelle® Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG.
Lactobacillus rhamnosus GG Culturelle® Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli.
Lactobacillus rhamnosus GG Culturelle® Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Increased susceptibility to dextran sulfate-induced mucositis of iron-overload ß-thalassemia mice, another endogenous cause of septicemia in thalassemia.
Lactobacillus rhamnosus GG Culturelle® Independent and Combined Effects of Probiotics and Prebiotics as Supplements or Food-Rich Diets on a Propionic-Acid-Induced Rodent Model of Autism Spectrum Disorder.
Lactobacillus rhamnosus GG Culturelle® Indigenous lactobacilli strains of food and human sources reverse enteropathogenic E. coli O26:H11-induced damage in intestinal epithelial cell lines: effect on redistribution of tight junction proteins.
Lactobacillus rhamnosus GG Culturelle® Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Infant food allergy: where are we now?
Lactobacillus rhamnosus GG Culturelle® Influence of Bacterial Competitors on <i>Salmonella enterica</i> and Enterohemorrhagic <i>Escherichia coli</i> Growth in Microbiological Media and Attachment to Vegetable Seeds.
Lactobacillus rhamnosus GG Culturelle® Influence of fermentation conditions on the surface properties and adhesion of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Influence of fruit-based beverages on efficacy of Lacticaseibacillus rhamnosus GG (Lactobacillus rhamnosus GG) against DSS-induced intestinal inflammation.
Lactobacillus rhamnosus GG Culturelle® Influence of orally administered Lactobacillus GG on respiratory immune response in a murine model of diet-induced obesity.
Lactobacillus rhamnosus GG Culturelle® Influence of Probiotic Culture Supernatants on In Vitro Biofilm Formation of Staphylococci.
Lactobacillus rhamnosus GG Culturelle® Influence of Probiotics on the Salivary Microflora Oral Streptococci and Their Integration into Oral Biofilm.
Lactobacillus rhamnosus GG Culturelle® Influence of Pulsed Electric Field on Accumulation of Calcium in <i>Lactobacillus rhamnosus</i> B 442.
Lactobacillus rhamnosus GG Culturelle® Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits.
Lactobacillus rhamnosus GG Culturelle® Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice.
Lactobacillus rhamnosus GG Culturelle® Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Inhibition of enteropathogens adhesion to human enterocyte-like HT-29 cells by a dairy strain of Propionibacterium acidipropionici.
Lactobacillus rhamnosus GG Culturelle® Inhibition of Listeria monocytogenes Growth, Adherence and Invasion in Caco-2 Cells by Potential Probiotic Lactic Acid Bacteria Isolated from Fecal Samples of Healthy Neonates.
Lactobacillus rhamnosus GG Culturelle® Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease.
Lactobacillus rhamnosus GG Culturelle® Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions.
Lactobacillus rhamnosus GG Culturelle® Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation.
Lactobacillus rhamnosus GG Culturelle® Inhibitory Effect of Lipoteichoic Acid Derived from Three Lactobacilli on Flagellin-Induced IL-8 Production in Porcine Peripheral Blood Mononuclear Cells.
Lactobacillus rhamnosus GG Culturelle® Inhibitory Effects of the <i>Lactobacillus rhamnosus</i> GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-?B Axis.
Lactobacillus rhamnosus GG Culturelle® Innate gut microbiota predisposes to high alcohol consumption.
Lactobacillus rhamnosus GG Culturelle® Intake of Lactobacillus rhamnosus GG (LGG) fermented milk before drinking alcohol reduces acetaldehyde levels and duration of flushing in drinkers with wild-type and heterozygous mutant ALDH2: a randomized, blinded crossover controlled trial.
Lactobacillus rhamnosus GG Culturelle® Integrated Phenotypic-Genotypic Analysis of Candidate Probiotic Weissella Cibaria Strains Isolated from Dairy Cows in Kuwait.
Lactobacillus rhamnosus GG Culturelle® Integrated Profiling of Gram-Positive and Gram-Negative Probiotic Genomes, Proteomes and Metabolomes Revealed Small Molecules with Differential Growth Inhibition of Antimicrobial-Resistant Pathogens.
Lactobacillus rhamnosus GG Culturelle® Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization?
Lactobacillus rhamnosus GG Culturelle® Interaction of Campylobacter spp. and human probiotics in chicken intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis.
Lactobacillus rhamnosus GG Culturelle® Interactions Between Commensal Bacteria and Enteric Neurons, via FPR1 Induction of ROS, Increase Gastrointestinal Motility in Mice.
Lactobacillus rhamnosus GG Culturelle® Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model.
Lactobacillus rhamnosus GG Culturelle® Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides.
Lactobacillus rhamnosus GG Culturelle® Intestinal adaptation is stimulated by partial enteral nutrition supplemented with the prebiotic short-chain fructooligosaccharide in a neonatal intestinal failure piglet model.
Lactobacillus rhamnosus GG Culturelle® Intestinal colonisation, microbiota and future probiotics?
Lactobacillus rhamnosus GG Culturelle® Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.
Lactobacillus rhamnosus GG Culturelle® Intestinal epithelial cell-derived components regulate transcriptome of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis.
Lactobacillus rhamnosus GG Culturelle® Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses.
Lactobacillus rhamnosus GG Culturelle® Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen-induced allergic asthma in a murine model.
Lactobacillus rhamnosus GG Culturelle® Intra-species Genomic and Physiological Variability Impact Stress Resistance in Strains of Probiotic Potential.
Lactobacillus rhamnosus GG Culturelle® Intravesical <i>Lactobacillus rhamnosus GG</i> is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial.
Lactobacillus rhamnosus GG Culturelle® Intravesical Lactobacillus rhamnosus GG versus Saline Bladder Wash: Protocol for a Randomized, Controlled, Comparative Effectiveness Clinical Trial.
Lactobacillus rhamnosus GG Culturelle® Investigating the Effect of Different Treatments with Lactic Acid Bacteria on the Fate of Listeria monocytogenes and Staphylococcus aureus Infection in Galleria mellonella Larvae.
Lactobacillus rhamnosus GG Culturelle® INVESTIGATION OF PROTECTIVE EFFECTS OF SYNBIOTICS ON ALLERGOPATHY FORMATION.
Lactobacillus rhamnosus GG Culturelle® Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow`s Milk Protein Allergy: a Randomised Double-Blind Placebo-Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Invited review: Microbe-mediated aflatoxin decontamination of dairy products and feeds.
Lactobacillus rhamnosus GG Culturelle® In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters.
Lactobacillus rhamnosus GG Culturelle® Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review.
Lactobacillus rhamnosus GG Culturelle® Isolated exopolysaccharides from Lactobacillus rhamnosus GG alleviated adipogenesis mediated by TLR2 in mice.
Lactobacillus rhamnosus GG Culturelle® Isolation and characterization of five novel probiotic strains from Korean infant and children faeces.
Lactobacillus rhamnosus GG Culturelle® Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics.
Lactobacillus rhamnosus GG Culturelle® Isolation and Culture of Single Microbial Cells by Laser Ejection Sorting Technology.
Lactobacillus rhamnosus GG Culturelle® Isolation of potential probiotic Lactobacillus rhamnosus strains from traditional fermented mare milk produced in Sumbawa Island of Indonesia.
Lactobacillus rhamnosus GG Culturelle® Isolation of Probiotic Piliated <i>Lactobacillus rhamnosus</i> Strains from Human Fecal Microbiota Using SpaA Antiserum-Based Colony Immunoblotting.
Lactobacillus rhamnosus GG Culturelle® Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds.
Lactobacillus rhamnosus GG Culturelle® Kinetics of adsorption and desorption of aflatoxin B1 by viable and nonviable bacteria.
Lactobacillus rhamnosus GG Culturelle® Kinetics of microbial hydrogenation of free linoleic acid to conjugated linoleic acids.
Lactobacillus rhamnosus GG Culturelle® Label-free quantitative proteomic analysis of the inhibition effect of Lactobacillus rhamnosus GG on Escherichia coli biofilm formation in co-culture.
Lactobacillus rhamnosus GG Culturelle® Lack of effect of <i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium lactis</i> Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lack of effect of Lactobacillus GG in breast-fed infants with rectal bleeding: a pilot double-blind randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection.
Lactobacillus rhamnosus GG Culturelle® Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
Lactobacillus rhamnosus GG Culturelle® Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Lactic acid production from corn stover using mixed cultures of Lactobacillus rhamnosus and Lactobacillus brevis.
Lactobacillus rhamnosus GG Culturelle® Lactic acid production on liquid distillery stillage by Lactobacillus rhamnosus immobilized onto zeolite.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus GG Counteracts Rotavirus-Induced Ion Secretion and Enterocyte Damage by Inhibiting Oxidative Stress and Apoptosis Through Specific Effects of Living and Postbiotic Preparations.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus GG inhibits infection of human keratinocytes by Staphylococcus aureus through mechanisms involving cell surface molecules and pH reduction.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus GG Survival and Quality Parameters in Kefir Produced from Kefir Grains and Natural Kefir Starter Culture.
Lactobacillus rhamnosus GG Culturelle® Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens.
Lactobacillus rhamnosus GG Culturelle® Lactiplantibacillus plantarum E51 protects against Clostridioides difficile-induced damages on Caco-2 intestinal barrier functions.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli for prevention of urogenital infections: a review.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus Bacteremia and Probiotics: A Review.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus derived from breast milk facilitates intestinal development in IUGR rats.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG does not affect D-lactic acidosis in diarrheic calves, in a clinical setting.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG effect in increasing IFN-gamma production in infants with cow`s milk allergy.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus ingluviei C37 from chicken inhibits inflammation in LPS-stimulated mouse macrophages.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus plantarum CS24.2 prevents Escherichia coli adhesion to HT-29 cells and also down-regulates enteropathogen-induced tumor necrosis factor-a and interleukin-8 expression.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus plantarum LB95 impairs the virulence potential of Gram-positive and Gram-negative food-borne pathogens in HT-29 and Vero cell cultures.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection?
Lactobacillus rhamnosus GG Culturelle® Lactobacillus reuteri glyceraldehyde-3-phosphate dehydrogenase functions in adhesion to intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by Lipopolysaccharide.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus and Staphylococcus epidermidis in gut microbiota: in vitro antimicrobial resistance.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a possible toxicity of high dose capsaicin.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Activation of Dendritic Cells and Neutrophils Depends on the Dose and Time of Exposure.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG alleviates colitis caused by chemotherapy via biofilm formation.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG alleviates ß-conglycinin-induced allergy by regulating the T cell receptor signaling pathway.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Ameliorated Long-Term Exposure to TiO(2) Nanoparticles Induced Microbiota-Mediated Liver and Colon Inflammation and Fructose-Caused Metabolic Abnormality in Metabolism Syndrome Mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG ameliorates deoxynivalenol-induced kidney oxidative damage and mitochondrial injury in weaned piglets.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG ameliorates DON-induced intestinal damage depending on the enrichment of beneficial bacteria in weaned piglets.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Ameliorates Liver Injury and Hypoxic Hepatitis in Rat Model of CLP-Induced Sepsis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Bifidobacterium animalis MB5 induce intestinal but not systemic antigen-specific hyporesponsiveness in ovalbumin-immunized rats.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Bifidobacterium bifidum TMC3115 Can Affect Development of Hippocampal Neurons Cultured In Vitro in a Strain-Dependent Manner.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and HbA1c in middle age and older adults without type 2 diabetes mellitus: A preliminary randomized study.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and its SpaC pilus adhesin modulate inflammatory responsiveness and TLR-related gene expression in the fetal human gut.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG as an Effective Probiotic for Murine Giardiasis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG as dietary supplement improved survival from lipopolysaccharides-induced sepsis in mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Attenuates Lipopolysaccharide-Induced Inflammation and Barrier Dysfunction by Regulating MAPK/NF-?B Signaling and Modulating Metabolome in the Piglet Intestine.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1a Pathway.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG components, SLP, gDNA and CpG, exert protective effects on mouse macrophages upon lipopolysaccharide challenge.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG decreases lipopolysaccharide-induced systemic inflammation in a gastrostomy-fed infant rat model.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG defense against Salmonella enterica serovar Typhimurium infection through modulation of M1 macrophage polarization.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Dosage Affects the Adjuvanticity and Protection Against Rotavirus Diarrhea in Gnotobiotic Pigs.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Effect on Behavior of Zebrafish During Chronic Ethanol Exposure.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Evaluation in Acute Diarrhea (LEAD): An Observational Study.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG for Cow`s Milk Allergy in Children: A Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Genomic and Phenotypic Stability in an Industrial Production Process.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG improves outcome in experimental pseudomonas aeruginosa pneumonia: potential role of regulatory T cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG in adenoid tissue: Double-blind, placebo-controlled, randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG in Experimental Oral Biofilms Exposed to Different Carbohydrate Sources.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG in the middle ear after randomized, double-blind, placebo-controlled oral administration.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG increases cyclooxygenase-2 expression and prostaglandin E2 secretion in colonic myofibroblasts via a MyD88-dependent mechanism during homeostasis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG increases Toll-like receptor 3 gene expression in murine small intestine ex vivo and in vivo.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG induced protective effect on allergic airway inflammation is associated with gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1-positive macrolide-resistant group A streptococci.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Intake Modifies Preschool Children`s Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Lysate Increases Re-Epithelialization of Keratinocyte Scratch Assays by Promoting Migration.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG microcapsules inhibit Escherichia coli biofilm formation in coculture.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG modifies the metabolome of pathobionts in gnotobiotic mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG modulates gastrointestinal absorption, excretion patterns, and toxicity in Holstein calves fed a single dose of aflatoxin B<sub>1</sub>.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG modulates innate signaling pathway and cytokine responses to rotavirus vaccine in intestinal mononuclear cells of gnotobiotic pigs transplanted with human gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Outcompetes Enterococcus faecium via Mucus-Binding Pili: Evidence for a Novel and Heterospecific Probiotic Mechanism.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Promotes Early B Lineage Development and IgA Production in the Lamina Propria in Piglets.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Promotes Intestinal Vitamin D Absorption by Upregulating Vitamin D Transporters in Senile Osteoporosis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG promotes M1 polarization in murine bone marrow-derived macrophages by activating TLR2/MyD88/MAPK signaling pathway.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Promotes Recovery of the Colon Barrier in Septic Mice through Accelerating ISCs Regeneration.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG reduces hepatic TNFa production and inflammation in chronic alcohol-induced liver injury.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Reverses Insulin Resistance but Does Not Block Its Onset in Diet-Induced Obese Mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG secreting an antigen and Interleukin-2 translocates across the gastrointestinal tract and induces an antigen specific immune response.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG SpaC pilin subunit binds to the carbohydrate moieties of intestinal glycoconjugates.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4<sup>+</sup> T cell induced-type I inflammation.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supernatant promotes intestinal mucin production through regulating 5-HT4R and gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supplementation during critical windows of gestation influences immune phenotype in Swiss albino mice offspring.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supplementation modulates the gut microbiota to promote butyrate production, protecting against deoxynivalenol exposure in nude mice.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG Suppresses Meningitic E. coli K1 Penetration across Human Intestinal Epithelial Cells In Vitro and Protects Neonatal Rats against Experimental Hematogenous Meningitis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG treatment potentiates ethanol-induced behavioral changes through modulation of intestinal epithelium in Danio rerio.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG normalizes gut dysmotility induced by environmental pollutants via affecting serotonin level in zebrafish larvae.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG-induced Expression of Leptin in the Intestine Orchestrates Epithelial Cell Proliferation.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus LRB mediated inhibition of oral streptococci.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus Sepsis Associated with Probiotic Therapy in a Term Infant with Congenital Heart Disease.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a review for clinicians.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus strain GG is a potential probiotic for calves.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 Cells.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus rhamnosusGG reduces hepatic fibrosis in a model of chronic liver disease in rats
Lactobacillus rhamnosus GG Culturelle® Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review.
Lactobacillus rhamnosus GG Culturelle® Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin).
Lactobacillus rhamnosus GG Culturelle® Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.
Lactobacillus rhamnosus GG Culturelle® Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
Lactobacillus rhamnosus GG Culturelle® Latilactobacillus curvatus FFZZH5L isolated from pickled cowpea enhanced antioxidant activity in Caenorhabditis elegans by upregulating the level of glutathione S-transferase.
Lactobacillus rhamnosus GG Culturelle® Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation.
Lactobacillus rhamnosus GG Culturelle® Lemon exosome-like nanoparticles enhance stress survival of gut bacteria by RNase P-mediated specific tRNA decay.
Lactobacillus rhamnosus GG Culturelle® Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from <i>C.</i> <i>d</i> <i>iff</i> Infection.
Lactobacillus rhamnosus GG Culturelle® Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis. Authors` reply.
Lactobacillus rhamnosus GG Culturelle® Light at night affects gut microbial community and negatively impacts host physiology in diurnal animals: Evidence from captive zebra finches.
Lactobacillus rhamnosus GG Culturelle® Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency.
Lactobacillus rhamnosus GG Culturelle® Limosilactobacillus reuteri BIO7251 administration improves metabolic phenotype in obese mice fed a high fat diet: an inter-organ crosstalk between gut, adipose tissue and nervous system.
Lactobacillus rhamnosus GG Culturelle® Limosilactobacillus reuteri inhibits the acid tolerance response in oral bacteria.
Lactobacillus rhamnosus GG Culturelle® Lipoteichoic Acid from Lacticaseibacillus rhamnosus GG Modulates Dendritic Cells and T Cells in the Gut.
Lactobacillus rhamnosus GG Culturelle® Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis.
Lactobacillus rhamnosus GG Culturelle® Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Lipoteichoic Acid of Probiotic <i>Lactobacillus plantarum</i> Attenuates Poly I:C-Induced IL-8 Production in Porcine Intestinal Epithelial Cells.
Lactobacillus rhamnosus GG Culturelle® Lipoteichoic acids of lactobacilli inhibit Enterococcus faecalis biofilm formation and disrupt the preformed biofilm.
Lactobacillus rhamnosus GG Culturelle® Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats.
Lactobacillus rhamnosus GG Culturelle® Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells.
Lactobacillus rhamnosus GG Culturelle® Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells.
Lactobacillus rhamnosus GG Culturelle® Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages.
Lactobacillus rhamnosus GG Culturelle® Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model.
Lactobacillus rhamnosus GG Culturelle® Live probiotic bacteria administered in a pathomimetic Leaky Gut Chip ameliorate impaired epithelial barrier and mucosal inflammation.
Lactobacillus rhamnosus GG Culturelle® Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG.
Lactobacillus rhamnosus GG Culturelle® Living, quiescent Lactobacillus plantarum Lp90 probiotic, delivered topically to full thickness tissues in vitro via a just-add-water cream delivery system, stimulates the expression of elastin protein.
Lactobacillus rhamnosus GG Culturelle® L-lactic acid production from apple pomace by sequential hydrolysis and fermentation.
Lactobacillus rhamnosus GG Culturelle® Long-Term Lacticaseibacillus rhamnosus GG Storage at Ambient Temperature in Vegetable Oil: Viability and Functional Assessments.
Lactobacillus rhamnosus GG Culturelle® Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials.
Lactobacillus rhamnosus GG Culturelle® Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up.
Lactobacillus rhamnosus GG Culturelle® Low concentrations of Lactobacillus rhamnosus GG (Yoba<sup>®</sup>) are safe in male Drosophila melanogaster.
Lactobacillus rhamnosus GG Culturelle® Low Interleukin 10 Production at Birth Is a Risk Factor for Atopic Dermatitis in Neonates with Bifidobacterium Colonization.
Lactobacillus rhamnosus GG Culturelle® Low Maternal Microbiota Sharing across Gut, Breast Milk and Vagina, as Revealed by 16S rRNA Gene and Reduced Metagenomic Sequencing.
Lactobacillus rhamnosus GG Culturelle® Lung transcriptional unresponsiveness and loss of early influenza virus control in infected neonates is prevented by intranasal Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Management strategies in the treatment of neonatal and pediatric gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
Lactobacillus rhamnosus GG Culturelle® Manufacturing process influences properties of probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Maternal Supplementation with LGG Reduces Vaccine-Specific Immune Responses in Infants at High-Risk of Developing Allergic Disease.
Lactobacillus rhamnosus GG Culturelle® Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages.
Lactobacillus rhamnosus GG Culturelle® Mechanism of Action of Probiotic Bacteria on Intestinal and Systemic Immunities and Antigen-Presenting Cells.
Lactobacillus rhamnosus GG Culturelle® Membrane Emulsification as an Emerging Method for Lacticaseibacillus rhamnosus GG(®) Encapsulation.
Lactobacillus rhamnosus GG Culturelle® Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
Lactobacillus rhamnosus GG Culturelle® Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children--updated analysis of randomised controlled trials.
Lactobacillus rhamnosus GG Culturelle® Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.
Lactobacillus rhamnosus GG Culturelle® Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease.
Lactobacillus rhamnosus GG Culturelle® Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children.
Lactobacillus rhamnosus GG Culturelle® Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway.
Lactobacillus rhamnosus GG Culturelle® Metabolomic Analysis of Lactobacillus acidophilus, L. gasseri, L. crispatus, and Lacticaseibacillus rhamnosus Strains in the Presence of Pomegranate Extract.
Lactobacillus rhamnosus GG Culturelle® Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.
Lactobacillus rhamnosus GG Culturelle® Mg<sup>2+</sup> improves the thermotolerance of probiotic Lactobacillus rhamnosus GG, Lactobacillus casei Zhang and Lactobacillus plantarum P-8.
Lactobacillus rhamnosus GG Culturelle® Microarray analysis and motif detection reveal new targets of the Salmonella enterica serovar Typhimurium HilA regulatory protein, including hilA itself.
Lactobacillus rhamnosus GG Culturelle® Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease.
Lactobacillus rhamnosus GG Culturelle® Microbiological and physicochemical quality of fresh-cut apple enriched with the probiotic strain Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Microbiota-Mediated Modulation of Organophosphate Insecticide Toxicity by Species-Dependent Interactions with Lactobacilli in a Drosophila melanogaster Insect Model.
Lactobacillus rhamnosus GG Culturelle® Microencapsulated Lactobacillus rhamnosus GG powders: relationship of powder physical properties to probiotic survival during storage.
Lactobacillus rhamnosus GG Culturelle® Microencapsulates by spray of Lacticaseibacillus rhamnosus GG from fermented whole or skimmed cow`s milk added with Mexican honeysuckle (Justicia spicigera) extract using mesquite gum as carrier agent.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation and Application of Probiotic Bacteria Lactiplantibacillus plantarum 299v Strain.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation of <i>Lactobacillus rhamnosus</i> GG with flaxseed mucilage using co-extrusion technique.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation of Lacticaseibacillus rhamnosus GG and L. plantarum 299 V by reverse spherification: a promising method to improve the survival of probiotics.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation of Lacticaseibacillus rhamnosus GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation of Lactobacillus casei and Lactobacillus rhamnosus in pectin and pectin-inulin microgel particles: Effect on bacterial survival under storage conditions.
Lactobacillus rhamnosus GG Culturelle® Microencapsulation of Lactobacillus rhamnosus GG by Transglutaminase Cross-Linked Soy Protein Isolate to Improve Survival in Simulated Gastrointestinal Conditions and Yoghurt.
Lactobacillus rhamnosus GG Culturelle® Micro-organisms administered in the benefit of the host: myths and facts.
Lactobacillus rhamnosus GG Culturelle® Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Milk Fat Globule Membrane Protects <i>Lactobacillus rhamnosus</i> GG from Bile Stress by Regulating Exopolysaccharide Production and Biofilm Formation.
Lactobacillus rhamnosus GG Culturelle® Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model.
Lactobacillus rhamnosus GG Culturelle® Mixed fermentation of blueberry pomace with L. rhamnosus GG and L. plantarum-1: Enhance the active ingredient, antioxidant activity and health-promoting benefits.
Lactobacillus rhamnosus GG Culturelle® Modulation of Active Gut Microbiota by <i>Lactobacillus rhamnosus</i> GG in a Diet Induced Obesity Murine Model.
Lactobacillus rhamnosus GG Culturelle® Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.
Lactobacillus rhamnosus GG Culturelle® Modulation of intestinal morphology and immunity in nile tilapia (Oreochromis niloticus) by Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Modulation of Lactobacillus rhamnosus GG on the gut microbiota and metabolism in mice with Clostridioides difficile infection.
Lactobacillus rhamnosus GG Culturelle® Modulation of Macrophage Function by <i>Lactobacillus</i>-Conditioned Medium.
Lactobacillus rhamnosus GG Culturelle® Modulation of Th1/Th2 balance by Lactobacillus strains isolated from Kimchi via stimulation of macrophage cell line J774A.1 in vitro.
Lactobacillus rhamnosus GG Culturelle® Modulation of the Gut Microbiome and Obesity Biomarkers by Lactobacillus Plantarum KC28 in a Diet-Induced Obesity Murine Model.
Lactobacillus rhamnosus GG Culturelle® Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28.
Lactobacillus rhamnosus GG Culturelle® Molecular Cloning, Expression of minD Gene from Lactobacillus acidophilus VTCC-B-871 and Analyses to Identify Lactobacillus rhamnosus PN04 from Vietnam Hottuynia cordata Thunb.
Lactobacillus rhamnosus GG Culturelle® Mouthwash Effects on LGG-Integrated Experimental Oral Biofilms.
Lactobacillus rhamnosus GG Culturelle® Mucosal adhesion and anti-inflammatory effects of <i>Lactobacillus rhamnosus</i> GG in the human colonic mucosa: A proof-of-concept study.
Lactobacillus rhamnosus GG Culturelle® Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.
Lactobacillus rhamnosus GG Culturelle® Mucosal immunology and probiotics.
Lactobacillus rhamnosus GG Culturelle® Multifactorial inhibition of lactobacilli against the respiratory tract pathogen Moraxella catarrhalis.
Lactobacillus rhamnosus GG Culturelle® Multifunctional properties of <i>Lactobacillus plantarum</i> strains WiKim83 and WiKim87 as a starter culture for fermented food.
Lactobacillus rhamnosus GG Culturelle® Multiple Proteins of Lacticaseibacillus rhamnosus GG Are Involved in the Protection of Keratinocytes From the Toxic Effects of Staphylococcus aureus.
Lactobacillus rhamnosus GG Culturelle® N, O-codoped hierarchical porous graphitic carbon for electrochemical immunosensing of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Naturally Fermented Milk From Northern Senegal: Bacterial Community Composition and Probiotic Enrichment With <i>Lactobacillus rhamnosus</i>.
Lactobacillus rhamnosus GG Culturelle® NEC-like intestinal injury is ameliorated by Lactobacillus rhamnosus GG in parallel with SIGIRR and A20 induction in neonatal mice.
Lactobacillus rhamnosus GG Culturelle® Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood.
Lactobacillus rhamnosus GG Culturelle® Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life.
Lactobacillus rhamnosus GG Culturelle® Neurobehavioural effects of Lactobacillus rhamnosus GG alone and in combination with prebiotics polydextrose and galactooligosaccharide in male rats exposed to early-life stress.
Lactobacillus rhamnosus GG Culturelle® Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson`s Disease.
Lactobacillus rhamnosus GG Culturelle® New insights about pilus formation in gut-adapted Lactobacillus rhamnosus GG from the crystal structure of the SpaA backbone-pilin subunit.
Lactobacillus rhamnosus GG Culturelle® New insights in enumeration methodologies of probiotic cells in finished products.
Lactobacillus rhamnosus GG Culturelle® New lactic acid bacterial strains from traditional Mongolian fermented milk products have altered adhesion to porcine gastric mucin depending on the carbon source.
Lactobacillus rhamnosus GG Culturelle® Next-generation multiparameter flow cytometry assay improves the assessment of oxidative stress in probiotics.
Lactobacillus rhamnosus GG Culturelle® No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.
Lactobacillus rhamnosus GG Culturelle® No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses.
Lactobacillus rhamnosus GG Culturelle® Non-Melanoma Skin Cancer: news from microbiota research.
Lactobacillus rhamnosus GG Culturelle® Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages.
Lactobacillus rhamnosus GG Culturelle® Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review.
Lactobacillus rhamnosus GG Culturelle® Non-thermal plasma and ultrasound-assisted open lactic acid fermentation of distillery stillage.
Lactobacillus rhamnosus GG Culturelle® Nutritionally enhanced fermented sausages as a vehicle for potential probiotic lactobacilli delivery.
Lactobacillus rhamnosus GG Culturelle® Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG).
Lactobacillus rhamnosus GG Culturelle® Online Monitoring of the Growth of Probiotic Bacteria and Metabolites in the Fermentation of a Teff Substrate Using Model-Based Calibration of 2D Fluorescence Spectra.
Lactobacillus rhamnosus GG Culturelle® Optimization of cultural conditions for enhancement of anti-quorum sensing potential in the probiotic strain Lactobacillus rhamnosus GG against Pseudomonas aeruginosa.
Lactobacillus rhamnosus GG Culturelle® Optimization of culture conditions for gamma-aminobutyric acid production in fermented adzuki bean milk.
Lactobacillus rhamnosus GG Culturelle® Optimization of lactic acid production using immobilized Lactobacillus Rhamnosus and carob pod waste from the Lebanese food industry.
Lactobacillus rhamnosus GG Culturelle® Optimizing Conditions in the Acid Tolerance Test for Potential Probiotics Using Response Surface Methodology.
Lactobacillus rhamnosus GG Culturelle® Oral Administration of <i>Lactobacillus rhamnosus</i> GG Ameliorates <i>Salmonella</i> Infantis-Induced Inflammation in a Pig Model via Activation of the IL-22BP/IL-22/STAT3 Pathway.
Lactobacillus rhamnosus GG Culturelle® Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection.
Lactobacillus rhamnosus GG Culturelle® Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets.
Lactobacillus rhamnosus GG Culturelle® Oral administration of lipoteichoic acid from Lactobacillus rhamnosus GG overcomes UVB-induced immunosuppression and impairs skin tumor growth in mice.
Lactobacillus rhamnosus GG Culturelle® Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial.
Lactobacillus rhamnosus GG Culturelle® Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
Lactobacillus rhamnosus GG Culturelle® Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
Lactobacillus rhamnosus GG Culturelle® Oral priming with oligodeoxynucleotide particles from Lactobacillus rhamnosus GG attenuates symptoms of dextran sodium sulfate-induced acute colitis in mice.
Lactobacillus rhamnosus GG Culturelle® Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Original behavior of L. rhamnosus GG encapsulated in freeze-dried alginate-silica microparticles revealed under simulated gastrointestinal conditions.
Lactobacillus rhamnosus GG Culturelle® P40 and P75 Are Singular Functional Muramidases Present in the <i>Lactobacillus casei /paracasei/rhamnosus</i> Taxon.
Lactobacillus rhamnosus GG Culturelle® Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
Lactobacillus rhamnosus GG Culturelle® Pathogen-Specific Effects of Probiotics in Children With Acute Gastroenteritis Seeking Emergency Care: A Randomized Trial.
Lactobacillus rhamnosus GG Culturelle® Peptide Extracts from Cultures of Certain Lactobacilli Inhibit Helicobacter pylori.
Lactobacillus rhamnosus GG Culturelle® Peptide profile of Camembert-type cheese: Effect of heat treatment and adjunct culture Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Peptides Affecting the Outer Membrane Lipid Asymmetry System (MlaA-OmpC/F) Reduce Avian Pathogenic Escherichia coli (APEC) Colonization in Chickens.
Lactobacillus rhamnosus GG Culturelle® Peptidoglycan recognition protein 3 (PglyRP3) has an anti-inflammatory role in intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring.
Lactobacillus rhamnosus GG Culturelle® Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption.
Lactobacillus rhamnosus GG Culturelle® Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.
Lactobacillus rhamnosus GG Culturelle® Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese.
Lactobacillus rhamnosus GG Culturelle® Persistence of the Probiotic Lacticaseibacillus rhamnosus Strain GG (LGG) in an In Vitro Model of the Gut Microbiome.
Lactobacillus rhamnosus GG Culturelle® Personalized B cell response to the <i>Lactobacillus rhamnosus GG</i> probiotic in healthy human subjects: a randomized trial.
Lactobacillus rhamnosus GG Culturelle® pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.
Lactobacillus rhamnosus GG Culturelle® Phenolic, flavonoid, and ß-carotene contents of provitamin A cassava hydrolysate with free and encapsulated Lactobacillus rhamnosus GG improves antioxidant biomarkers in kidney, heart and liver of Wistar rats.
Lactobacillus rhamnosus GG Culturelle® Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood.
Lactobacillus rhamnosus GG Culturelle® Phenotypical analysis of the Lactobacillus rhamnosus GG fimbrial spaFED operon: surface expression and functional characterization of recombinant SpaFED pili in Lactococcus lactis.
Lactobacillus rhamnosus GG Culturelle® pH-sustaining nanostructured hydroxyapatite/alginate composite hydrogel for gastric protection and intestinal release of Lactobacillus rhamnosusGG.
Lactobacillus rhamnosus GG Culturelle® Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media.
Lactobacillus rhamnosus GG Culturelle® Physicochemical analysis of non-fermented probiotic milk with probiotic Lactobacillus plantarum Ln1 isolated from Korea traditional fermented food.
Lactobacillus rhamnosus GG Culturelle® Physiological Characteristics and Anti-Diabetic Effect of Pediococcus pentosaceus KI62.
Lactobacillus rhamnosus GG Culturelle® Physiological Characteristics and Anti-obesity Effect of <i>Lactobacillus plantarum</i> K10.
Lactobacillus rhamnosus GG Culturelle® Piliation of Lactobacillus rhamnosus GG promotes adhesion, phagocytosis, and cytokine modulation in macrophages.
Lactobacillus rhamnosus GG Culturelle® Pilins in gram-positive bacteria: A structural perspective.
Lactobacillus rhamnosus GG Culturelle® Pilot Analysis of Early Lactobacillus rhamnosus GG for Infant Colic Prevention.
Lactobacillus rhamnosus GG Culturelle® Pistachio hull water-soluble polysaccharides as a novel prebiotic agent.
Lactobacillus rhamnosus GG Culturelle® Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson`s disease.
Lactobacillus rhamnosus GG Culturelle® Polymorphisms, Chromosomal Rearrangements, and Mutator Phenotype Development during Experimental Evolution of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Polysaccharide Hydrogels for the Protection of Dairy-Related Microorganisms in Adverse Environmental Conditions.
Lactobacillus rhamnosus GG Culturelle® Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics.
Lactobacillus rhamnosus GG Culturelle® Porphyromonas gingivalis induces cardiovascular dysfunction.
Lactobacillus rhamnosus GG Culturelle® Postbiotic Fractions of Probiotics Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG Show Immune-Modulating Effects.
Lactobacillus rhamnosus GG Culturelle® Postnatal probiotic supplementation can prevent and optimize treatment of childhood asthma and atopic disorders: A systematic review of randomized controlled trials.
Lactobacillus rhamnosus GG Culturelle® Potential Application of Apilactobacillus kunkeei for Human Use: Evaluation of Probiotic and Functional Properties.
Lactobacillus rhamnosus GG Culturelle® Potential beneficial properties of bacteriocin-producing lactic acid bacteria isolated from smoked salmon.
Lactobacillus rhamnosus GG Culturelle® Potential bioaccessibility of phenolic acids in whole wheat products during in vitro gastrointestinal digestion and probiotic fermentation.
Lactobacillus rhamnosus GG Culturelle® Potential Health-Promoting Effects of Two Candidate Probiotics Isolated from Infant Feces Using an Immune-Based Screening Strategy.
Lactobacillus rhamnosus GG Culturelle® Potential neuroprotective effects of heat-killed <i>Lactococcus lactis</i> KC24 using SH-SY5Y cells against oxidative stress induced by hydrogen peroxide.
Lactobacillus rhamnosus GG Culturelle® Potentially probiotic and bioprotective lactic acid bacteria starter cultures antagonise the Listeria monocytogenes adhesion to HT29 colonocyte-like cells.
Lactobacillus rhamnosus GG Culturelle® Prebiotic Agrocybe cylindracea crude polysaccharides combined with Lactobacillus rhamnosus GG postpone aging-related oxidative stress in mice.
Lactobacillus rhamnosus GG Culturelle® Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats.
Lactobacillus rhamnosus GG Culturelle® Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children.
Lactobacillus rhamnosus GG Culturelle® Pre-cultivation with Selected Prebiotics Enhances the Survival and the Stress Response of <i>Lactobacillus rhamnosus</i> Strains in Simulated Gastrointestinal Transit.
Lactobacillus rhamnosus GG Culturelle® Preliminary evaluation of Lactobacillus rhamnosus strain GG, a potential probiotic in dogs.
Lactobacillus rhamnosus GG Culturelle® Preliminary evaluation of probiotic properties of Lactobacillus strains isolated from Sardinian dairy products.
Lactobacillus rhamnosus GG Culturelle® Preliminary Evaluation of the Safety and Probiotic Potential of <i>Akkermansia muciniphila</i> DSM 22959 in Comparison with <i>Lactobacillus rhamnosus</i> GG.
Lactobacillus rhamnosus GG Culturelle® Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.
Lactobacillus rhamnosus GG Culturelle® Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Preservation of viability and antibacterial activity of Lactobacillus spp. in calcium alginate beads.
Lactobacillus rhamnosus GG Culturelle® Preserving viability of Lactobacillus rhamnosus GG in vitro and in vivo by a new encapsulation system.
Lactobacillus rhamnosus GG Culturelle® Presumed Allergic Proctocolitis Resolves with Probiotic Monotherapy: A Report of 4 Cases.
Lactobacillus rhamnosus GG Culturelle® Prevention of High-Fat Diet-Induced Hypercholesterolemia by Lactobacillus reuteri Fn041 Through Promoting Cholesterol and Bile Salt Excretion and Intestinal Mucosal Barrier Functions.
Lactobacillus rhamnosus GG Culturelle® Preventive Effects of Probiotic Supplementation on Neonatal Hyperbilirubinemia Caused by Isoimmunization.
Lactobacillus rhamnosus GG Culturelle® Primary care experience on Rinfodim 3® in children with recurrent respiratory infections.
Lactobacillus rhamnosus GG Culturelle® Primary exploration of host-microorganism interaction and enteritis treatment with an embedded membrane microfluidic chip of the human intestinal-vascular microsystem.
Lactobacillus rhamnosus GG Culturelle® Probiotic <i>Lactobacillus rhamnosus</i> GG Induces Alterations in Ileal Microbiota With Associated CD3<sup>-</sup>CD19<sup>-</sup>T-bet<sup>+</sup>IFN?<sup>+/-</sup> Cell Subset Homeostasis in Pigs Challenged With <i>Salmonella enterica</i> Serovar 4,[5],12:i:.
Lactobacillus rhamnosus GG Culturelle® Probiotic <i>Lactobacillus rhamnosus</i> GG Promotes Mouse Gut Microbiota Diversity and T Cell Differentiation.
Lactobacillus rhamnosus GG Culturelle® Probiotic <i>Lactobacillus</i> Strains Stimulate the Inflammatory Response and Activate Human Macrophages.
Lactobacillus rhamnosus GG Culturelle® Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis.
Lactobacillus rhamnosus GG Culturelle® Probiotic agents and infectious diseases: a modern perspective on a traditional therapy.
Lactobacillus rhamnosus GG Culturelle® Probiotic and Antioxidant Properties of Novel <i>Lactobacillus brevis</i> KCCM 12203P Isolated from Kimchi and Evaluation of Immune-Stimulating Activities of Its Heat-Killed Cells in RAW 264.7 Cells.
Lactobacillus rhamnosus GG Culturelle® Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease.
Lactobacillus rhamnosus GG Culturelle® Probiotic attributes and prevention of LPS-induced pro-inflammatory stress in RAW264.7 macrophages and human intestinal epithelial cell line (Caco-2) by newly isolated Weissella cibaria strains.
Lactobacillus rhamnosus GG Culturelle® Probiotic attributes of autochthonous Lactobacillus rhamnosus strains of human origin.
Lactobacillus rhamnosus GG Culturelle® Probiotic attributes of Lactobacillus strains isolated from food and of human origin.
Lactobacillus rhamnosus GG Culturelle® Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence.
Lactobacillus rhamnosus GG Culturelle® Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88.
Lactobacillus rhamnosus GG Culturelle® Probiotic bacteria cell surface-associated protein mineralized hydroxyapatite incorporated in porous scaffold: In vitro evaluation for bone cell growth and differentiation.
Lactobacillus rhamnosus GG Culturelle® Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function.
Lactobacillus rhamnosus GG Culturelle® Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.
Lactobacillus rhamnosus GG Culturelle® Probiotic Bacterial and Fungal Strains: Claims with Evidence.
Lactobacillus rhamnosus GG Culturelle® Probiotic Bacterial Application in Pediatric Critical Illness as Coadjuvants of Therapy.
Lactobacillus rhamnosus GG Culturelle® Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Probiotic characteristics and zearalenone-removal ability of a Bacillus licheniformis strain.
Lactobacillus rhamnosus GG Culturelle® Probiotic Characteristics of Lactobacillus plantarum FH185 Isolated from Human Feces.
Lactobacillus rhamnosus GG Culturelle® Probiotic characterization of <i>Lactobacillus brevis</i> KU15153 showing antimicrobial and antioxidant effect isolated from kimchi.
Lactobacillus rhamnosus GG Culturelle® Probiotic coated with glycol chitosan/alginate relieves oxidative damage and gut dysmotility induced by oxytetracycline in zebrafish larvae.
Lactobacillus rhamnosus GG Culturelle® Probiotic Cocktail Identified by Microbial Network Analysis Inhibits Growth, Virulence Gene Expression, and Host Cell Colonization of Vancomycin-Resistant Enterococci.
Lactobacillus rhamnosus GG Culturelle® Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.
Lactobacillus rhamnosus GG Culturelle® Probiotic edible films as a new strategy for developing functional bakery products: The case of pan bread.
Lactobacillus rhamnosus GG Culturelle® Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats.
Lactobacillus rhamnosus GG Culturelle® Probiotic effects on experimental graft-versus-host disease: let them eat yogurt.
Lactobacillus rhamnosus GG Culturelle® Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage.
Lactobacillus rhamnosus GG Culturelle® Probiotic features of Lactobacillus strains isolated from Ragusano and Pecorino Siciliano cheeses.
Lactobacillus rhamnosus GG Culturelle® Probiotic Gut Microbiota Isolate Interacts with Dendritic Cells via Glycosylated Heterotrimeric Pili.
Lactobacillus rhamnosus GG Culturelle® Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection.
Lactobacillus rhamnosus GG Culturelle® Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults.
Lactobacillus rhamnosus GG Culturelle® Probiotic intervention in neonates--will permanent colonization ensue?
Lactobacillus rhamnosus GG Culturelle® Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota.
Lactobacillus rhamnosus GG Culturelle® Probiotic intervention influences the salivary levels of Matrix Metalloproteinase (MMP)-9 and Tissue Inhibitor of metalloproteinases (TIMP)-1 in healthy adults.
Lactobacillus rhamnosus GG Culturelle® Probiotic lactic acid bacteria isolated from traditional Korean fermented foods based on ß-glucosidase activity.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lacticaseibacillus rhamnosus GG Increased Longevity and Resistance Against Foodborne Pathogens in Caenorhabditis elegans by Regulating MicroRNA miR-34.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration.
Lactobacillus rhamnosus GG Culturelle® Probiotic lactobacilli and bacteraemia in Stockholm.
Lactobacillus rhamnosus GG Culturelle® Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus fermentum KU200060 isolated from watery kimchi and its application in probiotic yogurt for oral health.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus plantarum Ln4 Showing Antimicrobial and Antibiofilm Effect against Streptococcus mutans KCTC 5124 Causing Dental Caries.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG (LGG) restores intestinal dysbacteriosis to alleviate upregulated inflammatory cytokines triggered by femoral diaphyseal fracture in adolescent rodent model.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG modulates the mucosal immune response in Giardia intestinalis-infected BALB/c mice.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG mono-association suppresses human rotavirus-induced autophagy in the gnotobiotic piglet intestine.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus Rhamnosus GG Protects Against P. Gingivalis And F. Nucleatum Gut Dysbiosis.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus GR-1 is a unique prophylactic agent that suppresses infection-induced myometrial cell responses.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus inhibits the formation of neutrophil extracellular traps.
Lactobacillus rhamnosus GG Culturelle® Probiotic Lactobacillus rhamnosus Reduces Organophosphate Pesticide Absorption and Toxicity to Drosophila melanogaster.
Lactobacillus rhamnosus GG Culturelle® Probiotic manipulation of the gastrointestinal microbiota.
Lactobacillus rhamnosus GG Culturelle® Probiotic modulation of dendritic cell function is influenced by ageing.
Lactobacillus rhamnosus GG Culturelle® Probiotic potential of selected lactic acid bacteria strains isolated from Brazilian kefir grains.
Lactobacillus rhamnosus GG Culturelle® Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis.
Lactobacillus rhamnosus GG Culturelle® Probiotic Properties and Immunomodulatory Activity of <i>Lactobacillus</i> Strains Isolated from Dairy Products.
Lactobacillus rhamnosus GG Culturelle® Probiotic Properties of <i>Bacillus</i> Strains Isolated from Stingless Bee (<i>Heterotrigona itama</i>) Honey Collected across Malaysia.
Lactobacillus rhamnosus GG Culturelle® Probiotic Properties of Lactic Acid Bacteria with High Conjugated Linoleic Acid Converting Activity Isolated from Jeot-Gal, High-Salt Fermented Seafood.
Lactobacillus rhamnosus GG Culturelle® Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage.
Lactobacillus rhamnosus GG Culturelle® Probiotic properties of Pediococcus strains isolated from jeotgals, salted and fermented Korean sea-food.
Lactobacillus rhamnosus GG Culturelle® Probiotic properties of Weissella strains isolated from human faeces.
Lactobacillus rhamnosus GG Culturelle® Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotic screening and safety evaluation of Lactobacillus strains from plants, artisanal goat cheese, human stools, and breast milk.
Lactobacillus rhamnosus GG Culturelle® Probiotic Supplementation and High-Intensity Interval Training Modify Anxiety-Like Behaviors and Corticosterone in High-Fat Diet-Induced Obesity Mice.
Lactobacillus rhamnosus GG Culturelle® Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
Lactobacillus rhamnosus GG Culturelle® Probiotic supplementation in healthy pre-school-aged children: What, why, how and when?
Lactobacillus rhamnosus GG Culturelle® Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants.
Lactobacillus rhamnosus GG Culturelle® Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being.
Lactobacillus rhamnosus GG Culturelle® Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men.
Lactobacillus rhamnosus GG Culturelle® Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation.
Lactobacillus rhamnosus GG Culturelle® Probiotic-fermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL/6J mice.
Lactobacillus rhamnosus GG Culturelle® Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma.
Lactobacillus rhamnosus GG Culturelle® Probiotics (Lactobacillus acidophilus and Lactobacillus rhamnosus GG) in Conjunction with Celecoxib (selective COX-2 inhibitor) Modulated DMH-Induced Early Experimental Colon Carcinogenesis.
Lactobacillus rhamnosus GG Culturelle® Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics ameliorate chronic low-grade inflammation and fat accumulation with gut microbiota composition change in diet-induced obese mice models.
Lactobacillus rhamnosus GG Culturelle® Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism.
Lactobacillus rhamnosus GG Culturelle® Probiotics and allergy.
Lactobacillus rhamnosus GG Culturelle® Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment.
Lactobacillus rhamnosus GG Culturelle® Probiotics and carriage of Streptococcus pneumoniae serotypes in Danish children, a double-blind randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine.
Lactobacillus rhamnosus GG Culturelle® Probiotics and Crohn`s disease.
Lactobacillus rhamnosus GG Culturelle® Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics and dietary counselling targeting maternal dietary fat intake modifies breast milk fatty acids and cytokines.
Lactobacillus rhamnosus GG Culturelle® Probiotics and gastrointestinal health.
Lactobacillus rhamnosus GG Culturelle® Probiotics and Maternal Mental Health: A Randomised Controlled Trial among Pregnant Women with Obesity.
Lactobacillus rhamnosus GG Culturelle® Probiotics and Periodontitis - A Literature Review.
Lactobacillus rhamnosus GG Culturelle® Probiotics and prebiotics: effects on diarrhea.
Lactobacillus rhamnosus GG Culturelle® Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.
Lactobacillus rhamnosus GG Culturelle® Probiotics and prevention of allergic disease.
Lactobacillus rhamnosus GG Culturelle® Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics and prevention of Clostridium difficile infection.
Lactobacillus rhamnosus GG Culturelle® Probiotics and respiratory and gastrointestinal tract infections in Finnish military conscripts - a randomised placebo-controlled double-blinded study.
Lactobacillus rhamnosus GG Culturelle® Probiotics and the immunological response to infant vaccinations; a double-blind randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics and their potential health claims.
Lactobacillus rhamnosus GG Culturelle® Probiotics and virulent human rotavirus modulate the transplanted human gut microbiota in gnotobiotic pigs.
Lactobacillus rhamnosus GG Culturelle® Probiotics as prevention and treatment for diarrhea.
Lactobacillus rhamnosus GG Culturelle® Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections.
Lactobacillus rhamnosus GG Culturelle® Probiotics as treatment for food allergies among pediatric patients: a meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Probiotics attenuate alcohol-induced muscle mechanical hyperalgesia: Preliminary observations.
Lactobacillus rhamnosus GG Culturelle® Probiotics enhance resistance to Streptococcus iniae in Nile tilapia (Oreochromis niloticus) reared in biofloc systems.
Lactobacillus rhamnosus GG Culturelle® Probiotics exert reciprocal effects on autophagy and interleukin-1ß expression in <i>Salmonella-</i>infected intestinal epithelial cells via autophagy-related 16L1 protein.
Lactobacillus rhamnosus GG Culturelle® Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water.
Lactobacillus rhamnosus GG Culturelle® Probiotics for chronic low back pain with type 1 Modic changes: a randomized double-blind, placebo-controlled trial with 1-year follow-up using Lactobacillus Rhamnosis GG.
Lactobacillus rhamnosus GG Culturelle® Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
Lactobacillus rhamnosus GG Culturelle® Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region.
Lactobacillus rhamnosus GG Culturelle® Probiotics for induction of remission in Crohn`s disease.
Lactobacillus rhamnosus GG Culturelle® Probiotics for infantile colic: Is there evidence beyond doubt? A meta-analysis and systematic review.
Lactobacillus rhamnosus GG Culturelle® Probiotics for maintaining remission of ulcerative colitis in adults.
Lactobacillus rhamnosus GG Culturelle® Probiotics for management of functional abdominal pain disorders in children.
Lactobacillus rhamnosus GG Culturelle® Probiotics for paediatric functional abdominal pain disorders: A rapid review.
Lactobacillus rhamnosus GG Culturelle® Probiotics for Prevention and Treatment of Clostridium difficile Infection.
Lactobacillus rhamnosus GG Culturelle® Probiotics for prevention and treatment of diarrhea.
Lactobacillus rhamnosus GG Culturelle® Probiotics for Prevention and Treatment of Diarrhea.
Lactobacillus rhamnosus GG Culturelle® Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
Lactobacillus rhamnosus GG Culturelle® Probiotics for respiratory tract infections in children attending day care centers-a systematic review.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the Prevention of Acute Respiratory-Tract Infections in Older People: Systematic Review.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients-A Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the Prevention of Nosocomial Diarrhea in Children.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Lactobacillus rhamnosus GG Culturelle® Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials.
Lactobacillus rhamnosus GG Culturelle® Probiotics for treating acute infectious diarrhoea.
Lactobacillus rhamnosus GG Culturelle® Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations.
Lactobacillus rhamnosus GG Culturelle® Probiotics in antibiotic-associated diarrhoea.
Lactobacillus rhamnosus GG Culturelle® Probiotics in Children: What Is the Evidence?
Lactobacillus rhamnosus GG Culturelle® Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Lactobacillus rhamnosus GG Culturelle® Probiotics in digestive diseases: focus on Lactobacillus GG.
Lactobacillus rhamnosus GG Culturelle® Probiotics in Functional Gastrointestinal Disorders.
Lactobacillus rhamnosus GG Culturelle® Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
Lactobacillus rhamnosus GG Culturelle® Probiotics in the treatment and prevention of allergies in children.
Lactobacillus rhamnosus GG Culturelle® Probiotics Increase Intramuscular Fat and Improve the Composition of Fatty Acids in Sunit Sheep through the Adenosine 5`-Monophosphate-Activated Protein Kinase (AMPK) Signaling Pathway.
Lactobacillus rhamnosus GG Culturelle® Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
Lactobacillus rhamnosus GG Culturelle® Probiotics Lactobacillus rhamnosus GG ATCC53103 and Lactobacillus plantarum JL01 induce cytokine alterations by the production of TCDA, DHA, and succinic and palmitic acids, and enhance immunity of weaned piglets.
Lactobacillus rhamnosus GG Culturelle® Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats.
Lactobacillus rhamnosus GG Culturelle® Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.
Lactobacillus rhamnosus GG Culturelle® Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season.
Lactobacillus rhamnosus GG Culturelle® Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis.
Lactobacillus rhamnosus GG Culturelle® Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis.
Lactobacillus rhamnosus GG Culturelle® Probiotics protect against tenofovir-induced mandibular bone loss in mice by rescuing mandible-derived mesenchymal stem cell proliferation and osteogenic differentiation.
Lactobacillus rhamnosus GG Culturelle® Probiotics Reduce Necrotizing Enterocolitis Severity in HIV-exposed Premature Infants.
Lactobacillus rhamnosus GG Culturelle® Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants.
Lactobacillus rhamnosus GG Culturelle® Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans.
Lactobacillus rhamnosus GG Culturelle® Probiotics, feeding tolerance, and growth: a comparison between HIV-exposed and unexposed very low birth weight infants.
Lactobacillus rhamnosus GG Culturelle® Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children.
Lactobacillus rhamnosus GG Culturelle® Probiotics, prebiotics and food allergy.
Lactobacillus rhamnosus GG Culturelle® Probiotics, prebiotics, and synbiotics.
Lactobacillus rhamnosus GG Culturelle® Probiotics.
Lactobacillus rhamnosus GG Culturelle® Probiotics: "living drugs".
Lactobacillus rhamnosus GG Culturelle® Probiotics: an update.
Lactobacillus rhamnosus GG Culturelle® Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial.
Lactobacillus rhamnosus GG Culturelle® Probiotics: sorting the evidence from the myths.
Lactobacillus rhamnosus GG Culturelle® Probiotics: To Use or Not to Use? That Is the Question.
Lactobacillus rhamnosus GG Culturelle® Probiotics-supplemented feeding in extremely low-birth-weight infants.
Lactobacillus rhamnosus GG Culturelle® Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis.
Lactobacillus rhamnosus GG Culturelle® Production and Characterization of a Novel Symbiotic Plant-based Beverage Rich in Antioxidant Phenolic: Mung Bean and Rye Sprouts.
Lactobacillus rhamnosus GG Culturelle® Production of a Functional Factor, p40, by Lactobacillus rhamnosus GG Is Promoted by Intestinal Epithelial Cell-Secreted Extracellular Vesicles.
Lactobacillus rhamnosus GG Culturelle® Proline-Rich Acidic Protein 1 (PRAP1) Protects the Gastrointestinal Epithelium From Irradiation-Induced Apoptosis.
Lactobacillus rhamnosus GG Culturelle® Prophylactic effects of oral administration of <i>Lactobacillus casei</i> on house dust mite-induced asthma in mice.
Lactobacillus rhamnosus GG Culturelle® Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis.
Lactobacillus rhamnosus GG Culturelle® Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study.
Lactobacillus rhamnosus GG Culturelle® Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.
Lactobacillus rhamnosus GG Culturelle® Protecting Effect of Bacillus coagulans T242 on HT-29 Cells Against AAPH-Induced Oxidative Damage.
Lactobacillus rhamnosus GG Culturelle® Protection from gastrointestinal diseases with the use of probiotics.
Lactobacillus rhamnosus GG Culturelle® Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Protective Effect of <i>Lactobacillus rhamnosus</i> GG on TiO<sub>2</sub> Nanoparticles-Induced Oxidative Stress Damage in the Liver of Young Rats.
Lactobacillus rhamnosus GG Culturelle® Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway.
Lactobacillus rhamnosus GG Culturelle® Protective Effects of a Novel <i>Lactobacillus brevis</i> Strain with Probiotic Characteristics Against <i>Staphylococcus aureus</i> Lipoteichoic Acid-Induced Intestinal Inflammatory Response.
Lactobacillus rhamnosus GG Culturelle® Protective effects of a novel Lactobacillus rhamnosus strain with probiotic characteristics against lipopolysaccharide-induced intestinal inflammation in vitro and in vivo.
Lactobacillus rhamnosus GG Culturelle® Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice.
Lactobacillus rhamnosus GG Culturelle® Protective effects of Lactobacillus rhamnosus GG against human rotavirus-induced diarrhoea in a neonatal mouse model.
Lactobacillus rhamnosus GG Culturelle® Protective Role of Postbiotic Mediators Secreted by Lactobacillus rhamnosus GG Versus Lipopolysaccharide-induced Damage in Human Colonic Smooth Muscle Cells.
Lactobacillus rhamnosus GG Culturelle® Proteome analysis of Lactobacillus rhamnosus GG using 2-D DIGE and mass spectrometry shows differential protein production in laboratory and industrial-type growth media.
Lactobacillus rhamnosus GG Culturelle® Proteomic analysis of microbial induced redox-dependent intestinal signaling.
Lactobacillus rhamnosus GG Culturelle® Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Protocol for a double-blind placebo-controlled trial to evaluate the efficacy of probiotics in reducing antibiotics for infection in care home residents: the Probiotics to Reduce Infections iN CarE home reSidentS (PRINCESS) trial.
Lactobacillus rhamnosus GG Culturelle® Purification and characterization of a proteinase from the probiotic Lactobacillus rhamnosus OXY.
Lactobacillus rhamnosus GG Culturelle® Purification, crystallization and preliminary crystallographic analysis of the SpaA backbone-pilin subunit from probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Purification, crystallization and preliminary X-ray diffraction analysis of SpaD, a backbone-pilin subunit encoded by the fimbrial spaFED operon in Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Quality control Lactobacillus strains for use with the API 50CH and API ZYM systems at 37 degrees C.
Lactobacillus rhamnosus GG Culturelle® Quantitative Appraisal of the Probiotic Attributes and In Vitro Adhesion Potential of Anti-listerial Bacteriocin-producing Lactic Acid Bacteria.
Lactobacillus rhamnosus GG Culturelle® Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria.
Lactobacillus rhamnosus GG Culturelle® Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR.
Lactobacillus rhamnosus GG Culturelle® Raman spectroscopic analysis of Lactobacillus rhamnosus GG in response to dehydration reveals DNA conformation changes.
Lactobacillus rhamnosus GG Culturelle® Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo.
Lactobacillus rhamnosus GG Culturelle® Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation.
Lactobacillus rhamnosus GG Culturelle® Randomised controlled trial of <i>Lactobacillus rhamnosus</i> (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol.
Lactobacillus rhamnosus GG Culturelle® Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.
Lactobacillus rhamnosus GG Culturelle® Randomized Clinical Trial Examining the Impact of <i>Lactobacillus rhamnosus</i> GG Probiotic Supplementation on Cognitive Functioning in Middle-aged and Older Adults.
Lactobacillus rhamnosus GG Culturelle® Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow`s milk allergy: the EPICMA study.
Lactobacillus rhamnosus GG Culturelle® Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients.
Lactobacillus rhamnosus GG Culturelle® Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy.
Lactobacillus rhamnosus GG Culturelle® Rapid adoption of Lactobacillus rhamnosus GG for acute gastroenteritis.
Lactobacillus rhamnosus GG Culturelle® Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD.
Lactobacillus rhamnosus GG Culturelle® Recovery of Lactobacillus rhamnosus GG from human colonic biopsies.
Lactobacillus rhamnosus GG Culturelle® Recovery of probiotic Lactobacillus rhamnosus GG in tonsil tissue after oral administration: randomised, placebo-controlled, double-blind clinical trial.
Lactobacillus rhamnosus GG Culturelle® Reduced neonatal regulatory T cell response to microbial stimuli associates with subsequent eczema in high-risk infants.
Lactobacillus rhamnosus GG Culturelle® Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation.
Lactobacillus rhamnosus GG Culturelle® Reduction in biogenic amines in douchi fermented by probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Reduction in cholesterol absorption in Caco-2 cells through the down-regulation of Niemann-Pick C1-like 1 by the putative probiotic strains Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 from fermented foods.
Lactobacillus rhamnosus GG Culturelle® Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin.
Lactobacillus rhamnosus GG Culturelle® Refinement of a therapeutic Shiga toxin-binding probiotic for human trials.
Lactobacillus rhamnosus GG Culturelle® Regulation of TLR4, p38 MAPkinase, I?B and miRNAs by inactivated strains of lactobacilli in human dendritic cells.
Lactobacillus rhamnosus GG Culturelle® Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow`s milk allergy in Italy.
Lactobacillus rhamnosus GG Culturelle® Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow`s milk allergy in Poland.
Lactobacillus rhamnosus GG Culturelle® Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow`s milk allergy in Spain.
Lactobacillus rhamnosus GG Culturelle® Removal of cholera toxin from aqueous solution by probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium.
Lactobacillus rhamnosus GG Culturelle® Removal of microcystin-LR by strains of metabolically active probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Removal of paralytic shellfish toxins by probiotic lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Removal of the cyanobacterial toxin microcystin-LR by human probiotics.
Lactobacillus rhamnosus GG Culturelle® Resistance of Lactobacillus plantarum KCTC 3099 from Kimchi to oxidative stress.
Lactobacillus rhamnosus GG Culturelle® Restitution of gut microbiota in Ugandan children administered with probiotics (<i>Lactobacillus rhamnosus</i> GG and <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB-12) during treatment for severe acute malnutrition.
Lactobacillus rhamnosus GG Culturelle® Restraining the TiO<sub>2</sub> nanoparticles-induced intestinal inflammation mediated by gut microbiota in juvenile rats via ingestion of Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Reversible aberrancies in gut microbiome of moderate and late preterm infants: results from a randomized, controlled trial.
Lactobacillus rhamnosus GG Culturelle® Ribosome-Engineered <i>Lacticaseibacillus rhamnosus</i> Strain GG Exhibits Cell Surface Glyceraldehyde-3-Phosphate Dehydrogenase Accumulation and Enhanced Adhesion to Human Colonic Mucin.
Lactobacillus rhamnosus GG Culturelle® Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study.
Lactobacillus rhamnosus GG Culturelle® Role of Lipoteichoic Acid from the Genus Apilactobacillus in Inducing a Strong IgA Response.
Lactobacillus rhamnosus GG Culturelle® Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Lactobacillus rhamnosus GG Culturelle® Role of Surface Coverage of Sessile Probiotics in Their Interplay with Pathogen Bacteria Investigated by Digital Holographic Microscopy.
Lactobacillus rhamnosus GG Culturelle® Root caries prevention via sodium fluoride, chlorhexidine and silver diamine fluoride in vitro.
Lactobacillus rhamnosus GG Culturelle® Rotavirus immunisation status affects the efficacy of Lacticaseibacillus rhamnosus GG for the treatment of children with acute diarrhoea: a meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study.
Lactobacillus rhamnosus GG Culturelle® Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.
Lactobacillus rhamnosus GG Culturelle® Safety and Potential Role of Lactobacillus rhamnosus GG Administration as Monotherapy in Ulcerative Colitis Patients with Mild-Moderate Clinical Activity.
Lactobacillus rhamnosus GG Culturelle® Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials.
Lactobacillus rhamnosus GG Culturelle® Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation <i>in vitro</i> and <i>in vivo</i>.
Lactobacillus rhamnosus GG Culturelle® Selection and characterization of a SpaCBA pilus-secreting food-grade derivative of Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Selection of indigenous Lactobacillus paracasei CD4 and Lactobacillus gastricus BTM 7 as probiotic: assessment of traits combined with principal component analysis.
Lactobacillus rhamnosus GG Culturelle® Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests.
Lactobacillus rhamnosus GG Culturelle® Selective Antagonism of Lactiplantibacillus plantarum and Pediococcus acidilactici against Vibrio and Aeromonas in the Bacterial Community of Artemia nauplii.
Lactobacillus rhamnosus GG Culturelle® Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Sensory characterization of functional guava symbiotic petit cheese product.
Lactobacillus rhamnosus GG Culturelle® Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.
Lactobacillus rhamnosus GG Culturelle® Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia.
Lactobacillus rhamnosus GG Culturelle® Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics.
Lactobacillus rhamnosus GG Culturelle® Shaving and breaking bacterial chains with a viscous flow.
Lactobacillus rhamnosus GG Culturelle® Shear-Enhanced Dynamic Adhesion of Lactobacillus rhamnosus GG on Intestinal Epithelia: Correlative Effect of Protein Expression and Interface Mechanics.
Lactobacillus rhamnosus GG Culturelle® Short communication: effect of exopolysaccharide isolated from "viili" on the adhesion of probiotics and pathogens to intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells.
Lactobacillus rhamnosus GG Culturelle® Short-term consumption of probiotic lactobacilli has no effect on acid production of supragingival plaque.
Lactobacillus rhamnosus GG Culturelle® Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors.
Lactobacillus rhamnosus GG Culturelle® Short-Term Tolerability, Safety, and Gut Microbial Composition Responses to a Multi-Strain Probiotic Supplement: An Open-Label Study in Healthy Adults.
Lactobacillus rhamnosus GG Culturelle® Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.
Lactobacillus rhamnosus GG Culturelle® Single bioreactor gastrointestinal tract simulator for study of survival of probiotic bacteria.
Lactobacillus rhamnosus GG Culturelle® Single-cell force spectroscopy of pili-mediated adhesion.
Lactobacillus rhamnosus GG Culturelle® Solid-State Fermentation of Arthrospira platensis to Implement New Food Products: Evaluation of Stabilization Treatments and Bacterial Growth on the Volatile Fraction.
Lactobacillus rhamnosus GG Culturelle® Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.
Lactobacillus rhamnosus GG Culturelle® Soy protein diet, but not Lactobacillus rhamnosus GG, decreases mucin-1, trefoil factor-3, and tumor necrosis factor-a in colon of dextran sodium sulfate-treated C57BL/6 mice.
Lactobacillus rhamnosus GG Culturelle® SpaB, an atypically adhesive basal pilin from the lactobacillar SpaCBA pilus: crystallization and X-ray diffraction analysis.
Lactobacillus rhamnosus GG Culturelle® Species- and Age/Generation-Dependent Adherence of Bifidobacterium bifidum to Human Intestinal Mucus In Vitro.
Lactobacillus rhamnosus GG Culturelle® Specific Lactobacillus probiotic strains decrease transepithelial glucose transport through GLUT2 downregulation in intestinal epithelial cell models.
Lactobacillus rhamnosus GG Culturelle® Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland.
Lactobacillus rhamnosus GG Culturelle® Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study.
Lactobacillus rhamnosus GG Culturelle® Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution.
Lactobacillus rhamnosus GG Culturelle® SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women.
Lactobacillus rhamnosus GG Culturelle® Stability and activity of specific antibodies against Streptococcus mutans and Streptococcus sobrinus in bovine milk fermented with Lactobacillus rhamnosus strain GG or treated at ultra-high temperature.
Lactobacillus rhamnosus GG Culturelle® Stability of <i>Lactobacillus rhamnosus</i> GG incorporated in edible films: Impact of anionic biopolymers and whey protein concentrate.
Lactobacillus rhamnosus GG Culturelle® Stability of Lactobacillus rhamnosus GG in prebiotic edible films.
Lactobacillus rhamnosus GG Culturelle® Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Starch propionylation acts as novel encapsulant for probiotic bacteria: A structural and functional analysis.
Lactobacillus rhamnosus GG Culturelle® State transitions and physicochemical aspects of cryoprotection and stabilization in freeze-drying of Lactobacillus rhamnosus GG (LGG).
Lactobacillus rhamnosus GG Culturelle® Statistical optimization of bambara groundnut protein isolate-alginate matrix systems on survival of encapsulated <i>Lactobacillus rhamnosus</i> GG.
Lactobacillus rhamnosus GG Culturelle® Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates.
Lactobacillus rhamnosus GG Culturelle® Strain-specific differences in behaviour among Lacticaseibacillus rhamnosus cell wall mutants during direct compression.
Lactobacillus rhamnosus GG Culturelle® Strain-specific probiotics properties of Lactobacillus fermentum, Lactobacillus plantarum and Lactobacillus brevis isolates from Brazilian food products.
Lactobacillus rhamnosus GG Culturelle® Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Lactobacillus rhamnosus GG Culturelle® Streptococcus macedonicus strains isolated from traditional fermented milks: resistance to gastrointestinal environment and adhesion ability.
Lactobacillus rhamnosus GG Culturelle® Streptococcus mutans levels in patients who received orthodontic brackets bonded using probiotic impregnated resin composite - a randomized clinical trial.
Lactobacillus rhamnosus GG Culturelle® Streptococcus strain D19(T) as a probiotic candidate to modulate oral health.
Lactobacillus rhamnosus GG Culturelle® Streptococcus thermophilus MN-ZLW-002 Can Inhibit Pre-adipocyte Differentiation through Macrophage Activation.
Lactobacillus rhamnosus GG Culturelle® Stretching polysaccharides on live cells using single molecule force spectroscopy.
Lactobacillus rhamnosus GG Culturelle® Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid.
Lactobacillus rhamnosus GG Culturelle® Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern.
Lactobacillus rhamnosus GG Culturelle® Structural diversity and prebiotic potential of short chain ß-manno-oligosaccharides generated from guar gum by endo-ß-mannanase (ManB-1601).
Lactobacillus rhamnosus GG Culturelle® Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103).
Lactobacillus rhamnosus GG Culturelle® Study of adhesion and survival of lactobacilli and bifidobacteria on table olives with the aim of formulating a new probiotic food.
Lactobacillus rhamnosus GG Culturelle® Study of anti-virus actions of metabolites of lactobacteria.
Lactobacillus rhamnosus GG Culturelle® Study on the Influence of Tea Extract on Probiotics in Skim Milk: From Probiotics Propagation to Metabolite.
Lactobacillus rhamnosus GG Culturelle® Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.
Lactobacillus rhamnosus GG Culturelle® Sugar fermentation in probiotic bacteria--an in vitro study.
Lactobacillus rhamnosus GG Culturelle® Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes.
Lactobacillus rhamnosus GG Culturelle® Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein.
Lactobacillus rhamnosus GG Culturelle® Surface binding of aflatoxin B(1) by lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® Surface display of p75, a Lactobacillus rhamnosus GG derived protein, on Bacillus subtilis spores and its antibacterial activity against Listeria monocytogenes.
Lactobacillus rhamnosus GG Culturelle® Surface proteins involved in the adhesion of Streptococcus salivarius to human intestinal epithelial cells.
Lactobacillus rhamnosus GG Culturelle® Survivability of probiotics encapsulated in alginate gel microbeads using a novel impinging aerosols method.
Lactobacillus rhamnosus GG Culturelle® Survival and Goat Milk Acidifying Activity of Lactobacillus rhamnosus GG Encapsulated with Agave Fructans in a Buttermilk Protein Matrix.
Lactobacillus rhamnosus GG Culturelle® Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Lactobacillus rhamnosus GG Culturelle® Survival of Lactobacillus rhamnosus GG as influenced by storage conditions and product matrixes.
Lactobacillus rhamnosus GG Culturelle® Survival of Lactobacillus rhamnosus strains inoculated in cheese matrix during simulated human digestion.
Lactobacillus rhamnosus GG Culturelle® Survival of pathogenic and lactobacilli species of fermented olives during simulated human digestion.
Lactobacillus rhamnosus GG Culturelle® Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars.
Lactobacillus rhamnosus GG Culturelle® Symbiotic maple saps minimize disruption of the mice intestinal microbiota after oral antibiotic administration.
Lactobacillus rhamnosus GG Culturelle® Synbiotic Amazonian palm berry (açai, Euterpe oleracea Mart.) ice cream improved Lactobacillus rhamnosus GG survival to simulated gastrointestinal stress.
Lactobacillus rhamnosus GG Culturelle® Synbiotic fermented soymilk with Weissella cibaria FB069 and xylooligosaccharides prevents proliferation in human colon cancer cells.
Lactobacillus rhamnosus GG Culturelle® Synbiotic impact of tagatose on viability of Lactobacillus rhamnosus strain GG mediated by the phosphotransferase system (PTS).
Lactobacillus rhamnosus GG Culturelle® Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain.
Lactobacillus rhamnosus GG Culturelle® Synbiotic-fluoride synergism on enamel remineralization, cytotoxicity and genotoxicity.
Lactobacillus rhamnosus GG Culturelle® Synbiotics in caries prevention: A scoping review.
Lactobacillus rhamnosus GG Culturelle® Synergistic effects of Lacticaseibacillus rhamnosus GG, glutamine, and curcumin on chronic unpredictable mild stress-induced depression in a mouse model.
Lactobacillus rhamnosus GG Culturelle® Synergistic oligodeoxynucleotide strongly promotes CpG-induced interleukin-6 production.
Lactobacillus rhamnosus GG Culturelle® Synthesis of Fucosyl-Oligosaccharides Using a-l-Fucosidase from <i>Lactobacillus rhamnosus</i> GG.
Lactobacillus rhamnosus GG Culturelle® Systematic Exploration of the Glycoproteome of the Beneficial Gut Isolate Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Systematic Review of Probiotics for Cystic Fibrosis Patients: Moving Forward.
Lactobacillus rhamnosus GG Culturelle® Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus rhamnosus GG Culturelle® Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update.
Lactobacillus rhamnosus GG Culturelle® Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults.
Lactobacillus rhamnosus GG Culturelle® Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of ß-lactams for pathogen-selective killing of <i>Escherichia coli</i>.
Lactobacillus rhamnosus GG Culturelle® Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group.
Lactobacillus rhamnosus GG Culturelle® Taxon-Specific Effects of Lactobacillus on Drosophila Host Development.
Lactobacillus rhamnosus GG Culturelle® Teff-Based Probiotic Functional Beverage Fermented with Lactobacillus rhamnosus and Lactobacillus plantarum.
Lactobacillus rhamnosus GG Culturelle® Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption.
Lactobacillus rhamnosus GG Culturelle® The Ability of Riboflavin-Overproducing Lactiplantibacillus plantarum Strains to Survive Under Gastrointestinal Conditions.
Lactobacillus rhamnosus GG Culturelle® The Application of Spray-Dried and Reconstituted Flaxseed Oil Cake Extract as Encapsulating Material and Carrier for Probiotic Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® The colonization of a simulator of the human intestinal microbial ecosystem by a probiotic strain fed on a fermented oat bran product: effects on the gastrointestinal microbiota.
Lactobacillus rhamnosus GG Culturelle® The Conditioned Medium of Lactobacillus rhamnoides GG Regulates Microglia/Macrophage Polarization and Improves Functional Recovery after Spinal Cord Injury in Rats.
Lactobacillus rhamnosus GG Culturelle® The Cooperation of Bifidobacterium longum and Active Vitamin D3 on Innate Immunity in Salmonella Colitis Mice via Vitamin D Receptor.
Lactobacillus rhamnosus GG Culturelle® The Detrimental Effects of Peripartum Antibiotics on Gut Proliferation and Formula Feeding Injury in Neonatal Mice Are Alleviated with Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® The different effects of probiotics treatment on Salmonella-induced interleukin-8 response in intestinal epithelia cells via PI3K/Akt and NOD2 expression.
Lactobacillus rhamnosus GG Culturelle® The distinct effects of orally administered Lactobacillus rhamnosus GG and Lactococcus lactis subsp. lactis C59 on gene expression in the murine small intestine.
Lactobacillus rhamnosus GG Culturelle® The dual effect of shellac on survival of spray-dried Lactobacillus rhamnosus GG microcapsules.
Lactobacillus rhamnosus GG Culturelle® The effect of alginate and chitosan concentrations on some properties of chitosan-coated alginate beads and survivability of encapsulated Lactobacillus rhamnosus in simulated gastrointestinal conditions and during heat processing.
Lactobacillus rhamnosus GG Culturelle® The effect of calcium ions on adhesion and competitive exclusion of Lactobacillus ssp. and E. coli O138.
Lactobacillus rhamnosus GG Culturelle® The Effect of Donor Human Milk Fortification on The Adhesion of Probiotics In Vitro.
Lactobacillus rhamnosus GG Culturelle® The effect of early probiotic exposure on the preterm infant gut microbiome development.
Lactobacillus rhamnosus GG Culturelle® The Effect of Encapsulating a Prebiotic-Based Biopolymer Delivery System for Enhanced Probiotic Survival.
Lactobacillus rhamnosus GG Culturelle® The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat.
Lactobacillus rhamnosus GG Culturelle® The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial.
Lactobacillus rhamnosus GG Culturelle® The effect of non-standard heat treatment of sheep`s milk on physico-chemical properties, sensory characteristics, and the bacterial viability of classical and probiotic yogurt.
Lactobacillus rhamnosus GG Culturelle® The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus.
Lactobacillus rhamnosus GG Culturelle® The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Lactobacillus rhamnosus GG Culturelle® The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.
Lactobacillus rhamnosus GG Culturelle® The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners.
Lactobacillus rhamnosus GG Culturelle® The effect of synbiotic-fluoride therapy on multi-species biofilm.
Lactobacillus rhamnosus GG Culturelle® The Effects of Plasmacytoid Dendritic Cell-Stimulative Lactic Acid Bacteria, <i>Lactococcus lactis</i> Strain Plasma, on Exercise-Induced Fatigue and Recovery via Immunomodulatory Action.
Lactobacillus rhamnosus GG Culturelle® The Effects of Single Strains and Mixtures of Probiotic Bacteria on Immune Profile in Liver, Spleen, and Peripheral Blood.
Lactobacillus rhamnosus GG Culturelle® The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study.
Lactobacillus rhamnosus GG Culturelle® The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats.
Lactobacillus rhamnosus GG Culturelle® The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature.
Lactobacillus rhamnosus GG Culturelle® The elimination of ochratoxin A by lactic acid bacteria strains.
Lactobacillus rhamnosus GG Culturelle® The exposure of infants to Lactobacillus rhamnosus GG in Finland.
Lactobacillus rhamnosus GG Culturelle® The expression of adhesin EF-Tu in response to mucin and its role in Lactobacillus adhesion and competitive inhibition of enteropathogens to mucin.
Lactobacillus rhamnosus GG Culturelle® The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells.
Lactobacillus rhamnosus GG Culturelle® The Foodborne Strain <i>Lactobacillus fermentum</i> MBC2 Triggers <i>pept-1</i>-Dependent Pro-Longevity Effects in <i>Caenorhabditis elegans</i>.
Lactobacillus rhamnosus GG Culturelle® The genetic basis underlying variation in production of the flavour compound diacetyl by Lactobacillus rhamnosus strains in milk.
Lactobacillus rhamnosus GG Culturelle® The good bugs: the use of probiotics in pediatrics.
Lactobacillus rhamnosus GG Culturelle® The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults.
Lactobacillus rhamnosus GG Culturelle® The Host-specific Microbiota is Required for Diet-Specific Metabolic Homeostasis.
Lactobacillus rhamnosus GG Culturelle® The Impact of Fermentation on Bee Pollen Polyphenolic Compounds Composition.
Lactobacillus rhamnosus GG Culturelle® The Impact of Formula Choice for the Management of Pediatric Cow`s Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study.
Lactobacillus rhamnosus GG Culturelle® The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years.
Lactobacillus rhamnosus GG Culturelle® The Impact of Storage Conditions on the Stability of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis Bb12 in Human Milk.
Lactobacillus rhamnosus GG Culturelle® The influence of probiotics on gastrointestinal tract infections among children attending childcare: A systematic review and meta-analysis.
Lactobacillus rhamnosus GG Culturelle® The influence of shear on the metabolite yield of Lactobacillus rhamnosus biofilms.
Lactobacillus rhamnosus GG Culturelle® The inhibitory impacts of Lactobacillus rhamnosus GG-derived extracellular vesicles on the growth of hepatic cancer cells.
Lactobacillus rhamnosus GG Culturelle® The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium.
Lactobacillus rhamnosus GG Culturelle® The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® The mechanisms of the protective effects of reconstituted skim milk during convective droplet drying of lactic acid bacteria.
Lactobacillus rhamnosus GG Culturelle® The mechanistic effects of human digestion on magnesium oxide nanoparticles: implications for probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium bifidum VPI 1124.
Lactobacillus rhamnosus GG Culturelle® The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression.
Lactobacillus rhamnosus GG Culturelle® The N-Terminal GYPSY Motif Is Required for Pilin-Specific Sortase SrtC1 Functionality in Lactobacillus rhamnosus Strain GG.
Lactobacillus rhamnosus GG Culturelle® The nutrient requirements of Lactobacillus rhamnosus GG and their application to fermented milk.
Lactobacillus rhamnosus GG Culturelle® The Possible Link Between Manufacturing and Probiotic Efficacy; a Molecular Point of View on Bifidobacterium.
Lactobacillus rhamnosus GG Culturelle® The Probiotic <i>Lactobacillus rhamnosus</i> for Alleviation of <i>Helicobacter pylori</i>-Associated Gastric Pathology in East Africa.
Lactobacillus rhamnosus GG Culturelle® The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut.
Lactobacillus rhamnosus GG Culturelle® The Probiotic Lactobacillus Prevents Citrobacter rodentium-Induced Murine Colitis in a TLR2-Dependent Manner.
Lactobacillus rhamnosus GG Culturelle® The production and biochemical characterization of a-carbonic anhydrase from Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® The protective role of probiotics in sepsis-induced rats.
Lactobacillus rhamnosus GG Culturelle® The regulatory effect of Lactobacillus rhamnosus GG on T lymphocyte and the development of intestinal villi in piglets of different periods.
Lactobacillus rhamnosus GG Culturelle® The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review.
Lactobacillus rhamnosus GG Culturelle® The role of probiotic exopolysaccharides in adhesion to mucin in different gastrointestinal conditions.
Lactobacillus rhamnosus GG Culturelle® The role of probiotics in prevention of oral diseases.
Lactobacillus rhamnosus GG Culturelle® The Soil Bacterium <i>Methylococcus capsulatus</i> Bath Interacts with Human Dendritic Cells to Modulate Immune Function.
Lactobacillus rhamnosus GG Culturelle® The Step-down approach in children with cow`s milk allergy: Results of a randomized controlled trial.
Lactobacillus rhamnosus GG Culturelle® The use of date waste for lactic acid production by a fed-batch culture using Lactobacillus casei subsp. rhamnosus.
Lactobacillus rhamnosus GG Culturelle® The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.
Lactobacillus rhamnosus GG Culturelle® The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care.
Lactobacillus rhamnosus GG Culturelle® The viability of complex coacervate encapsulated probiotics during simulated sequential gastrointestinal digestion affected by wall materials and drying methods.
Lactobacillus rhamnosus GG Culturelle® Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial.
Lactobacillus rhamnosus GG Culturelle® Thermal Aggregation of Calcium-Fortified Skim Milk Enhances Probiotic Protection during Convective Droplet Drying.
Lactobacillus rhamnosus GG Culturelle® Thirty Years of Lactobacillus rhamnosus GG: A Review.
Lactobacillus rhamnosus GG Culturelle® Titanium dioxide nanoparticle exposure alters metabolic homeostasis in a cell culture model of the intestinal epithelium and Drosophila melanogaster.
Lactobacillus rhamnosus GG Culturelle® To add or not to add probiotics to infant formulae? An updated systematic review.
Lactobacillus rhamnosus GG Culturelle® To screen or not to screen medical students for carriage of multidrug-resistant pathogens?
Lactobacillus rhamnosus GG Culturelle® Tocopherol and ascorbate have contrasting effects on the viability of microencapsulated Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Towards a better understanding of Lactobacillus rhamnosus GG--host interactions.
Lactobacillus rhamnosus GG Culturelle® Transcriptional Response and Enhanced Intestinal Adhesion Ability of <i>Lactobacillus rhamnosus</i> GG after Acid Stress.
Lactobacillus rhamnosus GG Culturelle® Transcriptional responses of human intestinal epithelial HT-29 cells to spore-displayed p40 derived from Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Transcriptome analysis of Lactobacillus rhamnosus GG strain treated with prebiotic - bovine lactoferrin under a cold environment.
Lactobacillus rhamnosus GG Culturelle® Transcriptome Analysis Reveals Immunomodulatory Effect of Spore-Displayed p75 on Human Intestinal Epithelial Caco-2 Cells.
Lactobacillus rhamnosus GG Culturelle® Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study.
Lactobacillus rhamnosus GG Culturelle® Transcriptomic responses of Caco-2 cells to Lactobacillus rhamnosus GG and Lactobacillus plantarum J26 against oxidative stress.
Lactobacillus rhamnosus GG Culturelle® Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains--a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GG Culturelle® Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
Lactobacillus rhamnosus GG Culturelle® Trimethylamine N-oxide reduction is related to probiotic strain specificity: A systematic review.
Lactobacillus rhamnosus GG Culturelle® Turmeric Extract: Potential Use as a Prebiotic and Anti-Inflammatory Compound?
Lactobacillus rhamnosus GG Culturelle® Tylosin-responsive chronic diarrhea in dogs.
Lactobacillus rhamnosus GG Culturelle® Uncovering surface-exposed antigens of Lactobacillus rhamnosus by cell shaving proteomics and two-dimensional immunoblotting.
Lactobacillus rhamnosus GG Culturelle® Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Lactobacillus rhamnosus GG Culturelle® Unravelling the functionality of anionic and non-ionic plant seed gums on milk protein cryogels conveying Lacticaseibacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Untargeted LC-QTOF-MS/MS based metabolomics approach for revealing bioactive components in probiotic fermented coffee brews.
Lactobacillus rhamnosus GG Culturelle® Update on In Vitro Diagnostic Tools and Treatments for Food Allergies.
Lactobacillus rhamnosus GG Culturelle® Use of imaging techniques to identify efficient controlled release systems of Lactobacillus rhamnosus GG during in vitro digestion.
Lactobacillus rhamnosus GG Culturelle® Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates.
Lactobacillus rhamnosus GG Culturelle® Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics.
Lactobacillus rhamnosus GG Culturelle® Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Lactobacillus rhamnosus GG Culturelle® Use of Probiotics in the Prevention of Nosocomial Infections.
Lactobacillus rhamnosus GG Culturelle® Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis.
Lactobacillus rhamnosus GG Culturelle® Use of viability staining in combination with flow cytometry for rapid viability assessment of Lactobacillus rhamnosus GG in complex protein matrices.
Lactobacillus rhamnosus GG Culturelle® Using Food and Nutritional Strategies to Induce Tolerance in Food-Allergic Children.
Lactobacillus rhamnosus GG Culturelle® Using recombinant Lactococci as an approach to dissect the immunomodulating capacity of surface piliation in probiotic Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Utility of Thermostable Xylanases of Mycothermus thermophilus in Generating Prebiotic Xylooligosaccharides.
Lactobacillus rhamnosus GG Culturelle® Vaginal colonization by orally administered Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes.
Lactobacillus rhamnosus GG Culturelle® Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species.
Lactobacillus rhamnosus GG Culturelle® Versatile human in vitro triple coculture model coincubated with adhered gut microbes reproducibly mimics pro-inflammatory host-microbe interactions in the colon.
Lactobacillus rhamnosus GG Culturelle® Viability of Lactobacillus rhamnosus GG in Simulated Gastrointestinal Conditions and After Baking White Pan Bread at Different Temperature and Time Regimes.
Lactobacillus rhamnosus GG Culturelle® Viability of Lactobacillus rhamnosus GG microencapsulated in alginate/chitosan hydrogel particles during storage and simulated gastrointestinal digestion: role of chitosan molecular weight.
Lactobacillus rhamnosus GG Culturelle® Viability of probiotic bacteria in maple sap products under storage and gastrointestinal conditions.
Lactobacillus rhamnosus GG Culturelle® Vitamin D receptor pathway is required for probiotic protection in colitis.
Lactobacillus rhamnosus GG Culturelle® Vitamin D3 and Lactobacillus rhamnosus GG/p40 Synergize to Protect Mice From Colitis by Promoting Vitamin D Receptor Expression and Epithelial Proliferation.
Lactobacillus rhamnosus GG Culturelle® Volatile sulfur compounds produced by probiotic bacteria in the presence of cysteine or methionine.
Lactobacillus rhamnosus GG Culturelle® Water activity in dry foods containing live probiotic bacteria should be carefully considered: a case study with Lactobacillus rhamnosus GG in flaxseed.
Lactobacillus rhamnosus GG Culturelle® Water sorption properties, molecular mobility and probiotic survival in freeze dried protein-carbohydrate matrices.
Lactobacillus rhamnosus GG Culturelle® What`s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies.
Lactobacillus rhamnosus GG Culturelle® Whole Genome Sequence of the Probiotic Strain Lactobacillus paracasei N1115, Isolated from Traditional Chinese Fermented Milk.
Lactobacillus rhamnosus GG Culturelle® Whole-Cell Biocatalysis for Producing Ginsenoside Rd from Rb1 Using Lactobacillus rhamnosus GG.
Lactobacillus rhamnosus GG Culturelle® Whole-genome shotgun sequencing of Lactobacillus rhamnosus MTCC 5462, a strain with probiotic potential.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic [A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)].
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic [Antifungal effect in selected natural compounds and probiotics and their possible use in prophylaxis of vulvovaginitis].
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic [Effect of oral <i>Lactobacillus</i> <i>rhamnosus</i> GR-1 and <i>Lactobacillus</i> <i>reuteri</i> RC-14 on vaginal Group B <i>Streptococcus</i> colonization and vaginal microbiome in late pregnancy].
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic [Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses].
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic <i>Lactobacillus rhamnosus</i> GR-1 Ameliorates <i>Escherichia coli</i>-Induced Activation of NLRP3 and NLRC4 Inflammasomes With Differential Requirement for ASC.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic <i>Lactobacillus rhamnosus</i> Probiotic Food as a Tool for Empowerment Across the Value Chain in Africa.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic <i>Lactobacillus rhamnosus</i> probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic A Novel Millet-Based Probiotic Fermented Food for the Developing World.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic A Randomized Controlled Open Label Crossover Trial to Study Vaginal Colonization of Orally Administered Lactobacillus Reuteri RC-14 and Rhamnosus GR-1 in Pregnant Women at High Risk for Preterm Labor.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Assessment of phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus sp.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Cervicovaginal microbiome dynamics after taking oral probiotics.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Changes in vaginal microbiota following antimicrobial and probiotic therapy.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Comparative Genomic and Phenotypic Analysis of the Vaginal Probiotic <i>Lactobacillus rhamnosus</i> GR-1.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Detection of a Lactobacillus substance that inhibits Escherichia coli.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Development and pilot evaluation of a novel probiotic mixture for the management of seasonal allergic rhinitis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Development of a locally sustainable functional food for people living with HIV in Sub-Saharan Africa: laboratory testing and sensory evaluation.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Disruption of urogenital biofilms by lactobacilli.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of 25 weeks probiotic supplementation on immune function of HIV patients.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of Lactobacillus rhamnosus GR-1 Supernatant on Cytokine and Chemokine Output From Human Amnion Cells Treated With Lipoteichoic Acid and Lipopolysaccharide.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of Oral Probiotic <i>Lactobacillus rhamnosus</i> GR-1 and <i>Lactobacillus</i> <i>reuteri</i> RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effectiveness of oral intake of <i>Lactobacillus rhamnosus GR-1</i> and <i>Lactobacillus reuteri RC-14</i> on Group B <i>Streptococcus</i> colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Effects of probiotics on the recurrence of bacterial vaginosis: a review.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Expression of fluorescent proteins in Lactobacillus rhamnosus to study host-microbe and microbe-microbe interactions.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Identification of collagen-binding proteins in Lactobacillus spp. with surface-enhanced laser desorption/ionization-time of flight ProteinChip technology.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Immobilization of cadmium and lead by <i>Lactobacillus rhamnosus</i> GR-1 mitigates apical-to-basolateral heavy metal translocation in a Caco-2 model of the intestinal epithelium.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Improvement of Myelopoiesis in Cyclophosphamide-Immunosuppressed Mice by Oral Administration of Viable or Non-Viable <i>Lactobacillus</i> Strains.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic In vitro interactions between probiotic bacteria and milk proteins probed by atomic force microscopy.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Influence of lactobacilli on the adhesion of Staphylococcus aureus and Candida albicans to fibers and epithelial cells.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen-induced allergic asthma in a murine model.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lacticaseibacillus rhamnosus GR-1, a.k.a. Lactobacillus rhamnosus GR-1: Past and Future Perspectives.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacilli for prevention of urogenital infections: a review.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 Alleviates Escherichia coli-Induced Inflammation via NF-?B and MAPKs Signaling in Bovine Endometrial Epithelial Cells.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 Ameliorates Escherichia coli-Induced Inflammation and Cell Damage via Attenuation of ASC-Independent NLRP3 Inflammasome Activation.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 attenuates foodborne Bacillus cereus-induced NLRP3 inflammasome activity in bovine mammary epithelial cells by protecting intercellular tight junctions.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75).
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 Limits Escherichia coli-Induced Inflammatory Responses via Attenuating MyD88-Dependent and MyD88-Independent Pathway Activation in Bovine Endometrial Epithelial Cells.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 Prevents Escherichia coli-Induced Apoptosis Through PINK1/Parkin-Mediated Mitophagy in Bovine Mastitis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lactobacillus rhamnosus GR-1-induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Lipopolysaccharide-Induced Profiles of Cytokine, Chemokine, and Growth Factors Produced by Human Decidual Cells Are Altered by Lactobacillus rhamnosus GR-1 Supernatant.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa-Supplemented Probiotic Yogurt.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Non-Antibiotic Prophylaxis for Urinary Tract Infections.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Novel probiotic approach to counter Paenibacillus larvae infection in honey bees.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Oral probiotics can resolve urogenital infections.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Pilot assessment of probiotics for pregnant women in Rwanda.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Preferential production of G-CSF by a protein-like Lactobacillus rhamnosus GR-1 secretory factor through activating TLR2-dependent signaling events without activation of JNKs.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic administration of lactobacillus rhamnosus GR-1 attenuates atherosclerotic plaque formation in ApoE-/- mice fed with a high-fat diet.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel-Group, Randomized, Controlled Study.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacilli for urogenital health in women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic lactobacilli: a potential prophylactic treatment for reducing pesticide absorption in humans and wildlife.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 is a unique prophylactic agent that suppresses infection-induced myometrial cell responses.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus GR-1 supplementation attenuates Pb-induced learning and memory deficits by reshaping the gut microbiota.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Lactobacillus rhamnosus Reduces Organophosphate Pesticide Absorption and Toxicity to Drosophila melanogaster.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotic Therapy and Functional Foods for Prevention of Urinary Tract Infections: State of the Art and Science.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics and the urologist.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics for the treatment of women with bacterial vaginosis.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics to prevent urinary tract infections: the rationale and evidence.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Probiotics. Some evidence of their effectiveness.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Randomized open-label pilot study of the influence of probiotics and the gut microbiome on toxic metal levels in Tanzanian pregnant women and school children.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Sensory evaluation of locally-grown fruit purees and inulin fibre on probiotic yogurt in Mwanza, Tanzania and the Microbial Analysis of Probiotic Yogurt Fortified with Moringa oleifera.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Substances released from probiotic Lactobacillus rhamnosus GR-1 potentiate NF-?B activity in Escherichia coli-stimulated urinary bladder cells.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Supplementation with fruit and okara soybean by-products and amaranth flour increases the folate production by starter and probiotic cultures.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The anti-inflammatory role of granulocyte colony-stimulating factor in macrophage-dendritic cell crosstalk after Lactobacillus rhamnosus GR-1 exposure.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The influence of probiotics on the cervical malignancy diagnostics quality.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The lectin-like protein 1 in Lactobacillus rhamnosus GR-1 mediates tissue-specific adherence to vaginal epithelium and inhibits urogenital pathogens.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The role of cranberry and probiotics in intestinal and urogenital tract health.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
Lactobacillus rhamnosus GR-1 RepHresh™ Pro-B™ Probiotic Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients.
Lactobacillus rhamnosus HA-111 Human Probiotics Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro.
Lactobacillus rhamnosus HA-111 Human Probiotics Cohort study of probiotics in a North American neonatal intensive care unit.
Lactobacillus rhamnosus HA-111 Human Probiotics Disentangling factors that shape the gut microbiota in German Shepherd dogs.
Lactobacillus rhamnosus HA-111 Human Probiotics Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
Lactobacillus rhamnosus HA-111 Human Probiotics Enteral supplementation with probiotics in preterm infants: A retrospective cohort study and 6-year follow-up.
Lactobacillus rhamnosus HA-111 Human Probiotics The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion.
Lactobacillus rhamnosus LbV96 (DSM 22560) AZO Complete Feminine Balance Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Lactobacillus rhamnosus LbV96 (DSM 22560) AZO Complete Feminine Balance Impact of oral administration of four <i>Lactobacillus</i> strains on Nugent score - systematic review and meta-analysis.
Lactobacillus rhamnosus Lcr35 Provacare® A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus.
Lactobacillus rhamnosus Lcr35 Provacare® Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Lactobacillus rhamnosus Lcr35 Provacare® Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.
Lactobacillus rhamnosus Lcr35 Provacare® Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells.
Lactobacillus rhamnosus Lcr35 Provacare® Combined Effects of Lactobacillus rhamnosus and Egg Oral Immunotherapy in a Mouse Model of Egg Allergy.
Lactobacillus rhamnosus Lcr35 Provacare® Comparative phase I randomized open-label pilot clinical trial of Gynophilus(®) (Lcr regenerans(®)) immediate release capsules versus slow release muco-adhesive tablets.
Lactobacillus rhamnosus Lcr35 Provacare® Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35(®) in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights.
Lactobacillus rhamnosus Lcr35 Provacare® Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children.
Lactobacillus rhamnosus Lcr35 Provacare® Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35.
Lactobacillus rhamnosus Lcr35 Provacare® Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
Lactobacillus rhamnosus Lcr35 Provacare® Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs.
Lactobacillus rhamnosus Lcr35 Provacare® Effects of Lactobacillus rhamnosus on asthma with an adoptive transfer of dendritic cells in mice.
Lactobacillus rhamnosus Lcr35 Provacare® Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
Lactobacillus rhamnosus Lcr35 Provacare® Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Lactobacillus rhamnosus Lcr35 Provacare® Immune Modulation Effects of Lactobacillus casei Variety rhamnosus on Enterocytes and Intestinal Stem Cells in a 5-FU-Induced Mucositis Mouse Model.
Lactobacillus rhamnosus Lcr35 Provacare® Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®.
Lactobacillus rhamnosus Lcr35 Provacare® Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
Lactobacillus rhamnosus Lcr35 Provacare® Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells.
Lactobacillus rhamnosus Lcr35 Provacare® Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus casei rhamnosus Lcr35 in the Management of Functional Constipation in Children: A Randomized Trial.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model.
Lactobacillus rhamnosus Lcr35 Provacare® Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
Lactobacillus rhamnosus Lcr35 Provacare® Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations.
Lactobacillus rhamnosus Lcr35 Provacare® Oral administration of Lactobacillus casei variety rhamnosus partially alleviates TMA-induced atopic dermatitis in mice through improving intestinal microbiota.
Lactobacillus rhamnosus Lcr35 Provacare® Oral probiotic treatment of Lactobacillus rhamnosus Lcr35(®) prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.
Lactobacillus rhamnosus Lcr35 Provacare® Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption.
Lactobacillus rhamnosus Lcr35 Provacare® Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years.
Lactobacillus rhamnosus Lcr35 Provacare® Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties.
Lactobacillus rhamnosus Lcr35 Provacare® Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans.
Lactobacillus rhamnosus Lcr35 Provacare® Routine probiotic use in very preterm infants: retrospective comparison of two cohorts.
Lactobacillus rhamnosus Lcr35 Provacare® SCID/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy.
Lactobacillus rhamnosus Lcr35 Provacare® Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
Lactobacillus rhamnosus Lcr35 Provacare® Systematic review of randomised controlled trials: probiotics for functional constipation.
Lactobacillus rhamnosus Lcr35 Provacare® Systematic review: probiotics for functional constipation in children.
Lactobacillus rhamnosus Lcr35 Provacare® The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model.
Lactobacillus rhamnosus Lcr35 Provacare® The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis.
Lactobacillus rhamnosus Lcr35 Provacare® Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women.
Lactobacillus rhamnosus Lr-32 Custom Probiotics A Multi-Strain Probiotic Formulation Improves Intestinal Barrier Function by the Modulation of Tight and Adherent Junction Proteins.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Cheese supplemented with probiotics reduced the Candida levels in denture wearers-RCT.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Chemical Constituents, Antioxidant, and a-Glucosidase Inhibitory Activities of Different Fermented Gynostemma Pentaphyllum Leaves and Untargeted Metabolomic Measurement of the Metabolite Variation.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Co-culture fermentation of peanut-soy milk for the development of a novel functional beverage.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Effect of probiotic Lactobacillus rhamnosus by-products on gingival epithelial cells challenged with Porphyromonas gingivalis.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Effect of Probiotics Lactobacillus acidophilus and Lacticaseibacillus rhamnosus on Antibacterial Response Gene Transcription of Human Peripheral Monocytes.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Effect of Storage Time and Bacterial Strain on the Quality of Probiotic Goat`s Milk Using Different Types and Doses of Collagens.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Engineered calprotectin-sensing probiotics for IBD surveillance in humans.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Escherichia coli Nissle 1917-Driven Microrobots for Effective Tumor Targeted Drug Delivery and Tumor Regression.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Impact of Pomegranate on Probiotic Growth, Viability, Transcriptome and Metabolism.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Maternal fish oil and/or probiotics intervention: Allergic diseases in children up to two years old.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Metagenomics of microbiota following probiotic supplementation in rats subjected to intestinal anastomosis.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Probiotic Fermented Goat`s and Sheep`s Milk: Effect of Type and Dose of Collagen on Survival of Four Strains of Probiotic Bacteria during Simulated In Vitro Digestion Conditions.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Production of Reactive Oxygen (ROS) and Nitrogen (RNS) Species in Macrophages J774A.1 Activated by the Interaction between Two Escherichia coli Pathotypes and Two Probiotic Commercial Strains.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12(®)Lactobacillus rhamnosus LGG(®) in colorectal cancer patients.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Restorative effects of Lactobacillus rhamnosus LR-32 on the gut microbiota, barrier integrity, and 5-HT metabolism in reducing feather-pecking behavior in laying hens with antibiotic-induced dysbiosis.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota.
Lactobacillus rhamnosus Lr-32 Custom Probiotics Technological Characterisation of Probiotic Lactic Acid Bacteria as Starter Cultures for Dry Fermented Sausages.
Lactobacillus rhamnosus Lr-32 Custom Probiotics The Crosstalk between Intestinal Epithelial Cells and Mast Cells Is Modulated by the Probiotic Supplementation in Co-Culture Models.
Lactobacillus rhamnosus Lr-32 Custom Probiotics The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry [Development of biotechnology of fermented milk product with Lactobacillus reuteri LR1 and the evaluation of its functional property in experiment in vitro and in vivo].
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Antimicrobial Sensitivity Assay for Bdellovibrio bacteriovorus.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Assessment of hemolytic activity, enzyme production and bacteriocin characterization of Bacillus subtilis LR1 isolated from the gastrointestinal tract of fish.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Association between physical activity and changes in intestinal microbiota composition: A systematic review.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Carob kibbles as an alternative raw material for production of kvass with probiotic potential.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Development of Antioxidant and Antihypertensive Properties during Growth of Lactobacillus helveticus, Lactobacillus rhamnosus and Lactobacillus reuteri on Cow`s Milk: Fermentation and Peptidomics Study.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Draft Genome Sequence of Lactobacillus rhamnosus Strain CBC-LR1, Isolated from Homemade Dairy Foods in Bulgaria.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Effect of copper sulfate on the external microbiota of adult common snook (Centropomus undecimalis).
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Effect of long-term dietary probiotic Lactobacillus reuteri 1 or antibiotics on meat quality, muscular amino acids and fatty acids in pigs.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Effects of a Potential Host Gut-Derived Probiotic, Bacillus subtilis 6-3-1, on the Growth, Non-specific Immune Response and Disease Resistance of Hybrid Grouper (Epinephelus fuscoguttatus??×?Epinephelus lanceolatus?).
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Effects of feed supplementation with 3 different probiotic Bacillus strains and their combination on the performance of broiler chickens challenged with Clostridium perfringens.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: An investigation of the intestine-adipose tissue axis.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Efficient production and secretion of bovine beta-lactoglobulin by Lactobacillus casei.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Exoproteome Analysis of Antagonistic Interactions between the Probiotic Bacteria Limosilactobacillus reuteri LR1 and Lacticaseibacillus rhamnosus F and Multidrug Resistant Strain of Klebsiella pneumonia.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry General Strategy for Bioluminescence Sensing of Peptidase Activity In Vivo Based on Tumor-Targeting Probiotic.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Heterozygosis drives maize hybrids to select elite 2,4-diacethylphloroglucinol-producing Pseudomonas strains among resident soil populations.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Influence of intensive and extensive breeding on lactic acid bacteria isolated from Gallus gallus domesticus ceca.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Lactobacillus cell-free supernatant as a novel bioagent and biosurfactant against Pseudomonas aeruginosa in the prevention and treatment of orthopedic implant infection.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Lactobacillus reuteri LR1 Improved Expression of Genes of Tight Junction Proteins via the MLCK Pathway in IPEC-1 Cells during Infection with Enterotoxigenic Escherichia coli K88.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry New methods for selecting and evaluating probiotics.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Physiological response, blood chemistry profile and mucus secretion of red sea bream (Pagrus major) fed diets supplemented with Lactobacillus rhamnosus under low salinity stress.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Probiotic potential of Lactobacillus on the intestinal microflora against Escherichia coli induced mice model through high-throughput sequencing.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Probiotics as an environment-friendly approach to enhance red sea bream, Pagrus major growth, immune response and oxidative status.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Probiotics mediated gut microbiota diversity shifts are associated with reduction in histopathology and shedding of Lawsonia intracellularis.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Production and stability of a multi-strain Bacillus based probiotic product for commercial use in poultry.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Promotility Action of the Probiotic Bifidobacterium lactis HN019 Extract Compared with Prucalopride in Isolated Rat Large Intestine.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Spatial Control of Probiotic Bacteria in the Gastrointestinal Tract Assisted by Magnetic Particles.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry The Effect of the Addition of Chokeberry Fiber on the Quality of Sheep`s Milk Fermented by Lactobacillus rhamnosus and Lactobacillus acidophilus.
Lactobacillus rhamnosus LR1 Flora Pro Fem with Cranberry Yeasts in foods and beverages: impact on product quality and safety.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic [EXPERIENCE OF THE RATIONAL ANTIBACTERIAL THERAPY CONDUCTION IN TREATMENT OF CHILDREN FOR THE BURN TRAUMA].
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Calcium phosphate supplementation increases faecal Lactobacillus spp. in a randomised trial of young adults.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Characterization of casein-derived peptide bioactivity: Differential effects on angiotensin-converting enzyme inhibition and cytokine and nitric oxide production.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Draft genome sequence of probiotic strain Lactobacillus rhamnosus R0011.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Effects of production methods and protective ingredients on the viability of probiotic Lactobacillus rhamnosus R0011 in air-dried alginate beads.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Fermentation of Wheat Bran and Whey Permeate by Mono-Cultures of Lacticaseibacillus rhamnosus Strains and Co-culture With Yeast Enhances Bioactive Properties.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Flow cytometry: a versatile technology for specific quantification and viability assessment of micro-organisms in multistrain probiotic products.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Lacticaseibacillus rhamnosus R0011 secretome attenuates Salmonella enterica serovar Typhimurium secretome-induced intestinal epithelial cell monolayer damage and pro-inflammatory mediator production in intestinal epithelial cell and antigen-presenting cell co-cultures.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Lactobacillus rhamnosus R0011 Treatment Enhanced Efficacy of Capecitabine against Colon Cancer in Male Balb/c Mice.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Milk fermented with <i>Lactobacillus rhamnosus</i> R0011 induces a regulatory cytokine profile in LPS-challenged U937 and THP-1 macrophages.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Pathogen-Specific Effects of Probiotics in Children With Acute Gastroenteritis Seeking Emergency Care: A Randomized Trial.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Pea-protein alginate encapsulation adversely affects development of clinical signs of Citrobacter rodentium-induced colitis in mice treated with probiotics.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotic Supplementation is Associated with Increased Antioxidant Capacity and Copper Chelation in <i>C. difficile</i>-Infected Fecal Water.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotic treatment restores normal developmental trajectories of fear memory retention in maternally separated infant rats.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Probiotics: To Use or Not to Use? That Is the Question.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Secretome-Mediated Interactions with Intestinal Epithelial Cells: A Role for Secretome Components from <i>Lactobacillus rhamnosus</i> R0011 in the Attenuation of <i>Salmonella enterica</i> Serovar Typhimurium Secretome and TNF-a-Induced Proinflammatory Responses.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Strategies to improve the survival of probiotic Lacticaseibacillus rhamnosus R0011 during the production and storage of granola bars.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Suppression of Intestinal Epithelial Cell Chemokine Production by <i>Lactobacillus rhamnosus</i> R0011 and <i>Lactobacillus helveticus</i> R0389 Is Mediated by Secreted Bioactive Molecules.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Survival of probiotics in pea protein-alginate microcapsules with or without chitosan coating during storage and in a simulated gastrointestinal environment.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Technological Characterisation of Probiotic Lactic Acid Bacteria as Starter Cultures for Dry Fermented Sausages.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic The Bioavailability of Glycyrrhizinic Acid Was Enhanced by Probiotic Lactobacillus rhamnosus R0011 Supplementation in Liver Fibrosis Rats.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic The determination of viable counts in probiotic cultures microencapsulated by spray-coating.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic The use of flow cytometry to accurately ascertain total and viable counts of Lactobacillus rhamnosus in chocolate.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update.
Lactobacillus rhamnosus R0011 Flora Pregnancy Care Probiotic Viability of Lactobacillus rhamnosus R0011 in an apple-based fruit juice under simulated storage conditions at the consumer level.
Lactobacillus rhamnosus W71 Ecologic® AAD Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus rhamnosus W71 Ecologic® AAD Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`.
Lactobacillus rhamnosus W71 Ecologic® AAD Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus rhamnosus W71 Ecologic® AAD Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion.
Lactobacillus salivarius HA-118 Human Probiotics Bifidobacterium longum R0175 attenuates post-myocardial infarction depressive-like behaviour in rats.
Lactobacillus salivarius HA-118 Human Probiotics Selective Probiotic Treatment Positively Modulates the Microbiota-Gut-Brain Axis in the BTBR Mouse Model of Autism.
Lactobacillus Salivarius Ls-33 Custom Probiotics Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli.
Lactobacillus Salivarius Ls-33 Custom Probiotics Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
Lactobacillus Salivarius Ls-33 Custom Probiotics Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.
Lactobacillus Salivarius Ls-33 Custom Probiotics Consumption of probiotics increases the effect of regulatory T cells in transfer colitis.
Lactobacillus Salivarius Ls-33 Custom Probiotics Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression.
Lactobacillus Salivarius Ls-33 Custom Probiotics Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents.
Lactobacillus Salivarius Ls-33 Custom Probiotics Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
Lactobacillus Salivarius Ls-33 Custom Probiotics Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome.
Lactobacillus Salivarius Ls-33 Custom Probiotics Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria.
Lactobacillus Salivarius Ls-33 Custom Probiotics Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Lactobacillus salivarius UCC118 UltraFlora® Integrity A long and abundant non-coding RNA in Lactobacillus salivarius.
Lactobacillus salivarius UCC118 UltraFlora® Integrity AI-2 signalling is induced by acidic shock in probiotic strains of Lactobacillus spp.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Allelic variation of bile salt hydrolase genes in Lactobacillus salivarius does not determine bile resistance levels.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Characterization of endogenous plasmids from Lactobacillus salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Combining de novo and reference-guided assembly with scaffold_builder.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Comparative and functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Comparative Genomics of Lactobacillus acidipiscis ACA-DC 1533 Isolated From Traditional Greek Kopanisti Cheese Against Species Within the Lactobacillus salivarius Clade.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Converging effects of a Bifidobacterium and Lactobacillus probiotic strain on mouse intestinal physiology.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Distribution of megaplasmids in Lactobacillus salivarius and other lactobacilli.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Expression, purification, crystallization and preliminary X-ray crystallographic data from TktA, a transketolase from the lactic acid bacterium Lactobacillus salivarius.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity High-resolution structures of Lactobacillus salivarius transketolase in the presence and absence of thiamine pyrophosphate.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial.
Lactobacillus salivarius UCC118 UltraFlora® Integrity In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Influence of adhesion and bacteriocin production by Lactobacillus salivarius on the intestinal epithelial cell transcriptional response.
Lactobacillus salivarius UCC118 UltraFlora® Integrity L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Lactobacillus salivarius Isolated from Patients with Rheumatoid Arthritis Suppresses Collagen-Induced Arthritis and Increases Treg Frequency in Mice.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Ligilactobacillus salivarius 7247 Strain: Probiotic Properties and Anti-Salmonella Effect with Prebiotics.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Macrophage cytokine responses to commensal Gram-positive Lactobacillus salivarius strains are TLR2-independent and Myd88-dependent.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Multireplicon genome architecture of Lactobacillus salivarius.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Polyphasic analysis indicates that Lactobacillus salivarius subsp. salivarius and Lactobacillus salivarius subsp. salicinius do not merit separate subspecies status.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Probiotics can generate FoxP3 T-cell responses in the small intestine and simultaneously inducing CD4 and CD8 T cell activation in the large intestine.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Structure of ribose 5-phosphate isomerase from the probiotic bacterium Lactobacillus salivarius UCC118.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Subspecies diversity in bacteriocin production by intestinal Lactobacillus salivarius strains.
Lactobacillus salivarius UCC118 UltraFlora® Integrity Targeting the microbiota to address diet-induced obesity: a time dependent challenge.
Lactobacillus salivarius UCC118 UltraFlora® Integrity The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.
Lactobacillus salivarius UCC118 UltraFlora® Integrity UCC118 supplementation reduces exercise-induced gastrointestinal permeability and remodels the gut microbiome in healthy humans.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Effects of probiotic Lactobacillus salivarius W24 on the compositional stability of oral microbial communities.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactobacillus salivarius W24 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support A human origin strain Lactobacillus acidophilus DDS-1 exhibits superior in vitro probiotic efficacy in comparison to plant or dairy origin probiotics.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Adherence potential of indigenous lactic acid bacterial isolates obtained from fermented foods of Western Himalayas to intestinal epithelial Caco-2 and HT-29 cell lines.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Anti-cariogenic property of Carica papaya, Trachyspermum ammi, Caesalpinia crista linn extracts and their effect on human oral keratinocytes.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Antimicrobial Susceptibility Testing and Tentative Epidemiological Cutoff Values for Five Bacillus Species Relevant for Use as Animal Feed Additives or for Plant Protection.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Beneficial Effects of Pomegranate Peel Extract and Probiotics on Pre-adipocyte Differentiation.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Biosynthesis of Zinc Oxide Nanoparticles by Lactobacillus spp and Investigation of their Antimicrobial Effect.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Characterization of certain bacterial strains for potential use as starter or probiotic cultures in dairy products.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Contradictory Results in Microbiome Science Exemplified by Recent Drosophila Research.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Cranberry Proanthocyanidins and Dietary Oligosaccharides Synergistically Modulate Lactobacillus plantarum Physiology.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Draft genome sequence of Lactiplantibacillus plantarum subsp. plantarum strain HF43, a human gut-associated potential probiotic.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Effect of Lactobacillaceae Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Effects of dietary Lactobacillus rhamnosus GG supplementation on the production performance, egg quality, eggshell ultrastructure, and lipid metabolism of late-phase laying hens.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Effects of oral Akkermansia muciniphila supplementation in healthy dogs following antimicrobial administration.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Enhanced production of surfactin using cassava wastewater and hydrophobic inducers: a prospection on new homologues.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Evaluation of Antimicrobial Effectiveness of Dental Cement Materials on Growth of Different Bacterial Strains.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Evaluation of the effect of soluble polysaccharides of palm kernel cake as a potential prebiotic on the growth of probiotics.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Extending viability of Lactobacillus plantarum and Lactobacillus johnsonii by microencapsulation in alginate microgels.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Faecalibacterium: a bacterial genus with promising human health applications.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus).
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Impact of electro-activated whey on growth, acid and bile resistance of Lacticaseibacillus rhamnosus GG and Lactobacillus acidophilus ATCC 4356.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Impact of simulated microgravity on bioremoval of heavy-metals by Lactobacillus acidophilus ATCC 4356 from water.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Improvement of probiotic viability through the design of novel biomaterials using coffee pulp wastes and Lactobacillus rhamnosus.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Inflatable Penile Prostheses Implantation: Does Antibiotic Exposure Matter?
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Influence of bovine lactoferrin on the growth of selected probiotic bacteria under aerobic conditions.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci).
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Inhibitory effect of lactobacilli supernatants on biofilm and filamentation of Candida albicans, Candida tropicalis, and Candida parapsilosis.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Lactobacilli and bacteremia in southern Finland, 1989-1992.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Lactobacillus casei BL23 modulates the innate immune response in Staphylococcus aureus-stimulated bovine mammary epithelial cells.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Late permissive hypercapnia and respiratory stability among very preterm infants: a pilot randomised trial.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Limnospira indica PCC 8005 Supplementation Prevents Pelvic Irradiation-Induced Dysbiosis but Not Acute Inflammation in Mice.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Living, quiescent Lactobacillus plantarum Lp90 probiotic, delivered topically to full thickness tissues in vitro via a just-add-water cream delivery system, stimulates the expression of elastin protein.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Monoassociation with Lactobacillus plantarum Disrupts Intestinal Homeostasis in Adult Drosophila melanogaster.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Neonatal seizures and white matter injury: Role of rotavirus infection and probiotics.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics against airway allergy: host factors to consider.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics against allergy: data, doubts, and perspectives.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics enhance resistance to Streptococcus iniae in Nile tilapia (Oreochromis niloticus) reared in biofloc systems.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics Increase Intramuscular Fat and Improve the Composition of Fatty Acids in Sunit Sheep through the Adenosine 5`-Monophosphate-Activated Protein Kinase (AMPK) Signaling Pathway.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Probiotics: a novel approach in the management of food allergy.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Selective Antagonism of Lactiplantibacillus plantarum and Pediococcus acidilactici against Vibrio and Aeromonas in the Bacterial Community of Artemia nauplii.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Stability of lactobacilli encapsulated in various microbial polymers.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Supplementation of xylitol-containing chewing gum with probiotics: a double blind, randomised pilot study focusing on saliva flow and saliva properties.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support The development of probiotic treatment in obesity: a review.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support The Effect of Cytotoxicity and Antimicrobial of Synthesized CuO NPs from Propolis on HEK-293?Cells and Lactobacillus acidophilus.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support The effects of a probiotic milk drink on bacterial composition in the supra- and subgingival biofilm: a pilot study.
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support The Lepidoptera Galleria mellonella "in vivo" model: a preliminary pilot study on oral administration of Lactobacillus plantarum (now Lactiplantibacillus plantarum).
Lactocaseibacillus rhamnosus ATCC 53103 resB® Lung Support Use of Selected Lactic Acid Bacteria for the Fermentation of Legume-Based Water Extracts.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA <i>Lactococcus lactis</i> Strain Plasma Improves Subjective Physical State and Presenteeism: A Randomized, Open-Label Crossover Study among Healthy Office Workers.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA A second look at intraepithelial Langerhans cells in mycosis fungoides and related disorders. Ultrastructural study with special reference to Langerhans granules and virus-like particles.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Administration of Lactococcus lactis strain Plasma induces maturation of plasmacytoid dendritic cells and protection from rotavirus infection in suckling mice.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria enhances antigen-specific immune responses.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria is effective against dengue virus infection in mice.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Characterization of genomic DNA of lactic acid bacteria for activation of plasmacytoid dendritic cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effect of <i>Lactococcus lactis</i> Strain Plasma on HHV-6 and HHV-7 Shedding in Saliva: A Prospective Observational Study.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of dietary Lactobacillus rhamnosus JCM1136 and Lactococcus lactis subsp. lactis JCM5805 on the growth, intestinal microbiota, morphology, immune response and disease resistance of juvenile Nile tilapia, Oreochromis niloticus.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of Heat-Killed Lactococcus lactis Strain Plasma on Skin Homeostasis-Related Genes and the Skin Microbiome among Healthy Adults: A Randomized Controlled Double-Blind Study.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of Lactococcus lactis subsp. lactis JCM5805 on colonization dynamics of gut microbiota and regulation of immunity in early ontogenetic stages of tilapia.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of low or high doses of short wavelength ultraviolet light (UVB) on Langerhans cells and skin allograft survival.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Effects of oral intake of plasmacytoid dendritic cells-stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and immunological response to influenza virus.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Efficacy of heat-killed Lactococcus lactis JCM 5805 on immunity and fatigue during consecutive high intensity exercise in male athletes: a randomized, placebo-controlled, double-blinded trial.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild COVID-19: protocol for an exploratory, multicentre, double-blinded, randomised controlled trial (PLATEAU study).
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Enhancement of immunomodulative effect of lactic acid bacteria on plasmacytoid dendritic cells with sucrose palmitate.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Exaggerated phosphorylation of brain tau protein in CRH KO mice exposed to repeated immobilization stress.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Expression and function of B7 on human epidermal Langerhans cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Glucagon-independent renal hyperaemia and hyperfiltration after an oral protein load in Child A liver cirrhosis.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Hematological and acid-base changes in men during prolonged exercise with and without sodium-lactate infusion.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Impact of Infectious Disease after Lactococcus lactis Strain Plasma Intake in Vietnamese Schoolchildren: A Randomized, Placebo-Controlled, Double-Blind Study.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Induction of anti-viral genes mediated by humoral factors upon stimulation with Lactococcus lactis strain plasma results in repression of dengue virus replication in vitro.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Lactococcus lactis Strain Plasma Intake Suppresses the Incidence of Dengue Fever-like Symptoms in Healthy Malaysians: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Lactococcus lactis subsp. lactis JCM 5805 activates natural killer cells via dendritic cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Leydig cell aging: Molecular mechanisms and treatments.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Long-term administration of pDC stimulative lactic acid bacteria, Lactococcus lactis strain Plasma, prevents immune-senescence and decelerates individual senescence.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Long-term administration of pDC-Stimulative Lactococcus lactis strain decelerates senescence and prolongs the lifespan of mice.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Oral administration of Lactococcus lactis subsp. lactis JCM5805 enhances lung immune response resulting in protection from murine parainfluenza virus infection.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Organ-specific (localized) synthesis of Ig light chain amyloid.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Plasma thrombin-antithrombin III complexes in the diagnosis of primary hepatocellular carcinoma complicating liver cirrhosis.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Plasmacytoid dendritic cell dysfunction caused by heat stress is improved by administration of <i>Lactococcus lactis</i> strain plasma in mice.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Reciprocal interaction between melatonin receptors (Mel(1a), Mel(1b), and Mel(1c)) and androgen receptor (AR) expression in immunoregulation of a seasonally breeding bird, Perdicula asiatica: role of photoperiod.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Staphylococcus aureus Epicutaneous Infection Is Suppressed by Lactococcus lactis Strain Plasma via Interleukin 17A Elicitation.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA The Effects of Dietary Supplementation of <i>Lactococcus lactis</i> Strain Plasma on Skin Microbiome and Skin Conditions in Healthy Subjects-A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA The Effects of Plasmacytoid Dendritic Cell-Stimulative Lactic Acid Bacteria, <i>Lactococcus lactis</i> Strain Plasma, on Exercise-Induced Fatigue and Recovery via Immunomodulatory Action.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Ultraviolet light depletes surface markers of Langerhans cells.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice.
Lactococcus lactis JCM5805 (L. lactis plasma) IMMUNOFLORA Vitronectins produced by human cirrhotic liver and CCl(4)-treated rats differ in their glycosylation pattern and tissue remodeling activity.
Lactococcus lactis LL-23 Custom Probiotics An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.
Lactococcus lactis LL-23 Custom Probiotics Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis.
Lactococcus lactis LL-23 Custom Probiotics Effect of giving probiotic supplement Lactobacillus acidophilus La-14 as an immunomodulator to maintain a respiratory system in Mus musculus.
Lactococcus lactis LL-23 Custom Probiotics Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
Lactococcus lactis LL-23 Custom Probiotics Enhancing Bioaccessibility of Plant Protein Using Probiotics: An In Vitro Study.
Lactococcus lactis LL-23 Custom Probiotics How frequent is routine use of probiotics in UK neonatal units?
Lactococcus lactis LL-23 Custom Probiotics Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.
Lactococcus lactis LL-23 Custom Probiotics Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study).
Lactococcus lactis LL-23 Custom Probiotics Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model.
Lactococcus lactis LL-23 Custom Probiotics Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis.
Lactococcus lactis LL-23 Custom Probiotics Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson`s disease in mice by delivering GLP-1 and modulating gut microbiota.
Lactococcus lactis LL-23 Custom Probiotics Potential Modulation of Inflammation by Probiotic and Omega-3 Supplementation in Elderly with Chronic Low-Grade Inflammation-A Randomized, Placebo-Controlled Trial.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health In vitro evidence for efficacy in food intolerance for the multispecies probiotic formulation Ecologic® Tolerance (Syngut™).
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactococcus lactis W19 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health The Gut Microbiome and Female Health.
Lactococcus lactis W58 Ecologic® Barrier for Metabolic Health Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study.
Lactoplantibacillus plantarum ATCC BAA-793 resB® Lung Support Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation.
Lactoplantibacillus plantarum ATCC BAA-793 resB® Lung Support Late permissive hypercapnia and respiratory stability among very preterm infants: a pilot randomised trial.
Limosilactobacillus reuteri SD5865 Natures-Way-Primadophilus-Reuteri-Pearls Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.
Limosilactobacillus reuteri SD5865 Natures-Way-Primadophilus-Reuteri-Pearls Limosilactobacillus reuteri in Health and Disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany)
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Advances in next-generation sequencing technology to analyze the microbiome of patients with chronic sinusitis].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Elafin-expressing probiotic Escherichia coli Nissle 1917 protects against experimental colitis].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Immunomodulating effect of killed, apathogenic Escherichia coli, strain Nissle 1917, on the macrophage system].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Long-term probiotic administration for irritable bowel syndrome: a legal need].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Probiotic therapy of pseudomembranous colitis. Combination of intestinal lavage and oral administration of Escherichia coli].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [The results of the use of a combined probiotic (Lactobacillus rhamnosus GG and Bifidobacterium animalis spp. lactis ?B-12) in children with gastrointestinal and skin manifestations of food allergy].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) <i>In Vitro</i> Evaluation of the Impact of the Probiotic <i>E. coli</i> Nissle 1917 on <i>Campylobacter jejuni</i>`s Invasion and Intracellular Survival in Human Colonic Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A Mechanistic Model for Colibactin-Induced Genotoxicity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A modified MacConkey agar for selective enumeration of necrotoxigenic E. coli O55 and probiotic E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A molecular view on the interference established between vaginal Lactobacilli and pathogenic Candida species: Challenges and opportunities for the development of new therapies.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A new approach in pseudomembranous colitis: probiotic Escherichia coli Nissle 1917 after intestinal lavage.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A Salmochelin S4-Inspired Ciprofloxacin Trojan Horse Conjugate.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A Simple <i>In Vitro</i> Gut Model for Studying the Interaction between Escherichia coli and the Intestinal Commensal Microbiota in Cecal Mucus.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A survey into the utilization of probiotics and medicinal plants among individuals afflicted with gastrointestinal disorders in healthcare institutions in Saïda, Algeria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A Universal Strategy to Promote Secretion of G+/G- Bacterial Extracellular Vesicles and Its Application in Host Innate Immune Responses.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Adaptive Laboratory Evolution of Probiotics toward Oxidative Stress Using a Microfluidic-Based Platform.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Advanced Methods for MALDI-MS Imaging of the Chemical Communication in Microbial Communities.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Adzuki and Mung Bean Sprouts Enriched with Probiotic Lactiplantibacillus plantarum 299v Improve Body Mass Gain and Antioxidant Status and Reduce the Undesirable Enzymatic Activity of Microbiota in Healthy Rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Akkermansia muciniphila modifies the association between metal exposure during pregnancy and depressive symptoms in late childhood.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Alarmin HMGB1 is released in the small intestine of gnotobiotic piglets infected with enteric pathogens and its level in plasma reflects severity of sepsis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Alginate encapsulation improves probiotics survival in carbonated sodas and beers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Algorithmic Programming of Sequential Logic and Genetic Circuits for Recording Biochemical Concentration in a Probiotic Bacterium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Amelioration of cadmium- and mercury-induced liver and kidney damage in rats by genetically engineered probiotic Escherichia coli Nissle 1917 producing pyrroloquinoline quinone with oral supplementation of citric acid.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ameliorative effects of probiotics in AlCl(3)-induced mouse model of Alzheimer`s disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ammonia recyclers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An adherent mucus layer attenuates the genotoxic effect of colibactin.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An engineered <i>E. coli</i> Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An engineered Escherichia coli Nissle 1917 increase the production of indole lactic acid in the gut.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An Engineered Probiotic Platform for Cancer Epitope-Independent Targeted Radionuclide Therapy of Solid Tumors.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Analysis of in vitro and in vivo effects of probiotics against Campylobacter spp.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Analysis of the <i>Escherichia coli</i> extracellular vesicle proteome identifies markers of purity and culture conditions.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antagonistic activity of Phaeobacter piscinae against the emerging fish pathogen Vibrio crassostreae in aquaculture feed algae.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antagonistic properties of Lactiplantibacillus plantarum MYSVB1 against Alternaria alternata: a putative probiotic strain isolated from the banyan tree fruit.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antibacterial Activity and Toxicity of Zinc Oxide Nanoparticles Combined with Supernatants of Lactobacillus spp. Against ESKAPE Bacteria: A Novel Mixture.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/PTEN signaling pathways.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Anti-genotoxic and anti-mutagenic activity of Escherichia coli Nissle 1917 as assessed by in vitro tests.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antimicrobial Cyclic Dipeptides from Japanese Quail (Coturnix japonica) Eggs Supplemented with Probiotic Lactobacillus plantarum.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antimicrobial effect of probiotic bacteriocins on Streptococcus mutans biofilm in a dynamic oral flow chamber model - an in vitro study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Antimicrobial Probiotics Reduce Salmonella enterica in Turkey Gastrointestinal Tracts.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Assessment of the Impact of Nutritional Intervention with the Probiotic Lactiplantibacillus plantarum 299v on Nutritional Status and Quality of Life of Hashimoto`s Thyroiditis Patients-A Randomized Double-Blind Study Protocol.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Assessment of the Safety and Efficacy of an Oral Probiotic-Based Vaccine Against Aspergillus Infection in Captive-Bred Humboldt Penguins (Spheniscus humboldti).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Association between kimchi consumption and obesity based on BMI and abdominal obesity in Korean adults: a cross-sectional analysis of the Health Examinees study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacillus licheniformis reduces mortality, improves symptoms, and controls residual pathogenicity in juvenile sea cucumbers Apostichopus japonicus infected with skin ulceration syndrome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacillus subtilis-597 induces changes in lung pathology and inflammation during influenza A virus infection in pigs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteria as tumor therapeutics?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteria-Based Live Vehicle for In Vivo Bioluminescence Imaging.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacterial navigation for tumor targeting and photothermally-triggered bacterial ghost transformation for spatiotemporal drug release.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacterially Synthesized Tellurium Nanorods for Elimination of Advanced Malignant Tumor by Photothermal Immunotherapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteriophage Cocktail and Microcin-Producing Probiotic Escherichia coli Protect Mice Against Gut Colonization With Multidrug-Resistant Escherichia coli Sequence Type 131.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Behavior of Shiga toxigenic Escherichia coli relevant to lettuce washing processes and consideration of factors for evaluating washing process surrogates.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Beneficial effects resulting from oral administration of Escherichia coli Nissle 1917 on a chronic colitis model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bifidobacteria and subsets of dendritic cells: friendly players in immune regulation!
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bioengineering of Escherichia coli Nissle 1917 for Production and Excretion of Spermidine, a Key Metabolite in Human Health.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Bioprocess development for endospore production by Bacillus coagulans using an optimized chemically defined medium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Caco-2 cell monolayer integrity and effect of probiotic Escherichia coli Nissle 1917 components.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Carboxyl-modified nanocellulose (cNC) enhances the stability of cNC/pullulan bio-nanocomposite hard capsule against moisture variation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Cashew By-Product as a Functional Substrate for the Development of Probiotic Fermented Milk.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Characterization and valorization of soybean residue (okara) for the development of synbiotic ice cream.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Characterization of cellulose production in Escherichia coli Nissle 1917 and its biological consequences.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Characterization of Eight Bacterial Biosensors for Microbial Diagnostic and Therapeutic Applications.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Characterizing a Propionate Sensor in E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Cheese containing probiotic Lactobacillus brevis NJ42 isolated from stingless bee honey reduces weight gain, fat accumulation, and glucose intolerance in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Chemical characterization and immunomodulatory properties of polysaccharides isolated from probiotic Lactobacillus casei LOCK 0919.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Chemical characterization of Cassia fistula polysaccharide (CFP) and its potential application as a prebiotic in synbiotic preparation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Chromosome evolution of Escherichia coli Nissle 1917 for high-level production of heparosan.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Chronic kidney disease and gut microbiota.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Clonal Parabacteroides from Gut Microfistulous Tracts as Transmissible Cytotoxic Succinate-Commensal Model of Crohn`s Disease Complications.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Clostridium butyricum MIYAIRI 588 alleviates periodontal bone loss in mice with diabetes mellitus.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Colonization of Germ-Free Piglets with Commensal Lactobacillus amylovorus, Lactobacillus mucosae, and Probiotic E. coli Nissle 1917 and Their Interference with Salmonella Typhimurium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Colorectal cancer detection and treatment with engineered probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Combination Therapy of TGF-ß Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Comparative metabolomics and structural characterizations illuminate colibactin pathway-dependent small molecules.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Construction and In Vitro Evaluation of a Tumor Acidic pH-Targeting Drug Delivery System Based on Escherichia coli Nissle 1917 Bacterial Ghosts.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Core elements of the vegetative replication control of the Inc1 plasmid pO104_90 of Escherichia coli O104:H4 also regulate its transfer frequency.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Correction: Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Correction: Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Corrigendum.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in <i>Escherichia coli</i> Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) CRISPRi-mediated suppression of E. coli Nissle 1917 virulence factors: A strategy for creating an engineered probiotic using csgD gene suppression.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Crohn`s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn`s disease?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Cross feeding of glucose metabolism byproducts of <i>Escherichia coli</i> human gut isolates and probiotic strains affect survival of <i>Vibrio cholerae</i>.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Cross-Talk between Probiotic Nissle 1917 and Human Colonic Epithelium Affects the Metabolite Composition and Demonstrates Host Antibacterial Effect.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Cyclic AMP (cAMP) Receptor Protein-cAMP Complex Regulates Heparosan Production in Escherichia coli Strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Defensive Function of Transposable Elements in Bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Deletion of the cheZ gene results in the loss of swimming ability and the decrease of adhesion ability to Caco-2 cells in Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Dendritic cells from Peyer`s patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of a functional Greek sheep yogurt incorporating a probiotic Lacticaseibacillus rhamnosus wild-type strain as adjunct starter culture.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic <i>Escherichia coli</i> Strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of a Technology for Protein-Based, Glueless Belevskaya Pastille with Study of the Impact of Probiotic Sourdough Dosage and Technological Parameters on Its Rheological Properties.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of Aspirin-Inducible Biosensors in <i>Escherichia coli</i> and SimCells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of probiotic E. coli Nissle 1917 for ß-alanine production by using protein and metabolic engineering.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Diagnosis: Programmed probiotics light up liver cancer in urine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Diet and migraine: what is proven?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Dietary supplementation with live or autolyzed yeast: Effects on performance, nutrient digestibility, and ruminal fermentation in dairy cows.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Dietary supplementation with probiotics promotes weight loss by reshaping the gut microbiome and energy metabolism in obese dogs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Differential immunomodulation of porcine bone marrow derived dendritic cells by E. coli Nissle 1917 and ß-glucans.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Disruption of Escherichia coli Nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell health.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Divergent morphological and microbiome strategies of two neighbor sponges to cope with low pH in Mediterranean CO(2) vents.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Do probiotics have a role in treatment of diarrhea among children with severe acute malnutrition?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Do probiotics improve symptoms in patients with irritable bowel syndrome?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Does micro-granulated yeast probiotic (Saccharomyces cerevisiae) supplementation in milk replacer affect health, growth, feed efficiency and economic gain of calves?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Dose effect of Actisaf Sc 47 yeast probiotic (Saccharomyces cerevisiae) supplementation on production, reproduction, and negative energy balance in early lactation dairy cows.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Dysosmobacter welbionis effects on glucose, lipid and energy metabolism are associated with specific bioactive lipids.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut microbiota and microbial metabolism.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of a Bacillus-Based Probiotic on Performance and Nutrient Digestibility When Substituting Soybean Meal with Rapeseed Meal in Grower-Finisher Diets.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of DSS on Bacterial Growth in Gastrointestinal Tract.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of exopolysaccharides yield and addition concentration of Lactobacillus helveticus on the processing characteristics of fermented milk and its mechanism.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of probiotic strains on interleukin 8 production by HT29/19A cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effect of Yogurt Ice Cream on the Viability and Antidiabetic Potential of the Probiotics Lactobacillus acidophilus, Lacticaseibacillus rhamnosus, and Bifidobacterium animalis subsp. lactis after In Vitro Digestion.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effectiveness of Bio-K+ for the prevention of Clostridioides difficile infection: Stepped-wedge cluster-randomized controlled trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of E scherichia coli Nissle 1917 on the Porcine Gut Microbiota, Intestinal Epithelium and Immune System in Early Life.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Escherichia coli Nissle 1917 and Ciprofloxacin on small intestinal epithelial cell mRNA expression in the neonatal piglet model of human rotavirus infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Escherichia coli strain Nissle 1917 on immune responses of Japanese quails (Coturnix japonica) to Newcastle disease vaccines.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Intestinal Microbiota on the Biological Transformation of Arsenic in Zebrafish: Contribution and Mechanism.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of Lactiplantibacillus plantarum on oxidative stress, mitophagy, and NLRP3 inflammasome activation in broiler breast meat.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of probiotic Escherichia coli Nissle 1917 on expression of cytochromes P450 along the gastrointestinal tract of male rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Effects of the non-commensal Methylococcus capsulatus Bath on mammalian immune cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics (PLAY ON).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficient Cytotoxicity of Recombinant Azurin in Escherichia coli Nissle 1917-Derived Minicells against Colon Cancer Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Efficient Robust Yield Method for Preparing Bacterial Ghosts by Escherichia coli Phage ID52 Lysis Protein E.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl<sub>2</sub> cross-linking for an effective treatment of inflammatory bowel diseases.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered calprotectin-sensing probiotics for IBD surveillance in humans.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant <i>Enterococcus</i> in the intestinal tract.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered probiotic overcomes pathogen defences using signal interference and antibiotic production to treat infection in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineered Recombinant <i>Escherichia coli</i> Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy <i>in Vivo</i>.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering a Cortisol Sensing Enteric Probiotic.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5-aminolevulinic acid.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering intelligent chassis cells via recombinase-based MEMORY circuits.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering ligand-specific biosensors for aromatic amino acids and neurochemicals.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Enhanced anti-proliferative efficacy of epothilone B loaded with Escherichia coli Nissle 1917 bacterial ghosts on the HeLa cells by mitochondrial pathway of apoptosis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Enhanced wound healing by recombinant Escherichia coli Nissle 1917 via human epidermal growth factor receptor in human intestinal epithelial cells: therapeutic implication using recombinant probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Enhancement of crystallinity of cellulose produced by Escherichia coli through heterologous expression of bcsD gene from Gluconacetobacter xylinus.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Enhancing the Contrast of Tumor Imaging for Image-Guided Surgery Using a Tumor-Targeting Probiotic with the Continuous Expression of a Biomarker.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Enhancing therapeutic effects of murine cancer vaccine by reshaping gut microbiota with Lactobacillus rhamnosus GG and jujube powder.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 administered as a dextranomar microsphere biofilm enhances immune responses against human rotavirus in a neonatal malnourished pig model colonized with human infant fecal microbiota.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 bacterial ghosts retain crucial surface properties and express chlamydial antigen: an imaging study of a delivery system for the ocular surface.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-?B-Mediated Activation of the MLCK-P-MLC Signaling Pathway.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917 secondary metabolism: aryl polyene biosynthesis and phosphopantetheinyl transferase crosstalk.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Nissle 1917-Driven Microrobots for Effective Tumor Targeted Drug Delivery and Tumor Regression.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli probiotic exhibits in vitro growth-limiting effects on clinical feline uropathogenic E coli isolates.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli Probiotic Strain ED1a in Pigs Has a Limited Impact on the Gut Carriage of Extended-Spectrum-ß-Lactamase-Producing E. coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli strain Nissle 1917: significant reduction of neonatal calf diarrhea.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Establishing a Multivariate Model for Predictable Antisense RNA-Mediated Repression.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Estimation of the bacteriocin ColE7 conjugation-based "kill" - "anti-kill" antimicrobial system by real-time PCR, fluorescence staining and bioluminescence assays.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Evaluation of Human Performance Aiding Live Synthetically Engineered Bacteria in a Gut-on-a-Chip.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Evaluation of probiotic bifidobacteria strains from Iranian traditional dairy products for their anti-hyperlipidemic potential.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering of Streptococcus thermophilus IDCC 2201, a novel antiuricemia strain.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Evolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn`s disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Expectations for employing Escherichia coli Nissle 1917 in food science and nutrition.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Exploratory Pilot Studies to Demonstrate Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Exploring diversity and functional traits of lactic acid bacteria in traditional vinegar fermentation: A review.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Fatty Acid Profile and Lipid Quality Indexes of the Meat and Backfat from Porkers Supplemented with EM Bokashi Probiotic.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Fecal bacterial microbiota in constipated patients before and after eight weeks of daily Bifidobacterium infantis 35624 administration.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Feed-additive of bioengineering strain with surface-displayed laccase degrades sulfadiazine in broiler manure and maintains intestinal flora structure.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Functional Analysis of Deoxyhexose Sugar Utilization in Escherichia coli Reveals Fermentative Metabolism under Aerobic Conditions.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) GABA synthesizing lactic acid bacteria and genomic analysis of Levilactobacillus brevis LAB6.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Galacto-oligosaccharide preconditioning improves metabolic activity and engraftment of Limosilactobacillus reuteri and stimulates osteoblastogenesis ex vivo.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetic circuits for feedback control of gamma-aminobutyric acid biosynthesis in probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetic Circuits for Feedback Control of Gamma-Aminobutyric Acid Biosynthesis in Probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile-duct ligated rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically engineered Escherichia coli Nissle 1917 synbiotic counters fructose-induced metabolic syndrome and iron deficiency.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically Engineered Escherichia coli Nissle 1917 Synbiotics Reduce Metabolic Effects Induced by Chronic Consumption of Dietary Fructose.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically engineering of Escherichia coli and immobilization on electrospun fibers for drug delivery purposes.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genetically stable CRISPR-based kill switches for engineered microbes.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genome dynamics and its impact on evolution of Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genome-wide identification of probiotic Escherichia coli Nissle 1917 (EcN) fitness genes during adhesion to the intestinal epithelial cells Caco-2.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Glycan-mediated interactions between bacteria, rotavirus and the host cells provide an additional mechanism of antiviral defence.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Glycine significantly enhances bacterial membrane vesicle production: a powerful approach for isolation of LPS-reduced membrane vesicles of probiotic Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Gorse (Ulex europeaus) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B12 producing commensal gut microbes.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Gut bacteria promote proliferation in benign S/RG/C2 colorectal tumour cells, and promote proliferation, migration and invasion in malignant HCT116 cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Gut Probiotics and Health of Dogs and Cats: Benefits, Applications, and Underlying Mechanisms.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with L. amylovorus, L. mucosae, E. coli Nissle 1917 and S. Typhimurium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) High-Throughput Quantification of Bacterial-Cell Interactions Using Virtual Colony Counts.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Human vaginal microbiota colonization is regulated by female sex hormones in a mouse model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Hypoxic Tumor Radiosensitization Using Engineered Probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Identification of a contact-dependent growth inhibition system in the probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Identification of a functional peptide of a probiotic bacterium-derived protein for the sustained effect on preventing colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Identification of a gene cluster for D-tagatose utilization in Escherichia coli B2 phylogroup.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Immunostimulatory Activity of Lactococcus lactis subsp. lactis CAB701 Isolated from Jeju Cabbage.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Impact of Escherichia coli probiotic strains ED1a and Nissle 1917 on the excretion and gut carriage of extended-spectrum beta-lactamase-producing E. coli in pigs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Impact of perinatal administration of probiotics on immune cell composition in neonatal mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improved digestive stability of probiotics encapsulated within poly(vinyl alcohol)/cellulose acetate hybrid fibers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improved Method for the Incorporation of Heme Cofactors into Recombinant Proteins Using Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Improving immunotherapy response through the use of designer bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In silico analyses of the genomes of three new bacteriocin-producing bacteria isolated from animal`s faeces.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro characterization of the digestive stress response and immunomodulatory properties of microorganisms isolated from smear-ripened cheese.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro comparison of the effects of probiotic, commensal and pathogenic strains on macrophage polarization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro fermentation test bed for evaluation of engineered probiotics in polymicrobial communities.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) In vitro safety and functional characterization of the novel Bacillus coagulans strain CGI314.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Increased cellulose production by heterologous expression of bcsA and B genes from Gluconacetobacterxylinus in E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Influence of probiotic and prebiotic supplementation on intestinal microbiota and resistance to Edwardsiella ictaluri infection in channel catfish (Ictalurus punctatus) following florfenicol administration.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Influence of probiotics on rat liver biotransformation enzymes.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Inhibition of bacterial swimming by heparin binding of flagellin FliC from Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn`s disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Insights from 100 Years of Research with Probiotic E. Coli
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Insights from the molecular characterization of mercury stress proteins identified by proteomics in E.coli nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Integration of Multiple Phage Attachment Sites System to Create the Chromosomal T7 System for Protein Production in Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intelligent bacteria for IBD.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Interrupting Vibrio cholerae infection of human epithelial cells with engineered commensal bacterial signaling.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from <i>Escherichia coli</i> Nissle 1917 in DSS-Experimental Colitis in Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal effect of the probiotic <i>Escherichia coli</i> strain Nissle 1917 and its OMV.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal Organoids in Colitis Research: Focusing on Variability and Cryopreservation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in Apc(Min/+) mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Irish dietitians` opinions and use of probiotics in patients with Clostridium difficile-associated disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Isolation, Characterization, and Safety Evaluation of the Novel Probiotic Strain Lacticaseibacillus paracasei IDCC 3401 via Genomic and Phenotypic Approaches.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic <i>E. coli</i> Strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lacticaseibacillus rhamnosus GG Improves Periodontal Bone Repair via Gut-Blood Axis in Hyperlipidemia.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus melliventris promotes hive productivity and immune functionality in Bombus terrestris performance in the greenhouse.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus paracasei JY062 Alleviates Glucolipid Metabolism Disorders via the Adipoinsular Axis and Gut Microbiota.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lactobacillus rhamnosus Sex-Specifically Attenuates Depressive-like Behavior and Mitigates Metabolic Consequences in Obesity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Limonin alleviates high-fat diet-induced dyslipidemia by regulating the intestinal barrier via the microbiota-related ILC3-IL22-IL22R pathway.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Limosilactobacillus reuteri DSM 17938 reverses gut metabolic dysfunction induced by Western diet in adult rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Lipopolysaccharide determination by reversed-phase high-performance liquid chromatography after fluorescence labeling.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Mechanism of action of gut microbiota and probiotic Lactobacillus rhamnosus GG on skeletal remodeling in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Membrane Vesicles Released by a hypervesiculating Escherichia coli Nissle 1917 tolR Mutant Are Highly Heterogeneous and Show Reduced Capacity for Epithelial Cell Interaction and Entry.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Metabolic modulation of tumours with engineered bacteria for immunotherapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Metabolomic and transcriptomic correlative analyses in germ-free mice link Lacticaseibacillus rhamnosus GG -associated metabolites to host intestinal fatty acid metabolism and ß-oxidation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Metabolomics Study on Pathogenic and Non-pathogenic <i>E</i>. <i>coli</i> with Closely Related Genomes with a Focus on Yersiniabactin and Its Known and Novel Derivatives.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microbial medics diagnose and treat gut inflammation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) MICROBIOME AND UVEITIDES. A REVIEW.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microbiota Diversity and Inflammation as a New Target to Improve Mood: Probiotic Use in Depressive Disorder.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microbiota-gut-brain axis drives overeating disorders.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microcins mediate competition among Enterobacteriaceae in the inflamed gut.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced In Situ Colonization and Immunoregulation of Colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Modulation of experimental autoimmune encephalomyelitis through colonisation of the gut with <i>Escherichia coli</i>.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Modulation of the Altered Intestinal Microbiota by Use of Antibiotics with a Novel Synbiotic on Wistar Rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Multi-parameter flow cytometry as a process analytical technology (PAT) approach for the assessment of bacterial ghost production.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Multispecies probiotics complex improves bile acids and gut microbiota metabolism status in an in vitro fermentation model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Nanocarrier-mediated probiotic delivery: a systematic meta-analysis assessing the biological effects.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Neutralization of the antimicrobial effect of glyphosate by humic acid in vitro.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) New strategy for cancer immunotherapy: using live engineered bacteria for metabolic modulation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) No Genotoxicity Is Detectable for <i>Escherichia coli</i> Strain Nissle 1917 by Standard In Vitro and In Vivo Tests.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Non-inhibitory levels of oxygen during cultivation increase freeze-drying stress tolerance in Limosilactobacillus reuteri DSM 17938.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Non-pathogenic Escherichia coli biofilms: effects of growth conditions and surface properties on structure and curli gene expression.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) On-chip dielectrophoretic recovery and detection of a lactate sensing probiotic from model human saliva.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Oral Administration of the Probiotic Strain <i>Escherichia coli</i> Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Oral probiotic therapy improves motor function in a rodent model of sensorimotor stroke.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Outer Membrane Vesicles and Soluble Factors Released by Probiotic <i>Escherichia coli</i> Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Outer Membrane Vesicles From Probiotic and Commensal Escherichia coli Activate NOD1-Mediated Immune Responses in Intestinal Epithelial Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Parasites, probiotics, and piglets: a novel approach to IBD.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Physiology of ?-aminobutyric acid production by Akkermansia muciniphila.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) pMPES: A Modular Peptide Expression System for the Delivery of Antimicrobial Peptides to the Site of Gastrointestinal Infections Using Probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Polyfunctional sugar-free white chocolate fortified with Lacticaseibacillus rhamnosus GG co-encapsulated with beet residue extract (Beta vulgaris L.).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Potential Benefit of Probiotic E. Coli Nissle in Term Neonates.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Potentiation of curing by a broad-host-range self-transmissible vector for displacing resistance plasmids to tackle AMR.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by Escherichia coli Nissle 1917 Prevents Allergic Poly-Sensitization in Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prebiotic Cellulose-Pullulan Matrix as a "Vehicle" for Probiotic Biofilm Delivery to the Host Large Intestine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prebiotics Plus Probiotics May Favorably Impact on Gut Permeability, Endocannabinoid Receptors, and Inflammatory Biomarkers in Patients with Coronary Artery Diseases: A Clinical Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Pre-clinical safety and toxicity assessment of Limosilactobacillus fermentum NCDC 400 in murine model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Preparation of Synbiotic Yogurt Sauce Containing Spirulina platensis Microalgae Extract and Its Effect on the Viability of Lactobacillus acidophilus.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in Escherichia coli: experimental and bioinformatics analyses.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Preventive effect of Lacticaseibacillus rhamnosus 2016SWU.05.0601 and its postbiotic elements on dextran sodium sulfate-induced colitis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic <i>Escherichia coli</i> Ameliorates Antibiotic-Associated Anxiety Responses in Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic and functional potential of lactic acid bacteria isolated from pulque and evaluation of their safety for food applications.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Bacteria from Human Milk Can Alleviate Oral Bovine Casein Sensitization in Juvenile Wistar Rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic E. coli Nissle 1917 biofilms on silicone substrates for bacterial interference against pathogen colonization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 alleviates the neurotoxicity caused by acrylamide in zebrafish.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 protect chicks from damage caused by Salmonella enterica serovar Enteritidis colonization.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic Supplementation With Saccharomyces boulardii and Enterococcus faecium Improves Gastric Pain and Bloating in Airline Pilots With Chronic Non-atrophic Gastritis: An Open-Label Study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic therapy of intestinal inflammation and infections.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic-Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotic-loaded seed mucilage-based edible coatings for fresh pistachio fruit preservation: an experimental and modeling study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics and prebiotics in ulcerative colitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics and prebiotics: effects on diarrhea.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics for children with uncomplicated severe acute malnutrition (PruSAM study): A randomized controlled trial in the Democratic Republic of Congo.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics for maintaining remission of ulcerative colitis in adults.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics for Prevention and Treatment of Clostridium difficile Infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics in irritable bowel syndrome: has the time arrived?
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics regulate the expression of COX-2 in intestinal epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics supplementation or probiotic-fortified products on sarcopenic indices in older adults: systematic review and meta-analysis from recent randomized controlled trials.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics, prebiotics, and synbiotics for patients with autism spectrum disorder: a meta-analysis and umbrella review.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Probiotics, prebiotics, and synbiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Production and Sensing of Butyrate in a Probiotic <i>Escherichia coli</i> Strain.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Production of Reactive Oxygen (ROS) and Nitrogen (RNS) Species in Macrophages J774A.1 Activated by the Interaction between Two Escherichia coli Pathotypes and Two Probiotic Commercial Strains.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Programmable probiotics for detection of cancer in urine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with <i>E</i>. <i>coli</i> strain Nissle 1917: a controlled pilot trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Protective effects of E. coli Nissle 1917 on chickens infected with Salmonella pullorum.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Proteomic analysis of outer membrane vesicles from the probiotic strain Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Pyrroloquinoline quinone (PQQ) producing Escherichia coli Nissle 1917 (EcN) alleviates age associated oxidative stress and hyperlipidemia, and improves mitochondrial function in ageing rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Quantifying and Engineering Mucus Adhesion of Probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Quantitative in vitro assay to evaluate the capability of yeast cell wall fractions from Trichosporon mycotoxinivorans to selectively bind gram negative pathogens.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) - evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Randomised controlled trial of the effects of kefir on behaviour, sleep and the microbiome in children with ADHD: a study protocol.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Rational Design and Characterization of Nitric Oxide Biosensors in E. coli Nissle 1917 and Mini SimCells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Rational design of a genome-based insulated system in Escherichia coli facilitates heterologous uricase expression for hyperuricemia treatment.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Recombinant probiotic therapy in experimental colitis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Recombinant production of omega-3 fatty acids by probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Redesign of ultrasensitive and robust RecA gene circuit to sense DNA damage.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Reductase-Labile Peptidic Supramolecular Hydrogels Aided in Oral Delivery of Probiotics.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Reduction in biogenic amines in douchi fermented by probiotic bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Release Factor Inhibiting Antimicrobial Peptides Improve Nonstandard Amino Acid Incorporation in Wild-type Bacterial Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Reprogramming T7RNA Polymerase in Escherichia coli Nissle 1917 under Specific Lac Operon for Efficient p-Coumaric Acid Production.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Research Note: The effects of a Lactobacillus helveticus ATCC 15009-derived postbiotic mitigating Salmonella Gallinarum colonization in commercial layer chicks.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Review article: antibiotics and probiotics in inflammatory bowel disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Saccharomyces cerevisiae boulardii accelerates intestinal microbiota maturation and is correlated with increased secretory IgA production in neonatal dairy calves.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Safety, efficacy, and impact on gut microbial ecology of a Bifidobacterium longum subspecies infantis LMG11588 supplementation in healthy term infants: a randomized, double-blind, controlled trial in the Philippines.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Safety, feasibility, and impact on the gut microbiome of kefir administration in critically ill adults.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Screening and characterization of lactic acid bacteria and fermentation of gamma-aminobutyric acid-enriched bamboo shoots.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Screening of probiotic Lactobacillus resistant to peanut allergy and with potential anti-allergic activity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Slowing Alzheimer`s disease progression through probiotic supplementation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Some relevant mitigating agents of chronic aflatoxin exposure: a treatise.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Special conditions allow binding of the siderophore salmochelin to siderocalin (NGAL-lipocalin).
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Specific regions of genome plasticity and genetic diversity of the commensal Escherichia coli A0 34/86.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) ß-Carotene Biosynthesis in Probiotic Bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Strain ŽP - the first bacterial conjugation-based "kill"-"anti-kill" antimicrobial system.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Strong Activity and No Resistance Induction Exerted by Cell-Free Supernatants from Lacticaseibacillus rhamnosus against Mono-Species and Dual-Species Biofilms of Wound Pathogens in In Vivo-like Conditions.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Structural characterization of phosphoethanolamine-modified lipid A from probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of <i>Escherichia coli</i>.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Supplementation of Labneh with Passion Fruit Peel Enhanced Survival of E. coli Nissle 1917 during Simulated Gastrointestinal Digestion and Adhesion to Caco-2 Cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Surveying the Genetic Design Space for Transcription Factor-Based Metabolite Biosensors: Synthetic Gamma-Aminobutyric Acid and Propionate Biosensors in E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Symbioflor2<sup>®</sup> <i>Escherichia coli</i> Genotypes Enhance Ileal and Colonic Gene Expression Associated with Mucosal Defense in Gnotobiotic Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Systems-ecology designed bacterial consortium protects from severe Clostridioides difficile infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) TcpC protein from E. coli Nissle improves epithelial barrier function involving PKC? and ERK1/2 signaling in HT-29/B6 cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The 2`-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The carbon storage regulator (Csr) system exerts a nutrient-specific control over central metabolism in Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of a single-strain probiotic administration in the treatment of thermal burns patients.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of a single-strain probiotic administration in the treatment of thermal burns patients.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of aqueous extract of Arctium lappa root on the survival of Lactobacillus acidophilus La-5 and Bifidobacterium bifidum Bb-12 and sensorial and physicochemical properties of synbiotic yogurt.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of Escherichia coli ŽP strain with a conjugation-based colicin E7 delivery on growth performance, hematological, biochemical, and histological parameters, gut microbiota, and nonspecific immunity of broilers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effects of pro-, pre-, and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Effects of Probiotic Lactobacillus rhamnosus GG on Fecal Flora and Serum Markers of Renal Injury in Mice with Chronic Kidney Disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer`s disease: a randomized, double-blind, placebo-controlled study.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Efficacy of a Mix of Probiotics (Limosilactobacillus reuteri LMG P-27481 and Lacticaseibacillus rhamnosus GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Clostridium difficile Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Efficacy of Lactobacillus delbrueckii ssp. bulgaricus Supplementation in Managing Body Weight and Blood Lipids of People with Overweight: A Randomized Pilot Trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The flagellin hypervariable region is a potential flagella display domain in probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Impact in Intestines and Microbiota in BALB/c Mice Through Consumption of Milk Fermented by Potentially Probiotic Lacticaseibacillus casei SJRP38 and Limosilactobacillus fermentum SJRP43.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The impact of Lactococcus lactis KUST48 on the transcription profile of Aeromonas hydrophila-infected zebrafish spleen.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in epithelial cells.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The oral administration of Lacticaseibacillus casei Shirota alleviates acetaminophen-induced liver injury through accelerated acetaminophen metabolism via the liver-gut axis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Polyphosphate Kinase of Escherichia coli Is Required for Full Production of the Genotoxin Colibactin.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The potential of Rhodobacter sphaeroides extract as an alternative supplement for cell culture systems.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Probiotic <i>Escherichia coli</i> Strain Nissle 1917 Combats Lambdoid Bacteriophages <i>stx</i> and ?.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn`s disease-associated E. coli LF82.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Response of the Honey Bee Gut Microbiota to Nosema ceranae Is Modulated by the Probiotic Pediococcus acidilactici and the Neonicotinoid Thiamethoxam.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The use of Escherichia coli strain Nissle 1917 shows promise for improving gastrointestinal and urinary health in dogs.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) The Viable but Non-Culturable (VBNC) State, a Poorly Explored Aspect of Beneficial Bacteria.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Transcriptional Profiling of the Probiotic <i>Escherichia coli</i> Nissle 1917 Strain under Simulated Microgravity.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Transcriptomic microRNA Profiling of Dendritic Cells in Response to Gut Microbiota-Secreted Vesicles.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Tumor Colonization and Therapy by Escherichia coli Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Tumor-targeted delivery of TAT-Apoptin fusion gene using Escherichia coli Nissle 1917 to colorectal cancer.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in mice.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Two more pieces of the colibactin genotoxin puzzle from <i>Escherichia coli</i> show incorporation of an unusual 1-aminocyclopropanecarboxylic acid moiety.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coli.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Ultrasonic pre-treatment to enhance drying of potentially probiotic guava (Psidium guajava): Impact on drying kinetics, Lacticaseibacillus rhamnosus GG viability, and functional quality.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Unlocking the potential of Escherichia coli K-12: A novel approach for malignancy reduction in colorectal cancer through gene expression modulation.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Unraveling the Genetic Adaptations in Cell Surface Composition and Transporters of Lactiplantibacillus plantarum for Enhanced Acid Tolerance.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Upregulation of Intestinal Mucin Expression by the Probiotic Bacterium E. coli Nissle 1917.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Use of Attenuated but Metabolically Competent Salmonella as a Probiotic To Prevent or Treat Salmonella Infection.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Whole Genome Sequencing and Comparative Analysis of the First Ehrlichia canis Isolate in China.
Mutaflor (Escherichia coli strain Nissle 1917) Mutaflor (Canada, Australia, Findland, Germany) Worm-Based Alternate Assessment of Probiotic Intervention against Gut Barrier Infection.
Oxalobacter formigenes DSM 4420 TrueMeds A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion.
Oxalobacter formigenes DSM 4420 TrueMeds A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Oxalobacter formigenes DSM 4420 TrueMeds Analysis of commercial kidney stone probiotic supplements.
Oxalobacter formigenes DSM 4420 TrueMeds Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
Oxalobacter formigenes DSM 4420 TrueMeds Evaluation of Oxalobacter formigenes DSM 4420 biodegradation activity for high oxalate media content: An in vitro model.
Oxalobacter formigenes DSM 4420 TrueMeds Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria.
Oxalobacter formigenes DSM 4420 TrueMeds Probiotic properties of Oxalobacter formigenes: an in vitro examination.
Oxalobacter formigenes DSM 4420 TrueMeds Probiotics for prevention of urinary stones.
Oxalobacter formigenes DSM 4420 TrueMeds Probiotics in the Prevention of the Calcium Oxalate Urolithiasis.
Oxalobacter formigenes DSM 4420 TrueMeds The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Assessment of Pediococcus acidilactici ATCC 8042 as potential Salmonella surrogate for thermal treatments of toasted oats cereal and peanut butter.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Evaluating Pediococcus acidilactici and Enterococcus faecium NRRL B-2354 as Thermal Surrogate Microorganisms for Salmonella for In-Plant Validation Studies of Low-Moisture Pet Food Products.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Fed-batch pediocin production by Pediococcus acidilactici NRRL B-5627 on whey.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Lethality of high-pressure carbon dioxide on Shiga toxin-producing Escherichia coli, Salmonella and surrogate organisms on beef jerky.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Nisin and pediocin production on mussel-processing waste supplemented with glucose and five nitrogen sources.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Nutritional factors affecting the production of two bacteriocins from lactic acid bacteria on whey.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Pediocin SA-1, an antimicrobial peptide from Pediococcus acidilactici NRRL B5627: production conditions, purification and characterization.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Pediocin SA-1: A selective bacteriocin for controlling Listeria monocytogenes in maize silages.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Pediococcus Acidilactici NRRL B-50517 as a Safe Probiotic for Regulation of Weight Related Pro-inflammatory Cytokines: A Double-blind Placebo-controlled Pilot Study
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Production of bacteriocin-like metabolites by lactic acid cultures isolated from sucuk samples.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Production of bacteriocins from Lactococcus lactis subsp. lactis CECT 539 and Pediococcus acidilactici NRRL B-5627 using mussel-processing wastes.
Pediococcus Acidilactici NRRL B-50517 Imagilin Nutri-5051 Rapid quantifiable assessment of nutritional parameters influencing pediocin production by Pediococcus acidilactici NRRL B5627.
Prescript Assist(multi species) Prescript Assist (dispute on formula change) Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Prescript Assist(multi species) Prescript Assist (dispute on formula change) Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled, 1-year extension of a previously published controlled clinical trial.
Propionibacterium freudenreichii shermanii Optim Propionibacter [Effect of cobalamin derivatives on DNA synthesis in cells of Propionibacterium freudenreichii subsp. shermanii].
Propionibacterium freudenreichii shermanii Optim Propionibacter [Isolation and purification of a protective protein from Propionibacterium freudenreichii subsp. Shermanii].
Propionibacterium freudenreichii shermanii Optim Propionibacter [Manganese-dependent ribonucleotide reductase of Propionibacterium freudenreichii subsp. shermanii: partial purification, characterization, and role in DNA biosynthesis].
Propionibacterium freudenreichii shermanii Optim Propionibacter [Protective and reactive effect of a cellular extract from propionic acid bacteria on Candida guilliermondii and Escherichia coli, inactivated by ultraviolet radiation].
Propionibacterium freudenreichii shermanii Optim Propionibacter A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Propionibacterium freudenreichii shermanii Optim Propionibacter A probiotic mixture including galactooligosaccharides decreases fecal ß-glucosidase activity but does not affect serum enterolactone concentration in men during a two-week intervention.
Propionibacterium freudenreichii shermanii Optim Propionibacter Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo.
Propionibacterium freudenreichii shermanii Optim Propionibacter Anti-stress activity of Propionibacterium freudenreichii : identification of a reactivative protein.
Propionibacterium freudenreichii shermanii Optim Propionibacter Biochemical properties of Streptococcus macedonicus strains isolated from Greek Kasseri cheese.
Propionibacterium freudenreichii shermanii Optim Propionibacter Biosynthesis of vitamin B12 by Propionibacterium freudenreichii subsp. shermanii ATCC 13673 using liquid acid protein residue of soybean as culture medium.
Propionibacterium freudenreichii shermanii Optim Propionibacter Capsular exopolysaccharide biosynthesis gene of Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Changes in growth and survival of Bifidobacterium by coculture with Propionibacterium in soy milk, cow`s milk, and modified MRS medium.
Propionibacterium freudenreichii shermanii Optim Propionibacter Changes in protein synthesis during thermal adaptation of Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Characterization of pRGO1, a plasmid from Propionibacterium acidipropionici, and its use for development of a host-vector system in propionibacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Characterizing the Antimicrobial Function of a Dairy-Originated Probiotic, <i>Propionibacterium freudenreichii</i>, Against Multidrug-Resistant <i>Salmonella enterica</i> Serovar Heidelberg in Turkey Poults.
Propionibacterium freudenreichii shermanii Optim Propionibacter Citrate Cycle Intermediates in the Metabolism of Aspartate and Lactate by Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Clinical studies on alleviating the symptoms of irritable bowel syndrome.
Propionibacterium freudenreichii shermanii Optim Propionibacter Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Propionibacterium freudenreichii shermanii Optim Propionibacter Cloning, sequencing, and expression of the uroporphyrinogen III methyltransferase cobA gene of Propionibacterium freudenreichii (shermanii).
Propionibacterium freudenreichii shermanii Optim Propionibacter Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution.
Propionibacterium freudenreichii shermanii Optim Propionibacter Conjugated linoleic acid content and organoleptic attributes of fermented milk products produced with probiotic bacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Construction of an expression vector for propionibacteria and its use in production of 5-aminolevulinic acid by Propionibacterium freudenreichii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Determination of metabolic fluxes during glucose catabolism in Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Determination of the Use of Lactobacillus plantarum and Propionibacterium freudenreichii Application on Fermentation Profile and Chemical Composition of Corn Silage.
Propionibacterium freudenreichii shermanii Optim Propionibacter Discovery of PPi-type Phosphoenolpyruvate Carboxykinase Genes in Eukaryotes and Bacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effect of crude and pure glycerol on biomass production and trehalose accumulation by Propionibacterium freudenreichii ssp. shermanii 1.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effect of Propionibacterium freudenreichii on Salmonella multiplication, motility, and association with avian epithelial cells1.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of expression of hemA and hemB genes on production of porphyrin in Propionibacterium freudenreichii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet.
Propionibacterium freudenreichii shermanii Optim Propionibacter Effects of Propionibacterium on the growth and mycotoxin production by some species of Fusarium and Alternaria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Engineering Propionibacterium freudenreichii subsp. shermanii for enhanced propionic acid fermentation: effects of overexpressing propionyl-CoA:Succinate CoA transferase.
Propionibacterium freudenreichii shermanii Optim Propionibacter First evidence of lysogeny in Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Growth engineering of Propionibacterium freudenreichii shermanii for organic acids and other value-added products formation.
Propionibacterium freudenreichii shermanii Optim Propionibacter Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16S rRNA-targeted probes by colony hybridization and PCR.
Propionibacterium freudenreichii shermanii Optim Propionibacter Improved trehalose production from biodiesel waste using parent and osmotically sensitive mutant of Propionibacterium freudenreichii subsp. shermanii under aerobic conditions.
Propionibacterium freudenreichii shermanii Optim Propionibacter In silico exploration of the fructose-6-phosphate phosphorylation step in glycolysis: genomic evidence of the coexistence of an atypical ATP-dependent along with a PPi-dependent phosphofructokinase in Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter In vivo 13C NMR study of the bidirectional reactions of the Wood-Werkman cycle and around the pyruvate node in Propionibacterium freudenreichii subsp. shermanii and Propionibacterium acidipropionici.
Propionibacterium freudenreichii shermanii Optim Propionibacter Interactions between pyruvate and lactate metabolism in Propionibacterium freudenreichii subsp. shermanii: in vivo (13)C nuclear magnetic resonance studies.
Propionibacterium freudenreichii shermanii Optim Propionibacter Interactive behavior of Saccharomyces cerevisiae, Bacillus pumilus and Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Kinetics of adsorption and desorption of aflatoxin B1 by viable and nonviable bacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Mechanism of inhibited growth of Bacillus pumilus by Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Metabolic engineering of Propionibacterium freudenreichii subsp. shermanii for xylose fermentation.
Propionibacterium freudenreichii shermanii Optim Propionibacter Metabolism of Aspartate by Propionibacterium freudenreichii subsp. shermanii: Effect on Lactate Fermentation.
Propionibacterium freudenreichii shermanii Optim Propionibacter Metagenomic and metatranscriptomic analysis of the microbial community in Swiss-type Maasdam cheese during ripening.
Propionibacterium freudenreichii shermanii Optim Propionibacter Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese.
Propionibacterium freudenreichii shermanii Optim Propionibacter Phenotypic and genetic diversity of enterococci isolated from Italian cheeses.
Propionibacterium freudenreichii shermanii Optim Propionibacter Probiotic bacteria as potential detoxification tools: assessing their heavy metal binding isotherms.
Propionibacterium freudenreichii shermanii Optim Propionibacter Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults.
Propionibacterium freudenreichii shermanii Optim Propionibacter Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China.
Propionibacterium freudenreichii shermanii Optim Propionibacter Production of extracellular bifidogenic growth stimulator (BGS) from Propionibacterium shermanii using a bioreactor system with a microfiltration module and an on-line controller for lactic acid concentration.
Propionibacterium freudenreichii shermanii Optim Propionibacter Production of Propionibacterium shermanii biomass and vitamin B12 on spent media.
Propionibacterium freudenreichii shermanii Optim Propionibacter Properties of Alanine Dehydrogenase and Aspartase from Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Propionic acid production in glycerol/glucose co-fermentation by Propionibacterium freudenreichii subsp. shermanii.
Propionibacterium freudenreichii shermanii Optim Propionibacter Quinone-dependent D-lactate dehydrogenase Dld (Cg1027) is essential for growth of Corynebacterium glutamicum on D-lactate.
Propionibacterium freudenreichii shermanii Optim Propionibacter Research on some factors influencing acid and exopolysaccharide produced by dairy propionibacterium strains isolated from traditional homemade Turkish cheeses.
Propionibacterium freudenreichii shermanii Optim Propionibacter Safety and efficacy of a feed additive consisting on <i>Propionibacterium freudenreichii</i> ssp. <i>shermanii</i>ATCC PTA-6752 for all animal species (Chr. Hansen A/S).
Propionibacterium freudenreichii shermanii Optim Propionibacter Screening of Propionibacterium spp. for potential probiotic properties.
Propionibacterium freudenreichii shermanii Optim Propionibacter Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter Study on bioactivity of cell-free filtrates from dairy propionibacteria.
Propionibacterium freudenreichii shermanii Optim Propionibacter The Effects of Single Strains and Mixtures of Probiotic Bacteria on Immune Profile in Liver, Spleen, and Peripheral Blood.
Propionibacterium freudenreichii shermanii Optim Propionibacter The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon.
Propionibacterium freudenreichii shermanii Optim Propionibacter Ultra-high performance liquid chromatographic and mass spectrometric analysis of active vitamin B12 in cells of Propionibacterium and fermented cereal matrices.
Propionibacterium freudenreichii shermanii Optim Propionibacter Utilization of Lactate Isomers by Propionibacterium freudenreichii subsp. shermanii: Regulatory Role for Intracellular Pyruvate.
Saccharomyces boulardii (Klaire Labs) Klaire Labs Saccharomyces boulardii PURLs: Help for recurrent bacterial vaginosis.
Saccharomyces boulardii (Klaire Labs) Klaire Labs Saccharomyces boulardii Reduction in Obsessive Compulsive Disorder and Self-Injurious Behavior With Saccharomyces boulardii in a Child with Autism: A Case Report.
Saccharomyces boulardii (Klaire Labs) Klaire Labs Saccharomyces boulardii Reversal of Irritable Bowel Syndrome, Sleep Disturbance, and Fatigue With an Elimination Diet, Lifestyle Modification, and Dietary Supplements: A Case Report.
Saccharomyces boulardii (Klaire Labs) Klaire Labs Saccharomyces boulardii Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
Saccharomyces boulardii (Klaire Labs) Klaire Labs Saccharomyces boulardii To start or not: Factors to consider when implementing routine probiotic use in the NICU.
Saccharomyces boulardii CNCM I-745 Florastor® [Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19].
Saccharomyces boulardii CNCM I-745 Florastor® [Saccharomyces boulardii CNCM I-745 - the medicinal yeast improves intestinal enzyme function].
Saccharomyces boulardii CNCM I-745 Florastor® [Saccharomyces boulardii CNCM I-745 influences the gut-associated immune system].
Saccharomyces boulardii CNCM I-745 Florastor® [Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea].
Saccharomyces boulardii CNCM I-745 Florastor® [The benefit of Saccharomyces boulardii CNCM I-745 in the management of vulvovaginal infections].
Saccharomyces boulardii CNCM I-745 Florastor® [The regulatory role of gut microbiota in inflammation in depression and anxiety].
Saccharomyces boulardii CNCM I-745 Florastor® <i>Saccharomyces boulardii CNCM I-745</i> changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model.
Saccharomyces boulardii CNCM I-745 Florastor® <i>Saccharomyces boulardii</i> CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review.
Saccharomyces boulardii CNCM I-745 Florastor® <i>Saccharomyces boulardii</i> CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers.
Saccharomyces boulardii CNCM I-745 Florastor® <i>Saccharomyces boulardii</i> Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following <i>Salmonella</i> Typhimurium Infection.
Saccharomyces boulardii CNCM I-745 Florastor® A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants.
Saccharomyces boulardii CNCM I-745 Florastor® Are probiotics and prebiotics effective in the prevention of travellers` diarrhea: A systematic review and meta-analysis.
Saccharomyces boulardii CNCM I-745 Florastor® Bacillus subtilis RBT-7/32 and Bacillus licheniformis RBT-11/17 as New Promising Strains for Use in Probiotic Feed Additives.
Saccharomyces boulardii CNCM I-745 Florastor® Beneficial effects of <i>Saccharomyces boulardii</i> CNCM I-745 on clinical disorders associated with intestinal barrier disruption.
Saccharomyces boulardii CNCM I-745 Florastor® Bioavailability of Macroelements from Synbiotic Sheep`s Milk Ice Cream.
Saccharomyces boulardii CNCM I-745 Florastor® Bioprocess optimization of glutathione production by Saccharomyces boulardii: biochemical characterization of glutathione peroxidase.
Saccharomyces boulardii CNCM I-745 Florastor® Bioprospecting of the probiotic potential of yeasts isolated from a wine environment.
Saccharomyces boulardii CNCM I-745 Florastor® Comparison of Amino Acid Profile, ACE Inhibitory Activity, and Organic Acid Profile of Cow and Goat Yogurts Produced with Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12, and Classical Yogurt Culture.
Saccharomyces boulardii CNCM I-745 Florastor® Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Saccharomyces boulardii CNCM I-745 Florastor® Detecting host responses to microbial stimulation using primary epithelial organoids.
Saccharomyces boulardii CNCM I-745 Florastor® Diversity of <i>Saccharomyces boulardii</i> CNCM I-745 mechanisms of action against intestinal infections.
Saccharomyces boulardii CNCM I-745 Florastor® Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing <i>Saccharomyces</i> to a Mixture of <i>Lactobacillus, Bifidobacterium</i>, and <i>Saccharomyces</i>.
Saccharomyces boulardii CNCM I-745 Florastor® Economic evaluation of S. boulardii CNCM I-745 for prevention of antibioticassociated diarrhoea in hospitalized patients.
Saccharomyces boulardii CNCM I-745 Florastor® Effect of a probiotic fermented milk supplementation on behavior and sleep.
Saccharomyces boulardii CNCM I-745 Florastor® Effect of Chilled Storage on Antioxidant Capacities and Volatile Flavors of Synbiotic Yogurt Made with Probiotic Yeast Saccharomyces boulardii CNCM I-745 in Combination with Inulin.
Saccharomyces boulardii CNCM I-745 Florastor® Effect of Probiotic Yogurt Supplementation(Bifidobacterium animalis ssp. lactis BB-12) on Gut Microbiota of Female Taekwondo Athletes and Its Relationship with Exercise-Related Psychological Fatigue.
Saccharomyces boulardii CNCM I-745 Florastor® Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.
Saccharomyces boulardii CNCM I-745 Florastor® Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial.
Saccharomyces boulardii CNCM I-745 Florastor® Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the faecal metabolome in children with coeliac disease autoimmunity: a randomised, double-blinded placebo-controlled clinical trial.
Saccharomyces boulardii CNCM I-745 Florastor® Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the single-cell fecal parasitome in children with celiac disease autoimmunity: a randomized, double-blind placebo-controlled clinical trial.
Saccharomyces boulardii CNCM I-745 Florastor® Effects of Probiotic Fermented Fruit Juice-Based Biotransformation by Lactic Acid Bacteria and Saccharomyces boulardii CNCM I-745 on Anti-Salmonella and Antioxidative Properties.
Saccharomyces boulardii CNCM I-745 Florastor® Efficacy and Safety of Probiotics in Geriatric Patients with Constipation: Systematic Review and Meta-Analysis.
Saccharomyces boulardii CNCM I-745 Florastor® Enterobacteriaceae are essential for the modulation of colitis severity by fungi.
Saccharomyces boulardii CNCM I-745 Florastor® Evaluation of Prebiotic Activity of Stellariae Radix Polysaccharides and Its Effects on Gut Microbiota.
Saccharomyces boulardii CNCM I-745 Florastor® Evaluation of the Potential Probiotic Yeast Characteristics with Anti-MRSA Abilities.
Saccharomyces boulardii CNCM I-745 Florastor® Exploring Extracellular Vesicles of Probiotic Yeast as Carriers of Biologically Active Molecules Transferred to Human Intestinal Cells.
Saccharomyces boulardii CNCM I-745 Florastor® Fermentation of araticum, baru and pequi by-products by probiotic strains: effects on microorganisms, short-chain fatty acids and bioactive compounds.
Saccharomyces boulardii CNCM I-745 Florastor® Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.
Saccharomyces boulardii CNCM I-745 Florastor® Functional Characterization of Fermented Beverages Based on Soy Milk and Sea Buckthorn Powder.
Saccharomyces boulardii CNCM I-745 Florastor® Gut Microbiota in Mexican Children With Acute Diarrhea: An Observational Study.
Saccharomyces boulardii CNCM I-745 Florastor® Gut Microbiota Regulates Epigenetic Remodelling in the Amygdala: A Role in Repeated Mild Traumatic Brain Injury (rMTBI)-Induced Anxiety.
Saccharomyces boulardii CNCM I-745 Florastor® Immunomodulatory effect of short-term supplementation with Bacillus toyonensis BCT-7112(T) and Saccharomyces boulardii CNCM I-745 in sheep vaccinated with Clostridium chauvoei.
Saccharomyces boulardii CNCM I-745 Florastor® In vitro assessment of probiotic attributes for strains contained in commercial formulations.
Saccharomyces boulardii CNCM I-745 Florastor® In Vitro Assessment of Probiotic Potential of Saccharomyces Cerevisiae DABRP5 Isolated from Bollo Batter, a Traditional Goan Fermented Food.
Saccharomyces boulardii CNCM I-745 Florastor® Influence of <i>Saccharomyces boulardii</i> CNCM I-745on the gut-associated immune system.
Saccharomyces boulardii CNCM I-745 Florastor® Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits.
Saccharomyces boulardii CNCM I-745 Florastor® Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition.
Saccharomyces boulardii CNCM I-745 Florastor® Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.
Saccharomyces boulardii CNCM I-745 Florastor® Modeling the Ethanol Tolerance of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii CNCM I-745 for its Possible Use in a Functional Beer.
Saccharomyces boulardii CNCM I-745 Florastor® Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-?B/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
Saccharomyces boulardii CNCM I-745 Florastor® Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome.
Saccharomyces boulardii CNCM I-745 Florastor® Oral Administration of Recombinant <i>Saccharomyces boulardii</i> Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice.
Saccharomyces boulardii CNCM I-745 Florastor® Physicochemical and Microbiological Properties of Synbiotic Yogurt Made with Probiotic Yeast <i>Saccharomyces boulardii</i> in Combination with Inulin.
Saccharomyces boulardii CNCM I-745 Florastor® Probiotic Saccharomyces boulardii attenuates cardiopulmonary bypass-induced acute lung injury by inhibiting ferroptosis.
Saccharomyces boulardii CNCM I-745 Florastor® Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.
Saccharomyces boulardii CNCM I-745 Florastor® Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region.
Saccharomyces boulardii CNCM I-745 Florastor® Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
Saccharomyces boulardii CNCM I-745 Florastor® Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation.
Saccharomyces boulardii CNCM I-745 Florastor® Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Saccharomyces boulardii CNCM I-745 Florastor® Retrospective analysis of EMR database to assess the effectiveness of <i>Saccharomyces boulardii</i> CNCM I-745 in children with acute diarrhoea during routine clinical practice.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 in different clinical conditions.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 Restores intestinal Barrier Integrity by Regulation of E-cadherin Recycling.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.
Saccharomyces boulardii CNCM I-745 Florastor® Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Saccharomyces boulardii CNCM I-745 Florastor® Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Saccharomyces boulardii CNCM I-745 Florastor® The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children.
Saccharomyces boulardii CNCM I-745 Florastor® The Host-specific Microbiota is Required for Diet-Specific Metabolic Homeostasis.
Saccharomyces boulardii CNCM I-745 Florastor® The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin.
Saccharomyces boulardii CNCM I-745 Florastor® Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment.
Saccharomyces boulardii CNCM I-745 Florastor® Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Saccharomyces boulardii CNCM I-745 Florastor® UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V.
Saccharomyces boulardii CNCM I-745 Florastor® Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations <i>Lactobacillus rhamnosus</i> GG and <i>Saccharomyces cerevisiae boulardii</i> exert synergistic antipathogenic activity <i>in vitro</i> against enterotoxigenic <i>Escherichia coli</i>.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Decrease in Salivary Serotonin in Response to Probiotic Supplementation With Saccharomyces boulardii in Healthy Volunteers Under Psychological Stress: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Development and validation of a new dynamic in vitro model of the piglet colon (PigutIVM): application to the study of probiotics.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a Campylobacter jejuni Infection.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Direct-fed microbial supplementation influences the bacteria community composition of the gastrointestinal tract of pre- and post-weaned calves.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of age.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of Feeding Saccharomyces cerevisiae boulardii CNCM I-1079 to Sows and Piglets on Piglets` Immune Response after Vaccination against Actinobacillus pleuropneumoniae.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of Saccharomyces boulardii Supplementation on Performance and Physiological Traits of Holstein Calves under Heat Stress Conditions.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of Saccharomyces cerevisiae boulardii on sows` farrowing duration and reproductive performance, and weanling piglets` performance and IgG concentration.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of Supplementation with <i>Saccharomyces Boulardii</i> on Academic Examination Performance and Related Stress in Healthy Medical Students: A Randomized, Double-Blind, Placebo-Controlled Trial.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of supplementation with Saccharomyces boulardii CNCM I-1079 on vaccine response to an inactivated bacterial vaccine in young Japanese Black calves: A field trial.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effect of the Probiotic Saccharomyces boulardii on Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of combined viral-bacterial challenge with or without supplementation of Saccharomyces cerevisiae boulardii strain CNCM I-1079 on immune upregulation and DMI in beef heifers.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of Mannheimia haemolytica challenge with or without supplementation of Saccharomyces cerevisiae boulardii strain CNCM I-1079 on immune upregulation and behavior in beef steers.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of probiotics Pediococcus acidilactici strain MA18/5M and Saccharomyces cerevisiae subsp. boulardii strain SB-CNCM I-1079 on fecal and intestinal microbiota of nursing and weanling piglets.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of Saccharomyces cerevisiae boulardii (CNCM I-1079) on feed intake, blood parameters, and production during early lactation.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Effects of Saccharomyces cerevisiae var. boulardii CNCM I-1079 on performance, colostrum and milk composition, and litter performance of mixed-parity sows in a tropical humid climate.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Efficacy of Levucell(®) SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for weaned piglets.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Investigation into In Vitro and In Vivo Caenorhabditis elegans Models to Select Cheese Yeasts as Probiotic Candidates for their Preventive Effects against Salmonella Typhimurium.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Saccharomyces cerevisiae boulardii accelerates intestinal microbiota maturation and is correlated with increased secretory IgA production in neonatal dairy calves.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Saccharomyces cerevisiae boulardii CNCM I-1079 affects health, growth, and fecal microbiota in milk-fed veal calves.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Saccharomyces cerevisiae boulardii CNCM I-1079 supplementation in finishing male pigs helps to cope with heat stress through feeding behaviour and gut microbiota modulation.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Saccharomyces cerevisiae Boulardii Reduces the Deoxynivalenol-Induced Alteration of the Intestinal Transcriptome.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Saccharomyces Cerevisiae Var Boulardii CNCM I-1079 Reduces Expression of Genes Involved in Inflammatory Response in Porcine Cells Challenged by Enterotoxigenic E. Coli and Influences Bacterial Communities in an In Vitro Model of the Weaning Piglet Colon.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae CNCM I-1079 for calves, all other ruminant species and camelids for rearing and for fattening (Danstart Ferment AG).
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Safety and efficacy of Levucell(®)SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for turkeys for fattening.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Safety and efficacy of Levucell(®)SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for all pigs.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations Safety and efficacy of Levucell(®)SB (Saccharomyces cerevisiae CNCM I-1079) as a feed additive for chickens for fattening and minor poultry species.
Saccharomyces cerevisiae boulardii CNCM I-1079 Pure Encapsulations The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics [Correction of halitosis in chronic inflammatory diseases of the oropharynx in adults].
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics [Effect of phytocompositions on biological activity of probiotic strains of Bacillus subtilis].
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics [Prophylaxis of chronic adenoiditis in the children].
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SAR S-CoV-2.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler`s diarrhea.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics A TaqMan™-based quantitative PCR screening assay for the probiotic Streptococcus salivarius K12 based on the specific detection of its megaplasmid-associated salivaricin B locus.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Antibacterial Activity of a Fractionated Pistacia lentiscus Oil Against Pharyngeal and Ear Pathogens, Alone or in Combination With Antibiotics.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Antimicrobial and antibiofilm activities of prenylated flavanones from Macaranga tanarius.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Antimicrobial and Antibiofilm Activity of the Probiotic Strain Streptococcus salivarius K12 against Oral Potential Pathogens.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Assessment of Efficacy of BLIS-Producing Probiotic K12 for the Prevention of Group A Streptococcus Pharyngitis: a Short Communication.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Bacteriocin Occurrence and Activity in Escherichia coli Isolated from Bovines and Wastewater.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Bifidobacterium infantis, Necrotizing Enterocolitis, Death, and the Role of Parents in the Neonatal Intensive Care Unit.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Bifidobacteriumlongum subsp. infantis EVC001 Administration Is Associated with a Significant Reduction in the Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Cavitation treatment as a means of modifying the antibacterial activity of various feed additives.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Characterization of Streptococcus salivarius growth and maintenance in artificial saliva.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis - Authors` reply.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Comparative Evaluation of Antibacterial Activity of Probiotics SK12 and SM18: An In Vitro Study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Comparative genomics of transport proteins in probiotic and pathogenic Escherichia coli and Salmonella enterica strains.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Detection and Specific Enumeration of Multi-Strain Probiotics in the Lumen Contents and Mucus Layers of the Rat Intestine After Oral Administration.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Developing oral probiotics from Streptococcus salivarius.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in Schools.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Entericidin is required for a probiotic treatment (Enterobacter sp. strain C6-6) to protect trout from cold-water disease challenge.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Genome sequence of the lantibiotic bacteriocin producer Streptococcus salivarius strain K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Genome-Based Comparison of Cyclic Di-GMP Signaling in Pathogenic and Commensal Escherichia coli Strains.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Growth characteristic of probiotic in fermented coconut milk and the antibacterial properties against Streptococcus pyogenes.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Heritability of oral microbial species in caries-active and caries-free twins.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Impact of Chlorhexidine Pretreatment Followed by Probiotic Streptococcus salivarius Strain K12 on Halitosis in Children: A Randomised Controlled Clinical Trial.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case-Control 24-Month Longitudinal Study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics In vitro Interactions between <i>Streptococcus intermedius</i> and <i>Streptococcus salivarius</i> K12 on a Titanium Cylindrical Surface.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Influence of Probiotic Culture Supernatants on In Vitro Biofilm Formation of Staphylococci.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Inhibitory effects of Streptococcus salivarius K12 on formation of cariogenic biofilm.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Metabolism of L-selenomethionine and selenite by probiotic bacteria: in vitro and in vivo studies.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Mitigation of the Toxic Effects of Periodontal Pathogens by Candidate Probiotics in Oral Keratinocytes, and in an Invertebrate Model.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Modulations in the offspring gut microbiome are refractory to postnatal synbiotic supplementation among juvenile primates.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Multi-Strain Probiotic Supplementation with a Product Containing Human-Native S. salivarius K12 in Healthy Adults Increases Oral S. salivarius.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Novel probiotic candidates for humans isolated from raw fruits and vegetables.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Oral bacteria as potential probiotics for the pharyngeal mucosa.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Oral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Oropharyngeal Probiotic ENT-K12 as an Effective Dietary Intervention for Children With Recurrent Respiratory Tract Infections During Cold Season.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Outsider to insider: resetting the natural host niche of commensal E. coli K-12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Pilot study to explore the prophylactic efficacy of oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngo-tonsillar episodes in pediatric patients.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Positive clinical outcomes derived from using <i>Streptococcus salivarius</i> K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Probiotic Streptococcus salivarius K12 Alleviates Radiation-Induced Oral Mucositis in Mice.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Probiotics for prevention of necrotizing enterocolitis: Where do we stand?
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Safety assessment of Streptococcus salivarius M18 a probiotic for oral health.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Salivary enzymes and exhaled air affect Streptococcus salivarius growth and physiological state in complemented artificial saliva.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Streptococcus salivarius K12 inhibits Candida albicans aggregation, biofilm formation and dimorphism.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Synbiotic Musa acuminata skin extract and Streptococcus salivarius K12 inhibit candida species biofilm formation.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The Effect of Oral Probiotics (Streptococcus Salivarius k12) on the Salivary Level of Secretory Immunoglobulin A, Salivation Rate, and Oral Biofilm: A Pilot Randomized Clinical Trial.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The Effect of Streptococcus salivarius K12 on Halitosis: a Double-Blind, Randomized, Placebo-Controlled Trial.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The influence of probiotic treatment on sulfasalazine metabolism in rat.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics The Selective Interaction of <i>Pistacia lentiscus</i> Oil vs. Human Streptococci, an Old Functional Food Revisited with New Tools.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Transepithelial activation of human leukocytes by probiotics and commensal bacteria: role of Enterobacteriaceae-type endotoxin.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children.
Streptococcus salivarius K12 BLIS ThroatHealth Oral Probiotics Use of Streptococcus salivarius K12 to reduce the incidence of pharyngo-tonsillitis and acute otitis media in children: a retrospective analysis in not-recurrent pediatric subjects.
Streptococcus thermophilus ST-21 Custom Probiotics Lemon Exosome-like Nanoparticles-Manipulated Probiotics Protect Mice from <i>C.</i> <i>d</i> <i>iff</i> Infection.
Streptococcus thermophilus ST-21 Custom Probiotics Persistent infection by Salmonella enterica servovar Typhimurium: are synbiotics a therapeutic option? - a case report.
Streptococcus thermophilus ST-21 Custom Probiotics The Impact of Conical and Nonconical Abutments on Bacterial Infiltration at the Implant-Abutment Interface.
Symbioflor 1 German Apotheke by Paul's Mart [Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin].
Symbioflor 1 German Apotheke by Paul's Mart [The effect of a bacterial immunostimulant (human Enterococcus faecalis bacteria) on the occurrence of relapse in patients with].
Symbioflor 1 German Apotheke by Paul's Mart A Comparative Transcriptomic Analysis of Human Placental Trophoblasts in Response to Pathogenic and Probiotic <i>Enterococcus faecalis</i> Interaction.
Symbioflor 1 German Apotheke by Paul's Mart A Review of Research Conducted with Probiotic <i>E. coli</i> Marketed as Symbioflor.
Symbioflor 1 German Apotheke by Paul's Mart Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1.
Symbioflor 1 German Apotheke by Paul's Mart Complete Genome Sequence of the Probiotic Enterococcus faecalis Symbioflor 1 Clone DSM 16431.
Symbioflor 1 German Apotheke by Paul's Mart Draft Genome Sequences of the Probiotic Enterococcus faecalis Symbioflor 1 Clones DSM16430 and DSM16434.
Symbioflor 1 German Apotheke by Paul's Mart Engineered <i>Salmonella enterica</i> serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.
Symbioflor 1 German Apotheke by Paul's Mart Functional characterization of pro-biotic pharmaceuticals by quantitative analysis of gene expression.
Symbioflor 1 German Apotheke by Paul's Mart Impact of actin on adhesion and translocation of Enterococcus faecalis.
Symbioflor 1 German Apotheke by Paul's Mart In silico analyses of the genomes of three new bacteriocin-producing bacteria isolated from animal`s faeces.
Symbioflor 1 German Apotheke by Paul's Mart In vitro comparison of commensal, probiotic and pathogenic strains of Enterococcus faecalis.
Symbioflor 1 German Apotheke by Paul's Mart In vitro comparison of the effects of probiotic, commensal and pathogenic strains on macrophage polarization.
Symbioflor 1 German Apotheke by Paul's Mart Influence of Catecholamines (Epinephrine/Norepinephrine) on Biofilm Formation and Adhesion in Pathogenic and Probiotic Strains of <i>Enterococcus faecalis</i>.
Symbioflor 1 German Apotheke by Paul's Mart Insights from 100 Years of Research with Probiotic E. Coli
Symbioflor 1 German Apotheke by Paul's Mart Probiotic Enterococcus faecalis Symbioflor 1 ameliorates pathobiont-induced miscarriage through bacterial antagonism and Th1-Th2 modulation in pregnant mice.
Symbioflor 1 German Apotheke by Paul's Mart Probiotic Enterococcus faecalis Symbioflor<sup>®</sup> down regulates virulence genes of EHEC in vitro and decrease pathogenicity in a Caenorhabditis elegans model.
Symbioflor 1 German Apotheke by Paul's Mart Probiotic Potential and Safety Evaluation of <i>Enterococcus faecalis</i> OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis.
Symbioflor 1 German Apotheke by Paul's Mart Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.
Symbioflor 2 German Apotheke by Paul's Mart [Immunomodulator action of living, nonpathogenic Enterococcus faecalis bacteria from humans].
Symbioflor 2 German Apotheke by Paul's Mart A Review of Research Conducted with Probiotic <i>E. coli</i> Marketed as Symbioflor.
Symbioflor 2 German Apotheke by Paul's Mart Complete Sequence of Probiotic Symbioflor 2 Escherichia coli Strain G3/10 and Draft Sequences of Symbioflor 2 E. coli Strains G1/2, G4/9, G5, G6/7, and G8.
Symbioflor 2 German Apotheke by Paul's Mart Engineered <i>Salmonella enterica</i> serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.
Symbioflor 2 German Apotheke by Paul's Mart Escherichia coli as a probiotic?
Symbioflor 2 German Apotheke by Paul's Mart Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.
Symbioflor 2 German Apotheke by Paul's Mart Insights from 100 Years of Research with Probiotic E. Coli
Symbioflor 2 German Apotheke by Paul's Mart Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection.
Symbioflor 2 German Apotheke by Paul's Mart Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
Symbioflor 2 German Apotheke by Paul's Mart Probiotic treatment of irritable bowel syndrome in children.
Symbioflor 2 German Apotheke by Paul's Mart Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
Symbioflor 2 German Apotheke by Paul's Mart Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. [The role of oral probiotic for bacterial vaginosis in pregnant women. A pilot study].
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Comment on: "Search and Selection of Probiotics that Improve Mucositis Symptoms in Oncologic Patients: A Systematic Review. <i>Nutrients</i> 2019, <i>11</i>, 2322".
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. DNA from probiotic bacteria modulates murine and human epithelial and immune function.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Effect of probiotic treatment on the clinical course, intestinal microbiome, and toxigenic Clostridium perfringens in dogs with acute hemorrhagic diarrhea.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Failure to improve parameters of lactose maldigestion using the multiprobiotic product VSL3 in lactose maldigesters: a pilot study.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Gut microbiota mediate vascular dysfunction in a murine model of sleep apnea: effect of probiotics.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Investigation of probiotics in multiple sclerosis.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an <i>In Vitro</i> and <i>In Vivo</i> Model of Hepatic Injury.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Orphan patients with inflammatory bowel disease - when we treat beyond evidence.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Pharmacotherapy for inducing and maintaining remission in pouchitis.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot Trial.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Probiotics for women`s health.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. The role of nutrition in diarrhoea syndromes.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization.
VSL3 / Visbiome / De Simone Formulation Alfasigma USA, Inc. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)